m6A-seq (polyA) report



Customer Name#######
Customer Institution#######
Customer Email#######
Project ID#######
Seller NameKyle Navel
Seller Emailknavel@lcsciences.com

Your reliable partner in genomics, transcriptomics and proteomics


1. Introduction


N6-Methyladenosine (m6A) is an abundant modification in mRNA and is found within some viruses, and most eukaryotes including mammals, insects, plants and yeast. It is also found in tRNA, rRNA, and small nuclear RNA (snRNA) as well as several long non-coding RNA.



m6A and m6Am are the two 6mA (6-methyladenine)-containing nucleotides in mRNA. 6mA is found in two distinct epitranscriptomic modifications: m6A (N6-methyladenosine) and m6Am (N6,2'-Odimethyladenosine). The methyl groups that are added enzymatically to alter the function of the nucleotide are shown in red. m6A is found in 5'UTRs, coding sequences, and 3'UTRs. m6Am is found in one place in mRNAs, the first encoded nucleotide, which is adjacent to the m7G (N7-methylguanosine) cap.

The methylation of adenosine is directed by a large m6A methyltransferase complex containing METTL3 as the SAM-binding sub-unit. In vitro, this methyltransferase complex preferentially methylates RNA oligonucleotides containing RRACH motif and a similar preference was identified in vivo in mapped m6A sites in Rous sarcoma virus genomic RNA and in bovine prolactin mRNA. Wilms' tumor 1-associating protein (WTAP) may function to regulate recruitment of the m6A methyltransferase complex to mRNA targets. More recent studies have characterized other key components of the m6A methyltransferase complex in mammals, including METTL14, KIAA1429(Vir), ZFP217, RMB15, RBM15b, HAKAI(CBLL1), ZC3H13 and other proteins. Following a 2010 speculation of m6A in mRNA being dynamic and reversible, the discovery of the first m6A demethylase, fat mass and obesity-associated protein (FTO) in 2011 confirmed this hypothesis and revitalized the interests in the study of m6A by He, Chuan in The University of Chicago. A second m6A demethylase alkB homolog 5 (ALKBH5) was later discovered as well.

The biological functions of m6A are mediated through a group of RNA binding proteins that specifically recognize the methylated adenosine on RNA. These binding proteins are named m6A readers. The YT521-B homology (YTH) domain family of proteins (YTHDF1, YTHDF2, YTHDF3, YTHDC1 and YTHDC2) have been characterized as direct m6A readers and have a conserved m6A-binding pocket. Insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1–3) are reported as a novel class of m6A readers. IGF2BPs use K homology (KH) domains to selectively recognize m6A-containing RNAs and promote their translation and stability. These m6A readers, together with m6A methyltransferases (writers) and demethylases (erasers), establish a complex mechanism of m6A regulation in which writers and erasers determine the distributions of m6A on RNA, whereas readers mediate m6A-dependent functions. m6A has also been shown to mediate a structural switch termed m6A switch.


A review named Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism published on Cell Research described the current understanding of the m6A modification, particularly the functions of its writers, erasers, readers in RNA metabolism, with an emphasis on its role in regulating the isoform dosage of mRNAs.



2. Materials and Methods


2.1 m6A Immunoprecipitation and library construction


Total RNA was extracted using Trizol reagent (Invitrogen, CA, USA) following the manufacturer's procedure. The total RNA quality and quantity were analysis of Bioanalyzer 2100 and RNA 6000 Nano LabChip Kit (Agilent, CA, USA) with RIN number >7.0. Approximately more than 50 ug of total RNA was subjected to isolate Poly (A) mRNA with poly-T oligo attached magnetic beads (Invitrogen). Following purification, the poly(A) mRNA fractions is fragmented into ~100-nt-long oligonucleotides using divalent cations under elevated temperature. Then the cleaved RNA fragments were subjected to incubated for 2h at 4℃ with m6A-specific antibody (No. 202003, Synaptic Systems, Germany) in IP buffer (50 mM Tris-HCl, 750 mM NaCl and 0.5% Igepal CA-630) supplemented with BSA (0.5 μg μl−1). The mixture was then incubated with protein-A beads and eluted with elution buffer (1 × IP buffer and 6.7mM m6A). Eluted RNA was precipitated by 75% ethanol. Eluted m6A-containing fragments (IP) and untreated input control fragments are converted to final cDNA library in accordance with a strand-specific library preparation by dUTP method. The average insert size for the paired-end libraries was ~100±50 bp. And then we performed the paired-end 2×150bp sequencing on an Illumina Novaseq™ 6000 platform at the LC-BIO Bio-tech ltd (Hangzhou, China) following the vendor's recommended protocol.



2.2 m6A-seq data analysis


Firstly, Cutadapt[1] and perl scripts in house were used to remove the reads that contained adaptor contamination, low quality bases and undetermined bases. Then sequence quality was verified using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). We used bowtie[2] to map reads to the genome of Homo sapiens (Version: GRCh38.p10) with default parameters. Mapped reads of IP and input libraries were provided for R package exomePeak[3], which identifies m6A peaks with bed or bam format that can be adapted for visualization on the UCSC genome browser or IGV software (http://www.igv.org/). MEME[4] and HOMER[5] were used for de novo and known motif finding followed by localization of the motif with respect to peak summit by perl scripts in house. Called peaks were annotated by intersection with gene architecture using ChIPseeker[6]. Then StringTie[7] was used to perform expression level for all mRNAs from input libraries by calculating FPKM (FPKM=[total_exon_fragments/mapped_reads(millions)×exon_length(kB)]). The differentially expressed mRNAs were selected with log2 (fold change) >1 or log2 (fold change) <-1 and p value < 0.05 by R package edgeR[8].



Reference:

[1] Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. Embnet Journal 17 (2011).

[2] Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature Methods 9, 357–359 (2012).

[3] Meng, J., et al. A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/Bioconductor package. Methods. 69(3), 274-281. (2014).

[4] Timothy L. Bailey, et al. MEME Suite: tools for motif discovery and searching. Nucleic Acids Research. 37.Web Server issue:202-8. (2009).

[5] Heinz, S., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and b cell identities. Molecular Cell. 38(4), 576. (2010).

[6] Yu, G., et al. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 31.14:2382. (2015).

[7] Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nature Biotechnology. 33, 290–295 (2015).

[8] Robinson, M. D. et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26(1), 139. (2010).




3. Project information


3.1 Sample information


Species: Human

Latin name: Homo sapiens

Specimens: METTL14 overexpress HEK293T cell line


3.2 Database


Dababase Web links Version/date
Genomeftp://ftp.ensembl.org/pub/release-91/fasta/homo_sapiens/dna/GRCh38.p10
Gene Orthology (GO)http://www.geneontology.org/2016.12
KEGGhttp://www.kegg.jp/2017.06

3.3 Bioinformatics software


Analysis item Software Version/date
Quality controlFastQC0.10.1
Quality controlPerl scripts in houseNA
Adapter removeCutadapt1.10
Genome mappingbowtie1.0
Trascripts assemblyStringTie1.0
Differential expression analysisR package: edgeR4.1
Peak CallingR package: exomePeak1.8
Diff Peak analysisR package: exomePeak1.8
Peak annotationCHIPseeker1.0
Motif predictionMEME1.0
Motif predictionHOMER4.1
GO and KEGG enrichment analysisPerl scripts in houseNA



4. Results


4.1 Quality control and statistics of Reads


Statistics of reads from 2 libraries was shown below. Results of FastQC, PCA analysis and sample correlation were deposited in summary/3_peak_calling and summary/9_quality_control/.


Sample_IDRaw_ReadsRaw_BasesValid_ReadsValid_BasesValid%Q20%Q30%GC%
M14_NC_IP515080427.78G510913286.74G86.6798.8796.6255.99
M14_NC6761030210.14G650791929.76G96.2397.1692.6852.05
M14_OE_IP270120684.08G268165783.57G87.5698.8996.6755.19
M14_OE7153453010.73G6869544610.30G96.0097.0592.4252.20

document location: summary/1_raw_data/data_stat.xlsx


4.2 Genome mapping


4.2.1 Statistics of mapped reads


SampleValid readsMapped readsUnique Mapped readsMulti Mapped readsPE Mapped readsReads map to sense strandReads map to antisense strandNon-splice reads
M14_NC6507919262363860(95.83%)27729750(42.61%)34634110(53.22%)44730600(68.73%)14989402(23.03%)15020050(23.08%)30009452(46.11%)
M14_NC_IP5109132848456971(94.84%)21705470(42.48%)26751501(52.36%)48241518(94.42%)14878094(29.12%)14879210(29.12%)29757304(58.24%)
M14_OE6869544666441960(96.72%)29479410(42.91%)36962550(53.81%)48817740(71.06%)15966870(23.24%)15990275(23.28%)31957145(46.52%)
M14_OE_IP2681657826055929(97.16%)11317596(42.20%)14738333(54.96%)25947782(96.76%)7873061(29.36%)7873692(29.36%)15746753(58.72%)

document location:summary/2_mapped_stat/mapped_stat_out.xlsx


4.2.2 Statistics of mapped region



document location:

summary/2_mapped_stat/mapped_region_stat.png

summary/2_mapped_stat/mapped_region_stat.xlsx


4.3 Peak calling on whole genome


The m6A-seq approach is analogous to ChIP-seq—both are based on global identification of regions of signal enrichment. Indeed, the distribution of sequence tags in m6A-seq data is quite similar to that of ChIP-seq: in both cases, enriched regions are discrete and form sharp peaks along the genome or transcriptome. As a marriage of ChIP-Seq and RNA-Seq, m6A-seq has the potential to study the transcriptome-wide distribution of various post-transcriptional RNA modifications. Compared with other relatively well studied data types such as ChIP-Seq and RNA-Seq, the study of m6A-seq data is still at very early stage, and existing protocols are not optimized for dealing with the intrinsic characteristic of m6A-seq data. We utilized an easy-to-use protocol of using exomePeak R/Bioconductor package along with other software programs such as bowtie, ChIPseeker, MEME and HOMER for analysis of m6A-seq data, which covers raw reads alignment, RNA methylation site detection, motif discovery, differential RNA methylation analysis, and functional analysis.


4.3.1 Peak calling


seqnamesstartendwidthgeneIdtranscriptIddistanceToTSSgeneNameDescriptionGOKEGGscoreblockCountblockSizesblockStartslg.plg.fdrfold_enrchmentannotationgeneChrgeneStartgeneEndgeneLengthgeneStrand
chr1630445630623179ENSG00000237973ENST00000414273-451MTCO1P12mitochondrially encoded cytochrome c oxidase I pseudogene 12 [Source:HGNC Symbol;Acc:HGNC:52014]NANA0.001179,0-5.8500000000-4.880000000011.7000000000Exon (ENST00000457540/ENSG00000225630, exon 1 of 1)163107463261615431
chr192482792488761ENSG00000187634ENST00000437963-263SAMD11sterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]GO:0003677(DNA binding);GO:0005634(nucleus)NA0.00161,0-2.5600000000-1.75000000004.94Exon (ENST00000420190/ENSG00000187634, exon 1 of 7)1925150935793106441
chr1942779942958180ENSG00000187634ENST00000464948613SAMD11sterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]GO:0003677(DNA binding);GO:0005634(nucleus)NA0.001180,0-4.1600000000-3.26000000004.553' UTR19421669428927271
chr1944042944581540ENSG00000188976ENST00000496938981NOC2LNOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517]GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0005654(nucleoplasm);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0003682(chromatin binding);GO:0042273(ribosomal large subunit biogenesis);GO:0042393(histone binding);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0070491(repressing transcription factor binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:0034644(cellular response to UV);GO:0031497(chromatin assembly);GO:0035067(negative regulation of histone acetylation);GO:0002903(negative regulation of B cell apoptotic process);GO:0031491(nucleosome binding);GO:0030690(Noc1p-Noc2p complex);GO:0030691(Noc2p-Noc3p complex)NA0.001540,0-52.5000000000-50.90000000008.333' UTR19453199455622442
chr1965596965715120ENSG00000187583ENST00000379410-782PLEKHN1pleckstrin homology domain containing N1 [Source:HGNC Symbol;Acc:HGNC:25284]GO:0016020(membrane);GO:0005886(plasma membrane);GO:0005515(protein binding)NA0.001120,0-2.7800000000-1.960000000010.90000000003' UTR196649797510886121
chr19748159758651051ENSG00000187642ENST00000479361776PERM1PPARGC1 and ESRR induced regulator, muscle 1 [Source:HGNC Symbol;Acc:HGNC:28208]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0014850(response to muscle activity)NA0.002294,154,0,897-39.1000000000-37.600000000050.80000000003' UTR197520597664114372
chr110142181014541324ENSG00000187608ENST00000379389795ISG15ISG15 ubiquitin-like modifier [Source:HGNC Symbol;Acc:HGNC:4053]GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0042742(defense response to bacterium);GO:0051607(defense response to virus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0045071(negative regulation of viral genome replication);GO:0016032(viral process);GO:0030501(positive regulation of bone mineralization);GO:0031397(negative regulation of protein ubiquitination);GO:0060337(type I interferon signaling pathway);GO:0019985(translesion synthesis);GO:0032480(negative regulation of type I interferon production);GO:0031386(protein tag);GO:0019941(modification-dependent protein catabolic process);GO:0032020(ISG15-protein conjugation);GO:0032649(regulation of interferon-gamma production);GO:0034340(response to type I interferon);GO:0045648(positive regulation of erythrocyte differentiation)04622(RIG-I-like receptor signaling pathway);05165(Human papillomavirus infection)0.001324,0-11.1000000000-104.643' UTR11013423101454011181
chr11045175104523561ENSG00000188157ENST00000479707-164AGRNagrin [Source:HGNC Symbol;Acc:HGNC:329]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)0.00161,0-6.6300000000-5.63000000004.33Exon (ENST00000379370/ENSG00000188157, exon 13 of 36)1104539910463499511
chr110463421046509168ENSG00000188157ENST00000466223-692AGRNagrin [Source:HGNC Symbol;Acc:HGNC:329]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)0.0028,113,0,55-13.3000000000-12.20000000003.15Exon (ENST00000379370/ENSG00000188157, exon 18 of 36)1104720110478656651
chr110480791048318240ENSG00000188157ENST00000492947-211AGRNagrin [Source:HGNC Symbol;Acc:HGNC:329]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)0.001240,0-25.2000000000-23.90000000002.16Exon (ENST00000379370/ENSG00000188157, exon 23 of 36)1104852910493948661
chr110549791055249271ENSG00000242590ENST000004183000AL645608.6NANANA0.001271,0-105-1032.363' UTR11055033105611610841
chr110554291056118690ENSG00000242590ENST00000418300396AL645608.6NANANA0.001690,0-115-11310.90000000003' UTR11055033105611610841
chr1105503310561161084ENSG00000242590ENST000004183000AL645608.6NANANA0.002183,219,0,865-78.4000000000-76.70000000009.993' UTR11055033105611610841
chr110645061065447942ENSG00000217801ENST000004510540AL390719.1NANANA0.00284,96,0,846-8.1200000000-7.08000000007.65Exon (ENST00000412397/ENSG00000217801, exon 4 of 10)11064518106644119241
chr110658601066276417ENSG00000217801ENST000004510541342AL390719.1NANANA0.001417,0-16.9000000000-15.70000000009.37Exon (ENST00000427998/ENSG00000217801, exon 4 of 4)11064518106644119241
chr112326231233519897ENSG00000176022ENST00000379198358B3GALT6beta-1,3-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:17978]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0006486(protein glycosylation);GO:0005794(Golgi apparatus);GO:0008378(galactosyltransferase activity);GO:0032580(Golgi cisterna membrane);GO:0000139(Golgi membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0005797(Golgi medial cisterna);GO:0035250(UDP-galactosyltransferase activity);GO:0030206(chondroitin sulfate biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0047220(galactosylxylosylprotein 3-beta-galactosyltransferase activity)00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)0.001897,0-20-18.70000000003.923' UTR11232265123504127771
chr112336681234235568ENSG00000176022ENST000003791981403B3GALT6beta-1,3-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:17978]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0006486(protein glycosylation);GO:0005794(Golgi apparatus);GO:0008378(galactosyltransferase activity);GO:0032580(Golgi cisterna membrane);GO:0000139(Golgi membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0005797(Golgi medial cisterna);GO:0035250(UDP-galactosyltransferase activity);GO:0030206(chondroitin sulfate biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0047220(galactosylxylosylprotein 3-beta-galactosyltransferase activity)00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)0.001568,0-146-1447.973' UTR11232265123504127771
chr112342951235041747ENSG00000176022ENST000003791982030B3GALT6beta-1,3-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:17978]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0006486(protein glycosylation);GO:0005794(Golgi apparatus);GO:0008378(galactosyltransferase activity);GO:0032580(Golgi cisterna membrane);GO:0000139(Golgi membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0005797(Golgi medial cisterna);GO:0035250(UDP-galactosyltransferase activity);GO:0030206(chondroitin sulfate biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0047220(galactosylxylosylprotein 3-beta-galactosyltransferase activity)00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)0.001747,0-59.9000000000-58.300000000017.10000000003' UTR11232265123504127771
chr113115271311677151ENSG00000283712ENST00000620702889MIR6727microRNA 6727 [Source:HGNC Symbol;Acc:HGNC:50171]NANA0.001151,0-7.5500000000-6.52000000004.783' UTR113125021312566652
chr113249941325280287ENSG00000224051ENST000004880110CPTPceramide-1-phosphate transfer protein [Source:HGNC Symbol;Acc:HGNC:28116]GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005829(cytosol);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006869(lipid transport);GO:0120013(intermembrane lipid transfer activity);GO:0120009(intermembrane lipid transfer);GO:0008289(lipid binding);GO:0005768(endosome);GO:0006687(glycosphingolipid metabolic process);GO:0010008(endosome membrane);GO:0005543(phospholipid binding);GO:0005548(phospholipid transporter activity);GO:0005640(nuclear outer membrane);GO:1902387(ceramide 1-phosphate binding);GO:1902388(ceramide 1-phosphate transporter activity);GO:1902389(ceramide 1-phosphate transport)NA0.002109,40,0,247-14.2000000000-134.075' UTR11325241132747122311
chr1132770913288971189ENSG00000169962ENST00000339381-2417TAS1R3taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)0.0011189,0-198-19614.80000000003' UTR11331314133530639931
chr11332037133209761ENSG00000169962ENST00000339381723TAS1R3taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)0.00161,0-2.4300000000-1.630000000010.2000000000Exon (ENST00000339381/ENSG00000169962, exon 3 of 6)11331314133530639931
chr113336651333814150ENSG00000169962ENST000003393812351TAS1R3taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)0.001150,0-3.2300000000-2.370000000012.5000000000Exon (ENST00000339381/ENSG00000169962, exon 6 of 6)11331314133530639931
chr113341121334321210ENSG00000169962ENST000003393812798TAS1R3taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)0.001210,0-3.2300000000-2.37000000007.42Exon (ENST00000339381/ENSG00000169962, exon 6 of 6)11331314133530639931
chr11334381133444161ENSG00000169962ENST000003393813067TAS1R3taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)0.00161,0-2.6800000000-1.860000000010.9000000000Exon (ENST00000339381/ENSG00000169962, exon 6 of 6)11331314133530639931
chr114002641400502239ENSG00000224870ENST000004535210AL391244.1NANANA0.001239,0-4.8100000000-3.88000000002.79Exon (ENST00000448629/ENSG00000224870, exon 2 of 3)11400419140204616281
chr1140071014020461337ENSG00000224870ENST00000453521291AL391244.1NANANA0.0011337,0-42.7000000000-41.200000000019.10000000003' UTR11400419140204616281
chr114392261439496271ENSG00000179403ENST000004713983491VWA1von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005604(basement membrane);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0005788(endoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0030198(extracellular matrix organization);GO:0048266(behavioral response to pain);GO:0005614(interstitial matrix)NA0.001271,0-22.6000000000-21.30000000002.253' UTR11435735143717714431
chr1143970614409041199ENSG00000179403ENST000004713983971VWA1von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005604(basement membrane);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0005788(endoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0030198(extracellular matrix organization);GO:0048266(behavioral response to pain);GO:0005614(interstitial matrix)NA011199,0-943-Inf17.10000000003' UTR11435735143717714431
chr114417431442313571ENSG00000179403ENST000004713986008VWA1von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005604(basement membrane);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0005788(endoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0030198(extracellular matrix organization);GO:0048266(behavioral response to pain);GO:0005614(interstitial matrix)NA0.001571,0-23.8000000000-22.50000000005.783' UTR11435735143717714431
chr114423731442732360ENSG00000179403ENST000004713986638VWA1von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005604(basement membrane);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0005788(endoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0030198(extracellular matrix organization);GO:0048266(behavioral response to pain);GO:0005614(interstitial matrix)NA0.001360,0-13.4000000000-12.3000000000253' UTR11435735143717714431
chr114958751496234360ENSG00000284740ENST00000641974-7016AL645728.2NANANA0.001360,0-30.7000000000-29.300000000046.10000000003' UTR11503250150945262031
chr115238691524297429ENSG00000197785ENST000004008300ATAD3AATPase family, AAA domain containing 3A [Source:HGNC Symbol;Acc:HGNC:25567]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0043066(negative regulation of apoptotic process);GO:0016049(cell growth);GO:0042645(mitochondrial nucleoid)NA0.00296,25,0,404-4.0200000000-3.120000000015.6000000000Exon (ENST00000378756/ENSG00000197785, exon 10 of 16)11524273152933150591
chr1152775015293191570ENSG00000197785ENST000004008303477ATAD3AATPase family, AAA domain containing 3A [Source:HGNC Symbol;Acc:HGNC:25567]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0043066(negative regulation of apoptotic process);GO:0016049(cell growth);GO:0042645(mitochondrial nucleoid)NA0.002113,97,0,1473-3.2600000000-2.40000000004.22Exon (ENST00000378756/ENSG00000197785, exon 14 of 16)11524273152933150591
chr115343301534657328ENSG00000205090ENST000006244265693TMEM240transmembrane protein 240 [Source:HGNC Symbol;Acc:HGNC:25186]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0097060(synaptic membrane)NA0.001328,0-17.7000000000-16.50000000005.993' UTR11539056154035012952
chr116235441623977434ENSG00000197530ENST000005084550MIB2mindbomb E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:30577]GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0003779(actin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007219(Notch signaling pathway);GO:0005768(endosome);GO:0005829(cytosol);GO:0000209(protein polyubiquitination);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0061630(ubiquitin protein ligase activity);GO:0000151(ubiquitin ligase complex);GO:0005769(early endosome)NA0.002156,204,0,230-8.7300000000-7.670000000083' UTR1162358116242096291
chr116249921625302311ENSG00000197530ENST000005081480MIB2mindbomb E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:30577]GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0003779(actin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007219(Notch signaling pathway);GO:0005768(endosome);GO:0005829(cytosol);GO:0000209(protein polyubiquitination);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0061630(ubiquitin protein ligase activity);GO:0000151(ubiquitin ligase complex);GO:0005769(early endosome)NA0.002194,17,0,294-12.4000000000-11.20000000004.643' UTR1162508716257636771
chr116303111630610300ENSG00000197530ENST00000470373838MIB2mindbomb E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:30577]GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0003779(actin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007219(Notch signaling pathway);GO:0005768(endosome);GO:0005829(cytosol);GO:0000209(protein polyubiquitination);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0061630(ubiquitin protein ligase activity);GO:0000151(ubiquitin ligase complex);GO:0005769(early endosome)NA0.001300,0-35-33.600000000055.40000000003' UTR11629473163060511331
chr1215084621560405195ENSG00000067606ENST000004787705459PRKCZprotein kinase C zeta [Source:HGNC Symbol;Acc:HGNC:9412]GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0035556(intracellular signal transduction);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0004697(protein kinase C activity);GO:0030054(cell junction);GO:0006954(inflammatory response);GO:0005768(endosome);GO:0070062(extracellular exosome);GO:0007165(signal transduction);GO:0032753(positive regulation of interleukin-4 production);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:2000667(positive regulation of interleukin-13 secretion);GO:2001181(positive regulation of interleukin-10 secretion);GO:0043066(negative regulation of apoptotic process);GO:0016020(membrane);GO:0031982(vesicle);GO:0005911(cell-cell junction);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:0030010(establishment of cell polarity);GO:0018105(peptidyl-serine phosphorylation);GO:0060291(long-term synaptic potentiation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0043560(insulin receptor substrate binding);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:2000664(positive regulation of interleukin-5 secretion);GO:0045630(positive regulation of T-helper 2 cell differentiation);GO:0031333(negative regulation of protein complex assembly);GO:0015459(potassium channel regulator activity);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0043274(phospholipase binding);GO:0071889(14-3-3 protein binding);GO:0000226(microtubule cytoskeleton organization);GO:0001954(positive regulation of cell-matrix adhesion);GO:0007166(cell surface receptor signaling pathway);GO:0007616(long-term memory);GO:0008284(positive regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0016477(cell migration);GO:0031532(actin cytoskeleton reorganization);GO:0031584(activation of phospholipase D activity);GO:0032148(activation of protein kinase B activity);GO:0032869(cellular response to insulin stimulus);GO:0034613(cellular protein localization);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0047496(vesicle transport along microtubule);GO:0050806(positive regulation of synaptic transmission);GO:0051222(positive regulation of protein transport);GO:0051291(protein heterooligomerization);GO:0051346(negative regulation of hydrolase activity);GO:0051899(membrane depolarization);GO:0060081(membrane hyperpolarization);GO:0070528(protein kinase C signaling);GO:0072659(protein localization to plasma membrane);GO:1990138(neuron projection extension);GO:2000553(positive regulation of T-helper 2 cell cytokine production);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005815(microtubule organizing center);GO:0005923(bicellular tight junction);GO:0005938(cell cortex);GO:0016324(apical plasma membrane);GO:0016363(nuclear matrix);GO:0031252(cell leading edge);GO:0031941(filamentous actin);GO:0035748(myelin sheath abaxonal region);GO:0043203(axon hillock);GO:0043231(intracellular membrane-bounded organelle);GO:0043234(protein complex);GO:0045121(membrane raft);GO:0045179(apical cortex);GO:0048471(perinuclear region of cytoplasm);GO:0005622(intracellular)04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04071(Sphingolipid signaling pathway);04144(Endocytosis);04530(Tight junction);04611(Platelet activation);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04926(Relaxin signaling pathway);04360(Axon guidance);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05165(Human papillomavirus infection)0.002134,46,0,5149-3.8400000000-2.95000000002.563' UTR121453872185116397301
chr121846032185395793ENSG00000182873ENST00000444529-214PRKCZ-AS1PRKCZ antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40477]NANA0.00296,474,0,319-36.7000000000-35.30000000006.163' UTR12182735218438916552
chr1222947422325163043ENSG00000157933ENST000005084160SKISKI proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10896]GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005737(cytoplasm);GO:0048147(negative regulation of fibroblast proliferation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0006351(transcription, DNA-templated);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0046332(SMAD binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0019901(protein kinase binding);GO:0008285(negative regulation of cell proliferation);GO:0031625(ubiquitin protein ligase binding);GO:0043234(protein complex);GO:0005667(transcription factor complex);GO:0019904(protein domain specific binding);GO:0030509(BMP signaling pathway);GO:0070491(repressing transcription factor binding);GO:0016605(PML body);GO:0060395(SMAD protein signal transduction);GO:0060021(palate development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0001843(neural tube closure);GO:0005813(centrosome);GO:0022011(myelination in peripheral nervous system);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0017053(transcriptional repressor complex);GO:0030514(negative regulation of BMP signaling pathway);GO:0045668(negative regulation of osteoblast differentiation);GO:0043388(positive regulation of DNA binding);GO:0060349(bone morphogenesis);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0009948(anterior/posterior axis specification);GO:0008283(cell proliferation);GO:0043585(nose morphogenesis);GO:0060325(face morphogenesis);GO:0070207(protein homotrimerization);GO:0030326(embryonic limb morphogenesis);GO:0046811(histone deacetylase inhibitor activity);GO:0002089(lens morphogenesis in camera-type eye);GO:0010626(negative regulation of Schwann cell proliferation);GO:0014902(myotube differentiation);GO:0021772(olfactory bulb development);GO:0031064(negative regulation of histone deacetylation);GO:0035019(somatic stem cell population maintenance);GO:0043010(camera-type eye development);GO:0048593(camera-type eye morphogenesis);GO:0048666(neuron development);GO:0048741(skeletal muscle fiber development);GO:0048870(cell motility);GO:0060041(retina development in camera-type eye)NA0.002262,38,0,3005-17.8000000000-16.60000000003.83Exon (ENST00000378536/ENSG00000157933, exon 1 of 7)122324792303038705601
chr1230605023074541405ENSG00000157933ENST000005071792404SKISKI proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10896]GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005737(cytoplasm);GO:0048147(negative regulation of fibroblast proliferation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0006351(transcription, DNA-templated);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0046332(SMAD binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0019901(protein kinase binding);GO:0008285(negative regulation of cell proliferation);GO:0031625(ubiquitin protein ligase binding);GO:0043234(protein complex);GO:0005667(transcription factor complex);GO:0019904(protein domain specific binding);GO:0030509(BMP signaling pathway);GO:0070491(repressing transcription factor binding);GO:0016605(PML body);GO:0060395(SMAD protein signal transduction);GO:0060021(palate development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0001843(neural tube closure);GO:0005813(centrosome);GO:0022011(myelination in peripheral nervous system);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0017053(transcriptional repressor complex);GO:0030514(negative regulation of BMP signaling pathway);GO:0045668(negative regulation of osteoblast differentiation);GO:0043388(positive regulation of DNA binding);GO:0060349(bone morphogenesis);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0009948(anterior/posterior axis specification);GO:0008283(cell proliferation);GO:0043585(nose morphogenesis);GO:0060325(face morphogenesis);GO:0070207(protein homotrimerization);GO:0030326(embryonic limb morphogenesis);GO:0046811(histone deacetylase inhibitor activity);GO:0002089(lens morphogenesis in camera-type eye);GO:0010626(negative regulation of Schwann cell proliferation);GO:0014902(myotube differentiation);GO:0021772(olfactory bulb development);GO:0031064(negative regulation of histone deacetylation);GO:0035019(somatic stem cell population maintenance);GO:0043010(camera-type eye development);GO:0048593(camera-type eye morphogenesis);GO:0048666(neuron development);GO:0048741(skeletal muscle fiber development);GO:0048870(cell motility);GO:0060041(retina development in camera-type eye)NA0.002201,878,0,527-128-12610.80000000003' UTR1230364623043687231
chr123076632308023361ENSG00000157933ENST000005071794017SKISKI proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10896]GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005737(cytoplasm);GO:0048147(negative regulation of fibroblast proliferation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0006351(transcription, DNA-templated);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0046332(SMAD binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0019901(protein kinase binding);GO:0008285(negative regulation of cell proliferation);GO:0031625(ubiquitin protein ligase binding);GO:0043234(protein complex);GO:0005667(transcription factor complex);GO:0019904(protein domain specific binding);GO:0030509(BMP signaling pathway);GO:0070491(repressing transcription factor binding);GO:0016605(PML body);GO:0060395(SMAD protein signal transduction);GO:0060021(palate development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0001843(neural tube closure);GO:0005813(centrosome);GO:0022011(myelination in peripheral nervous system);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0017053(transcriptional repressor complex);GO:0030514(negative regulation of BMP signaling pathway);GO:0045668(negative regulation of osteoblast differentiation);GO:0043388(positive regulation of DNA binding);GO:0060349(bone morphogenesis);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0009948(anterior/posterior axis specification);GO:0008283(cell proliferation);GO:0043585(nose morphogenesis);GO:0060325(face morphogenesis);GO:0070207(protein homotrimerization);GO:0030326(embryonic limb morphogenesis);GO:0046811(histone deacetylase inhibitor activity);GO:0002089(lens morphogenesis in camera-type eye);GO:0010626(negative regulation of Schwann cell proliferation);GO:0014902(myotube differentiation);GO:0021772(olfactory bulb development);GO:0031064(negative regulation of histone deacetylation);GO:0035019(somatic stem cell population maintenance);GO:0043010(camera-type eye development);GO:0048593(camera-type eye morphogenesis);GO:0048666(neuron development);GO:0048741(skeletal muscle fiber development);GO:0048870(cell motility);GO:0060041(retina development in camera-type eye)NA0.001361,0-21.6000000000-20.30000000002.883' UTR1230364623043687231
chr123098492310119271ENSG00000157933ENST000005071796203SKISKI proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10896]GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005737(cytoplasm);GO:0048147(negative regulation of fibroblast proliferation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0006351(transcription, DNA-templated);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0046332(SMAD binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0019901(protein kinase binding);GO:0008285(negative regulation of cell proliferation);GO:0031625(ubiquitin protein ligase binding);GO:0043234(protein complex);GO:0005667(transcription factor complex);GO:0019904(protein domain specific binding);GO:0030509(BMP signaling pathway);GO:0070491(repressing transcription factor binding);GO:0016605(PML body);GO:0060395(SMAD protein signal transduction);GO:0060021(palate development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0001843(neural tube closure);GO:0005813(centrosome);GO:0022011(myelination in peripheral nervous system);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0017053(transcriptional repressor complex);GO:0030514(negative regulation of BMP signaling pathway);GO:0045668(negative regulation of osteoblast differentiation);GO:0043388(positive regulation of DNA binding);GO:0060349(bone morphogenesis);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0009948(anterior/posterior axis specification);GO:0008283(cell proliferation);GO:0043585(nose morphogenesis);GO:0060325(face morphogenesis);GO:0070207(protein homotrimerization);GO:0030326(embryonic limb morphogenesis);GO:0046811(histone deacetylase inhibitor activity);GO:0002089(lens morphogenesis in camera-type eye);GO:0010626(negative regulation of Schwann cell proliferation);GO:0014902(myotube differentiation);GO:0021772(olfactory bulb development);GO:0031064(negative regulation of histone deacetylation);GO:0035019(somatic stem cell population maintenance);GO:0043010(camera-type eye development);GO:0048593(camera-type eye morphogenesis);GO:0048666(neuron development);GO:0048741(skeletal muscle fiber development);GO:0048870(cell motility);GO:0060041(retina development in camera-type eye)NA0.001271,0-20.8000000000-19.500000000047.60000000003' UTR1230364623043687231
chr1239189523932301336ENSG00000157916ENST000004434380RER1retention in endoplasmic reticulum sorting receptor 1 [Source:HGNC Symbol;Acc:HGNC:30309]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0005886(plasma membrane);GO:0003674(molecular_function);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0030173(integral component of Golgi membrane);GO:0033130(acetylcholine receptor binding);GO:0007528(neuromuscular junction development);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090004(positive regulation of establishment of protein localization to plasma membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0009986(cell surface)NA0.00264,57,0,1279-4.5200000000-3.60000000002.715' UTR12393174240231691431
chr124030482403168121ENSG00000157916ENST000004621291097RER1retention in endoplasmic reticulum sorting receptor 1 [Source:HGNC Symbol;Acc:HGNC:30309]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0005886(plasma membrane);GO:0003674(molecular_function);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0030173(integral component of Golgi membrane);GO:0033130(acetylcholine receptor binding);GO:0007528(neuromuscular junction development);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090004(positive regulation of establishment of protein localization to plasma membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0009986(cell surface)NA0.001121,0-6.5100000000-5.51000000001.493' UTR12401951240322712771
chr124033482403767420ENSG00000157916ENST000004621291397RER1retention in endoplasmic reticulum sorting receptor 1 [Source:HGNC Symbol;Acc:HGNC:30309]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0005886(plasma membrane);GO:0003674(molecular_function);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0030173(integral component of Golgi membrane);GO:0033130(acetylcholine receptor binding);GO:0007528(neuromuscular junction development);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090004(positive regulation of establishment of protein localization to plasma membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0009986(cell surface)NA0.001420,0-49.2000000000-47.60000000004.023' UTR12401951240322712771
chr124048752405444570ENSG00000157916ENST000004621292924RER1retention in endoplasmic reticulum sorting receptor 1 [Source:HGNC Symbol;Acc:HGNC:30309]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0005886(plasma membrane);GO:0003674(molecular_function);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0030173(integral component of Golgi membrane);GO:0033130(acetylcholine receptor binding);GO:0007528(neuromuscular junction development);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090004(positive regulation of establishment of protein localization to plasma membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0009986(cell surface)NA0.001570,0-39-37.50000000002.543' UTR12401951240322712771
chr12504093250418391ENSG00000149527ENST000004623795446PLCH2phospholipase C eta 2 [Source:HGNC Symbol;Acc:HGNC:29037]GO:0005622(intracellular);GO:0035556(intracellular signal transduction);GO:0004629(phospholipase C activity);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0005509(calcium ion binding);GO:0007165(signal transduction);GO:0006629(lipid metabolic process);GO:0016042(lipid catabolic process);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0008081(phosphoric diester hydrolase activity);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0005575(cellular_component);GO:0043647(inositol phosphate metabolic process);GO:0046488(phosphatidylinositol metabolic process)00562(Inositol phosphate metabolism)0.00191,0-2.8800000000-2.040000000011.70000000003' UTR12498647250552868821
chr125468452547401557ENSG00000272449ENST00000606645380AL139246.5NANANA0.001557,0-9.7100000000-8.630000000034.4000000000Exon (ENST00000606645/ENSG00000272449, exon 1 of 1)1254646525474609961
chr125631132563352240ENSG00000157873ENST000004803051312TNFRSF14TNF receptor superfamily member 14 [Source:HGNC Symbol;Acc:HGNC:11912]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0002741(positive regulation of cytokine secretion involved in immune response);GO:0046642(negative regulation of alpha-beta T cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:2000406(positive regulation of T cell migration);GO:0009897(external side of plasma membrane);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006954(inflammatory response);GO:0046718(viral entry into host cell);GO:0097190(apoptotic signaling pathway);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0016032(viral process);GO:0031625(ubiquitin protein ligase binding);GO:0006955(immune response);GO:0007275(multicellular organism development);GO:0032496(response to lipopolysaccharide);GO:0042127(regulation of cell proliferation);GO:0007166(cell surface receptor signaling pathway);GO:0042981(regulation of apoptotic process);GO:0001618(virus receptor activity);GO:0031295(T cell costimulation);GO:0005031(tumor necrosis factor-activated receptor activity)04060(Cytokine-cytokine receptor interaction);05168(Herpes simplex infection)0.001240,0-14.9000000000-13.70000000003.763' UTR12561801256345216521
chr1256359125650831493ENSG00000225931ENST00000456687-1327AL139246.2NANANA0.002239,31,0,1462-31.9000000000-30.500000000025.50000000003' UTR12566410256988834791
chr125867982587100303ENSG00000157870ENST000003784270FAM213Bfamily with sequence similarity 213 member B [Source:HGNC Symbol;Acc:HGNC:28390]GO:0005737(cytoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0006629(lipid metabolic process);GO:0005829(cytosol);GO:0005783(endoplasmic reticulum);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0098869(cellular oxidant detoxification);GO:0070062(extracellular exosome);GO:0001516(prostaglandin biosynthetic process);GO:0006693(prostaglandin metabolic process);GO:0043209(myelin sheath);GO:0047017(prostaglandin-F synthase activity);GO:0016209(antioxidant activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)00590(Arachidonic acid metabolism)0.002151,59,0,244-24.9000000000-23.60000000008.15Exon (ENST00000493183/ENSG00000157870, exon 2 of 7)12586798259146346661
chr125894112589680270ENSG00000157870ENST00000476686817FAM213Bfamily with sequence similarity 213 member B [Source:HGNC Symbol;Acc:HGNC:28390]GO:0005737(cytoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0006629(lipid metabolic process);GO:0005829(cytosol);GO:0005783(endoplasmic reticulum);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0098869(cellular oxidant detoxification);GO:0070062(extracellular exosome);GO:0001516(prostaglandin biosynthetic process);GO:0006693(prostaglandin metabolic process);GO:0043209(myelin sheath);GO:0047017(prostaglandin-F synthase activity);GO:0016209(antioxidant activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)00590(Arachidonic acid metabolism)0.001270,0-25.6000000000-24.20000000002.333' UTR12588594259146828751
chr12590455259054490ENSG00000157870ENST000004766861861FAM213Bfamily with sequence similarity 213 member B [Source:HGNC Symbol;Acc:HGNC:28390]GO:0005737(cytoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0006629(lipid metabolic process);GO:0005829(cytosol);GO:0005783(endoplasmic reticulum);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0098869(cellular oxidant detoxification);GO:0070062(extracellular exosome);GO:0001516(prostaglandin biosynthetic process);GO:0006693(prostaglandin metabolic process);GO:0043209(myelin sheath);GO:0047017(prostaglandin-F synthase activity);GO:0016209(antioxidant activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor)00590(Arachidonic acid metabolism)0.00190,0-4.4700000000-3.55000000001.453' UTR12588594259146828751
chr125910222591469448ENSG00000142606ENST000004718401209MMEL1membrane metalloendopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:14668]GO:0006508(proteolysis);GO:0004222(metalloendopeptidase activity);GO:0008237(metallopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0008233(peptidase activity);GO:0005576(extracellular region)NA0.001448,0-182-18097.60000000003' UTR12590639259267820402
chr13454695345478591ENSG00000130762ENST00000378378269ARHGEF16Rho guanine nucleotide exchange factor 16 [Source:HGNC Symbol;Acc:HGNC:15515]GO:0005737(cytoplasm);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction);GO:0005515(protein binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005829(cytosol);GO:0045296(cadherin binding);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0090630(activation of GTPase activity);GO:0030971(receptor tyrosine kinase binding);GO:0060326(cell chemotaxis);GO:0043065(positive regulation of apoptotic process);GO:0017048(Rho GTPase binding);GO:0030165(PDZ domain binding);GO:0090004(positive regulation of establishment of protein localization to plasma membrane);GO:0043547(positive regulation of GTPase activity)NA0.00191,0-2.9500000000-2.11000000005.475' UTR134544263481113266881
chr134632483463577330ENSG00000130762ENST00000378373-2428ARHGEF16Rho guanine nucleotide exchange factor 16 [Source:HGNC Symbol;Acc:HGNC:15515]GO:0005737(cytoplasm);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction);GO:0005515(protein binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005829(cytosol);GO:0045296(cadherin binding);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0090630(activation of GTPase activity);GO:0030971(receptor tyrosine kinase binding);GO:0060326(cell chemotaxis);GO:0043065(positive regulation of apoptotic process);GO:0017048(Rho GTPase binding);GO:0030165(PDZ domain binding);GO:0090004(positive regulation of establishment of protein localization to plasma membrane);GO:0043547(positive regulation of GTPase activity)NA0.001330,0-6.1400000000-5.15000000003.42Exon (ENST00000378378/ENSG00000130762, exon 2 of 15)134660053481113151091
chr134807843481053270ENSG00000272088ENST00000606489-6193AL512413.1NANANA0.001270,0-3.4300000000-2.570000000011.70000000003' UTR1348724634876273821
chr136250023625450449ENSG00000158109ENST000003783440TPRG1Ltumor protein p63 regulated 1 like [Source:HGNC Symbol;Acc:HGNC:27007]GO:0016020(membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0031410(cytoplasmic vesicle);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0070062(extracellular exosome);GO:0030672(synaptic vesicle membrane);GO:0008021(synaptic vesicle);GO:0042802(identical protein binding)NA0.002272,27,0,422-15.2000000000-1436.70000000005' UTR13625002363012751261
chr136287863628935150ENSG00000158109ENST000003445793736TPRG1Ltumor protein p63 regulated 1 like [Source:HGNC Symbol;Acc:HGNC:27007]GO:0016020(membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0031410(cytoplasmic vesicle);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0070062(extracellular exosome);GO:0030672(synaptic vesicle membrane);GO:0008021(synaptic vesicle);GO:0042802(identical protein binding)NA0.001150,0-5.4000000000-4.44000000001.773' UTR13625050363012750781
chr136299483630127180ENSG00000158109ENST000003445794898TPRG1Ltumor protein p63 regulated 1 like [Source:HGNC Symbol;Acc:HGNC:27007]GO:0016020(membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0031410(cytoplasmic vesicle);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0070062(extracellular exosome);GO:0030672(synaptic vesicle membrane);GO:0008021(synaptic vesicle);GO:0042802(identical protein binding)NA0.001180,0-9.9600000000-8.870000000016.40000000003' UTR13625050363012750781
chr137076073707757151ENSG00000235131ENST000004165546541AL136528.2NANANA0.001151,0-3.6100000000-2.74000000005.27Exon (ENST00000378295/ENSG00000078900, exon 4 of 14)13712200371429820992
chr137335083733748241ENSG00000227372ENST000006241672840TP73-AS1TP73 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:29052]NANA0.001241,0-7.1000000000-6.09000000005.273' UTR1373560137365889882
chr1374661037513444735ENSG00000227372ENST000004180880TP73-AS1TP73 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:29052]NANA0.00382,145,13,0,1204,4722-17.4000000000-16.200000000015.2000000000Exon (ENST00000636250/ENSG00000162592, exon 1 of 6)137359843746776107932
chr137850963785244149ENSG00000272153ENST0000060745988AL365330.1NANANA0.001149,0-4.2100000000-3.30000000005.86Exon (ENST00000607459/ENSG00000272153, exon 1 of 1)1378500837855385311
chr160984956098795301ENSG00000069424ENST000004817892239KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 [Source:HGNC Symbol;Acc:HGNC:6229]GO:0016021(integral component of membrane);GO:0005249(voltage-gated potassium channel activity);GO:0006813(potassium ion transport);GO:0071805(potassium ion transmembrane transport);GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005829(cytosol);GO:0005244(voltage-gated ion channel activity);GO:0006811(ion transport);GO:0034765(regulation of ion transmembrane transport);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0065009(regulation of molecular function);GO:0030054(cell junction);GO:0045202(synapse);GO:0005874(microtubule);GO:0030424(axon);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043312(neutrophil degranulation);GO:0035579(specific granule membrane);GO:0070821(tertiary granule membrane);GO:0015459(potassium channel regulator activity);GO:0043005(neuron projection);GO:2000008(regulation of protein localization to cell surface);GO:0008076(voltage-gated potassium channel complex);GO:0004033(aldo-keto reductase (NADP) activity);GO:0044224(juxtaparanode region of axon);GO:1901379(regulation of potassium ion transmembrane transport);GO:0070995(NADPH oxidation);GO:1990031(pinceau fiber);GO:0002244(hematopoietic progenitor cell differentiation);GO:0050905(neuromuscular process);GO:0014069(postsynaptic density);GO:0043679(axon terminus)NA0.001301,0-41.7000000000-40.20000000003.713' UTR16096256609881025551
chr16099214609930491ENSG00000069424ENST000004817892958KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 [Source:HGNC Symbol;Acc:HGNC:6229]GO:0016021(integral component of membrane);GO:0005249(voltage-gated potassium channel activity);GO:0006813(potassium ion transport);GO:0071805(potassium ion transmembrane transport);GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005829(cytosol);GO:0005244(voltage-gated ion channel activity);GO:0006811(ion transport);GO:0034765(regulation of ion transmembrane transport);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0065009(regulation of molecular function);GO:0030054(cell junction);GO:0045202(synapse);GO:0005874(microtubule);GO:0030424(axon);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043312(neutrophil degranulation);GO:0035579(specific granule membrane);GO:0070821(tertiary granule membrane);GO:0015459(potassium channel regulator activity);GO:0043005(neuron projection);GO:2000008(regulation of protein localization to cell surface);GO:0008076(voltage-gated potassium channel complex);GO:0004033(aldo-keto reductase (NADP) activity);GO:0044224(juxtaparanode region of axon);GO:1901379(regulation of potassium ion transmembrane transport);GO:0070995(NADPH oxidation);GO:1990031(pinceau fiber);GO:0002244(hematopoietic progenitor cell differentiation);GO:0050905(neuromuscular process);GO:0014069(postsynaptic density);GO:0043679(axon terminus)NA0.00191,0-2.8300000000-22.093' UTR16096256609881025551
chr160995446099694151ENSG00000069424ENST000004817893288KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 [Source:HGNC Symbol;Acc:HGNC:6229]GO:0016021(integral component of membrane);GO:0005249(voltage-gated potassium channel activity);GO:0006813(potassium ion transport);GO:0071805(potassium ion transmembrane transport);GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005829(cytosol);GO:0005244(voltage-gated ion channel activity);GO:0006811(ion transport);GO:0034765(regulation of ion transmembrane transport);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0065009(regulation of molecular function);GO:0030054(cell junction);GO:0045202(synapse);GO:0005874(microtubule);GO:0030424(axon);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043312(neutrophil degranulation);GO:0035579(specific granule membrane);GO:0070821(tertiary granule membrane);GO:0015459(potassium channel regulator activity);GO:0043005(neuron projection);GO:2000008(regulation of protein localization to cell surface);GO:0008076(voltage-gated potassium channel complex);GO:0004033(aldo-keto reductase (NADP) activity);GO:0044224(juxtaparanode region of axon);GO:1901379(regulation of potassium ion transmembrane transport);GO:0070995(NADPH oxidation);GO:1990031(pinceau fiber);GO:0002244(hematopoietic progenitor cell differentiation);GO:0050905(neuromuscular process);GO:0014069(postsynaptic density);GO:0043679(axon terminus)NA0.001151,0-7.0900000000-6.08000000002.943' UTR16096256609881025551
chr161009236101193271ENSG00000069424ENST000004817894667KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 [Source:HGNC Symbol;Acc:HGNC:6229]GO:0016021(integral component of membrane);GO:0005249(voltage-gated potassium channel activity);GO:0006813(potassium ion transport);GO:0071805(potassium ion transmembrane transport);GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005829(cytosol);GO:0005244(voltage-gated ion channel activity);GO:0006811(ion transport);GO:0034765(regulation of ion transmembrane transport);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0065009(regulation of molecular function);GO:0030054(cell junction);GO:0045202(synapse);GO:0005874(microtubule);GO:0030424(axon);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043312(neutrophil degranulation);GO:0035579(specific granule membrane);GO:0070821(tertiary granule membrane);GO:0015459(potassium channel regulator activity);GO:0043005(neuron projection);GO:2000008(regulation of protein localization to cell surface);GO:0008076(voltage-gated potassium channel complex);GO:0004033(aldo-keto reductase (NADP) activity);GO:0044224(juxtaparanode region of axon);GO:1901379(regulation of potassium ion transmembrane transport);GO:0070995(NADPH oxidation);GO:1990031(pinceau fiber);GO:0002244(hematopoietic progenitor cell differentiation);GO:0050905(neuromuscular process);GO:0014069(postsynaptic density);GO:0043679(axon terminus)NA0.001271,0-33.7000000000-32.300000000022.90000000003' UTR16096256609881025551
chr165808826581091210ENSG00000204859ENST00000488936794ZBTB48zinc finger and BTB domain containing 48 [Source:HGNC Symbol;Acc:HGNC:4930]GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005694(chromosome);GO:0005515(protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0042802(identical protein binding);GO:0000781(chromosome, telomeric region);GO:0044212(transcription regulatory region DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003691(double-stranded telomeric DNA binding);GO:0010833(telomere maintenance via telomere lengthening)NA0.001210,0-14.6000000000-13.50000000005.14Exon (ENST00000319084/ENSG00000204859, exon 2 of 3)16580088658810580181
chr165889826589280299ENSG00000204859ENST00000466941295ZBTB48zinc finger and BTB domain containing 48 [Source:HGNC Symbol;Acc:HGNC:4930]GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005694(chromosome);GO:0005515(protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0042802(identical protein binding);GO:0000781(chromosome, telomeric region);GO:0044212(transcription regulatory region DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003691(double-stranded telomeric DNA binding);GO:0010833(telomere maintenance via telomere lengthening)NA0.001299,0-12-10.900000000028.90000000003' UTR1658868765892805941
chr166138356614104270ENSG00000116273ENST0000049538573PHF13PHD finger protein 13 [Source:HGNC Symbol;Acc:HGNC:22983]GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0016569(covalent chromatin modification);GO:0051301(cell division);GO:0007049(cell cycle);GO:0005654(nucleoplasm);GO:0007059(chromosome segregation);GO:0003682(chromatin binding);GO:0030261(chromosome condensation);GO:0000278(mitotic cell cycle);GO:0035064(methylated histone binding);GO:0007076(mitotic chromosome condensation)NA0.001270,0-18.2000000000-176.075' UTR16613762662264588841
chr166199386620297360ENSG00000041988ENST00000054650-4569THAP3THAP domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20855]GO:0003676(nucleic acid binding);GO:0046872(metal ion binding);GO:0003677(DNA binding);GO:0005515(protein binding)NA0.001360,0-11.1000000000-9.99000000002.37Exon (ENST00000377648/ENSG00000116273, exon 3 of 4)16624866663356587001
chr166214906621909420ENSG00000041988ENST00000054650-2957THAP3THAP domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20855]GO:0003676(nucleic acid binding);GO:0046872(metal ion binding);GO:0003677(DNA binding);GO:0005515(protein binding)NA0.001420,0-32.9000000000-31.50000000004.783' UTR16624866663356587001
chr166328876633516630ENSG00000041988ENST000004806474492THAP3THAP domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20855]GO:0003676(nucleic acid binding);GO:0046872(metal ion binding);GO:0003677(DNA binding);GO:0005515(protein binding)NA0.001630,0-66.6000000000-64.900000000016.40000000003' UTR16628395663032619321
chr166342396634628390ENSG00000041988ENST000004806475844THAP3THAP domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20855]GO:0003676(nucleic acid binding);GO:0046872(metal ion binding);GO:0003677(DNA binding);GO:0005515(protein binding)NA0.001390,0-20.1000000000-18.80000000005.403' UTR16628395663032619321
chr16785504680700121498ENSG00000171735ENST000004674040CAMTA1calmodulin binding transcription activator 1 [Source:HGNC Symbol;Acc:HGNC:18806]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0001077(transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0043565(sequence-specific DNA binding);GO:0050885(neuromuscular process controlling balance)NA0.00272,19,0,21479-3.1000000000-2.250000000012.50000000005' UTR167855186872019865021
chr17732491773258090ENSG00000171735ENST00000495233-3828CAMTA1calmodulin binding transcription activator 1 [Source:HGNC Symbol;Acc:HGNC:18806]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0001077(transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0043565(sequence-specific DNA binding);GO:0050885(neuromuscular process controlling balance)NA0.00190,0-2.6500000000-1.830000000010.9000000000Exon (ENST00000303635/ENSG00000171735, exon 12 of 23)177364087767856314491
chr177727407772920181ENSG00000049245ENST0000047035733VAMP3vesicle associated membrane protein 3 [Source:HGNC Symbol;Acc:HGNC:12644]GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0030054(cell junction);GO:0045202(synapse);GO:0006906(vesicle fusion);GO:0043231(intracellular membrane-bounded organelle);GO:0005622(intracellular);GO:0061024(membrane organization);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0042147(retrograde transport, endosome to Golgi);GO:0000149(SNARE binding);GO:0005484(SNAP receptor activity);GO:0061025(membrane fusion);GO:0030670(phagocytic vesicle membrane);GO:0031201(SNARE complex);GO:0043005(neuron projection);GO:0032588(trans-Golgi network membrane);GO:0030136(clathrin-coated vesicle);GO:0006461(protein complex assembly);GO:0030133(transport vesicle);GO:0006887(exocytosis);GO:0030665(clathrin-coated vesicle membrane);GO:0001921(positive regulation of receptor recycling);GO:0055038(recycling endosome membrane);GO:0034446(substrate adhesion-dependent cell spreading);GO:0055037(recycling endosome);GO:0017075(syntaxin-1 binding);GO:0006904(vesicle docking involved in exocytosis);GO:0017156(calcium ion regulated exocytosis);GO:0035493(SNARE complex assembly);GO:0043001(Golgi to plasma membrane protein transport);GO:1903531(negative regulation of secretion by cell);GO:0009986(cell surface);GO:0016324(apical plasma membrane);GO:0030141(secretory granule);GO:0031410(cytoplasmic vesicle);GO:0043229(intracellular organelle);GO:0048471(perinuclear region of cytoplasm)04130(SNARE interactions in vesicular transport);04145(Phagosome)0.001181,0-7.6300000000-6.60000000004.515' UTR17772707777980671001
chr1796284079653782539ENSG00000116288ENST000004692250PARK7Parkinsonism associated deglycase [Source:HGNC Symbol;Acc:HGNC:16369]GO:0048471(perinuclear region of cytoplasm);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0005739(mitochondrion);GO:0042803(protein homodimerization activity);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0008233(peptidase activity);GO:0006508(proteolysis);GO:0006914(autophagy);GO:0098793(presynapse);GO:0045121(membrane raft);GO:0098869(cellular oxidant detoxification);GO:0006954(inflammatory response);GO:0042802(identical protein binding);GO:0003729(mRNA binding);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0050821(protein stabilization);GO:0007338(single fertilization);GO:0005102(receptor binding);GO:0005913(cell-cell adherens junction);GO:0005507(copper ion binding);GO:0051897(positive regulation of protein kinase B signaling);GO:0032091(negative regulation of protein binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0007005(mitochondrion organization);GO:1903206(negative regulation of hydrogen peroxide-induced cell death);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0019900(kinase binding);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0034599(cellular response to oxidative stress);GO:1901215(negative regulation of neuron death);GO:0000785(chromatin);GO:0060548(negative regulation of cell death);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:0019899(enzyme binding);GO:1990381(ubiquitin-specific protease binding);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0043524(negative regulation of neuron apoptotic process);GO:1903202(negative regulation of oxidative stress-induced cell death);GO:1903377(negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway);GO:1903599(positive regulation of mitophagy);GO:0006517(protein deglycosylation);GO:0050727(regulation of inflammatory response);GO:0070301(cellular response to hydrogen peroxide);GO:0051444(negative regulation of ubiquitin-protein transferase activity);GO:0031397(negative regulation of protein ubiquitination);GO:0043066(negative regulation of apoptotic process);GO:0032148(activation of protein kinase B activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0030424(axon);GO:0060765(regulation of androgen receptor signaling pathway);GO:2000825(positive regulation of androgen receptor activity);GO:1905259(negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway);GO:0051881(regulation of mitochondrial membrane potential);GO:0005747(mitochondrial respiratory chain complex I);GO:1903208(negative regulation of hydrogen peroxide-induced neuron death);GO:1903094(negative regulation of protein K48-linked deubiquitination);GO:2000157(negative regulation of ubiquitin-specific protease activity);GO:0010273(detoxification of copper ion);GO:0070491(repressing transcription factor binding);GO:0043523(regulation of neuron apoptotic process);GO:0097110(scaffold protein binding);GO:0001933(negative regulation of protein phosphorylation);GO:0044390(ubiquitin-like protein conjugating enzyme binding);GO:0003713(transcription coactivator activity);GO:0016532(superoxide dismutase copper chaperone activity);GO:0016684(oxidoreductase activity, acting on peroxide as acceptor);GO:0019955(cytokine binding);GO:0036470(tyrosine 3-monooxygenase activator activity);GO:0036478(L-dopa decarboxylase activator activity);GO:0036524(protein deglycase activity);GO:0044388(small protein activating enzyme binding);GO:0045340(mercury ion binding);GO:0050681(androgen receptor binding);GO:1903135(cupric ion binding);GO:1903136(cuprous ion binding);GO:0002866(positive regulation of acute inflammatory response to antigenic stimulus);GO:0006469(negative regulation of protein kinase activity);GO:0007265(Ras protein signal transduction);GO:0009438(methylglyoxal metabolic process);GO:0019249(lactate biosynthetic process);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032757(positive regulation of interleukin-8 production);GO:0033234(negative regulation of protein sumoylation);GO:0033864(positive regulation of NAD(P)H oxidase activity);GO:0036471(cellular response to glyoxal);GO:0036526(peptidyl-cysteine deglycation);GO:0036527(peptidyl-arginine deglycation);GO:0036528(peptidyl-lysine deglycation);GO:0036529(protein deglycation, glyoxal removal);GO:0036530(protein deglycation, methylglyoxal removal);GO:0036531(glutathione deglycation);GO:0042743(hydrogen peroxide metabolic process);GO:0046295(glycolate biosynthetic process);GO:0046826(negative regulation of protein export from nucleus);GO:0050787(detoxification of mercury ion);GO:0090073(positive regulation of protein homodimerization activity);GO:1900182(positive regulation of protein localization to nucleus);GO:1901671(positive regulation of superoxide dismutase activity);GO:1901984(negative regulation of protein acetylation);GO:1902903(regulation of supramolecular fiber organization);GO:1902958(positive regulation of mitochondrial electron transport, NADH to ubiquinone);GO:1903073(negative regulation of death-inducing signaling complex assembly);GO:1903122(negative regulation of TRAIL-activated apoptotic signaling pathway);GO:1903168(positive regulation of pyrroline-5-carboxylate reductase activity);GO:1903178(positive regulation of tyrosine 3-monooxygenase activity);GO:1903181(positive regulation of dopamine biosynthetic process);GO:1903189(glyoxal metabolic process);GO:1903197(positive regulation of L-dopa biosynthetic process);GO:1903200(positive regulation of L-dopa decarboxylase activity);GO:1903384(negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway);GO:2000679(positive regulation of transcription regulatory region DNA binding);GO:2001268(negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:0016605(PML body);GO:0051920(peroxiredoxin activity);GO:0001963(synaptic transmission, dopaminergic);GO:0008344(adult locomotory behavior);GO:0018323(enzyme active site formation via L-cysteine sulfinic acid);GO:0034614(cellular response to reactive oxygen species);GO:0042177(negative regulation of protein catabolic process);GO:0042542(response to hydrogen peroxide);GO:0051583(dopamine uptake involved in synaptic transmission);GO:0051899(membrane depolarization);GO:0060081(membrane hyperpolarization);GO:1902177(positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1903428(positive regulation of reactive oxygen species biosynthetic process);GO:2000277(positive regulation of oxidative phosphorylation uncoupler activity);GO:0005758(mitochondrial intermembrane space);GO:0005759(mitochondrial matrix);GO:0005783(endoplasmic reticulum);GO:0043005(neuron projection);GO:0044297(cell body)05012(Parkinson's disease)0.00236,55,0,2484-3.5600000000-2.680000000014.1000000000Exon (ENST00000493373/ENSG00000116288, exon 2 of 7)179653517985282199321
chr179848767985146271ENSG00000200344ENST00000363474-1893Y_RNAY RNA [Source:RFAM;Acc:RF00019]NANA0.001271,0-33.2000000000-31.80000000003.243' UTR1798288179829831032
chr192452379245387151ENSG00000049239ENST000006024775393H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.001151,0-3.4100000000-2.55000000002.11Exon (ENST00000377403/ENSG00000049239, exon 2 of 5)192398449267898280551
chr19264594926465461ENSG00000049239ENST00000495451-876H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.00161,0-2.5700000000-1.75000000002.04Exon (ENST00000377403/ENSG00000049239, exon 5 of 5)19265530927133758081
chr19264864926492461ENSG00000049239ENST00000495451-606H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.00161,0-3.3000000000-2.44000000001.983' UTR19265530927133758081
chr192651049265313210ENSG00000049239ENST00000495451-217H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.001210,0-9.6000000000-8.52000000004.123' UTR19265530927133758081
chr192689409269269330ENSG00000049239ENST000004954513410H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.001330,0-47.2000000000-45.60000000009.693' UTR19265530927133758081
chr19269809926989991ENSG00000049239ENST000004954514279H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.00191,0-4.0100000000-3.12000000003.813' UTR19265530927133758081
chr192706489270887240ENSG00000049239ENST000004954515118H6PDhexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795]GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005783(endoplasmic reticulum);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0017057(6-phosphogluconolactonase activity);GO:0006098(pentose-phosphate shunt);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0047936(glucose 1-dehydrogenase [NAD(P)] activity);GO:0030246(carbohydrate binding);GO:0006739(NADP metabolic process);GO:0097305(response to alcohol);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0043231(intracellular membrane-bounded organelle)00030(Pentose phosphate pathway)0.001240,0-6.1600000000-5.17000000003.083' UTR19265530927133758081
chr193557459356581837ENSG00000171621ENST0000037739938SPSB1splA/ryanodine receptor domain and SOCS box containing 1 [Source:HGNC Symbol;Acc:HGNC:30628]GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0005515(protein binding);GO:0005829(cytosol);GO:0000209(protein polyubiquitination);GO:0043687(post-translational protein modification);GO:0004842(ubiquitin-protein transferase activity)NA0.001837,0-58.5000000000-56.80000000006.425' UTR193557079367575118691
chr193676529368338687ENSG00000171621ENST0000037739911945SPSB1splA/ryanodine receptor domain and SOCS box containing 1 [Source:HGNC Symbol;Acc:HGNC:30628]GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0005515(protein binding);GO:0005829(cytosol);GO:0000209(protein polyubiquitination);GO:0043687(post-translational protein modification);GO:0004842(ubiquitin-protein transferase activity)NA0.001687,0-61.7000000000-6015.90000000003' UTR193557079367575118691
chr193692639369472210ENSG00000171621ENST0000037739913556SPSB1splA/ryanodine receptor domain and SOCS box containing 1 [Source:HGNC Symbol;Acc:HGNC:30628]GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0005515(protein binding);GO:0005829(cytosol);GO:0000209(protein polyubiquitination);GO:0043687(post-translational protein modification);GO:0004842(ubiquitin-protein transferase activity)NA0.001210,0-6.0900000000-5.110000000013.30000000003' UTR193557079367575118691
chr196022109602629420ENSG00000188807ENST00000510900-3585TMEM201transmembrane protein 201 [Source:HGNC Symbol;Acc:HGNC:33719]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005856(cytoskeleton);GO:0000922(spindle pole);GO:0005637(nuclear inner membrane);GO:0005521(lamin binding);GO:0051015(actin filament binding);GO:0007097(nuclear migration);GO:0010761(fibroblast migration);GO:0031965(nuclear membrane)NA0.001420,0-25.6000000000-24.30000000003.883' UTR19606214960768514721
chr196132599613438180ENSG00000188807ENST000005084005531TMEM201transmembrane protein 201 [Source:HGNC Symbol;Acc:HGNC:33719]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005856(cytoskeleton);GO:0000922(spindle pole);GO:0005637(nuclear inner membrane);GO:0005521(lamin binding);GO:0051015(actin filament binding);GO:0007097(nuclear migration);GO:0010761(fibroblast migration);GO:0031965(nuclear membrane)NA0.001180,0-5.9100000000-4.94000000002.703' UTR19607728961324755201
chr197269349727322389ENSG00000171603ENST000004772646164CLSTN1calsyntenin 1 [Source:HGNC Symbol;Acc:HGNC:17447]GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005509(calcium ion binding);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0005794(Golgi apparatus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0070062(extracellular exosome);GO:0001540(amyloid-beta binding);GO:0019894(kinesin binding);GO:0042988(X11-like protein binding);GO:0001558(regulation of cell growth);GO:0050806(positive regulation of synaptic transmission);GO:0051965(positive regulation of synapse assembly);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0009986(cell surface);GO:0014069(postsynaptic density)NA0.001389,0-13.1000000000-11.90000000008.813' UTR19729028973348644592
chr199826589982807150ENSG00000241326ENST00000413148-334AL603962.1NANANA0.001150,0-3.8000000000-2.91000000004.293' UTR19983141998456814281
chr11003325110033401151ENSG00000130939ENST000003771530UBE4Bubiquitination factor E4B [Source:HGNC Symbol;Acc:HGNC:12500]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0000151(ubiquitin ligase complex);GO:0034450(ubiquitin-ubiquitin ligase activity);GO:0000209(protein polyubiquitination);GO:0019899(enzyme binding);GO:0009411(response to UV);GO:0008626(granzyme-mediated apoptotic signaling pathway);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0051117(ATPase binding);GO:0061630(ubiquitin protein ligase activity);GO:0003222(ventricular trabecula myocardium morphogenesis);GO:0006513(protein monoubiquitination);GO:0031175(neuron projection development);GO:0034976(response to endoplasmic reticulum stress);GO:0044257(cellular protein catabolic process);GO:0051865(protein autoubiquitination)04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis)0.001151,0-7.7400000000-6.71000000002.065' UTR11003327410073118398451
chr11030407410304554481ENSG00000264501ENST00000584329-1911RN7SL731PRNA, 7SL, cytoplasmic 731, pseudogene [Source:HGNC Symbol;Acc:HGNC:46747]NANA0.001481,0-8.8200000000-7.76000000002.77Exon (ENST00000377093/ENSG00000054523, exon 21 of 21)110306465103067572931
chr110403109104128729764ENSG00000142657ENST000004932880PGDphosphogluconate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:8891]GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0004616(phosphogluconate dehydrogenase (decarboxylating) activity);GO:0006098(pentose-phosphate shunt);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0009051(pentose-phosphate shunt, oxidative branch);GO:0019322(pentose biosynthetic process);GO:0019521(D-gluconate metabolic process)00030(Pentose phosphate pathway);00480(Glutathione metabolism)0.00528,119,70,135,39,0,1052,4962,8309,9725-18-16.700000000060.90000000003' UTR1104128341041704442111

Definition of table:

TermDescription
seqnamesThe name of the chromosome (e.g. chr3, chrY, chr2 random) or scaffold (e.g. scaffold10671)
startThe starting position of the methylation site in the chromosome or scaffold.
endThe ending position of the RNA methylation site in the chromosome or scaffold.
widthPeak region of methylation
geneIdDefines the ID of gene on which the RNA methylation site locates
transcriptIdDefines the ID of transcript on which the RNA methylation site locates
distanceToTSSDistrance from Peak site to transcription start site
geneNameDefines the name of gene (gene symbol) on which the RNA methylation site locates
GOGene ontology term and descriptionhttp://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
scorep-value of the peak
blockCountThe number of blocks (exons) the RNA methylation site spans.
blockSizesA comma-separated list of the block sizes. The number of items in this list should correspond to blockCount.
blockStartsA comma-separated list of block starts. All of the blockStart positions should be calculated relative to chromStart. The number of items in this list should correspond to blockCount.
lg.plog10(p-value) of the peak, indicating the significance of the peak as an RNA methylation site.
lg.fdrlog10(fdr) of the peak, indicating the significance of the peak as an RNA methylation site after multiple hypothesis correction.
fold_enrchmentfold enrichment within the peak in the IP sample compared with the input sample.
annotationLocation of peak, such as 3' UTR...
geneStartThe starting position of gene in the chromosome or scaffold.
geneEndThe ending position of gene in the chromosome or scaffold.
geneLengthlength of gene
geneStrand1=sense strand or "+"; 2=antisense strand or "-"

document location: summary/3_peak_calling/*/*_peak.xlsx


4.3.2 Accumulation of m6A-IP reads




document location:

summary/3_Peak_Calling/heatmap.png

summary/3_Peak_Calling/distProfile.png


4.4 Differential Methylation


4.4.1 Diff peak analysis


seqnamesstartendwidthgeneIdtranscriptIddistanceToTSSgeneNameDescriptionGOKEGGscoreblockCountblockSizesblockStartslg.plg.fdrfold_enrchmentdiff.lg.fdrdiff.lg.pdiff.log2.fcannotationgeneChrgeneStartgeneEndgeneLengthgeneStrand
chr110463421046449108ENSG00000188157ENST00000466223-752AGRNagrin [Source:HGNC Symbol;Acc:HGNC:329]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)0.0028,53,0,55-6.80-5.801.58-1.73-2.96-1.47Exon (ENST00000379370/ENSG00000188157, exon 18 of 36)1104720110478656651
chr110480791048288210ENSG00000188157ENST00000492947-241AGRNagrin [Source:HGNC Symbol;Acc:HGNC:329]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)0.001210,0-28.10-26.801.77-1.56-2.74-0.44Exon (ENST00000379370/ENSG00000188157, exon 23 of 36)1104852910493948661
chr110554291056118690ENSG00000242590ENST00000418300396AL645608.6NANANA0.001690,0-192-1908.10-1.37-2.47-0.243' UTR11055033105611610841
chr1132770913288971189ENSG00000169962ENST00000339381-2417TAS1R3taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)011189,0-310-30713.50-5.29-7.32-0.473' UTR11331314133530639931
chr1143970614409041199ENSG00000179403ENST000004713983971VWA1von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005604(basement membrane);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0005788(endoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0030198(extracellular matrix organization);GO:0048266(behavioral response to pain);GO:0005614(interstitial matrix)NA011199,0-1690-Inf14.20-5.65-7.74-0.353' UTR11435735143717714431
chr115343301534657328ENSG00000205090ENST000006244265693TMEM240transmembrane protein 240 [Source:HGNC Symbol;Acc:HGNC:25186]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0097060(synaptic membrane)NA0.001328,0-18.10-16.904.18-2.70-4.22-1.673' UTR11539056154035012952
chr125631132563352240ENSG00000157873ENST000004803051312TNFRSF14TNF receptor superfamily member 14 [Source:HGNC Symbol;Acc:HGNC:11912]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0002741(positive regulation of cytokine secretion involved in immune response);GO:0046642(negative regulation of alpha-beta T cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:2000406(positive regulation of T cell migration);GO:0009897(external side of plasma membrane);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006954(inflammatory response);GO:0046718(viral entry into host cell);GO:0097190(apoptotic signaling pathway);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0016032(viral process);GO:0031625(ubiquitin protein ligase binding);GO:0006955(immune response);GO:0007275(multicellular organism development);GO:0032496(response to lipopolysaccharide);GO:0042127(regulation of cell proliferation);GO:0007166(cell surface receptor signaling pathway);GO:0042981(regulation of apoptotic process);GO:0001618(virus receptor activity);GO:0031295(T cell costimulation);GO:0005031(tumor necrosis factor-activated receptor activity)04060(Cytokine-cytokine receptor interaction);05168(Herpes simplex infection)0.001240,0-16-14.902.92-2.04-3.36-1.363' UTR12561801256345216521
chr125910512591469419ENSG00000142606ENST000004718401209MMEL1membrane metalloendopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:14668]GO:0006508(proteolysis);GO:0004222(metalloendopeptidase activity);GO:0008237(metallopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0008233(peptidase activity);GO:0005576(extracellular region)NA0.001419,0-289-28647.50-2.13-3.48-0.613' UTR12590639259267820402
chr166138356614104270ENSG00000116273ENST0000049538573PHF13PHD finger protein 13 [Source:HGNC Symbol;Acc:HGNC:22983]GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0016569(covalent chromatin modification);GO:0051301(cell division);GO:0007049(cell cycle);GO:0005654(nucleoplasm);GO:0007059(chromosome segregation);GO:0003682(chromatin binding);GO:0030261(chromosome condensation);GO:0000278(mitotic cell cycle);GO:0035064(methylated histone binding);GO:0007076(mitotic chromosome condensation)NA0.001270,0-21.90-20.704-1.53-2.69-1.345' UTR16613762662264588841
chr11102331011023998689ENSG00000120948ENST000006177570TARDBPTAR DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11571]GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0003730(mRNA 3'-UTR binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0001205(transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding);GO:0032024(positive regulation of insulin secretion);GO:0034976(response to endoplasmic reticulum stress);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005726(perichromatin fibrils);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0035061(interchromatin granule);GO:0042802(identical protein binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003690(double-stranded DNA binding);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0010629(negative regulation of gene expression);GO:0051726(regulation of cell cycle);GO:0001933(negative regulation of protein phosphorylation);GO:0042981(regulation of apoptotic process);GO:0043922(negative regulation by host of viral transcription);GO:0071765(nuclear inner membrane organization)NA01689,0-327-Inf4.35-2.38-3.810.333' UTR111023323110241528301
chr111750615117544463832ENSG00000177674ENST000004717653103AGTRAPangiotensin II receptor associated protein [Source:HGNC Symbol;Acc:HGNC:13539]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0038166(angiotensin-activated signaling pathway);GO:0004945(angiotensin type II receptor activity);GO:0001666(response to hypoxia);GO:0008217(regulation of blood pressure);GO:0005886(plasma membrane);GO:0005938(cell cortex)NA0.002157,22,0,3810-10.60-9.543.80-1.62-2.81-1.613' UTR1117475121175480272911
chr112009708120119572250ENSG00000270914ENST000006032875351AL096840.1NANANA0219,462,0,1788-330-Inf5.02-1.55-2.720.303' UTR11201721612017308932
chr11540989515410163269ENSG00000142634ENST000003759800EFHD2EF-hand domain family member D2 [Source:HGNC Symbol;Acc:HGNC:28670]GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005509(calcium ion binding);GO:0045121(membrane raft);GO:0045296(cadherin binding)NA0.001269,0-20.60-19.301.61-3.57-5.31-0.675' UTR11540989515430343204491
chr115719789157280938305ENSG00000116786ENST00000477849-1752PLEKHM2pleckstrin homology and RUN domain containing M2 [Source:HGNC Symbol;Acc:HGNC:29131]GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0019894(kinesin binding);GO:0007030(Golgi organization);GO:0032418(lysosome localization);GO:0032880(regulation of protein localization);GO:0010008(endosome membrane);GO:1903527(positive regulation of membrane tubulation)05132(Salmonella infection)05132,60,229,819,15,0,1540,5528,7225,8290-524-Inf13.60-5.08-7.08-0.51Exon (ENST00000375799/ENSG00000116786, exon 6 of 20)1157298451573411542711
chr11578459515784893299ENSG00000162458ENST000005091387522FBLIM1filamin binding LIM protein 1 [Source:HGNC Symbol;Acc:HGNC:24686]GO:0001650(fibrillar center);GO:0005925(focal adhesion);GO:0030054(cell junction);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0007155(cell adhesion);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005829(cytosol);GO:0001725(stress fiber);GO:0005938(cell cortex);GO:0008360(regulation of cell shape);GO:0016337(single organismal cell-cell adhesion);GO:0031005(filamin binding);GO:0033623(regulation of integrin activation);GO:0034329(cell junction assembly)NA0.001299,0-74.70-73.103-1.77-3.01-0.553' UTR1157770731578483877661
chr11965686919657463595ENSG00000158748ENST00000289753-7824HTR65-hydroxytryptamine receptor 6 [Source:HGNC Symbol;Acc:HGNC:5301]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0004993(G-protein coupled serotonin receptor activity);GO:0098664(G-protein coupled serotonin receptor signaling pathway);GO:0005887(integral component of plasma membrane);GO:0007268(chemical synaptic transmission);GO:0032008(positive regulation of TOR signaling);GO:0030594(neurotransmitter receptor activity);GO:0007187(G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0004969(histamine receptor activity);GO:0021795(cerebral cortex cell migration);GO:0005929(cilium)04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)01595,0-1210-Inf30-2.29-3.70-0.303' UTR11966528719679562142761
chr11965687319657441569ENSG00000158748ENST00000289753-7846HTR65-hydroxytryptamine receptor 6 [Source:HGNC Symbol;Acc:HGNC:5301]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0004993(G-protein coupled serotonin receptor activity);GO:0098664(G-protein coupled serotonin receptor signaling pathway);GO:0005887(integral component of plasma membrane);GO:0007268(chemical synaptic transmission);GO:0032008(positive regulation of TOR signaling);GO:0030594(neurotransmitter receptor activity);GO:0007187(G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0004969(histamine receptor activity);GO:0021795(cerebral cortex cell migration);GO:0005929(cilium)04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)01569,0-1210-Inf27.10-2.56-4.03-0.333' UTR11966528719679562142761
chr12182219821822707510ENSG00000187942ENST00000484271701LDLRAD2low density lipoprotein receptor class A domain containing 2 [Source:HGNC Symbol;Acc:HGNC:32071]GO:0016020(membrane);GO:0016021(integral component of membrane)NA0.001510,0-103-10124.50-1.45-2.59-0.643' UTR1218214972182254810521
chr12286499422865174181ENSG00000133216ENST000004904360EPHB2EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005634(nucleus);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0005887(integral component of plasma membrane);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0030425(dendrite);GO:0005576(extracellular region);GO:0030424(axon);GO:0005829(cytosol);GO:0010628(positive regulation of gene expression);GO:0048013(ephrin receptor signaling pathway);GO:0060997(dendritic spine morphogenesis);GO:0060021(palate development);GO:0001525(angiogenesis);GO:0007411(axon guidance);GO:0071679(commissural neuron axon guidance);GO:0051965(positive regulation of synapse assembly);GO:0042472(inner ear morphogenesis);GO:0007612(learning);GO:0007611(learning or memory);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0098794(postsynapse);GO:1900273(positive regulation of long-term synaptic potentiation);GO:0001540(amyloid-beta binding);GO:0005005(transmembrane-ephrin receptor activity);GO:0044877(macromolecular complex binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0007413(axonal fasciculation);GO:0022038(corpus callosum development);GO:0031915(positive regulation of synaptic plasticity);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048168(regulation of neuronal synaptic plasticity);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0060996(dendritic spine development);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity);GO:0004872(receptor activity);GO:0005102(receptor binding);GO:0008046(axon guidance receptor activity);GO:0042802(identical protein binding);GO:0000902(cell morphogenesis);GO:0009887(animal organ morphogenesis);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0031290(retinal ganglion cell axon guidance);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028;GO:0043025(neuronal cell body)04360(Axon guidance)0.001181,0-5.34-4.391.32-1.52-2.68-0.66Exon (ENST00000544305/ENSG00000133216, exon 5 of 7)12286515922882840176821
chr12446905324469263211ENSG00000001461ENST0000043201212887NIPAL3NIPA like domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25233]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:1903830(magnesium ion transmembrane transport)NA0.001211,0-6.64-5.652.20-2.10-3.44-1.813' UTR12445616624466378102131
chr12549826525498714450ENSG00000157978ENST00000374338-44866LDLRAP1low density lipoprotein receptor adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:18640]GO:0042632(cholesterol homeostasis);GO:0006810(transport);GO:0005737(cytoplasm);GO:0009967(positive regulation of signal transduction);GO:0006629(lipid metabolic process);GO:0005829(cytosol);GO:0008202(steroid metabolic process);GO:0005515(protein binding);GO:0008203(cholesterol metabolic process);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0061024(membrane organization);GO:0005769(early endosome);GO:0009925(basal plasma membrane);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0009898(cytoplasmic side of plasma membrane);GO:0030424(axon);GO:0030665(clathrin-coated vesicle membrane);GO:0030159(receptor signaling complex scaffold activity);GO:0030276(clathrin binding);GO:0030121(AP-1 adaptor complex);GO:0035615(clathrin adaptor activity);GO:0030122(AP-2 adaptor complex);GO:0001540(amyloid-beta binding);GO:0034383(low-density lipoprotein particle clearance);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:0055037(recycling endosome);GO:0050750(low-density lipoprotein particle receptor binding);GO:0006898(receptor-mediated endocytosis);GO:1905602(positive regulation of receptor-mediated endocytosis involved in cholesterol transport);GO:0001784(phosphotyrosine residue binding);GO:0090003(regulation of establishment of protein localization to plasma membrane);GO:0005883(neurofilament);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0031623(receptor internalization);GO:0043393(regulation of protein binding);GO:0035591(signaling adaptor activity);GO:0035612(AP-2 adaptor complex binding);GO:0042982(amyloid precursor protein metabolic process);GO:0090205(positive regulation of cholesterol metabolic process)04144(Endocytosis);04979(Cholesterol metabolism)0.001450,0-15.30-14.104.33-1.76-3-1.043' UTR12554358025568886253071
chr12616993026170489560ENSG00000142684ENST000002708120ZNF593zinc finger protein 593 [Source:HGNC Symbol;Acc:HGNC:30943]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0030687(preribosome, large subunit precursor);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0043023(ribosomal large subunit binding);GO:0000055(ribosomal large subunit export from nucleus);GO:1903026(negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding)NA0.002254,72,0,488-117-1154.95-3.29-4.97-0.835' UTR126169942261708739321
chr126573328265750301703ENSG00000117676ENST000004389771058RPS6KA1ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430]GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0000287(magnesium ion binding);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0035556(intracellular signal transduction);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0005654(nucleoplasm);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0043066(negative regulation of apoptotic process);GO:0007165(signal transduction);GO:0045597(positive regulation of cell differentiation);GO:0030307(positive regulation of cell growth);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043620(regulation of DNA-templated transcription in response to stress);GO:0006915(apoptotic process);GO:0072574(hepatocyte proliferation);GO:0043555(regulation of translation in response to stress);GO:2000491(positive regulation of hepatic stellate cell activation)04010(MAPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04931(Insulin resistance)0.00234,952,0,751-51.70-50.2016.10-2.21-3.60-0.613' UTR1265722702657473424651
chr126696040266974191380ENSG00000117713ENST000004575990ARID1AAT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0006338(chromatin remodeling);GO:0090544(BAF-type complex);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0005515(protein binding);GO:0007399(nervous system development);GO:0045893(positive regulation of transcription, DNA-templated);GO:0003713(transcription coactivator activity);GO:0000790(nuclear chromatin);GO:0030521(androgen receptor signaling pathway);GO:0016922(ligand-dependent nuclear receptor binding);GO:0031491(nucleosome binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006344(maintenance of chromatin silencing);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030900(forebrain development);GO:0042766(nucleosome mobilization);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0048096(chromatin-mediated maintenance of transcription);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:1901998(toxin transport);GO:0016514(SWI/SNF complex);GO:0071564(npBAF complex);GO:0071565(nBAF complex)05225(Hepatocellular carcinoma)0.0011380,0-182-18018.80-2.02-3.34-0.725' UTR12669640426780817844141
chr12677476026775000241ENSG00000117713ENST000005327810ARID1AAT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0006338(chromatin remodeling);GO:0090544(BAF-type complex);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0005515(protein binding);GO:0007399(nervous system development);GO:0045893(positive regulation of transcription, DNA-templated);GO:0003713(transcription coactivator activity);GO:0000790(nuclear chromatin);GO:0030521(androgen receptor signaling pathway);GO:0016922(ligand-dependent nuclear receptor binding);GO:0031491(nucleosome binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006344(maintenance of chromatin silencing);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030900(forebrain development);GO:0042766(nucleosome mobilization);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0048096(chromatin-mediated maintenance of transcription);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:1901998(toxin transport);GO:0016514(SWI/SNF complex);GO:0071564(npBAF complex);GO:0071565(nBAF complex)05225(Hepatocellular carcinoma)0.001241,0-13.40-12.301.92-2.03-3.35-0.883' UTR1267748702678098361141
chr126863228268644571230ENSG00000175793ENST0000033927690SFNstratifin [Source:HGNC Symbol;Acc:HGNC:10773]GO:0005739(mitochondrion);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0019904(protein domain specific binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0042802(identical protein binding);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0061024(membrane organization);GO:0007165(signal transduction);GO:0005615(extracellular space);GO:0061436(establishment of skin barrier);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0030659(cytoplasmic vesicle membrane);GO:0001836(release of cytochrome c from mitochondria);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045606(positive regulation of epidermal cell differentiation);GO:0008426(protein kinase C inhibitor activity);GO:0019901(protein kinase binding);GO:0051219(phosphoprotein binding);GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0003334(keratinocyte development);GO:0006469(negative regulation of protein kinase activity);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010482(regulation of epidermal cell division);GO:0010839(negative regulation of keratinocyte proliferation);GO:0030216(keratinocyte differentiation);GO:0030307(positive regulation of cell growth);GO:0031424(keratinization);GO:0043588(skin development);GO:0046827(positive regulation of protein export from nucleus);GO:0051726(regulation of cell cycle)04110(Cell cycle);04115(p53 signaling pathway);04960(Aldosterone-regulated sodium reabsorption)011230,0-570-Inf26.10-3.37-5.06-0.193' UTR1268631382686445713201
chr12699370726994096390ENSG00000253368ENST000005221110TRNP1TMF1-regulated nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:34348]GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0042127(regulation of cell proliferation);GO:0051726(regulation of cell cycle);GO:0005719(nuclear euchromatin);GO:0021696(cerebellar cortex morphogenesis);GO:0061351(neural precursor cell proliferation)NA0.001390,0-184-1823.86-2.99-4.58-0.505' UTR1269937072700089871921
chr126994545270001205576ENSG00000253368ENST00000531285226TRNP1TMF1-regulated nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:34348]GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0042127(regulation of cell proliferation);GO:0051726(regulation of cell cycle);GO:0005719(nuclear euchromatin);GO:0021696(cerebellar cortex morphogenesis);GO:0061351(neural precursor cell proliferation)NA0286,274,0,5302-728-Inf3.37-12.10-14.90-0.433' UTR1269943192700010957911
chr12874297928743188210ENSG00000198492ENST000004688633888YTHDF2YTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675]GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0000932(P-body);GO:0005515(protein binding);GO:0006959(humoral immune response);GO:1990247(N6-methyladenosine-containing RNA binding);GO:0048598(embryonic morphogenesis);GO:0043488(regulation of mRNA stability);GO:0061157(mRNA destabilization);GO:1903679(positive regulation of cap-independent translational initiation)NA0.001210,0-10.90-9.801.68-1.32-2.41-0.63Exon (ENST00000542507/ENSG00000198492, exon 5 of 6)1287390912874288337931
chr1313489513136439215442ENSG00000229044ENST00000430143-2152AL451070.1NANANA0.00224,361,0,15081-48.60-47.103.74-1.72-2.940.573' UTR13133306731346799137332
chr13143423331434441209ENSG00000168528ENST0000053638420420SERINC2serine incorporator 2 [Source:HGNC Symbol;Acc:HGNC:23231]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006665(sphingolipid metabolic process);GO:0006658(phosphatidylserine metabolic process);GO:0070062(extracellular exosome);GO:0015194(L-serine transmembrane transporter activity);GO:0015825(L-serine transport);GO:1904219(positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity);GO:1904222(positive regulation of serine C-palmitoyltransferase activity)NA0.001209,0-20.60-19.402.11-2.64-4.15-0.883' UTR13141381331434680208681
chr13158703031587626597ENSG00000142910ENST000004805861879TINAGL1tubulointerstitial nephritis antigen like 1 [Source:HGNC Symbol;Acc:HGNC:19168]GO:0005615(extracellular space);GO:0005515(protein binding);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0005576(extracellular region);GO:0006955(immune response);GO:0005044(scavenger receptor activity);GO:0006898(receptor-mediated endocytosis);GO:0030247(polysaccharide binding);GO:0070062(extracellular exosome);GO:0007155(cell adhesion);GO:0016197(endosomal transport);GO:0031012(extracellular matrix);GO:0005201(extracellular matrix structural constituent);GO:0043236(laminin binding);GO:0005737(cytoplasm)NA0.001597,0-85.30-83.703.02-2.18-3.56-0.373' UTR1315851513158644212921
chr132193259321954212163ENSG00000160050ENST00000373602-4965CCDC28Bcoiled-coil domain containing 28B [Source:HGNC Symbol;Acc:HGNC:28163]GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0060271(cilium assembly);GO:0030030(cell projection organization)NA0.00342,96,520,0,806,1643-129-1289.21-1.38-2.49-0.293' UTR1322003863220538750021
chr13277098132771550570ENSG00000162522ENST000003734805314KIAA1522KIAA1522 [Source:HGNC Symbol;Acc:HGNC:29301]GO:0030154(cell differentiation)NA0.001570,0-296-2933.67-3.38-5.07-0.31Exon (ENST00000401073/ENSG00000162522, exon 6 of 7)1327656673277497093041
chr13328159333281831239ENSG00000160094ENST000004779341243ZNF362zinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding)NA0.001239,0-37.40-364.54-1.61-2.801.09Exon (ENST00000539719/ENSG00000160094, exon 6 of 9)1332803503328197316241
chr1361561993617154615348ENSG00000116871ENST000003731510MAP7D1MAP7 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25514]GO:0000226(microtubule cytoskeleton organization);GO:0015630(microtubule cytoskeleton);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005819(spindle);GO:0005198(structural molecule activity)NA04265,76,345,34,0,1016,14772,15314-938-Inf8.10-2.99-4.58-0.275' UTR13615620236180840246391
chr13618031036180849540ENSG00000116871ENST000004871141289MAP7D1MAP7 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25514]GO:0000226(microtubule cytoskeleton organization);GO:0015630(microtubule cytoskeleton);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005819(spindle);GO:0005198(structural molecule activity)NA0.001540,0-175-17322.90-1.31-2.39-0.273' UTR1361790213618031512951
chr136296667363043087642ENSG00000214193ENST00000453908-2079SH3D21SH3 domain containing 21 [Source:HGNC Symbol;Acc:HGNC:26236]GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0070062(extracellular exosome)NA04104,199,144,513,0,4219,4886,7129-516-Inf23.60-3.44-5.150.483' UTR13630638736321230148441
chr13632237936322529151ENSG00000142694ENST000004904661086EVA1Beva-1 homolog B [Source:HGNC Symbol;Acc:HGNC:25558]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding)NA0.001151,0-16.50-15.302.15-2.08-3.42-0.803' UTR1363222813632361513352
chr13779958437800211628ENSG00000233728ENST00000433474668AL929472.3NANANA0.001628,0-246-2443.73-1.68-2.88-0.293' UTR1377997203780087911602
chr13780810937808495387ENSG00000196449ENST000003730440YRDCyrdC N6-threonylcarbamoyltransferase domain containing [Source:HGNC Symbol;Acc:HGNC:28905]GO:0016020(membrane);GO:0005739(mitochondrion);GO:0003725(double-stranded RNA binding);GO:0005737(cytoplasm);GO:0000049(tRNA binding);GO:0051051(negative regulation of transport);GO:0016779(nucleotidyltransferase activity);GO:0002949(tRNA threonylcarbamoyladenosine modification);GO:0006450(regulation of translational fidelity)NA0.001387,0-121-12011.60-5.53-7.61-1.115' UTR1378029443780818552422
chr139026376390346368261ENSG00000168653ENST0000037296958NDUFS5NADH:ubiquinone oxidoreductase subunit S5 [Source:HGNC Symbol;Acc:HGNC:7712]GO:0016020(membrane);GO:0055114(oxidation-reduction process);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:0070469(respiratory chain);GO:0005758(mitochondrial intermembrane space);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0005747(mitochondrial respiratory chain complex I)00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))0327,218,245,0,2347,8016-353-Inf113-1.40-2.51-0.805' UTR1390263183903463683191
chr1393883873940953121145ENSG00000127603ENST000005302750MACF1microtubule-actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0005874(microtubule);GO:0045296(cadherin binding);GO:0051015(actin filament binding);GO:0045773(positive regulation of axon extension);GO:0032587(ruffle membrane);GO:0042060(wound healing);GO:0051893(regulation of focal adhesion assembly);GO:0032886(regulation of microtubule-based process);GO:0030177(positive regulation of Wnt signaling pathway);GO:0010632(regulation of epithelial cell migration);GO:0043001(Golgi to plasma membrane protein transport);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0015629(actin cytoskeleton)NA0.002272,29,0,21116-94.90-93.202.87-2.41-3.850.535' UTR13940950339428092185901
chr13941259039412830241ENSG00000127603ENST000006411041567MACF1microtubule-actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0005874(microtubule);GO:0045296(cadherin binding);GO:0051015(actin filament binding);GO:0045773(positive regulation of axon extension);GO:0032587(ruffle membrane);GO:0042060(wound healing);GO:0051893(regulation of focal adhesion assembly);GO:0032886(regulation of microtubule-based process);GO:0030177(positive regulation of Wnt signaling pathway);GO:0010632(regulation of epithelial cell migration);GO:0043001(Golgi to plasma membrane protein transport);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0015629(actin cytoskeleton)NA0.001241,0-12.30-11.201.41-1.77-3.010.42Exon (ENST00000530275/ENSG00000127603, exon 1 of 6)1394110233941648254601
chr13948570839485888181ENSG00000183682ENST00000331593-5758BMP8Abone morphogenetic protein 8a [Source:HGNC Symbol;Acc:HGNC:21650]GO:0008083(growth factor activity);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0005125(cytokine activity);GO:0005615(extracellular space);GO:0030154(cell differentiation);GO:0060395(SMAD protein signal transduction);GO:0001503(ossification);GO:0051216(cartilage development);GO:0005160(transforming growth factor beta receptor binding);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0030509(BMP signaling pathway);GO:0042981(regulation of apoptotic process);GO:0043408(regulation of MAPK cascade);GO:0048468(cell development);GO:2000505(regulation of energy homeostasis);GO:0046676(negative regulation of insulin secretion);GO:0070700(BMP receptor binding);GO:0002024(diet induced thermogenesis)04350(TGF-beta signaling pathway);04390(Hippo signaling pathway)0.001181,0-43.40-41.901.84-3.02-4.620.443' UTR13949164639525935342901
chr14335908143359533453ENSG00000117399ENST0000037246268CDC20cell division cycle 20 [Source:HGNC Symbol;Acc:HGNC:1723]GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0051301(cell division);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0000922(spindle pole);GO:0005815(microtubule organizing center);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016579(protein deubiquitination);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition);GO:0008022(protein C-terminus binding);GO:0010997(anaphase-promoting complex binding);GO:0097027(ubiquitin-protein transferase activator activity);GO:1904668(positive regulation of ubiquitin protein ligase activity);GO:0007062(sister chromatid cohesion);GO:0019899(enzyme binding);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0005680(anaphase-promoting complex);GO:0005819(spindle);GO:0090129(positive regulation of synapse maturation);GO:0031915(positive regulation of synaptic plasticity);GO:0042826(histone deacetylase binding);GO:0007064(mitotic sister chromatid cohesion);GO:0008284(positive regulation of cell proliferation);GO:0040020(regulation of meiotic nuclear division);GO:0050773(regulation of dendrite development);GO:0090307(mitotic spindle assembly);GO:0005813(centrosome);GO:0043234(protein complex);GO:0048471(perinuclear region of cytoplasm)04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);05203(Viral carcinogenesis);05166(HTLV-I infection)02316,44,0,409-434-Inf8.93-2.16-3.52-0.575' UTR1433590134336320341911
chr14360362743604166540ENSG00000142949ENST00000463041-1416PTPRFprotein tyrosine phosphatase, receptor type F [Source:HGNC Symbol;Acc:HGNC:9670]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0007155(cell adhesion);GO:0004725(protein tyrosine phosphatase activity);GO:0016791(phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0005886(plasma membrane);GO:0008201(heparin binding);GO:0070062(extracellular exosome);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0005887(integral component of plasma membrane);GO:0016477(cell migration);GO:0007185(transmembrane receptor protein tyrosine phosphatase signaling pathway);GO:0005001(transmembrane receptor protein tyrosine phosphatase activity);GO:0032403(protein complex binding);GO:0035373(chondroitin sulfate proteoglycan binding);GO:0010975(regulation of neuron projection development);GO:0031102(neuron projection regeneration);GO:0048679(regulation of axon regeneration);GO:1900121(negative regulation of receptor binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body)04514(Cell adhesion molecules (CAMs));04520(Adherens junction);04910(Insulin signaling pathway);04931(Insulin resistance)01540,0-1250-Inf5.59-5.19-7.20-0.30Exon (ENST00000359947/ENSG00000142949, exon 16 of 34)1436055824360686812871
chr14396760343968022420ENSG00000117408ENST00000486876443IPO13importin 13 [Source:HGNC Symbol;Acc:HGNC:16853]GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0005515(protein binding);GO:0008536(Ran GTPase binding);GO:0008139(nuclear localization sequence binding);GO:0008565(protein transporter activity);GO:0031965(nuclear membrane);GO:0006606(protein import into nucleus)NA0.001420,0-11.90-10.808.32-1.36-2.45-1.483' UTR143967160439676635041
chr14397230343972592290ENSG00000132768ENST00000527319834DPH2DPH2 homolog [Source:HGNC Symbol;Acc:HGNC:3004]GO:0016740(transferase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine);GO:0090560(2-(3-amino-3-carboxypropyl)histidine synthase activity)NA0.00232,178,0,112-36.90-35.602.55-1.35-2.45-0.543' UTR1439714694397280813401
chr14399036243990781420ENSG00000159214ENST00000486064-578CCDC24coiled-coil domain containing 24 [Source:HGNC Symbol;Acc:HGNC:28688]GO:0005515(protein binding)NA0.001420,0-144-1422.31-1.47-2.62-0.233' UTR1439913594399652451661
chr14463203444632296263ENSG00000187147ENST000004974690RNF220ring finger protein 220 [Source:HGNC Symbol;Acc:HGNC:25552]GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0005515(protein binding);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0004842(ubiquitin-protein transferase activity);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)NA0.002179,62,0,201-49.80-48.3016.10-3.07-4.68-1.085' UTR14463223544645081128471
chr14550895545509194240ENSG00000132763ENST00000477188-239MMACHCmethylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria [Source:HGNC Symbol;Acc:HGNC:24525]GO:0005737(cytoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0042803(protein homodimerization activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0031419(cobalamin binding);GO:0071949(FAD binding);GO:0009235(cobalamin metabolic process);GO:0043295(glutathione binding);GO:0006749(glutathione metabolic process);GO:0032451(demethylase activity);GO:0009236(cobalamin biosynthetic process);GO:0033787(cyanocobalamin reductase (cyanide-eliminating) activity);GO:0070988(demethylation);GO:0005739(mitochondrion)04977(Vitamin digestion and absorption)0.001240,0-28.60-27.302.56-1.46-2.60-0.70Exon (ENST00000401061/ENSG00000132763, exon 4 of 4)1455094334551050510731
chr145606656456078361181ENSG00000281825ENST00000626823-926AL355480.4NANANA0225,516,0,665-331-Inf6.35-3.85-5.640.523' UTR14560565745605730742
chr150970312509743043993ENSG00000123080ENST00000371761368CDKN2Ccyclin dependent kinase inhibitor 2C [Source:HGNC Symbol;Acc:HGNC:1789]GO:0008285(negative regulation of cell proliferation);GO:0005737(cytoplasm);GO:0005634(nucleus);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0005829(cytosol);GO:0019901(protein kinase binding);GO:0030308(negative regulation of cell growth);GO:0007050(cell cycle arrest);GO:0000082(G1/S transition of mitotic cell cycle);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0042326(negative regulation of phosphorylation);GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0048709(oligodendrocyte differentiation)04110(Cell cycle);05202(Transcriptional misregulation in cancers);05166(HTLV-I infection);01522(Endocrine resistance)0.002186,412,0,3581-131-1294.45-1.56-2.74-0.485' UTR1509699445097455846151
chr15506434555064673329ENSG00000162402ENST000004809628319USP24ubiquitin specific peptidase 24 [Source:HGNC Symbol;Acc:HGNC:12623]GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0005654(nucleoplasm)NA0.001329,0-8.58-7.541.83-2.31-3.72-0.843' UTR1550718135507299211802
chr18558285585583304450ENSG00000142871ENST000004804131655CYR61cysteine rich angiogenic inducer 61 [Source:HGNC Symbol;Acc:HGNC:2654]GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0001934(positive regulation of protein phosphorylation);GO:0030335(positive regulation of cell migration);GO:0030513(positive regulation of BMP signaling pathway);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0000166(nucleotide binding);GO:0007155(cell adhesion);GO:0005576(extracellular region);GO:0005520(insulin-like growth factor binding);GO:0001558(regulation of cell growth);GO:0006935(chemotaxis);GO:0008201(heparin binding);GO:0044267(cellular protein metabolic process);GO:0031012(extracellular matrix);GO:0043687(post-translational protein modification);GO:0007267(cell-cell signaling);GO:0005578(proteinaceous extracellular matrix);GO:0045669(positive regulation of osteoblast differentiation);GO:0005788(endoplasmic reticulum lumen);GO:0009653(anatomical structure morphogenesis);GO:0008283(cell proliferation);GO:0045860(positive regulation of protein kinase activity);GO:0005178(integrin binding);GO:0019838(growth factor binding);GO:0050840(extracellular matrix binding);GO:0001649(osteoblast differentiation);GO:0002041(intussusceptive angiogenesis);GO:0003181(atrioventricular valve morphogenesis);GO:0003278(apoptotic process involved in heart morphogenesis);GO:0003281(ventricular septum development);GO:0010518(positive regulation of phospholipase activity);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016337(single organismal cell-cell adhesion);GO:0030198(extracellular matrix organization);GO:0033690(positive regulation of osteoblast proliferation);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0044319(wound healing, spreading of cells);GO:0045597(positive regulation of cell differentiation);GO:0060413(atrial septum morphogenesis);GO:0060548(negative regulation of cell death);GO:0060591(chondroblast differentiation);GO:0060710(chorio-allantoic fusion);GO:0060716(labyrinthine layer blood vessel development);GO:0061036(positive regulation of cartilage development);GO:0072593(reactive oxygen species metabolic process);GO:2000304(positive regulation of ceramide biosynthetic process);GO:0005615(extracellular space)NA01450,0-661-Inf5.26-1.35-2.450.173' UTR185581200855820999001
chr1109929406109930004599ENSG00000184371ENST0000052600113749CSF1colony stimulating factor 1 [Source:HGNC Symbol;Acc:HGNC:2432]GO:0016021(integral component of membrane);GO:0008083(growth factor activity);GO:0005125(cytokine activity);GO:0005615(extracellular space);GO:0010628(positive regulation of gene expression);GO:0048471(perinuclear region of cytoplasm);GO:0030335(positive regulation of cell migration);GO:0016020(membrane);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0030154(cell differentiation);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0006954(inflammatory response);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0008283(cell proliferation);GO:0008284(positive regulation of cell proliferation);GO:0042803(protein homodimerization activity);GO:0005788(endoplasmic reticulum lumen);GO:0030097(hemopoiesis);GO:0001954(positive regulation of cell-matrix adhesion);GO:0045860(positive regulation of protein kinase activity);GO:0042117(monocyte activation);GO:0030316(osteoclast differentiation);GO:0045672(positive regulation of osteoclast differentiation);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0032270(positive regulation of cellular protein metabolic process);GO:0045651(positive regulation of macrophage differentiation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0030225(macrophage differentiation);GO:1990682(CSF1-CSF1R complex);GO:0010759(positive regulation of macrophage chemotaxis);GO:0005157(macrophage colony-stimulating factor receptor binding);GO:0002158(osteoclast proliferation);GO:0003006(developmental process involved in reproduction);GO:0010743(regulation of macrophage derived foam cell differentiation);GO:0030278(regulation of ossification);GO:0032946(positive regulation of mononuclear cell proliferation);GO:0038145(macrophage colony-stimulating factor signaling pathway);GO:0040018(positive regulation of multicellular organism growth);GO:0042488(positive regulation of odontogenesis of dentin-containing tooth);GO:0045657(positive regulation of monocyte differentiation);GO:0046579(positive regulation of Ras protein signal transduction);GO:0048873(homeostasis of number of cells within a tissue);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060611(mammary gland fat development);GO:0060763(mammary duct terminal end bud growth);GO:1902228(positive regulation of macrophage colony-stimulating factor signaling pathway);GO:1904141(positive regulation of microglial cell migration)04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04668(TNF signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);04380(Osteoclast differentiation);05323(Rheumatoid arthritis)0.001599,0-101-99.403.50-3.81-5.59-0.553' UTR110991565710992254968931
chr1111766908111767088181ENSG00000064703ENST000005342004491DDX20DEAD-box helicase 20 [Source:HGNC Symbol;Acc:HGNC:2743]GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0004386(helicase activity);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0005730(nucleolus);GO:0000387(spliceosomal snRNP assembly);GO:0005654(nucleoplasm);GO:0010501(RNA secondary structure unwinding);GO:0043065(positive regulation of apoptotic process);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0005856(cytoskeleton);GO:0004004(ATP-dependent RNA helicase activity);GO:0051170(nuclear import);GO:0032797(SMN complex);GO:0034719(SMN-Sm protein complex);GO:0097504(Gemini of coiled bodies);GO:0006396(RNA processing);GO:0070491(repressing transcription factor binding);GO:0000244(spliceosomal tri-snRNP complex assembly);GO:0019904(protein domain specific binding);GO:0030674(protein binding, bridging);GO:0042826(histone deacetylase binding);GO:0008285(negative regulation of cell proliferation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048477(oogenesis);GO:0050810(regulation of steroid biosynthetic process);GO:0017053(transcriptional repressor complex);GO:0090571(RNA polymerase II transcription repressor complex)03013(RNA transport)0.001181,0-5.34-4.382.71-1.38-2.491.993' UTR111176241711176583034141
chr1112456911112457360450ENSG00000143079ENST0000060703993CTTNBP2NLCTTNBP2 N-terminal like [Source:HGNC Symbol;Acc:HGNC:25330]GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0015629(actin cytoskeleton);GO:0051721(protein phosphatase 2A binding);GO:0032410(negative regulation of transporter activity);GO:0034763(negative regulation of transmembrane transport)NA0.001450,0-55.80-54.303.12-1.43-2.560.46Exon (ENST00000271277/ENSG00000143079, exon 6 of 6)111245681811246345666391
chr11476158611476195243664ENSG00000116128ENST000004732924248BCL9B-cell CLL/lymphoma 9 [Source:HGNC Symbol;Acc:HGNC:1008]GO:0005634(nucleus);GO:0003713(transcription coactivator activity);GO:0008013(beta-catenin binding);GO:0014908(myotube differentiation involved in skeletal muscle regeneration);GO:0035019(somatic stem cell population maintenance);GO:0035914(skeletal muscle cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060070(canonical Wnt signaling pathway);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0005515(protein binding);GO:0016055(Wnt signaling pathway);GO:0005654(nucleoplasm);GO:1904837(beta-catenin-TCF complex assembly)NA0.00242,709,0,2955-129-1274.68-1.36-2.46-0.38Exon (ENST00000234739/ENSG00000116128, exon 7 of 10)114761161314761590242901
chr1149900232149900798567ENSG00000178096ENST00000369150606BOLA1bolA family member 1 [Source:HGNC Symbol;Acc:HGNC:24263]GO:0005739(mitochondrion);GO:0005515(protein binding)NA0.001567,0-277-27415-1.31-2.39-0.403' UTR11498996261499005489231
chr1150471599150472347749ENSG00000143374ENST00000438568-15017TARS2threonyl-tRNA synthetase 2, mitochondrial (putative) [Source:HGNC Symbol;Acc:HGNC:30740]GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0006412(translation);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0042803(protein homodimerization activity);GO:0016874(ligase activity);GO:0005759(mitochondrial matrix);GO:0004812(aminoacyl-tRNA ligase activity);GO:0006418(tRNA aminoacylation for protein translation);GO:0006450(regulation of translational fidelity);GO:0016876(ligase activity, forming aminoacyl-tRNA and related compounds);GO:0043039(tRNA aminoacylation);GO:0004829(threonine-tRNA ligase activity);GO:0006435(threonyl-tRNA aminoacylation);GO:0002161(aminoacyl-tRNA editing activity);GO:0070159(mitochondrial threonyl-tRNA aminoacylation)00970(Aminoacyl-tRNA biosynthesis)0.001749,0-121-1194.21-1.44-2.570.33Exon (ENST00000492220/ENSG00000163125, exon 11 of 11)1150487364150507609202461
chr1151286971151287420450ENSG00000143373ENST00000426871-64ZNF687zinc finger protein 687 [Source:HGNC Symbol;Acc:HGNC:29277]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding)NA0.001450,0-71-69.403.65-1.37-2.47-0.40Exon (ENST00000336715/ENSG00000143373, exon 2 of 9)115128748415129190344201
chr1151291491151291731241ENSG00000143373ENST000004366141040ZNF687zinc finger protein 687 [Source:HGNC Symbol;Acc:HGNC:29277]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding)NA0.001241,0-32.80-31.408.65-1.85-3.12-1.873' UTR11512904511512913378871
chr1151759642151759911270ENSG00000143436ENST000004958671009MRPL9mitochondrial ribosomal protein L9 [Source:HGNC Symbol;Acc:HGNC:14277]GO:0003723(RNA binding);GO:0006412(translation);GO:0005739(mitochondrion);GO:0030529(intracellular ribonucleoprotein complex);GO:0005622(intracellular);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0005515(protein binding);GO:0005743(mitochondrial inner membrane);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination);GO:0005761(mitochondrial ribosome);GO:0005762(mitochondrial large ribosomal subunit)03010(Ribosome)0.001270,0-48.60-47.202.67-1.76-2.990.543' UTR115175988415176092010372
chr1153661237153661385149ENSG00000143553ENST000004785582510SNAPINSNAP associated protein [Source:HGNC Symbol;Acc:HGNC:17145]GO:0005737(cytoplasm);GO:0016020(membrane);GO:0006886(intracellular protein transport);GO:0005794(Golgi apparatus);GO:0005765(lysosomal membrane);GO:1904115(axon cytoplasm);GO:0005829(cytosol);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0048471(perinuclear region of cytoplasm);GO:0030054(cell junction);GO:0045202(synapse);GO:0031410(cytoplasmic vesicle);GO:0005764(lysosome);GO:0031083(BLOC-1 complex);GO:0006887(exocytosis);GO:0016032(viral process);GO:0008333(endosome to lysosome transport);GO:0008089(anterograde axonal transport);GO:0032438(melanosome organization);GO:0048490(anterograde synaptic vesicle transport);GO:0030672(synaptic vesicle membrane);GO:0031175(neuron projection development);GO:0048489(synaptic vesicle transport);GO:0008021(synaptic vesicle);GO:0030141(secretory granule);GO:0007269(neurotransmitter secretion);GO:0000149(SNARE binding);GO:0007040(lysosome organization);GO:0007042(lysosomal lumen acidification);GO:0007268(chemical synaptic transmission);GO:0008090(retrograde axonal transport);GO:0010977(negative regulation of neuron projection development);GO:0016079(synaptic vesicle exocytosis);GO:0016188(synaptic vesicle maturation);GO:0031629(synaptic vesicle fusion to presynaptic active zone membrane);GO:0032418(lysosome localization);GO:0034629(cellular protein complex localization);GO:0043393(regulation of protein binding);GO:0051604(protein maturation);GO:0072553(terminal button organization);GO:0097352(autophagosome maturation);GO:1902774(late endosome to lysosome transport);GO:1902824(positive regulation of late endosome to lysosome transport);GO:0099078(BORC complex)NA0.001149,0-5.38-4.421.28-1.34-2.43-0.513' UTR115365872715366156428381
chr1155017775155018522748ENSG00000160685ENST000002921763327ZBTB7Bzinc finger and BTB domain containing 7B [Source:HGNC Symbol;Acc:HGNC:18668]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0006366(transcription from RNA polymerase II promoter);GO:0007398(ectoderm development);GO:0010628(positive regulation of gene expression);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0042803(protein homodimerization activity);GO:0043370(regulation of CD4-positive, alpha-beta T cell differentiation);GO:0043376(regulation of CD8-positive, alpha-beta T cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)NA0.001748,0-49.90-48.508.79-2.94-4.52-0.633' UTR115501444815501698125341
chr11557370181557385301513ENSG00000132676ENST000004917776DAP3death associated protein 3 [Source:HGNC Symbol;Acc:HGNC:2673]GO:0003723(RNA binding);GO:0000166(nucleotide binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0030529(intracellular ribonucleoprotein complex);GO:0005840(ribosome);GO:0005525(GTP binding);GO:0015935(small ribosomal subunit);GO:0006915(apoptotic process);GO:0005515(protein binding);GO:0005761(mitochondrial ribosome);GO:0003735(structural constituent of ribosome);GO:0005763(mitochondrial small ribosomal subunit);GO:0005743(mitochondrial inner membrane);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination);GO:0097190(apoptotic signaling pathway)NA0.00246,374,0,1139-270-2689.95-2.17-3.540.763' UTR115573701215573901019991
chr1156114674156115004331ENSG00000160789ENST000003683000LMNAlamin A/C [Source:HGNC Symbol;Acc:HGNC:6636]GO:0030334(regulation of cell migration);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005882(intermediate filament);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0031012(extracellular matrix);GO:0031965(nuclear membrane);GO:0005635(nuclear envelope);GO:0036498(IRE1-mediated unfolded protein response);GO:0034504(protein localization to nucleus);GO:0071456(cellular response to hypoxia);GO:0007077(mitotic nuclear envelope disassembly);GO:0005652(nuclear lamina);GO:0007084(mitotic nuclear envelope reassembly);GO:0008285(negative regulation of cell proliferation);GO:0030951(establishment or maintenance of microtubule cytoskeleton polarity);GO:0090343(positive regulation of cell aging);GO:0006997(nucleus organization);GO:0006998(nuclear envelope organization);GO:0010628(positive regulation of gene expression);GO:0035105(sterol regulatory element binding protein import into nucleus);GO:0055015(ventricular cardiac muscle cell development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:1900180(regulation of protein localization to nucleus);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0005638(lamin filament)04210(Apoptosis);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))01331,0-4050-Inf8.29-3.57-5.31-0.205' UTR1156114707156140089253831
chr11561152741561232007927ENSG00000160789ENST000005023570LMNAlamin A/C [Source:HGNC Symbol;Acc:HGNC:6636]GO:0030334(regulation of cell migration);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005882(intermediate filament);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0031012(extracellular matrix);GO:0031965(nuclear membrane);GO:0005635(nuclear envelope);GO:0036498(IRE1-mediated unfolded protein response);GO:0034504(protein localization to nucleus);GO:0071456(cellular response to hypoxia);GO:0007077(mitotic nuclear envelope disassembly);GO:0005652(nuclear lamina);GO:0007084(mitotic nuclear envelope reassembly);GO:0008285(negative regulation of cell proliferation);GO:0030951(establishment or maintenance of microtubule cytoskeleton polarity);GO:0090343(positive regulation of cell aging);GO:0006997(nucleus organization);GO:0006998(nuclear envelope organization);GO:0010628(positive regulation of gene expression);GO:0035105(sterol regulatory element binding protein import into nucleus);GO:0055015(ventricular cardiac muscle cell development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:1900180(regulation of protein localization to nucleus);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0005638(lamin filament)04210(Apoptosis);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))0.0021,59,0,7868-33.30-31.901.45-1.48-2.63-0.44Exon (ENST00000368301/ENSG00000160789, exon 4 of 13)1156123142156134528113871
chr11566419631566460924130ENSG00000132692ENST000004577770BCANbrevican [Source:HGNC Symbol;Acc:HGNC:23059]GO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0007155(cell adhesion);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0031225(anchored component of membrane);GO:0005540(hyaluronic acid binding);GO:0043202(lysosomal lumen);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0005796(Golgi lumen);GO:0005201(extracellular matrix structural constituent);GO:0001501(skeletal system development);GO:0007417(central nervous system development);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030207(chondroitin sulfate catabolic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0022617(extracellular matrix disassembly);GO:0021766(hippocampus development)NA0.002313,46,0,4084-173-1717.08-3.27-4.94-0.785' UTR115664211415664768255691
chr1158094725158095174450ENSG00000183853ENST000003681728045KIRREL1kirre like nephrin family adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:15734]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0007411(axon guidance);GO:0005911(cell-cell junction);GO:0031295(T cell costimulation);GO:0017022(myosin binding);GO:0001933(negative regulation of protein phosphorylation);GO:0007588(excretion);GO:0016337(single organismal cell-cell adhesion);GO:0030838(positive regulation of actin filament polymerization);GO:0031253(cell projection membrane);GO:0043198(dendritic shaft);GO:0045121(membrane raft)NA0.001450,0-285-2834-2.94-4.51-0.363' UTR1158086680158100262135831
chr1159782219159782543325ENSG00000158716ENST000003681071216DUSP23dual specificity phosphatase 23 [Source:HGNC Symbol;Acc:HGNC:21480]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016791(phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0005829(cytosol);GO:0004721(phosphoprotein phosphatase activity);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0004722(protein serine/threonine phosphatase activity)NA01325,0-500-Inf34.20-1.64-2.83-0.353' UTR115978100315978254315411
chr1162383343162383792450ENSG00000239887ENST000004586261613C1orf226chromosome 1 open reading frame 226 [Source:HGNC Symbol;Acc:HGNC:34351]NANA0.001450,0-37-35.603.09-1.39-2.510.573' UTR116238173016238681850891
chr11659059291659082702342ENSG00000283936ENST000006362910MIR3658microRNA 3658 [Source:HGNC Symbol;Acc:HGNC:38963]NANA0.00241,587,0,1755-108-1073.77-1.73-2.960.433' UTR1165907921165907976561
chr1169106354169106683330ENSG00000143153ENST0000036781531ATP1B1ATPase Na+/K+ transporting subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:804]GO:0006810(transport);GO:0016020(membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0005622(intracellular);GO:0016021(integral component of membrane);GO:0007155(cell adhesion);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0050900(leukocyte migration);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0090662(ATP hydrolysis coupled transmembrane transport);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0042383(sarcolemma);GO:1903278(positive regulation of sodium ion export from cell);GO:1903779(regulation of cardiac conduction);GO:1903561(extracellular vesicle);GO:0051117(ATPase binding);GO:0050821(protein stabilization);GO:0060048(cardiac muscle contraction);GO:0005524(ATP binding);GO:0010107(potassium ion import);GO:0014704(intercalated disc);GO:0016887(ATPase activity);GO:0023026(MHC class II protein complex binding);GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0006883(cellular sodium ion homeostasis);GO:0030007(cellular potassium ion homeostasis);GO:0036376(sodium ion export from cell);GO:0055119(relaxation of cardiac muscle);GO:0086009(membrane repolarization);GO:0086013(membrane repolarization during cardiac muscle cell action potential);GO:0086064(cell communication by electrical coupling involved in cardiac conduction);GO:1990573(potassium ion import across plasma membrane);GO:0008144(drug binding);GO:0001671(ATPase activator activity);GO:0006874(cellular calcium ion homeostasis);GO:0010468(regulation of gene expression);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0032781(positive regulation of ATPase activity);GO:0044861(protein transport into plasma membrane raft);GO:0046034(ATP metabolic process);GO:0072659(protein localization to plasma membrane);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903281(positive regulation of calcium:sodium antiporter activity);GO:1903288(positive regulation of potassium ion import);GO:0008022(protein C-terminus binding);GO:0019901(protein kinase binding);GO:0001666(response to hypoxia);GO:0030001(metal ion transport);GO:1903169(regulation of calcium ion transmembrane transport);GO:0005901(caveola);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0043209(myelin sheath)04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04925(Aldosterone synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation)0.001330,0-29.40-28.102.75-2.11-3.46-0.875' UTR1169106323169132019256971
chr1169131346169131466121ENSG00000143153ENST0000049479723439ATP1B1ATPase Na+/K+ transporting subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:804]GO:0006810(transport);GO:0016020(membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0005622(intracellular);GO:0016021(integral component of membrane);GO:0007155(cell adhesion);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0050900(leukocyte migration);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0090662(ATP hydrolysis coupled transmembrane transport);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0042383(sarcolemma);GO:1903278(positive regulation of sodium ion export from cell);GO:1903779(regulation of cardiac conduction);GO:1903561(extracellular vesicle);GO:0051117(ATPase binding);GO:0050821(protein stabilization);GO:0060048(cardiac muscle contraction);GO:0005524(ATP binding);GO:0010107(potassium ion import);GO:0014704(intercalated disc);GO:0016887(ATPase activity);GO:0023026(MHC class II protein complex binding);GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0006883(cellular sodium ion homeostasis);GO:0030007(cellular potassium ion homeostasis);GO:0036376(sodium ion export from cell);GO:0055119(relaxation of cardiac muscle);GO:0086009(membrane repolarization);GO:0086013(membrane repolarization during cardiac muscle cell action potential);GO:0086064(cell communication by electrical coupling involved in cardiac conduction);GO:1990573(potassium ion import across plasma membrane);GO:0008144(drug binding);GO:0001671(ATPase activator activity);GO:0006874(cellular calcium ion homeostasis);GO:0010468(regulation of gene expression);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0032781(positive regulation of ATPase activity);GO:0044861(protein transport into plasma membrane raft);GO:0046034(ATP metabolic process);GO:0072659(protein localization to plasma membrane);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903281(positive regulation of calcium:sodium antiporter activity);GO:1903288(positive regulation of potassium ion import);GO:0008022(protein C-terminus binding);GO:0019901(protein kinase binding);GO:0001666(response to hypoxia);GO:0030001(metal ion transport);GO:1903169(regulation of calcium ion transmembrane transport);GO:0005901(caveola);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0043209(myelin sheath)04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04925(Aldosterone synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation)0.001121,0-9.13-8.071.48-1.47-2.620.62Exon (ENST00000367816/ENSG00000143153, exon 7 of 7)1169107907169127399194931
chr11715324231715354583036ENSG00000117523ENST00000495585-6372PRRC2Cproline rich coiled-coil 2C [Source:HGNC Symbol;Acc:HGNC:24903]GO:0003723(RNA binding);GO:0016020(membrane);GO:0008022(protein C-terminus binding);GO:0002244(hematopoietic progenitor cell differentiation)NA0.002539,31,0,3005-282-2805.25-10.10-12.700.773' UTR1171541830171593511516821
chr1171557638171558027390ENSG00000117523ENST0000049558515808PRRC2Cproline rich coiled-coil 2C [Source:HGNC Symbol;Acc:HGNC:24903]GO:0003723(RNA binding);GO:0016020(membrane);GO:0008022(protein C-terminus binding);GO:0002244(hematopoietic progenitor cell differentiation)NA0.001390,0-211-2094.08-3.39-5.090.47Exon (ENST00000367742/ENSG00000117523, exon 19 of 34)1171541830171593511516821
chr1178916503178916713211ENSG00000116191ENST0000047887122665RALGPS2Ral GEF with PH domain and SH3 binding motif 2 [Source:HGNC Symbol;Acc:HGNC:30279]GO:0005737(cytoplasm);GO:0016020(membrane);GO:0007264(small GTPase mediated signal transduction);GO:0005886(plasma membrane);GO:0043547(positive regulation of GTPase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0032485(regulation of Ral protein signal transduction);GO:0005622(intracellular)NA0.001211,0-9.38-8.322.79-1.64-2.831.433' UTR1178893838178916375225381
chr1179917842179918291450ENSG00000143337ENST0000044796413876TOR1AIP1torsin 1A interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:29456]GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0005515(protein binding);GO:0005637(nuclear inner membrane);GO:0008092(cytoskeletal protein binding);GO:0034504(protein localization to nucleus);GO:0032781(positive regulation of ATPase activity);GO:0001671(ATPase activator activity);GO:0051117(ATPase binding);GO:0005521(lamin binding);GO:0071763(nuclear membrane organization);GO:0005635(nuclear envelope)NA0.001450,0-56.40-54.903.34-2.62-4.120.573' UTR1179903966179918171142061
chr1180196307180196845539ENSG00000116260ENST000004430590QSOX1quiescin sulfhydryl oxidase 1 [Source:HGNC Symbol;Acc:HGNC:9756]GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0045454(cell redox homeostasis);GO:0045171(intercellular bridge);GO:0005576(extracellular region);GO:0000139(Golgi membrane);GO:0005615(extracellular space);GO:0003756(protein disulfide isomerase activity);GO:0016972(thiol oxidase activity);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0043312(neutrophil degranulation);GO:0030173(integral component of Golgi membrane);GO:0002576(platelet degranulation);GO:0005788(endoplasmic reticulum lumen);GO:0031093(platelet alpha granule lumen);GO:0016971(flavin-linked sulfhydryl oxidase activity);GO:0016242(negative regulation of macroautophagy);GO:0035580(specific granule lumen);GO:1904724(tertiary granule lumen);GO:0005623(cell)NA01539,0-1690-Inf6.74-2.49-3.95-0.22Exon (ENST00000367602/ENSG00000116260, exon 12 of 12)118019668218019801613351
chr1200848977200849246270ENSG00000118200ENST00000475326-6848CAMSAP2calmodulin regulated spectrin associated protein family member 2 [Source:HGNC Symbol;Acc:HGNC:29188]GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0031175(neuron projection development);GO:0008017(microtubule binding);GO:0005874(microtubule);GO:0005516(calmodulin binding);GO:0005813(centrosome);GO:1990752(microtubule end);GO:0000226(microtubule cytoskeleton organization);GO:0030507(spectrin binding);GO:0051011(microtubule minus-end binding);GO:0033043(regulation of organelle organization)NA0.001270,0-12-10.902.22-1.42-2.540.92Exon (ENST00000358823/ENSG00000118200, exon 11 of 17)120085609420085772416311
chr1201782690201783465776ENSG00000134369ENST0000046913060NAV1neuron navigator 1 [Source:HGNC Symbol;Acc:HGNC:15989]GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0005874(microtubule);GO:0001578(microtubule bundle formation);GO:0001764(neuron migration);GO:0015630(microtubule cytoskeleton);GO:0043194(axon initial segment)NA0.002180,60,0,716-38.60-37.202.46-2.44-3.89-0.78Exon (ENST00000367302/ENSG00000134369, exon 8 of 30)1201782630201798608159791
chr1201876152201876421270ENSG00000198700ENST000004567071837IPO9importin 9 [Source:HGNC Symbol;Acc:HGNC:19425]GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0008536(Ran GTPase binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005635(nuclear envelope);GO:0042393(histone binding);GO:0008565(protein transporter activity);GO:0006606(protein import into nucleus)NA01270,0-324-Inf3.66-2.19-3.570.353' UTR120187431520187637320591
chr1203165520203165968449ENSG00000133055ENST000006213809815MYBPHmyosin binding protein H [Source:HGNC Symbol;Acc:HGNC:7552]GO:0007155(cell adhesion);GO:0005515(protein binding);GO:0051015(actin filament binding);GO:0051371(muscle alpha-actinin binding);GO:0097493(structural molecule activity conferring elasticity);GO:0007015(actin filament organization);GO:0045214(sarcomere organization);GO:0071688(striated muscle myosin thick filament assembly);GO:0005859(muscle myosin complex);GO:0030018(Z disc);GO:0031430(M band);GO:0032982(myosin filament);GO:0008307(structural constituent of muscle);GO:0006942(regulation of striated muscle contraction)NA01449,0-357-Inf4.93-3.16-4.800.393' UTR120316781120317578379732
chr120668497420672900844035ENSG00000162889ENST000003671030MAPKAPK2mitogen-activated protein kinase-activated protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:6887]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005654(nucleoplasm);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005813(centrosome);GO:0005515(protein binding);GO:0006974(cellular response to DNA damage stimulus);GO:0006954(inflammatory response);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0043488(regulation of mRNA stability);GO:0032496(response to lipopolysaccharide);GO:0005516(calmodulin binding);GO:0004871(signal transducer activity);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0031572(G2 DNA damage checkpoint);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0006950(response to stress);GO:0018105(peptidyl-serine phosphorylation);GO:1900034(regulation of cellular response to heat);GO:0000187(activation of MAPK activity);GO:0034097(response to cytokine);GO:0002224(toll-like receptor signaling pathway);GO:0007265(Ras protein signal transduction);GO:0032680(regulation of tumor necrosis factor production);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0006691(leukotriene metabolic process);GO:0000165(MAPK cascade);GO:0004683(calmodulin-dependent protein kinase activity);GO:0009931(calcium-dependent protein serine/threonine kinase activity);GO:0051019(mitogen-activated protein kinase binding);GO:0032675(regulation of interleukin-6 production);GO:0044351(macropinocytosis);GO:0046777(protein autophosphorylation);GO:0038066(p38MAPK cascade);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0048255(mRNA stabilization);GO:0048839(inner ear development)04010(MAPK signaling pathway);04370(VEGF signaling pathway);04218(Cellular senescence);04722(Neurotrophin signaling pathway);05203(Viral carcinogenesis);05167(Kaposi's sarcoma-associated herpesvirus infection)0.003535,140,75,0,43736,43960-99.10-97.408.76-1.38-2.49-0.325' UTR1206685037206734283492471
chr12124443442124463792036ENSG00000117691ENST0000047238911353NENFneudesin neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:30384]GO:0046872(metal ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0012505(endomembrane system);GO:0016020(membrane);GO:0032099(negative regulation of appetite);GO:0008083(growth factor activity);GO:0043410(positive regulation of MAPK cascade)NA0.00299,550,0,1486-251-24914.20-1.35-2.45-0.393' UTR121243299121243503320431
chr1214663689214663869181ENSG00000117724ENST000004698628541CENPFcentromere protein F [Source:HGNC Symbol;Acc:HGNC:1857]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0015031(protein transport);GO:0005654(nucleoplasm);GO:0051301(cell division);GO:0005694(chromosome);GO:0042803(protein homodimerization activity);GO:0008134(transcription factor binding);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0048471(perinuclear region of cytoplasm);GO:0030154(cell differentiation);GO:0000922(spindle pole);GO:0005819(spindle);GO:0030496(midbody);GO:0007059(chromosome segregation);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0005829(cytosol);GO:0003682(chromatin binding);GO:0008283(cell proliferation);GO:0070840(dynein complex binding);GO:0007517(muscle organ development);GO:0008022(protein C-terminus binding);GO:0071897(DNA biosynthetic process);GO:0007062(sister chromatid cohesion);GO:0045892(negative regulation of transcription, DNA-templated);GO:0000785(chromatin);GO:0016363(nuclear matrix);GO:0005635(nuclear envelope);GO:0000278(mitotic cell cycle);GO:0051310(metaphase plate congression);GO:0007094(mitotic spindle assembly checkpoint);GO:0000940(condensed chromosome outer kinetochore);GO:0042493(response to drug);GO:0051726(regulation of cell cycle);GO:0016202(regulation of striated muscle tissue development);GO:0001822(kidney development);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0021591(ventricular system development);GO:0051382(kinetochore assembly);GO:0005813(centrosome);GO:0005930(axoneme);GO:0036064(ciliary basal body);GO:0045120(pronucleus);GO:0097539(ciliary transition fiber)NA0.001181,0-6.50-5.511.97-3.14-4.781.823' UTR121465514821465741022631
chr1215620254215620493240ENSG00000136636ENST000004656501549KCTD3potassium channel tetramerization domain containing 3 [Source:HGNC Symbol;Acc:HGNC:21305]GO:0051260(protein homooligomerization)NA0.001240,0-21.70-20.502.17-2.45-3.900.78Exon (ENST00000259154/ENSG00000136636, exon 18 of 18)121561870521562020314991
chr12237529232237573754453ENSG00000162909ENST00000474026-249CAPN2calpain 2 [Source:HGNC Symbol;Acc:HGNC:1479]GO:0016787(hydrolase activity);GO:0005622(intracellular);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0030425(dendrite);GO:0051493(regulation of cytoskeleton organization);GO:0071230(cellular response to amino acid stimulus);GO:0070062(extracellular exosome);GO:0005783(endoplasmic reticulum);GO:0022617(extracellular matrix disassembly);GO:0045121(membrane raft);GO:0005794(Golgi apparatus);GO:0008092(cytoskeletal protein binding);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0046982(protein heterodimerization activity);GO:0001666(response to hypoxia);GO:0001824(blastocyst development);GO:0007520(myoblast fusion);GO:0016540(protein autoprocessing);GO:0000785(chromatin);GO:0005634(nucleus);GO:0005764(lysosome);GO:0030864(cortical actin cytoskeleton);GO:0031143(pseudopodium);GO:0097038(perinuclear endoplasmic reticulum)04141(Protein processing in endoplasmic reticulum);04210(Apoptosis);04217(Necroptosis);04218(Cellular senescence);04510(Focal adhesion);05010(Alzheimer's disease)0.00334,170,7,0,2557,4446-73.40-71.801.59-1.85-3.120.26Exon (ENST00000433674/ENSG00000162909, exon 9 of 21)1223757624223776018183951
chr1231000180231000536357ENSG00000173409ENST000004598914420ARV1ARV1 homolog, fatty acid homeostasis modulator [Source:HGNC Symbol;Acc:HGNC:29561]GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006629(lipid metabolic process);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008202(steroid metabolic process);GO:0006869(lipid transport);GO:0008206(bile acid metabolic process);GO:0030301(cholesterol transport);GO:0090181(regulation of cholesterol metabolic process);GO:0008203(cholesterol metabolic process);GO:0005794(Golgi apparatus);GO:0006695(cholesterol biosynthetic process);GO:0015248(sterol transporter activity);GO:0032383(regulation of intracellular cholesterol transport);GO:0006665(sphingolipid metabolic process);GO:0097036(regulation of plasma membrane sterol distribution);GO:0032541(cortical endoplasmic reticulum)NA0.001357,0-70.40-68.809.31-1.35-2.45-0.593' UTR123099576023100059548361
chr12346070082346094832476ENSG00000168264ENST000004914300IRF2BP2interferon regulatory factor 2 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:21729]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated)NA02630,63,0,2413-415-Inf3.07-1.36-2.460.163' UTR12346072312346080948642
chr1244053839244054435597ENSG00000179456ENST000003587042556ZBTB18zinc finger and BTB domain containing 18 [Source:HGNC Symbol;Acc:HGNC:13030]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0045171(intercellular bridge);GO:0015630(microtubule cytoskeleton);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0007519(skeletal muscle tissue development);GO:0000228(nuclear chromosome)NA0.001597,0-76-74.402.38-4.73-6.670.47Exon (ENST00000622512/ENSG00000179456, exon 2 of 2)124405128324405747661941
chr1244054555244055389835ENSG00000179456ENST000003587043272ZBTB18zinc finger and BTB domain containing 18 [Source:HGNC Symbol;Acc:HGNC:13030]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0045171(intercellular bridge);GO:0015630(microtubule cytoskeleton);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0007519(skeletal muscle tissue development);GO:0000228(nuclear chromosome)NA01835,0-344-Inf5.83-2.44-3.890.273' UTR124405128324405747661941
chr1248847393248847961569ENSG00000171163ENST000004620376562ZNF692zinc finger protein 692 [Source:HGNC Symbol;Acc:HGNC:26049]GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter)NA0.001569,0-24.10-22.901.76-3.20-4.86-0.52Exon (ENST00000306562/ENSG00000171161, exon 4 of 4)124885037724885452341472
chr1975204975412209ENSG00000187642ENST000004793611229PERM1PPARGC1 and ESRR induced regulator, muscle 1 [Source:HGNC Symbol;Acc:HGNC:28208]GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0014850(response to muscle activity)NA0.001209,0-8.76-7.717.95-1.49-2.64-2.533' UTR197520597664114372
chr113353651336229865ENSG00000107404ENST000006324453193DVL1dishevelled segment polarity protein 1 [Source:HGNC Symbol;Acc:HGNC:3084]GO:0005737(cytoplasm);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0016055(Wnt signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0098793(presynapse);GO:0042802(identical protein binding);GO:0006366(transcription from RNA polymerase II promoter);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0019899(enzyme binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050821(protein stabilization);GO:0060070(canonical Wnt signaling pathway);GO:0099054(presynapse assembly);GO:1905386(positive regulation of protein localization to presynapse);GO:0016328(lateral plasma membrane);GO:0005109(frizzled binding);GO:0019901(protein kinase binding);GO:0001505(regulation of neurotransmitter levels);GO:0006469(negative regulation of protein kinase activity);GO:0007269(neurotransmitter secretion);GO:0007528(neuromuscular junction development);GO:0021915(neural tube development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0032091(negative regulation of protein binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0034504(protein localization to nucleus);GO:0043113(receptor clustering);GO:0048813(dendrite morphogenesis);GO:0050808(synapse organization);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:1903827(regulation of cellular protein localization);GO:1904886(beta-catenin destruction complex disassembly);GO:0030426(growth cone);GO:0043005(neuron projection);GO:0045202(synapse);GO:0008013(beta-catenin binding);GO:0048365(Rac GTPase binding);GO:0001932(regulation of protein phosphorylation);GO:0001933(negative regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0010976(positive regulation of neuron projection development);GO:0022007(convergent extension involved in neural plate elongation);GO:0031122(cytoplasmic microtubule organization);GO:0035176(social behavior);GO:0035372(protein localization to microtubule);GO:0048668(collateral sprouting);GO:0048675(axon extension);GO:0060029(convergent extension involved in organogenesis);GO:0060134(prepulse inhibition);GO:0060997(dendritic spine morphogenesis);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090103(cochlea morphogenesis);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:0005874(microtubule);GO:0014069(postsynaptic density);GO:0015630(microtubule cytoskeleton);GO:0030136(clathrin-coated vesicle);GO:0030424(axon);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:1990909(Wnt signalosome);GO:0005622(intracellular)04310(Wnt signaling pathway);04330(Notch signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);05166(HTLV-I infection);05165(Human papillomavirus infection)0.001865,0-96.20-94.608.25-1.85-3.13-0.333' UTR11336412133942230112
chr115989051599173269ENSG00000228594ENST00000422725923FNDC10fibronectin type III domain containing 10 [Source:HGNC Symbol;Acc:HGNC:42951]GO:0016020(membrane);GO:0016021(integral component of membrane)NA0.001269,0-12.10-112.46-1.64-2.84-1.083' UTR11598012160009620852

Definition of table:

TermDescription
seqnamesThe name of the chromosome (e.g. chr3, chrY, chr2 random) or scaffold (e.g. scaffold10671)
startThe starting position of the methylation site in the chromosome or scaffold.
endThe ending position of the RNA methylation site in the chromosome or scaffold.
widthPeak region of methylation
geneIdDefines the ID of gene on which the RNA methylation site locates
transcriptIdDefines the ID of transcript on which the RNA methylation site locates
distanceToTSSDistrance from Peak site to transcription start site
geneNameDefines the name of gene (gene symbol) on which the RNA methylation site locates
GOGene ontology term and description http://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
scorep-value of the peak
blockCountThe number of blocks (exons) the RNA methylation site spans.
blockSizesA comma-separated list of the block sizes. The number of items in this list should correspond to blockCount.
blockStartsA comma-separated list of block starts. All of the blockStart positions should be calculated relative to chromStart. The number of items in this list should correspond to blockCount.
lg.plog10(p-value) of the peak, indicating the significance of the peak as an RNA methylation site.
lg.fdrlog10(fdr) of the peak, indicating the significance of the peak as an RNA methylation site after multiple hypothesis correction.
fold_enrchmentfold enrichment within the peak in the IP sample compared with the input sample.
diff.lg.fdrresults from differential methylation analysis, log10(fdr) of the peak as a differential methylation site between the two experimental conditions tested.
diff.lg.presults from differential methylation analysis, log10(pvalue) of the peak as a differential methylation site between the two experimental conditions tested.
diff.log2.fcresults from differential methylation analysis, log2(odds ratio) of the peak as a differential methylation site between the two experimental conditions tested.
annotationLocation of peak, such as 3' UTR, first exon...
geneStartThe starting position of gene in the chromosome or scaffold.
geneEndThe ending position of gene in the chromosome or scaffold.
geneLengthlength of gene
geneStrand1=sense strand or "+"; 2=antisense strand or "-"

document location:summary/4_diff_peak/*VS*/*VS*_diffPeak.xlsx


peak distribution within different gene contexts:





document location:summary/4_diff_peak/*VS*/*VS*_diffPeak_pie.png


4.5 Motif identification


Besides differential methylation sites, R package-exomePeak also reports all the detected RNA methylation sites in BED format, based on which the motifs of RNA methylation sites can be detected. The sequence motifs, conjectured to have a biological significance, can be identified in both ChIP-Seq and m6A-seq. The main computational difference is whether to search the reverse complement strand. While a DNA motif may appear on either strand of the two, RNA motif should appear only on the strand where the transcript is located, and thus the strand information should be kept at all times. When the strand information of the RNA fragment is lost in MeRIP-Seq unstranded library construction, it may still be derived from the information of transcripts to which the fragments (reads) are mapped. We use MEME (http://meme-suite.org/) and HOMER (http://homer.ucsd.edu/homer/motif/) to discover RRACH motif of m6A and other noval motifs in methylated sequences.


RRACH motif identification:


de novo motif prediction


document location: summary/5_motif/

4.6 Overview of gene expression


StringTie was utilized to assemble all trascripts from mapped reads (bam format) by mapping software Bowtie. Also both gene level and transcript level were estimated by StringTie using FPKM (FPKM=[total_exon_fragments/mapped_reads(millions)×exon_length(kB)]).


4.6.1 Gene expression profiling


gene_idgene_nametranscript_idGOKEGGKO_ENTRYECDescriptionFPKM.M14_OEFPKM.M14_NC
ENSG00000000003TSPAN6ENST00000612152;ENST00000373020;ENST00000614008;ENST00000496771;ENST00000494424GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004871(signal transducer activity);GO:0005887(integral component of plasma membrane);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0007166(cell surface receptor signaling pathway);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0039532(negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1901223(negative regulation of NIK/NF-kappaB signaling)NANANAtetraspanin 6 [Source:HGNC Symbol;Acc:HGNC:11858]4.624.58
ENSG00000000419DPM1ENST00000371582GO:0005634(nucleus);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0005783(endoplasmic reticulum);GO:0005515(protein binding);GO:0006486(protein glycosylation);GO:0006506(GPI anchor biosynthetic process);GO:0005789(endoplasmic reticulum membrane);GO:0004169(dolichyl-phosphate-mannose-protein mannosyltransferase activity);GO:0004582(dolichyl-phosphate beta-D-mannosyltransferase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0019348(dolichol metabolic process);GO:0035268(protein mannosylation);GO:0035269(protein O-linked mannosylation);GO:0033185(dolichol-phosphate-mannose synthase complex);GO:0097502(mannosylation);GO:0005537(mannose binding);GO:0043178(alcohol binding);GO:0019673(GDP-mannose metabolic process);GO:0043231(intracellular membrane-bounded organelle)00510(N-Glycan biosynthesis)K00721EC:2.4.1.83dolichyl-phosphate mannosyltransferase subunit 1, catalytic [Source:HGNC Symbol;Acc:HGNC:3005]15.121392077050519.435594011599
ENSG00000000457SCYL3ENST00000367771;ENST00000367772;ENST00000423670GO:0005737(cytoplasm);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005794(Golgi apparatus);GO:0042995(cell projection);GO:0005515(protein binding);GO:0030027(lamellipodium);GO:0016477(cell migration);GO:0004672(protein kinase activity);GO:0004672(protein kinase activity)NANANASCY1 like pseudokinase 3 [Source:HGNC Symbol;Acc:HGNC:19285]1.291.38
ENSG00000000460C1orf112ENST00000472795;ENST00000496973;ENST00000359326;ENST00000286031NANANANAchromosome 1 open reading frame 112 [Source:HGNC Symbol;Acc:HGNC:25565]2.082.01
ENSG00000000938FGRENST00000374005GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005743(mitochondrial inner membrane);GO:0004713(protein tyrosine kinase activity);GO:0005886(plasma membrane);GO:0005829(cytosol);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0005515(protein binding);GO:0016235(aggresome);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0007229(integrin-mediated signaling pathway);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0005576(extracellular region);GO:0005758(mitochondrial intermembrane space);GO:0070062(extracellular exosome);GO:0019901(protein kinase binding);GO:0032587(ruffle membrane);GO:0030335(positive regulation of cell migration);GO:0030154(cell differentiation);GO:0050830(defense response to Gram-positive bacterium);GO:0043312(neutrophil degranulation);GO:0008360(regulation of cell shape);GO:0042127(regulation of cell proliferation);GO:0034774(secretory granule lumen);GO:0046777(protein autophosphorylation);GO:0016477(cell migration);GO:0001784(phosphotyrosine residue binding);GO:0009615(response to virus);GO:0045859(regulation of protein kinase activity);GO:0015629(actin cytoskeleton);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0050764(regulation of phagocytosis);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0050715(positive regulation of cytokine secretion);GO:0034987(immunoglobulin receptor binding);GO:0002768(immune response-regulating cell surface receptor signaling pathway);GO:0034988(Fc-gamma receptor I complex binding);GO:0043306(positive regulation of mast cell degranulation);GO:0045088(regulation of innate immune response)04062(Chemokine signaling pathway);05169(Epstein-Barr virus infection)K08891EC:2.7.10.2FGR proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:3697]0.090.09
ENSG00000000971CFHENST00000367429;ENST00000630130;ENST00000496761;ENST00000466229GO:0005515(protein binding);GO:0005576(extracellular region);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0030449(regulation of complement activation);GO:0070062(extracellular exosome);GO:0072562(blood microparticle);GO:0005615(extracellular space);GO:0008201(heparin binding);GO:0006956(complement activation);GO:0006957(complement activation, alternative pathway);GO:0043395(heparan sulfate proteoglycan binding);GO:0043395(heparan sulfate proteoglycan binding)04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection);05150(Staphylococcus aureus infection)K04004NAcomplement factor H [Source:HGNC Symbol;Acc:HGNC:4883]1.481.13
ENSG00000001036FUCA2ENST00000002165;ENST00000451668GO:0016787(hydrolase activity);GO:0005975(carbohydrate metabolic process);GO:0005515(protein binding);GO:0008152(metabolic process);GO:0005576(extracellular region);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0005615(extracellular space);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0006004(fucose metabolic process);GO:0043687(post-translational protein modification);GO:0043312(neutrophil degranulation);GO:0005788(endoplasmic reticulum lumen);GO:0035578(azurophil granule lumen);GO:0009617(response to bacterium);GO:0004560(alpha-L-fucosidase activity);GO:0016139(glycoside catabolic process);GO:2000535(regulation of entry of bacterium into host cell);GO:2000535(regulation of entry of bacterium into host cell)00511(Other glycan degradation);00511(Other glycan degradation)K01206EC:3.2.1.51fucosidase, alpha-L- 2, plasma [Source:HGNC Symbol;Acc:HGNC:4008]32.406350513784532.2261575510204
ENSG00000001084GCLCENST00000509541;ENST00000229416;ENST00000515580;ENST00000514373;ENST00000514004;ENST00000505294GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016874(ligase activity);GO:0000287(magnesium ion binding);GO:0050880(regulation of blood vessel size);GO:0004357(glutamate-cysteine ligase activity);GO:0006750(glutathione biosynthetic process);GO:0005829(cytosol);GO:0043066(negative regulation of apoptotic process);GO:0006979(response to oxidative stress);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045454(cell redox homeostasis);GO:0009408(response to heat);GO:0006536(glutamate metabolic process);GO:0009725(response to hormone);GO:0050662(coenzyme binding);GO:0043531(ADP binding);GO:0016595(glutamate binding);GO:0046982(protein heterodimerization activity);GO:0006534(cysteine metabolic process);GO:0006749(glutathione metabolic process);GO:0007568(aging);GO:0007584(response to nutrient);GO:0008637(apoptotic mitochondrial changes);GO:0009410(response to xenobiotic stimulus);GO:0014823(response to activity);GO:0019852(L-ascorbic acid metabolic process);GO:0031397(negative regulation of protein ubiquitination);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032869(cellular response to insulin stimulus);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0043524(negative regulation of neuron apoptotic process);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0044752(response to human chorionic gonadotropin);GO:0046685(response to arsenic-containing substance);GO:0046686(response to cadmium ion);GO:0051409(response to nitrosative stress);GO:0051900(regulation of mitochondrial depolarization);GO:0070555(response to interleukin-1);GO:0071260(cellular response to mechanical stimulus);GO:0071333(cellular response to glucose stimulus);GO:0071372(cellular response to follicle-stimulating hormone stimulus);GO:0097069(cellular response to thyroxine stimulus);GO:2000490(negative regulation of hepatic stellate cell activation);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0017109(glutamate-cysteine ligase complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)00270(Cysteine and methionine metabolism);00480(Glutathione metabolism);04216(Ferroptosis);04216(Ferroptosis)K11204EC:6.3.2.2glutamate-cysteine ligase catalytic subunit [Source:HGNC Symbol;Acc:HGNC:4311]5.645.90
ENSG00000001167NFYAENST00000341376GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0005515(protein binding);GO:0048511(rhythmic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0016602(CCAAT-binding factor complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0001046(core promoter sequence-specific DNA binding);GO:0090575(RNA polymerase II transcription factor complex);GO:0045540(regulation of cholesterol biosynthetic process);GO:0044212(transcription regulatory region DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0032993(protein-DNA complex)04612(Antigen processing and presentation);05152(Tuberculosis)K08064NAnuclear transcription factor Y subunit alpha [Source:HGNC Symbol;Acc:HGNC:7804]9.9810.213219
ENSG00000001460STPG1ENST00000374409;ENST00000468303;ENST00000497384;ENST00000435187;ENST00000498488;ENST00000483528;ENST00000475760GO:0005739(mitochondrion);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0003674(molecular_function);GO:0005622(intracellular);GO:0043065(positive regulation of apoptotic process);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process);GO:0090073(positive regulation of protein homodimerization activity);GO:0090073(positive regulation of protein homodimerization activity)NANANAsperm tail PG-rich repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:28070]0.850.89
ENSG00000001461NIPAL3ENST00000374399;ENST00000003912;ENST00000488155;ENST00000358028;ENST00000475663GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:1903830(magnesium ion transmembrane transport);GO:1903830(magnesium ion transmembrane transport)NANANANIPA like domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25233]0.830.87
ENSG00000001497LAS1LENST00000374807;ENST00000374811;ENST00000484069GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0030687(preribosome, large subunit precursor);GO:0071339(MLL1 complex);GO:0000470(maturation of LSU-rRNA);GO:0000460(maturation of 5.8S rRNA);GO:0006325(chromatin organization);GO:0000478(endonucleolytic cleavage involved in rRNA processing);GO:0000478(endonucleolytic cleavage involved in rRNA processing)NANANALAS1 like, ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726]12.981820878153515.0097013342279
ENSG00000001561ENPP4ENST00000321037GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005886(plasma membrane);GO:0070062(extracellular exosome);GO:0043312(neutrophil degranulation);GO:0007596(blood coagulation);GO:0007599(hemostasis);GO:0101003(ficolin-1-rich granule membrane);GO:0047710(bis(5'-adenosyl)-triphosphatase activity);GO:0030194(positive regulation of blood coagulation);GO:0046130(purine ribonucleoside catabolic process)00230(Purine metabolism)K18424EC:3.6.1.29ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) [Source:HGNC Symbol;Acc:HGNC:3359]1.752.34
ENSG00000001617SEMA3FENST00000450338;ENST00000002829GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0021675(nerve development);GO:0048846(axon extension involved in axon guidance);GO:0061549(sympathetic ganglion development);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:0038191(neuropilin binding);GO:0007411(axon guidance);GO:0045499(chemorepellent activity);GO:0001755(neural crest cell migration);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021785(branchiomotor neuron axon guidance);GO:0036486(ventral trunk neural crest cell migration);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance)04360(Axon guidance);04360(Axon guidance)K06840NAsemaphorin 3F [Source:HGNC Symbol;Acc:HGNC:10728]0.160.26
ENSG00000001626CFTRENST00000003084;ENST00000429014;ENST00000608965GO:0016020(membrane);GO:0006811(ion transport);GO:0005254(chloride channel activity);GO:1902476(chloride transmembrane transport);GO:0006821(chloride transport);GO:0006810(transport);GO:0005737(cytoplasm);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016787(hydrolase activity);GO:0005829(cytosol);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0016887(ATPase activity);GO:0005260(intracellular ATPase-gated chloride channel activity);GO:0015106(bicarbonate transmembrane transporter activity);GO:0015108(chloride transmembrane transporter activity);GO:0006695(cholesterol biosynthetic process);GO:0006904(vesicle docking involved in exocytosis);GO:0015701(bicarbonate transport);GO:0030301(cholesterol transport);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0045921(positive regulation of exocytosis);GO:0048240(sperm capacitation);GO:0051454(intracellular pH elevation);GO:0060081(membrane hyperpolarization);GO:0071320(cellular response to cAMP);GO:1902161(positive regulation of cyclic nucleotide-gated ion channel activity);GO:0005887(integral component of plasma membrane);GO:0016324(apical plasma membrane);GO:0034707(chloride channel complex);GO:0005768(endosome);GO:0070062(extracellular exosome);GO:0061024(membrane organization);GO:0010008(endosome membrane);GO:0016579(protein deubiquitination);GO:0043234(protein complex);GO:0005769(early endosome);GO:0031901(early endosome membrane);GO:0055037(recycling endosome);GO:0055038(recycling endosome membrane);GO:0019899(enzyme binding);GO:0009986(cell surface);GO:0030165(PDZ domain binding);GO:0005765(lysosomal membrane);GO:0019869(chloride channel inhibitor activity);GO:0043225(ATPase-coupled anion transmembrane transporter activity);GO:0099133(ATP hydrolysis coupled anion transmembrane transport);GO:1904322(cellular response to forskolin);GO:0030665(clathrin-coated vesicle membrane);GO:0030660(Golgi-associated vesicle membrane);GO:0031205(endoplasmic reticulum Sec complex);GO:0017081(chloride channel regulator activity);GO:0035377(transepithelial water transport);GO:0050891(multicellular organismal water homeostasis);GO:1902943(positive regulation of voltage-gated chloride channel activity);GO:1902943(positive regulation of voltage-gated chloride channel activity)02010(ABC transporters);04024(cAMP signaling pathway);04152(AMPK signaling pathway);04530(Tight junction);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05110(Vibrio cholerae infection);05110(Vibrio cholerae infection)K05031EC:3.6.3.49cystic fibrosis transmembrane conductance regulator [Source:HGNC Symbol;Acc:HGNC:1884]0.020.03
ENSG00000001629ANKIB1ENST00000265742;ENST00000413588GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0005737(cytoplasm);GO:0000151(ubiquitin ligase complex);GO:0061630(ubiquitin protein ligase activity);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0000209(protein polyubiquitination);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0031624(ubiquitin conjugating enzyme binding);GO:0031624(ubiquitin conjugating enzyme binding)NANANAankyrin repeat and IBR domain containing 1 [Source:HGNC Symbol;Acc:HGNC:22215]4.905.67
ENSG00000001630CYP51A1ENST00000003100GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0005783(endoplasmic reticulum);GO:0004497(monooxygenase activity);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005506(iron ion binding);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0008398(sterol 14-demethylase activity);GO:0033488(cholesterol biosynthetic process via 24,25-dihydrolanosterol);GO:0070988(demethylation);GO:0043231(intracellular membrane-bounded organelle);GO:0006629(lipid metabolic process);GO:0005789(endoplasmic reticulum membrane);GO:0006694(steroid biosynthetic process);GO:0008202(steroid metabolic process);GO:0016126(sterol biosynthetic process);GO:0008203(cholesterol metabolic process);GO:0005886(plasma membrane);GO:0006695(cholesterol biosynthetic process);GO:0031090(organelle membrane);GO:0045540(regulation of cholesterol biosynthetic process);GO:0016125(sterol metabolic process)00100(Steroid biosynthesis)K05917EC:1.14.13.70cytochrome P450 family 51 subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:2649]18.486938394698118.9701182474227
ENSG00000001631KRIT1ENST00000394507;ENST00000470309GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005886(plasma membrane);GO:0050790(regulation of catalytic activity);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0030054(cell junction);GO:0005874(microtubule);GO:0008017(microtubule binding);GO:2000114(regulation of establishment of cell polarity);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0030695(GTPase regulator activity);GO:0005911(cell-cell junction);GO:0032403(protein complex binding);GO:0001525(angiogenesis);GO:0001937(negative regulation of endothelial cell proliferation);GO:0007264(small GTPase mediated signal transduction);GO:0010596(negative regulation of endothelial cell migration);GO:0016525(negative regulation of angiogenesis);GO:0045454(cell redox homeostasis);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:0032092(positive regulation of protein binding);GO:0043234(protein complex);GO:0043234(protein complex)04015(Rap1 signaling pathway);04015(Rap1 signaling pathway)K17705NAKRIT1, ankyrin repeat containing [Source:HGNC Symbol;Acc:HGNC:1573]1.911.96
ENSG00000002016RAD52ENST00000358495;ENST00000468231;ENST00000536177GO:0005634(nucleus);GO:0003677(DNA binding);GO:0006281(DNA repair);GO:0005515(protein binding);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0000724(double-strand break repair via homologous recombination);GO:0042802(identical protein binding);GO:0005654(nucleoplasm);GO:0043234(protein complex);GO:0000730(DNA recombinase assembly);GO:0045002(double-strand break repair via single-strand annealing);GO:0051260(protein homooligomerization);GO:0006302(double-strand break repair);GO:0032993(protein-DNA complex);GO:0034599(cellular response to oxidative stress);GO:0003697(single-stranded DNA binding);GO:0010792(DNA double-strand break processing involved in repair via single-strand annealing);GO:2000819(regulation of nucleotide-excision repair);GO:2000819(regulation of nucleotide-excision repair)03440(Homologous recombination);03440(Homologous recombination)K10873NARAD52 homolog, DNA repair protein [Source:HGNC Symbol;Acc:HGNC:9824]0.730.77
ENSG00000002079MYH16ENST00000439784;ENST00000452010NANANANAmyosin heavy chain 16 pseudogene [Source:HGNC Symbol;Acc:HGNC:31038]1.932.30
ENSG00000002330BADENST00000394532;ENST00000493798;ENST00000492141;ENST00000544271GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0005515(protein binding);GO:0005741(mitochondrial outer membrane);GO:0008656(cysteine-type endopeptidase activator activity involved in apoptotic process);GO:0019903(protein phosphatase binding);GO:0030346(protein phosphatase 2B binding);GO:0043422(protein kinase B binding);GO:0046982(protein heterodimerization activity);GO:0071889(14-3-3 protein binding);GO:0001666(response to hypoxia);GO:0001836(release of cytochrome c from mitochondria);GO:0006007(glucose catabolic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007283(spermatogenesis);GO:0008283(cell proliferation);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009725(response to hormone);GO:0009749(response to glucose);GO:0010033(response to organic substance);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0014070(response to organic cyclic compound);GO:0019050(suppression by virus of host apoptotic process);GO:0019221(cytokine-mediated signaling pathway);GO:0021987(cerebral cortex development);GO:0032024(positive regulation of insulin secretion);GO:0032355(response to estradiol);GO:0032570(response to progesterone);GO:0033133(positive regulation of glucokinase activity);GO:0033574(response to testosterone);GO:0034201(response to oleic acid);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0042493(response to drug);GO:0042542(response to hydrogen peroxide);GO:0042593(glucose homeostasis);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043200(response to amino acid);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0044342(type B pancreatic cell proliferation);GO:0045471(response to ethanol);GO:0045579(positive regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0046031(ADP metabolic process);GO:0046034(ATP metabolic process);GO:0051384(response to glucocorticoid);GO:0051592(response to calcium ion);GO:0060139(positive regulation of apoptotic process by virus);GO:0060154(cellular process regulating host cell cycle in response to virus);GO:0071247(cellular response to chromate);GO:0071396(cellular response to lipid);GO:0097190(apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:1901216(positive regulation of neuron death);GO:1902220(positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress);GO:2000078(positive regulation of type B pancreatic cell development);GO:0008289(lipid binding);GO:0019901(protein kinase binding);GO:0010508(positive regulation of autophagy);GO:0071260(cellular response to mechanical stimulus);GO:0097191(extrinsic apoptotic signaling pathway);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0005543(phospholipid binding);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0097193(intrinsic apoptotic signaling pathway);GO:0071456(cellular response to hypoxia);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0050679(positive regulation of epithelial cell proliferation);GO:0001844(protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway);GO:0071316(cellular response to nicotine);GO:0046902(regulation of mitochondrial membrane permeability);GO:0046931(pore complex assembly);GO:0045862(positive regulation of proteolysis);GO:0097202(activation of cysteine-type endopeptidase activity);GO:0045918(negative regulation of cytolysis);GO:0045918(negative regulation of cytolysis)04014(Ras signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04510(Focal adhesion);04910(Insulin signaling pathway);04919(Thyroid hormone signaling pathway);04722(Neurotrophin signaling pathway);05200(Pathways in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05223(Non-small cell lung cancer);05010(Alzheimer's disease);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05161(Hepatitis B);05160(Hepatitis C);05165(Human papillomavirus infection);05145(Toxoplasmosis);01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance);01522(Endocrine resistance)K02158NABCL2 associated agonist of cell death [Source:HGNC Symbol;Acc:HGNC:936]22.60602886826724.080227941452
ENSG00000002549LAP3ENST00000226299;ENST00000508497;ENST00000509583;ENST00000503467GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0005622(intracellular);GO:0008233(peptidase activity);GO:0006508(proteolysis);GO:0030145(manganese ion binding);GO:0030496(midbody);GO:0008235(metalloexopeptidase activity);GO:0005925(focal adhesion);GO:0004177(aminopeptidase activity);GO:0070062(extracellular exosome);GO:0019538(protein metabolic process);GO:0005739(mitochondrion);GO:0005802(trans-Golgi network);GO:0005802(trans-Golgi network)00330(Arginine and proline metabolism);00480(Glutathione metabolism);00480(Glutathione metabolism)NANAleucine aminopeptidase 3 [Source:HGNC Symbol;Acc:HGNC:18449]1.821.94
ENSG00000002586CD99ENST00000381192;ENST00000449611;ENST00000482293GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0007155(cell adhesion);GO:0005925(focal adhesion);GO:0050776(regulation of immune response);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005737(cytoplasm)04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration);04670(Leukocyte transendothelial migration)K06520NACD99 molecule (Xg blood group) [Source:HGNC Symbol;Acc:HGNC:7082]17.132919233556614.8691970523752
ENSG00000002587HS3ST1ENST00000002596GO:0016740(transferase activity);GO:0005794(Golgi apparatus);GO:0008146(sulfotransferase activity);GO:0016021(integral component of membrane);GO:0005796(Golgi lumen);GO:0006024(glycosaminoglycan biosynthetic process);GO:0008467([heparan sulfate]-glucosamine 3-sulfotransferase 1 activity)00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)K01024EC:2.8.2.23heparan sulfate-glucosamine 3-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:5194]1.641.73
ENSG00000002726AOC1ENST00000493429GO:0046872(metal ion binding);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0008270(zinc ion binding);GO:0042803(protein homodimerization activity);GO:0005886(plasma membrane);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005509(calcium ion binding);GO:0005507(copper ion binding);GO:0005777(peroxisome);GO:0005923(bicellular tight junction);GO:0008201(heparin binding);GO:0070062(extracellular exosome);GO:0004872(receptor activity);GO:0006805(xenobiotic metabolic process);GO:0043312(neutrophil degranulation);GO:0008131(primary amine oxidase activity);GO:0048038(quinone binding);GO:0009308(amine metabolic process);GO:0035580(specific granule lumen);GO:0008144(drug binding);GO:0032403(protein complex binding);GO:0046677(response to antibiotic);GO:0042493(response to drug);GO:0071504(cellular response to heparin);GO:0071280(cellular response to copper ion);GO:0071420(cellular response to histamine);GO:0052597(diamine oxidase activity);GO:0052598(histamine oxidase activity);GO:0052599(methylputrescine oxidase activity);GO:0052600(propane-1,3-diamine oxidase activity);GO:0035874(cellular response to copper ion starvation);GO:0097185(cellular response to azide)00330(Arginine and proline metabolism);00340(Histidine metabolism);00380(Tryptophan metabolism)NANAamine oxidase, copper containing 1 [Source:HGNC Symbol;Acc:HGNC:80]00.05
ENSG00000002745WNT16ENST00000222462GO:0005102(receptor binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0016055(Wnt signaling pathway);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0010628(positive regulation of gene expression);GO:0005737(cytoplasm);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0030182(neuron differentiation);GO:0046330(positive regulation of JNK cascade);GO:0005109(frizzled binding);GO:0045165(cell fate commitment);GO:0090399(replicative senescence);GO:0060548(negative regulation of cell death);GO:0090403(oxidative stress-induced premature senescence);GO:0030216(keratinocyte differentiation);GO:0003408(optic cup formation involved in camera-type eye development);GO:0043616(keratinocyte proliferation);GO:0046849(bone remodeling);GO:0060317(cardiac epithelial to mesenchymal transition)04310(Wnt signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05205(Proteoglycans in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);05166(HTLV-I infection);05165(Human papillomavirus infection)K01558NAWnt family member 16 [Source:HGNC Symbol;Acc:HGNC:16267]0.010.00
ENSG00000002746HECW1ENST00000395891;ENST00000471043GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0061630(ubiquitin protein ligase activity);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)NANANAHECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:22195]0.000.01
ENSG00000002822MAD1L1ENST00000481633;ENST00000265854;ENST00000406869;ENST00000437877;ENST00000444373;ENST00000421113;ENST00000491858;ENST00000464742;ENST00000459731;ENST00000486340;ENST00000469871;ENST00000429625GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0051301(cell division);GO:0005694(chromosome);GO:0015629(actin cytoskeleton);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0005643(nuclear pore);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0007094(mitotic spindle assembly checkpoint);GO:0007062(sister chromatid cohesion);GO:0007093(mitotic cell cycle checkpoint);GO:0072686(mitotic spindle);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0090235(regulation of metaphase plate congression);GO:0042130(negative regulation of T cell proliferation);GO:0048538(thymus development);GO:1901990(regulation of mitotic cell cycle phase transition);GO:0000922(spindle pole);GO:0000922(spindle pole)04110(Cell cycle);04914(Progesterone-mediated oocyte maturation);05203(Viral carcinogenesis);05203(Viral carcinogenesis)K06638NAMAD1 mitotic arrest deficient like 1 [Source:HGNC Symbol;Acc:HGNC:6762]4.123.64
ENSG00000002834LASP1ENST00000433206;ENST00000318008;ENST00000584106;ENST00000443937;ENST00000419929;ENST00000579123GO:0005737(cytoplasm);GO:0006810(transport);GO:0046872(metal ion binding);GO:0034220(ion transmembrane transport);GO:0009967(positive regulation of signal transduction);GO:0003779(actin binding);GO:0006811(ion transport);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0015075(ion transmembrane transporter activity);GO:0051015(actin filament binding);GO:0005925(focal adhesion);GO:0030864(cortical actin cytoskeleton);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0005938(cell cortex);GO:0005070(SH3/SH2 adaptor activity);GO:0005070(SH3/SH2 adaptor activity)NANANALIM and SH3 protein 1 [Source:HGNC Symbol;Acc:HGNC:6513]192.271292394137191.150864861351
ENSG00000002919SNX11ENST00000581298;ENST00000393405;ENST00000580875;ENST00000583320GO:0005622(intracellular);GO:0006886(intracellular protein transport);GO:0035091(phosphatidylinositol binding);GO:0006810(transport);GO:0016020(membrane);GO:0015031(protein transport);GO:0005515(protein binding);GO:0008289(lipid binding);GO:0005768(endosome);GO:0019898(extrinsic component of membrane);GO:0006897(endocytosis);GO:0016050(vesicle organization);GO:1901981(phosphatidylinositol phosphate binding);GO:1901981(phosphatidylinositol phosphate binding)NANANAsorting nexin 11 [Source:HGNC Symbol;Acc:HGNC:14975]6.847.03
ENSG00000002933TMEM176AENST00000462826GO:0016020(membrane);GO:0016021(integral component of membrane);GO:2001199(negative regulation of dendritic cell differentiation)NANANAtransmembrane protein 176A [Source:HGNC Symbol;Acc:HGNC:24930]00.00
ENSG00000003056M6PRENST00000539143;ENST00000541507;ENST00000537621;ENST00000543258;ENST00000540837GO:0016021(integral component of membrane);GO:0005537(mannose binding);GO:0015578(mannose transmembrane transporter activity);GO:0015761(mannose transport);GO:0000323(lytic vacuole);GO:0006810(transport);GO:0016020(membrane);GO:0005765(lysosomal membrane);GO:0048471(perinuclear region of cytoplasm);GO:0007165(signal transduction);GO:0005764(lysosome);GO:0005886(plasma membrane);GO:0061024(membrane organization);GO:0005887(integral component of plasma membrane);GO:0005802(trans-Golgi network);GO:0032588(trans-Golgi network membrane);GO:0005515(protein binding);GO:0030133(transport vesicle);GO:0004888(transmembrane signaling receptor activity);GO:0030665(clathrin-coated vesicle membrane);GO:0030904(retromer complex);GO:0006898(receptor-mediated endocytosis);GO:0005768(endosome);GO:0008333(endosome to lysosome transport);GO:1905394(retromer complex binding);GO:0033299(secretion of lysosomal enzymes);GO:0005770(late endosome);GO:0005770(late endosome)04145(Phagosome);04142(Lysosome);04142(Lysosome)NANAmannose-6-phosphate receptor, cation dependent [Source:HGNC Symbol;Acc:HGNC:6752]37.893884554143538.733813394493
ENSG00000003096KLHL13ENST00000371876;ENST00000540167GO:0016567(protein ubiquitination);GO:0051301(cell division);GO:0007049(cell cycle);GO:0005829(cytosol);GO:0043687(post-translational protein modification);GO:0004842(ubiquitin-protein transferase activity);GO:0000910(cytokinesis);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0030496(midbody);GO:0030496(midbody)04120(Ubiquitin mediated proteolysis);04120(Ubiquitin mediated proteolysis)K10447NAkelch like family member 13 [Source:HGNC Symbol;Acc:HGNC:22931]0.590.84
ENSG00000003137CYP26B1ENST00000001146GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0004497(monooxygenase activity);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005506(iron ion binding);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0006805(xenobiotic metabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0060349(bone morphogenesis);GO:0016709(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen);GO:0031090(organelle membrane);GO:0006766(vitamin metabolic process);GO:0001972(retinoic acid binding);GO:0008401(retinoic acid 4-hydroxylase activity);GO:0016125(sterol metabolic process);GO:0034653(retinoic acid catabolic process);GO:0048387(negative regulation of retinoic acid receptor signaling pathway);GO:0030326(embryonic limb morphogenesis);GO:0007283(spermatogenesis);GO:0001709(cell fate determination);GO:0001768(establishment of T cell polarity);GO:0006954(inflammatory response);GO:0007140(male meiotic nuclear division);GO:0009954(proximal/distal pattern formation);GO:0010628(positive regulation of gene expression);GO:0042573(retinoic acid metabolic process);GO:0043587(tongue morphogenesis);GO:0045580(regulation of T cell differentiation);GO:0048384(retinoic acid receptor signaling pathway);GO:0048385(regulation of retinoic acid receptor signaling pathway);GO:0061436(establishment of skin barrier);GO:0070268(cornification);GO:0071300(cellular response to retinoic acid);GO:2001037(positive regulation of tongue muscle cell differentiation)00830(Retinol metabolism)K12664NAcytochrome P450 family 26 subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:20581]0.470.42
ENSG00000003147ICA1ENST00000402384;ENST00000406470;ENST00000455539;ENST00000422063;ENST00000490041;ENST00000446305GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0005829(cytosol);GO:0005794(Golgi apparatus);GO:0019904(protein domain specific binding);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0031410(cytoplasmic vesicle);GO:0050796(regulation of insulin secretion);GO:0030667(secretory granule membrane);GO:0030672(synaptic vesicle membrane);GO:0003674(molecular_function);GO:0006836(neurotransmitter transport);GO:0030658(transport vesicle membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)04940(Type I diabetes mellitus);04940(Type I diabetes mellitus)K19863NAislet cell autoantigen 1 [Source:HGNC Symbol;Acc:HGNC:5343]0.530.55
ENSG00000003249DBNDD1ENST00000002501;ENST00000623401;ENST00000392973;ENST00000568838GO:0005737(cytoplasm);GO:0030672(synaptic vesicle membrane);GO:0031175(neuron projection development);GO:0031175(neuron projection development)NANANAdysbindin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28455]11.613477874765211.6739960402839
ENSG00000003393ALS2ENST00000264276;ENST00000439495;ENST00000482891;ENST00000467448;ENST00000496244;ENST00000409632;ENST00000410052GO:0005829(cytosol);GO:0042803(protein homodimerization activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction);GO:0005515(protein binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0030425(dendrite);GO:0048812(neuron projection morphogenesis);GO:0030027(lamellipodium);GO:0030426(growth cone);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0061024(membrane organization);GO:0043234(protein complex);GO:0005769(early endosome);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0001726(ruffle);GO:0031982(vesicle);GO:0045860(positive regulation of protein kinase activity);GO:0005813(centrosome);GO:0017137(Rab GTPase binding);GO:0007032(endosome organization);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0051036(regulation of endosome size);GO:0001662(behavioral fear response);GO:0001701(in utero embryonic development);GO:0001881(receptor recycling);GO:0006979(response to oxidative stress);GO:0007409(axonogenesis);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0008219(cell death);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0016601(Rac protein signal transduction);GO:0035022(positive regulation of Rac protein signal transduction);GO:0035249(synaptic transmission, glutamatergic);GO:0043087(regulation of GTPase activity);GO:0005737(cytoplasm);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030424(axon);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0043231(intracellular membrane-bounded organelle);GO:0043231(intracellular membrane-bounded organelle)05014(Amyotrophic lateral sclerosis (ALS));05014(Amyotrophic lateral sclerosis (ALS))K04575NAALS2, alsin Rho guanine nucleotide exchange factor [Source:HGNC Symbol;Acc:HGNC:443]5.075.75
ENSG00000003400CASP10ENST00000286186;ENST00000272879;ENST00000374650GO:0016787(hydrolase activity);GO:0042981(regulation of apoptotic process);GO:0005515(protein binding);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0004197(cysteine-type endopeptidase activity);GO:0005829(cytosol);GO:0031625(ubiquitin protein ligase binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0097190(apoptotic signaling pathway);GO:0007166(cell surface receptor signaling pathway);GO:0097200(cysteine-type endopeptidase activity involved in execution phase of apoptosis);GO:0097194(execution phase of apoptosis);GO:0097342(ripoptosome);GO:0031265(CD95 death-inducing signaling complex);GO:0035877(death effector domain binding);GO:0097199(cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:0097199(cysteine-type endopeptidase activity involved in apoptotic signaling pathway)04668(TNF signaling pathway);04210(Apoptosis);04622(RIG-I-like receptor signaling pathway);05152(Tuberculosis);05161(Hepatitis B);05161(Hepatitis B)K04400EC:3.4.22.63caspase 10 [Source:HGNC Symbol;Acc:HGNC:1500]1.401.38
ENSG00000003402CFLARENST00000309955;ENST00000342795;ENST00000395148;ENST00000441224;ENST00000423241;ENST00000425030;ENST00000440180;ENST00000457277;ENST00000494258;ENST00000470178;ENST00000470664GO:0005737(cytoplasm);GO:0042981(regulation of apoptotic process);GO:0043085(positive regulation of catalytic activity);GO:0005515(protein binding);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0004197(cysteine-type endopeptidase activity);GO:0002020(protease binding);GO:0005123(death receptor binding);GO:0032403(protein complex binding);GO:0001666(response to hypoxia);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010976(positive regulation of neuron projection development);GO:0032869(cellular response to insulin stimulus);GO:0033574(response to testosterone);GO:0043066(negative regulation of apoptotic process);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0071392(cellular response to estradiol stimulus);GO:0071456(cellular response to hypoxia);GO:0071549(cellular response to dexamethasone stimulus);GO:0071732(cellular response to nitric oxide);GO:0072126(positive regulation of glomerular mesangial cell proliferation);GO:1903055(positive regulation of extracellular matrix organization);GO:1903427(negative regulation of reactive oxygen species biosynthetic process);GO:1903845(negative regulation of cellular response to transforming growth factor beta stimulus);GO:1903944(negative regulation of hepatocyte apoptotic process);GO:1904036(negative regulation of epithelial cell apoptotic process);GO:2000347(positive regulation of hepatocyte proliferation);GO:0031264(death-inducing signaling complex);GO:0031265(CD95 death-inducing signaling complex);GO:0045121(membrane raft);GO:0005829(cytosol);GO:0016032(viral process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0008047(enzyme activator activity);GO:0097200(cysteine-type endopeptidase activity involved in execution phase of apoptosis);GO:0007519(skeletal muscle tissue development);GO:0014732(skeletal muscle atrophy);GO:0014842(regulation of skeletal muscle satellite cell proliferation);GO:0014866(skeletal myofibril assembly);GO:0043403(skeletal muscle tissue regeneration);GO:0060544(regulation of necroptotic process);GO:0097194(execution phase of apoptosis);GO:1901740(negative regulation of myoblast fusion);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0097342(ripoptosome);GO:0097342(ripoptosome)04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04217(Necroptosis);05142(Chagas disease (American trypanosomiasis));05142(Chagas disease (American trypanosomiasis))K04724NACASP8 and FADD like apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:1876]1.491.50
ENSG00000003436TFPIENST00000392365;ENST00000409676;ENST00000421427;ENST00000420747GO:0005615(extracellular space);GO:0016020(membrane);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0010951(negative regulation of endopeptidase activity);GO:0005783(endoplasmic reticulum);GO:0005576(extracellular region);GO:0031225(anchored component of membrane);GO:0005886(plasma membrane);GO:0030414(peptidase inhibitor activity);GO:0010466(negative regulation of peptidase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0009986(cell surface);GO:0007596(blood coagulation);GO:0007599(hemostasis);GO:0031090(organelle membrane);GO:0004866(endopeptidase inhibitor activity);GO:0007598(blood coagulation, extrinsic pathway);GO:0032355(response to estradiol);GO:0032496(response to lipopolysaccharide);GO:0071222(cellular response to lipopolysaccharide);GO:0071347(cellular response to interleukin-1);GO:0071347(cellular response to interleukin-1)04610(Complement and coagulation cascades);04610(Complement and coagulation cascades)K03909NAtissue factor pathway inhibitor [Source:HGNC Symbol;Acc:HGNC:11760]2.633.02
ENSG00000003509NDUFAF7ENST00000455230;ENST00000474154;ENST00000441905GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0005739(mitochondrion);GO:0005615(extracellular space);GO:0005515(protein binding);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0005759(mitochondrial matrix);GO:0019899(enzyme binding);GO:0035243(protein-arginine omega-N symmetric methyltransferase activity);GO:0019918(peptidyl-arginine methylation, to symmetrical-dimethyl arginine);GO:0046034(ATP metabolic process);GO:0046034(ATP metabolic process)NANANANADH:ubiquinone oxidoreductase complex assembly factor 7 [Source:HGNC Symbol;Acc:HGNC:28816]1.842.03
ENSG00000003756RBM5ENST00000347869;ENST00000464087;ENST00000492472;ENST00000437500;ENST00000496179;ENST00000471995;ENST00000494360;ENST00000474470;ENST00000479275GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0042981(regulation of apoptotic process);GO:0005515(protein binding);GO:0005681(spliceosomal complex);GO:0006915(apoptotic process);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003729(mRNA binding);GO:0008285(negative regulation of cell proliferation);GO:0043065(positive regulation of apoptotic process);GO:0003677(DNA binding);GO:0000398(mRNA splicing, via spliceosome);GO:0006396(RNA processing);GO:0000245(spliceosomal complex assembly);GO:0000245(spliceosomal complex assembly)NANANARNA binding motif protein 5 [Source:HGNC Symbol;Acc:HGNC:9902]2.092.24
ENSG00000003987MTMR7ENST00000180173GO:0005737(cytoplasm);GO:0016787(hydrolase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0016791(phosphatase activity);GO:0016311(dephosphorylation);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0005515(protein binding);GO:0046856(phosphatidylinositol dephosphorylation);GO:0005829(cytosol);GO:0052866(phosphatidylinositol phosphate phosphatase activity);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006470(protein dephosphorylation);GO:0004438(phosphatidylinositol-3-phosphatase activity);GO:0052629(phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity);GO:0046855(inositol phosphate dephosphorylation);GO:0016020(membrane)00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)K18083EC:3.1.3.64 3.1.3.95myotubularin related protein 7 [Source:HGNC Symbol;Acc:HGNC:7454]0.140.12
ENSG00000003989SLC7A2ENST00000494857;ENST00000470360GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0015171(amino acid transmembrane transporter activity);GO:0003333(amino acid transmembrane transport);GO:1990822(basic amino acid transmembrane transport);GO:0006865(amino acid transport);GO:1903826(arginine transmembrane transport);GO:0005887(integral component of plasma membrane);GO:0015174(basic amino acid transmembrane transporter activity);GO:0006520(cellular amino acid metabolic process);GO:0000064(L-ornithine transmembrane transporter activity);GO:0005289(high-affinity arginine transmembrane transporter activity);GO:0005292(high-affinity lysine transmembrane transporter activity);GO:0015181(arginine transmembrane transporter activity);GO:0015189(L-lysine transmembrane transporter activity);GO:0061459(L-arginine transmembrane transporter activity);GO:0097626(low-affinity L-arginine transmembrane transporter activity);GO:0097627(high-affinity L-ornithine transmembrane transporter activity);GO:0002537(nitric oxide production involved in inflammatory response);GO:0006809(nitric oxide biosynthetic process);GO:0015809(arginine transport);GO:0042116(macrophage activation);GO:0043030(regulation of macrophage activation);GO:0050727(regulation of inflammatory response);GO:0097638(L-arginine import across plasma membrane);GO:0097639(L-lysine import across plasma membrane);GO:0097640(L-ornithine import across plasma membrane);GO:1902023(L-arginine transport);GO:1903352(L-ornithine transmembrane transport);GO:1903352(L-ornithine transmembrane transport)NANANAsolute carrier family 7 member 2 [Source:HGNC Symbol;Acc:HGNC:11060]1.721.86
ENSG00000004059ARF5ENST00000000233;ENST00000463733;ENST00000467281;ENST00000489673GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0015031(protein transport);GO:0005525(GTP binding);GO:0007264(small GTPase mediated signal transduction);GO:0000166(nucleotide binding);GO:0005794(Golgi apparatus);GO:0005622(intracellular);GO:0048471(perinuclear region of cytoplasm);GO:0016192(vesicle-mediated transport);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0005886(plasma membrane);GO:0003924(GTPase activity);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER)04144(Endocytosis);04144(Endocytosis)K07940NAADP ribosylation factor 5 [Source:HGNC Symbol;Acc:HGNC:658]32.631066497594942.6214167316943
ENSG00000004139SARM1ENST00000379061;ENST00000585482GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0005739(mitochondrion);GO:0042995(cell projection);GO:0005515(protein binding);GO:0030054(cell junction);GO:0045202(synapse);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0005874(microtubule);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0030425(dendrite);GO:0030424(axon);GO:0005829(cytosol);GO:0034128(negative regulation of MyD88-independent toll-like receptor signaling pathway);GO:0048814(regulation of dendrite morphogenesis);GO:1901214(regulation of neuron death);GO:0009749(response to glucose);GO:0042981(regulation of apoptotic process);GO:0015630(microtubule cytoskeleton);GO:0031315(extrinsic component of mitochondrial outer membrane);GO:0031315(extrinsic component of mitochondrial outer membrane)NANANAsterile alpha and TIR motif containing 1 [Source:HGNC Symbol;Acc:HGNC:17074]0.280.39
ENSG00000004142POLDIP2ENST00000540200GO:0005634(nucleus);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0042645(mitochondrial nucleoid);GO:0005739(mitochondrion);GO:0016242(negative regulation of macroautophagy);GO:0045931(positive regulation of mitotic cell cycle);GO:0070584(mitochondrion morphogenesis)NANANADNA polymerase delta interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:23781]85.14871281.740311
ENSG00000004399PLXND1ENST00000324093;ENST00000501038;ENST00000504524;ENST00000506979;ENST00000508630;ENST00000512807;ENST00000503166;ENST00000504767GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0007165(signal transduction);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0017154(semaphorin receptor activity);GO:0071526(semaphorin-plexin signaling pathway);GO:0005887(integral component of plasma membrane);GO:0030027(lamellipodium);GO:0008360(regulation of cell shape);GO:0043087(regulation of GTPase activity);GO:0030334(regulation of cell migration);GO:0019904(protein domain specific binding);GO:0001525(angiogenesis);GO:0007162(negative regulation of cell adhesion);GO:0050772(positive regulation of axonogenesis);GO:0043542(endothelial cell migration);GO:0007416(synapse assembly);GO:0045765(regulation of angiogenesis);GO:0001569(branching involved in blood vessel morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003279(cardiac septum development);GO:0032092(positive regulation of protein binding);GO:0035904(aorta development);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0060976(coronary vasculature development);GO:0060976(coronary vasculature development)NANANAplexin D1 [Source:HGNC Symbol;Acc:HGNC:9107]9.948.62
ENSG00000004455AK2ENST00000629371;ENST00000491241;ENST00000487289GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0006139(nucleobase-containing compound metabolic process);GO:0005739(mitochondrion);GO:0019205(nucleobase-containing compound kinase activity);GO:0004017(adenylate kinase activity);GO:0016776(phosphotransferase activity, phosphate group as acceptor);GO:0006172(ADP biosynthetic process);GO:0046939(nucleotide phosphorylation);GO:0005758(mitochondrial intermembrane space);GO:0070062(extracellular exosome);GO:0015949(nucleobase-containing small molecule interconversion);GO:0046033(AMP metabolic process);GO:0046034(ATP metabolic process);GO:0005743(mitochondrial inner membrane);GO:0036126(sperm flagellum);GO:0097226(sperm mitochondrial sheath);GO:0097226(sperm mitochondrial sheath)00230(Purine metabolism);00730(Thiamine metabolism);00730(Thiamine metabolism)NANAadenylate kinase 2 [Source:HGNC Symbol;Acc:HGNC:362]27.711263129037926.2483904843723
ENSG00000004468CD38ENST00000226279GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016787(hydrolase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0005886(plasma membrane);GO:0030890(positive regulation of B cell proliferation);GO:0070062(extracellular exosome);GO:0003953(NAD+ nucleosidase activity);GO:0050135(NAD(P)+ nucleosidase activity);GO:0043066(negative regulation of apoptotic process);GO:0007165(signal transduction);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050853(B cell receptor signaling pathway);GO:0097190(apoptotic signaling pathway);GO:0042493(response to drug);GO:0019674(NAD metabolic process);GO:0016849(phosphorus-oxygen lyase activity);GO:0061809(NAD+ nucleotidase, cyclic ADP-ribose generating);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0001666(response to hypoxia);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007565(female pregnancy);GO:0009725(response to hormone);GO:0030307(positive regulation of cell growth);GO:0032024(positive regulation of insulin secretion);GO:0032355(response to estradiol);GO:0032526(response to retinoic acid);GO:0032570(response to progesterone);GO:0033194(response to hydroperoxide);GO:0034097(response to cytokine);GO:0045779(negative regulation of bone resorption);GO:0045907(positive regulation of vasoconstriction);GO:0060292(long term synaptic depression);GO:0070555(response to interleukin-1);GO:0005634(nucleus);GO:0009986(cell surface);GO:0043231(intracellular membrane-bounded organelle)00760(Nicotinate and nicotinamide metabolism);04020(Calcium signaling pathway);04640(Hematopoietic cell lineage);04921(Oxytocin signaling pathway);04970(Salivary secretion);04972(Pancreatic secretion);05169(Epstein-Barr virus infection)K01242EC:3.2.2.6 2.4.99.20CD38 molecule [Source:HGNC Symbol;Acc:HGNC:1667]0.000.01
ENSG00000004478FKBP4ENST00000001008;ENST00000540260;ENST00000538622;ENST00000543037;ENST00000539181GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016853(isomerase activity);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0000413(protein peptidyl-prolyl isomerization);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0005515(protein binding);GO:0005528(FK506 binding);GO:0005874(microtubule);GO:0031072(heat shock protein binding);GO:0030424(axon);GO:0044295(axonal growth cone);GO:0070062(extracellular exosome);GO:0061077(chaperone-mediated protein folding);GO:1900034(regulation of cellular response to heat);GO:0010977(negative regulation of neuron projection development);GO:0006457(protein folding);GO:0030674(protein binding, bridging);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0032767(copper-dependent protein binding);GO:0035259(glucocorticoid receptor binding);GO:0048156(tau protein binding);GO:0051219(phosphoprotein binding);GO:0006463(steroid hormone receptor complex assembly);GO:0006825(copper ion transport);GO:0007566(embryo implantation);GO:0030521(androgen receptor signaling pathway);GO:0030850(prostate gland development);GO:0031111(negative regulation of microtubule polymerization or depolymerization);GO:0031115(negative regulation of microtubule polymerization);GO:0031503(protein complex localization);GO:0046661(male sex differentiation);GO:0048608(reproductive structure development);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043234(protein complex);GO:0048471(perinuclear region of cytoplasm);GO:0048471(perinuclear region of cytoplasm)04915(Estrogen signaling pathway);04915(Estrogen signaling pathway)K09571EC:5.2.1.8FK506 binding protein 4 [Source:HGNC Symbol;Acc:HGNC:3720]16.710622235521216.9041828025097
ENSG00000004487KDM1AENST00000356634;ENST00000400181;ENST00000494920;ENST00000602503GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016491(oxidoreductase activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0016575(histone deacetylation);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0003682(chromatin binding);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0000784(nuclear chromosome, telomeric region);GO:0043234(protein complex);GO:0032454(histone demethylase activity (H3-K9 specific));GO:0033169(histone H3-K9 demethylation);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0045892(negative regulation of transcription, DNA-templated);GO:0004407(histone deacetylase activity);GO:0044212(transcription regulatory region DNA binding);GO:0043426(MRF binding);GO:0032452(histone demethylase activity);GO:0019899(enzyme binding);GO:0032091(negative regulation of protein binding);GO:0007596(blood coagulation);GO:0050681(androgen receptor binding);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0002039(p53 binding);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0008134(transcription factor binding);GO:0032451(demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0042162(telomeric DNA binding);GO:0061752(telomeric repeat-containing RNA binding);GO:0006482(protein demethylation);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034720(histone H3-K4 demethylation);GO:0043392(negative regulation of DNA binding);GO:0055001(muscle cell development);GO:0071480(cellular response to gamma radiation);GO:1903827(regulation of cellular protein localization);GO:0005667(transcription factor complex);GO:1990391(DNA repair complex);GO:0000380(alternative mRNA splicing, via spliceosome);GO:0010976(positive regulation of neuron projection development);GO:0014070(response to organic cyclic compound);GO:0021987(cerebral cortex development);GO:0035563(positive regulation of chromatin binding);GO:0042551(neuron maturation);GO:0045793(positive regulation of cell size);GO:0046098(guanine metabolic process);GO:0060992(response to fungicide);GO:0071320(cellular response to cAMP);GO:0071320(cellular response to cAMP)NANANAlysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079]11.214198233854612.557098750138
ENSG00000004534RBM6ENST00000442092;ENST00000443081;ENST00000454079;ENST00000434592;ENST00000488807;ENST00000446471;ENST00000478026GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005515(protein binding);GO:0003677(DNA binding);GO:0006396(RNA processing);GO:0006396(RNA processing)NANANARNA binding motif protein 6 [Source:HGNC Symbol;Acc:HGNC:9903]3.913.49
ENSG00000004660CAMKK1ENST00000381769;ENST00000348335;ENST00000158166;ENST00000573483GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0035556(intracellular signal transduction);GO:0005829(cytosol);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0045860(positive regulation of protein kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0004683(calmodulin-dependent protein kinase activity)05034(Alcoholism);05034(Alcoholism)K00908EC:2.7.11.17calcium/calmodulin dependent protein kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:1469]2.352.21
ENSG00000004700RECQLENST00000444129GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0004386(helicase activity);GO:0008026(ATP-dependent helicase activity);GO:0032508(DNA duplex unwinding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0006310(DNA recombination);GO:0005737(cytoplasm);GO:0004003(ATP-dependent DNA helicase activity);GO:0006281(DNA repair);GO:0000724(double-strand break repair via homologous recombination);GO:0003678(DNA helicase activity);GO:0009378(four-way junction helicase activity);GO:0043140(ATP-dependent 3'-5' DNA helicase activity);GO:0005694(chromosome);GO:0000733(DNA strand renaturation);GO:0036310(annealing helicase activity)NANANARecQ like helicase [Source:HGNC Symbol;Acc:HGNC:9948]4.454.65
ENSG00000004766VPS50ENST00000251739;ENST00000544910;ENST00000471188;ENST00000495039;ENST00000458707GO:0006810(transport);GO:0016020(membrane);GO:0015031(protein transport);GO:0005768(endosome);GO:0070062(extracellular exosome);GO:0055037(recycling endosome);GO:0000149(SNARE binding);GO:0032456(endocytic recycling);GO:1990745(EARP complex);GO:1990745(EARP complex)NANANAVPS50, EARP/GARPII complex subunit [Source:HGNC Symbol;Acc:HGNC:25956]0.800.92
ENSG00000004776HSPB6ENST00000004982GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0042803(protein homodimerization activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005212(structural constituent of eye lens);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding);GO:0006937(regulation of muscle contraction);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0045766(positive regulation of angiogenesis);GO:0061077(chaperone-mediated protein folding)NANANAheat shock protein family B (small) member 6 [Source:HGNC Symbol;Acc:HGNC:26511]0.080.35
ENSG00000004777ARHGAP33ENST00000378944;ENST00000221905;ENST00000601474;ENST00000591438;ENST00000586918GO:0006810(transport);GO:0015031(protein transport);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0005515(protein binding);GO:0005096(GTPase activator activity);GO:0035091(phosphatidylinositol binding);GO:0005829(cytosol);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0019901(protein kinase binding);GO:0007264(small GTPase mediated signal transduction);GO:0043234(protein complex);GO:0005938(cell cortex);GO:0015629(actin cytoskeleton);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005886(plasma membrane)NANANARho GTPase activating protein 33 [Source:HGNC Symbol;Acc:HGNC:23085]1.041.00
ENSG00000004779NDUFAB1ENST00000007516;ENST00000484769;ENST00000570319;ENST00000567761GO:0005654(nucleoplasm);GO:0055114(oxidation-reduction process);GO:0005739(mitochondrion);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0005759(mitochondrial matrix);GO:0070469(respiratory chain);GO:0009249(protein lipoylation);GO:0005509(calcium ion binding);GO:0031966(mitochondrial membrane);GO:0005515(protein binding);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0005829(cytosol);GO:0034641(cellular nitrogen compound metabolic process);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0005747(mitochondrial respiratory chain complex I);GO:0005743(mitochondrial inner membrane);GO:0000035(acyl binding);GO:0000036(ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process);GO:0005504(fatty acid binding);GO:0031177(phosphopantetheine binding);GO:0006635(fatty acid beta-oxidation);GO:0009245(lipid A biosynthetic process);GO:0009245(lipid A biosynthetic process)00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD));04932(Non-alcoholic fatty liver disease (NAFLD))K03955NANADH:ubiquinone oxidoreductase subunit AB1 [Source:HGNC Symbol;Acc:HGNC:7694]11.4240511143759.47
ENSG00000004799PDK4ENST00000005178GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0006468(protein phosphorylation);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005975(carbohydrate metabolic process);GO:0006885(regulation of pH);GO:0008286(insulin receptor signaling pathway);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0010565(regulation of cellular ketone metabolic process);GO:0010906(regulation of glucose metabolic process);GO:0042304(regulation of fatty acid biosynthetic process);GO:0042593(glucose homeostasis);GO:0042594(response to starvation);GO:0045124(regulation of bone resorption);GO:0046320(regulation of fatty acid oxidation);GO:0005743(mitochondrial inner membrane);GO:0009267(cellular response to starvation);GO:0006006(glucose metabolic process);GO:0004672(protein kinase activity);GO:0071398(cellular response to fatty acid);GO:0072593(reactive oxygen species metabolic process);GO:2000811(negative regulation of anoikis);GO:0004740(pyruvate dehydrogenase (acetyl-transferring) kinase activity)NANANApyruvate dehydrogenase kinase 4 [Source:HGNC Symbol;Acc:HGNC:8812]2.202.50
ENSG00000004838ZMYND10ENST00000231749;ENST00000475688GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005815(microtubule organizing center);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0034451(centriolar satellite);GO:0036158(outer dynein arm assembly);GO:0036158(outer dynein arm assembly)NANANAzinc finger MYND-type containing 10 [Source:HGNC Symbol;Acc:HGNC:19412]0.040.04
ENSG00000004846ABCB5ENST00000404938GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0030154(cell differentiation);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0016887(ATPase activity);GO:0005887(integral component of plasma membrane);GO:0015562(efflux transmembrane transporter activity);GO:0006855(drug transmembrane transport);GO:0042391(regulation of membrane potential);GO:0008559(xenobiotic-transporting ATPase activity);GO:0042908(xenobiotic transport);GO:0048058(compound eye corneal lens development)02010(ABC transporters)K05660NAATP binding cassette subfamily B member 5 [Source:HGNC Symbol;Acc:HGNC:46]00.00
ENSG00000004864SLC25A13ENST00000265631;ENST00000416240;ENST00000490072;ENST00000492869GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0046872(metal ion binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005509(calcium ion binding);GO:0089711(L-glutamate transmembrane transport);GO:0005887(integral component of plasma membrane);GO:0006754(ATP biosynthetic process);GO:0005313(L-glutamate transmembrane transporter activity);GO:0006094(gluconeogenesis);GO:0045333(cellular respiration);GO:0005215(transporter activity);GO:0051592(response to calcium ion);GO:0015813(L-glutamate transport);GO:0015172(acidic amino acid transmembrane transporter activity);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015810(aspartate transport);GO:0043490(malate-aspartate shuttle);GO:0089712(L-aspartate transmembrane transport);GO:0089712(L-aspartate transmembrane transport)NANANAsolute carrier family 25 member 13 [Source:HGNC Symbol;Acc:HGNC:10983]11.38135992452836.79
ENSG00000004866ST7ENST00000265437;ENST00000434836;ENST00000393443;ENST00000543837GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)NANANAsuppression of tumorigenicity 7 [Source:HGNC Symbol;Acc:HGNC:11351]1.812.28
ENSG00000004897CDC27ENST00000066544GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016567(protein ubiquitination);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0008283(cell proliferation);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0070979(protein K11-linked ubiquitination);GO:0005680(anaphase-promoting complex);GO:0019903(protein phosphatase binding);GO:0005813(centrosome);GO:0005819(spindle);GO:0005876(spindle microtubule);GO:0007091(metaphase/anaphase transition of mitotic cell cycle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051301(cell division)04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);05166(HTLV-I infection)K03350NAcell division cycle 27 [Source:HGNC Symbol;Acc:HGNC:1728]4.955.27
ENSG00000004948CALCRENST00000359558GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0004888(transmembrane signaling receptor activity);GO:0007166(cell surface receptor signaling pathway);GO:0004948(calcitonin receptor activity);GO:0015031(protein transport);GO:0005887(integral component of plasma membrane);GO:0005515(protein binding);GO:0004872(receptor activity);GO:0010628(positive regulation of gene expression);GO:0008565(protein transporter activity);GO:0007189(adenylate cyclase-activating G-protein coupled receptor signaling pathway);GO:0097643(amylin receptor activity);GO:0030816(positive regulation of cAMP metabolic process);GO:0030819(positive regulation of cAMP biosynthetic process);GO:0031623(receptor internalization);GO:0072659(protein localization to plasma membrane);GO:0097647(amylin receptor signaling pathway);GO:1903440(amylin receptor complex);GO:0010739(positive regulation of protein kinase A signaling);GO:0010942(positive regulation of cell death);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1905665(positive regulation of calcium ion import across plasma membrane);GO:0045762(positive regulation of adenylate cyclase activity);GO:0051384(response to glucocorticoid);GO:0032841(calcitonin binding);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0030279(negative regulation of ossification);GO:0030316(osteoclast differentiation);GO:0043488(regulation of mRNA stability);GO:0001669(acrosomal vesicle);GO:0005929(cilium)04080(Neuroactive ligand-receptor interaction);04380(Osteoclast differentiation)K04576NAcalcitonin receptor [Source:HGNC Symbol;Acc:HGNC:1440]00.02
ENSG00000004961HCCSENST00000321143GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0016829(lyase activity);GO:0004408(holocytochrome-c synthase activity);GO:0009887(animal organ morphogenesis);GO:0055114(oxidation-reduction process);GO:0018063(cytochrome c-heme linkage)00860(Porphyrin and chlorophyll metabolism)K01764EC:4.4.1.17holocytochrome c synthase [Source:HGNC Symbol;Acc:HGNC:4837]10.575973611134911.5431174154176
ENSG00000004975DVL2ENST00000005340;ENST00000576840;ENST00000571745;ENST00000574143;ENST00000572285GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0005737(cytoplasm);GO:0001934(positive regulation of protein phosphorylation);GO:0003151(outflow tract morphogenesis);GO:0043507(positive regulation of JUN kinase activity);GO:0005634(nucleus);GO:0016020(membrane);GO:0005654(nucleoplasm);GO:0035556(intracellular signal transduction);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0016235(aggresome);GO:0016604(nuclear body);GO:0007275(multicellular organism development);GO:0016055(Wnt signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding);GO:0006366(transcription from RNA polymerase II promoter);GO:0061024(membrane organization);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060070(canonical Wnt signaling pathway);GO:0005109(frizzled binding);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:1904886(beta-catenin destruction complex disassembly);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030674(protein binding, bridging);GO:0043621(protein self-association);GO:0048365(Rac GTPase binding);GO:0001843(neural tube closure);GO:0003007(heart morphogenesis);GO:0007379(segment specification);GO:0007507(heart development);GO:0022007(convergent extension involved in neural plate elongation);GO:0034613(cellular protein localization);GO:0035282(segmentation);GO:0035329(hippo signaling);GO:0035567(non-canonical Wnt signaling pathway);GO:0043547(positive regulation of GTPase activity);GO:0044340(canonical Wnt signaling pathway involved in regulation of cell proliferation);GO:0051259(protein oligomerization);GO:0060029(convergent extension involved in organogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0090103(cochlea morphogenesis);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0016328(lateral plasma membrane);GO:0030136(clathrin-coated vesicle);GO:0045177(apical part of cell);GO:0045334(clathrin-coated endocytic vesicle);GO:0005622(intracellular);GO:0005622(intracellular)04310(Wnt signaling pathway);04330(Notch signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);05166(HTLV-I infection);05165(Human papillomavirus infection);05165(Human papillomavirus infection)K02353NAdishevelled segment polarity protein 2 [Source:HGNC Symbol;Acc:HGNC:3086]6.856.68
ENSG00000005001PRSS22ENST00000161006;ENST00000576381;ENST00000572061;ENST00000570950GO:0016787(hydrolase activity);GO:0008233(peptidase activity);GO:0006508(proteolysis);GO:0005576(extracellular region);GO:0004252(serine-type endopeptidase activity);GO:0008236(serine-type peptidase activity);GO:0046658(anchored component of plasma membrane);GO:0019897(extrinsic component of plasma membrane);GO:0019897(extrinsic component of plasma membrane)NANANAprotease, serine 22 [Source:HGNC Symbol;Acc:HGNC:14368]0.070.01
ENSG00000005007UPF1ENST00000262803;ENST00000601981;ENST00000600012;ENST00000598209;ENST00000600310;ENST00000598471;ENST00000596842GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0005515(protein binding);GO:0000932(P-body);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0005829(cytosol);GO:0071222(cellular response to lipopolysaccharide);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0000784(nuclear chromosome, telomeric region);GO:0071347(cellular response to interleukin-1);GO:0061014(positive regulation of mRNA catabolic process);GO:0035145(exon-exon junction complex);GO:0004004(ATP-dependent RNA helicase activity);GO:0071044(histone mRNA catabolic process);GO:0042162(telomeric DNA binding);GO:0032204(regulation of telomere maintenance);GO:0044770(cell cycle phase transition);GO:0044530(supraspliceosomal complex);GO:0006260(DNA replication);GO:0000294(nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay);GO:0006406(mRNA export from nucleus);GO:0006449(regulation of translational termination);GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0006281(DNA repair);GO:0032201(telomere maintenance via semi-conservative replication);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0009048(dosage compensation by inactivation of X chromosome)03013(RNA transport);03015(mRNA surveillance pathway);03015(mRNA surveillance pathway)K14326EC:3.6.4.-UPF1, RNA helicase and ATPase [Source:HGNC Symbol;Acc:HGNC:9962]13.336573025581412.5983437909302
ENSG00000005020SKAP2ENST00000345317;ENST00000468712;ENST00000432747;ENST00000481204;ENST00000487720GO:0005737(cytoplasm);GO:0009967(positive regulation of signal transduction);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0042113(B cell activation);GO:0007165(signal transduction);GO:0006461(protein complex assembly);GO:0005070(SH3/SH2 adaptor activity);GO:0002757(immune response-activating signal transduction);GO:0008285(negative regulation of cell proliferation);GO:0008285(negative regulation of cell proliferation)NANANAsrc kinase associated phosphoprotein 2 [Source:HGNC Symbol;Acc:HGNC:15687]3.553.52
ENSG00000005022SLC25A5ENST00000317881;ENST00000475354;ENST00000460013GO:0003723(RNA binding);GO:0006810(transport);GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005215(transporter activity);GO:0055085(transmembrane transport);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005515(protein binding);GO:0007059(chromosome segregation);GO:0070062(extracellular exosome);GO:0016032(viral process);GO:0005887(integral component of plasma membrane);GO:0031012(extracellular matrix);GO:0008284(positive regulation of cell proliferation);GO:1901029(negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:0042645(mitochondrial nucleoid);GO:0050796(regulation of insulin secretion);GO:0031625(ubiquitin protein ligase binding);GO:0015866(ADP transport);GO:0071817(MMXD complex);GO:0005471(ATP:ADP antiporter activity);GO:0015207(adenine transmembrane transporter activity);GO:0015853(adenine transport);GO:0015867(ATP transport);GO:1990830(cellular response to leukemia inhibitory factor);GO:0043209(myelin sheath);GO:0045121(membrane raft);GO:0045121(membrane raft)04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04217(Necroptosis);04218(Cellular senescence);05012(Parkinson's disease);05016(Huntington's disease);05166(HTLV-I infection);05166(HTLV-I infection)K05863NAsolute carrier family 25 member 5 [Source:HGNC Symbol;Acc:HGNC:10991]90.06843138891.6869279393334
ENSG00000005059MCUBENST00000394650;ENST00000452915GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:0006811(ion transport);GO:0031305(integral component of mitochondrial inner membrane);GO:0006816(calcium ion transport);GO:0065009(regulation of molecular function);GO:0031224(intrinsic component of membrane);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0051560(mitochondrial calcium ion homeostasis);GO:0019855(calcium channel inhibitor activity);GO:0034704(calcium channel complex);GO:1990246(uniplex complex);GO:0036444(mitochondrial calcium uptake);GO:0036444(mitochondrial calcium uptake)NANANAmitochondrial calcium uniporter dominant negative beta subunit [Source:HGNC Symbol;Acc:HGNC:26076]1.632.60
ENSG00000005075POLR2JENST00000292614;ENST00000393794GO:0005634(nucleus);GO:0046983(protein dimerization activity);GO:0003677(DNA binding);GO:0006351(transcription, DNA-templated);GO:0005515(protein binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006370(7-methylguanosine mRNA capping);GO:0050434(positive regulation of viral transcription);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0042795(snRNA transcription from RNA polymerase II promoter);GO:0000398(mRNA splicing, via spliceosome);GO:0060964(regulation of gene silencing by miRNA);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016070(RNA metabolic process);GO:0035019(somatic stem cell population maintenance);GO:0005665(DNA-directed RNA polymerase II, core complex);GO:0001055(RNA polymerase II activity);GO:0030275(LRR domain binding);GO:0030275(LRR domain binding)00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);05016(Huntington's disease);05169(Epstein-Barr virus infection);05169(Epstein-Barr virus infection)K03008NARNA polymerase II subunit J [Source:HGNC Symbol;Acc:HGNC:9197]18.700574810332114.9102474273063
ENSG00000005100DHX33ENST00000225296;ENST00000575153GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005730(nucleolus);GO:0016787(hydrolase activity);GO:0004386(helicase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0004004(ATP-dependent RNA helicase activity);GO:0000182(rDNA binding);GO:0045943(positive regulation of transcription from RNA polymerase I promoter);GO:0006396(RNA processing);GO:0033613(activating transcription factor binding);GO:0033613(activating transcription factor binding)04621(NOD-like receptor signaling pathway);04621(NOD-like receptor signaling pathway)K17820EC:3.6.4.13DEAH-box helicase 33 [Source:HGNC Symbol;Acc:HGNC:16718]9.339.26
ENSG00000005108THSD7AENST00000423059GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0005576(extracellular region);GO:0030154(cell differentiation);GO:0070062(extracellular exosome);GO:0001525(angiogenesis)NANANAthrombospondin type 1 domain containing 7A [Source:HGNC Symbol;Acc:HGNC:22207]0.060.10
ENSG00000005156LIG3ENST00000378526;ENST00000262327;ENST00000590181;ENST00000586407;ENST00000586058;ENST00000593099GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0051301(cell division);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0016874(ligase activity);GO:0005515(protein binding);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0006260(DNA replication);GO:0003909(DNA ligase activity);GO:0003910(DNA ligase (ATP) activity);GO:0051103(DNA ligation involved in DNA repair);GO:0071897(DNA biosynthetic process);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0000724(double-strand break repair via homologous recombination);GO:0006288(base-excision repair, DNA ligation);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006302(double-strand break repair);GO:0090298(negative regulation of mitochondrial DNA replication);GO:0006266(DNA ligation);GO:0006266(DNA ligation)03410(Base excision repair);03410(Base excision repair)K10776EC:6.5.1.1DNA ligase 3 [Source:HGNC Symbol;Acc:HGNC:6600]2.592.60
ENSG00000005175RPAP3ENST00000005386;ENST00000548211;ENST00000551293GO:0005515(protein binding);GO:0097255(R2TP complex);GO:0097255(R2TP complex)NANANARNA polymerase II associated protein 3 [Source:HGNC Symbol;Acc:HGNC:26151]2.262.54
ENSG00000005187ACSM3ENST00000501740;ENST00000614721;ENST00000289416;ENST00000562251;ENST00000567711GO:0042632(cholesterol homeostasis);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0003824(catalytic activity);GO:0006629(lipid metabolic process);GO:0008152(metabolic process);GO:0006631(fatty acid metabolic process);GO:0005739(mitochondrion);GO:0016874(ligase activity);GO:0005759(mitochondrial matrix);GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008217(regulation of blood pressure);GO:0003996(acyl-CoA ligase activity);GO:0004321(fatty-acyl-CoA synthase activity);GO:0015645(fatty acid ligase activity);GO:0047760(butyrate-CoA ligase activity);GO:0006633(fatty acid biosynthetic process);GO:0006637(acyl-CoA metabolic process);GO:0006637(acyl-CoA metabolic process)00650(Butanoate metabolism);00650(Butanoate metabolism)K01896EC:6.2.1.2acyl-CoA synthetase medium chain family member 3 [Source:HGNC Symbol;Acc:HGNC:10522]0.700.82
ENSG00000005189REXO5ENST00000566993;ENST00000261377;ENST00000563068;ENST00000563617;ENST00000563045GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0016787(hydrolase activity);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0004527(exonuclease activity);GO:0004518(nuclease activity);GO:0070062(extracellular exosome);GO:0005730(nucleolus);GO:0005730(nucleolus)03008(Ribosome biogenesis in eukaryotes);03008(Ribosome biogenesis in eukaryotes)K14570EC:3.1.-.-RNA exonuclease 5 [Source:HGNC Symbol;Acc:HGNC:24661]1.992.09
ENSG00000005194CIAPIN1ENST00000394391;ENST00000563561;ENST00000566284GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0008168(methyltransferase activity);GO:0005739(mitochondrion);GO:0008152(metabolic process);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0032259(methylation);GO:0051536(iron-sulfur cluster binding);GO:0005730(nucleolus);GO:0016226(iron-sulfur cluster assembly);GO:0051537(2 iron, 2 sulfur cluster binding);GO:0005758(mitochondrial intermembrane space);GO:0043066(negative regulation of apoptotic process);GO:0030097(hemopoiesis);GO:0030097(hemopoiesis)NANANAcytokine induced apoptosis inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:28050]6.635.13
ENSG00000005206SPPL2BENST00000613503;ENST00000586332;ENST00000614794;ENST00000586111;ENST00000593243GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0005794(Golgi apparatus);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0005813(centrosome);GO:0042803(protein homodimerization activity);GO:0015629(actin cytoskeleton);GO:0008233(peptidase activity);GO:0006508(proteolysis);GO:0000139(Golgi membrane);GO:0004190(aspartic-type endopeptidase activity);GO:0005764(lysosome);GO:0031293(membrane protein intracellular domain proteolysis);GO:0005515(protein binding);GO:0005768(endosome);GO:0010008(endosome membrane);GO:0030660(Golgi-associated vesicle membrane);GO:0006509(membrane protein ectodomain proteolysis);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0033619(membrane protein proteolysis);GO:0050776(regulation of immune response);GO:0042500(aspartic endopeptidase activity, intramembrane cleaving);GO:0071458(integral component of cytoplasmic side of endoplasmic reticulum membrane);GO:0071556(integral component of lumenal side of endoplasmic reticulum membrane);GO:0071556(integral component of lumenal side of endoplasmic reticulum membrane)NANANAsignal peptide peptidase like 2B [Source:HGNC Symbol;Acc:HGNC:30627]2.552.23
ENSG00000005238FAM214BENST00000378566;ENST00000603301;ENST00000378561;ENST00000605392GO:0005515(protein binding);GO:0005634(nucleus);GO:0005634(nucleus)NANANAfamily with sequence similarity 214 member B [Source:HGNC Symbol;Acc:HGNC:25666]1.662.09
ENSG00000005243COPZ2ENST00000580409;ENST00000621465;ENST00000579263;ENST00000580174GO:0006810(transport);GO:0015031(protein transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0031410(cytoplasmic vesicle);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0030663(COPI-coated vesicle membrane);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0030133(transport vesicle);GO:0030126(COPI vesicle coat);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0005801(cis-Golgi network);GO:0005801(cis-Golgi network)NANANAcoatomer protein complex subunit zeta 2 [Source:HGNC Symbol;Acc:HGNC:19356]2.543.04
ENSG00000005249PRKAR2BENST00000265717GO:2000480(negative regulation of cAMP-dependent protein kinase activity);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0008603(cAMP-dependent protein kinase regulator activity);GO:0030552(cAMP binding);GO:0001932(regulation of protein phosphorylation);GO:0005952(cAMP-dependent protein kinase complex);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0006631(fatty acid metabolic process);GO:0007612(learning);GO:0045859(regulation of protein kinase activity);GO:0097332(response to antipsychotic drug);GO:0097338(response to clozapine);GO:0005743(mitochondrial inner membrane);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0045121(membrane raft);GO:0048471(perinuclear region of cytoplasm);GO:0097546(ciliary base);GO:0098794(postsynapse);GO:0005813(centrosome);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0031625(ubiquitin protein ligase binding);GO:0000086(G2/M transition of mitotic cell cycle);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0097711(ciliary basal body docking);GO:0035556(intracellular signal transduction);GO:0007596(blood coagulation);GO:0003091(renal water homeostasis);GO:0034199(activation of protein kinase A activity);GO:0071377(cellular response to glucagon stimulus);GO:0004862(cAMP-dependent protein kinase inhibitor activity);GO:0034236(protein kinase A catalytic subunit binding)04910(Insulin signaling pathway)K04739NAprotein kinase cAMP-dependent type II regulatory subunit beta [Source:HGNC Symbol;Acc:HGNC:9392]2.482.75
ENSG00000005302MSL3ENST00000361672;ENST00000312196;ENST00000337339;ENST00000398527GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0003677(DNA binding);GO:0006325(chromatin organization);GO:0005654(nucleoplasm);GO:0006338(chromatin remodeling);GO:0035064(methylated histone binding);GO:0043984(histone H4-K16 acetylation);GO:0006342(chromatin silencing);GO:0016575(histone deacetylation);GO:0043968(histone H2A acetylation);GO:0035267(NuA4 histone acetyltransferase complex);GO:0072487(MSL complex);GO:0072487(MSL complex)NANANAMSL complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7370]0.780.52
ENSG00000005339CREBBPENST00000262367;ENST00000573517;ENST00000635899;ENST00000636895GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0016740(transferase activity);GO:0003713(transcription coactivator activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0016746(transferase activity, transferring acyl groups);GO:0005515(protein binding);GO:0000123(histone acetyltransferase complex);GO:0007165(signal transduction);GO:0016604(nuclear body);GO:0048511(rhythmic process);GO:0004402(histone acetyltransferase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0003712(transcription cofactor activity);GO:0016573(histone acetylation);GO:0031648(protein destabilization);GO:0002223(stimulatory C-type lectin receptor signaling pathway);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0003682(chromatin binding);GO:0001666(response to hypoxia);GO:0016032(viral process);GO:0004871(signal transducer activity);GO:0008134(transcription factor binding);GO:0042981(regulation of apoptotic process);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:1904837(beta-catenin-TCF complex assembly);GO:0000790(nuclear chromatin);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0006461(protein complex assembly);GO:0042592(homeostatic process);GO:0007219(Notch signaling pathway);GO:0042733(embryonic digit morphogenesis);GO:0001078(transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001191(transcriptional repressor activity, RNA polymerase II transcription factor binding);GO:0032481(positive regulation of type I interferon production);GO:0002039(p53 binding);GO:0019216(regulation of lipid metabolic process);GO:1900034(regulation of cellular response to heat);GO:0003684(damaged DNA binding);GO:0000987(core promoter proximal region sequence-specific DNA binding);GO:0034644(cellular response to UV);GO:0045637(regulation of myeloid cell differentiation);GO:0001105(RNA polymerase II transcription coactivator activity);GO:0016407(acetyltransferase activity);GO:0006473(protein acetylation);GO:0034212(peptide N-acetyltransferase activity);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0043426(MRF binding);GO:0008589(regulation of smoothened signaling pathway);GO:0008589(regulation of smoothened signaling pathway)04310(Wnt signaling pathway);04330(Notch signaling pathway);04350(TGF-beta signaling pathway);04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04024(cAMP signaling pathway);04110(Cell cycle);04520(Adherens junction);04922(Glucagon signaling pathway);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04720(Long-term potentiation);05200(Pathways in cancer);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05211(Renal cell carcinoma);05215(Prostate cancer);05016(Huntington's disease);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05167(Kaposi's sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05165(Human papillomavirus infection)K04498EC:2.3.1.48CREB binding protein [Source:HGNC Symbol;Acc:HGNC:2348]4.924.95
ENSG00000005379TSPOAP1ENST00000581692GO:0030156(benzodiazepine receptor binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005515(protein binding);GO:0098793(presynapse);GO:0008150(biological_process);GO:0005829(cytosol);GO:0014047(glutamate secretion);GO:0007269(neurotransmitter secretion);GO:0006700(C21-steroid hormone biosynthetic process)NANANATSPO associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16831]00.01
ENSG00000005421PON1ENST00000222381GO:0005615(extracellular space);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0005576(extracellular region);GO:0016311(dephosphorylation);GO:0005509(calcium ion binding);GO:0004064(arylesterase activity);GO:0070062(extracellular exosome);GO:0072562(blood microparticle);GO:0034364(high-density lipoprotein particle);GO:0042803(protein homodimerization activity);GO:0051099(positive regulation of binding);GO:0019372(lipoxygenase pathway);GO:0005543(phospholipid binding);GO:0034366(spherical high-density lipoprotein particle);GO:0010875(positive regulation of cholesterol efflux);GO:0046470(phosphatidylcholine metabolic process);GO:0009605(response to external stimulus);GO:0009636(response to toxic substance);GO:0004063(aryldialkylphosphatase activity);GO:0102007(acyl-L-homoserine-lactone lactonohydrolase activity);GO:0006629(lipid metabolic process);GO:0008203(cholesterol metabolic process);GO:0019439(aromatic compound catabolic process);GO:0031667(response to nutrient levels);GO:0032411(positive regulation of transporter activity);GO:0046395(carboxylic acid catabolic process);GO:0046434(organophosphate catabolic process);GO:0070542(response to fatty acid);GO:1902617(response to fluoride);GO:0043231(intracellular membrane-bounded organelle)NANANAparaoxonase 1 [Source:HGNC Symbol;Acc:HGNC:9204]0.050.06
ENSG00000005436GCFC2ENST00000321027GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0045892(negative regulation of transcription, DNA-templated);GO:0000398(mRNA splicing, via spliceosome);GO:0071008(U2-type post-mRNA release spliceosomal complex);GO:0000245(spliceosomal complex assembly)NANANAGC-rich sequence DNA-binding factor 2 [Source:HGNC Symbol;Acc:HGNC:1317]0.830.78
ENSG00000005448WDR54ENST00000461531;ENST00000465134;ENST00000468778NANANANAWD repeat domain 54 [Source:HGNC Symbol;Acc:HGNC:25770]3.382.12
ENSG00000005469CROTENST00000419147;ENST00000412227;ENST00000442291GO:0006810(transport);GO:0043231(intracellular membrane-bounded organelle);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0005777(peroxisome);GO:0005102(receptor binding);GO:0005782(peroxisomal matrix);GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase);GO:0006635(fatty acid beta-oxidation);GO:0006091(generation of precursor metabolites and energy);GO:0009437(carnitine metabolic process);GO:0008458(carnitine O-octanoyltransferase activity);GO:0015908(fatty acid transport);GO:0015936(coenzyme A metabolic process);GO:0051791(medium-chain fatty acid metabolic process);GO:0005739(mitochondrion);GO:0005739(mitochondrion)04146(Peroxisome);04146(Peroxisome)K05940EC:2.3.1.137carnitine O-octanoyltransferase [Source:HGNC Symbol;Acc:HGNC:2366]1.101.15
ENSG00000005471ABCB4ENST00000265723GO:0006810(transport);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton);GO:0006869(lipid transport);GO:0031410(cytoplasmic vesicle);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0016887(ATPase activity);GO:0045121(membrane raft);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0005887(integral component of plasma membrane);GO:0016324(apical plasma membrane);GO:0030136(clathrin-coated vesicle);GO:0006629(lipid metabolic process);GO:0032782(bile acid secretion);GO:0019216(regulation of lipid metabolic process);GO:0045332(phospholipid translocation);GO:2001140(positive regulation of phospholipid transport);GO:0042493(response to drug);GO:0042908(xenobiotic transport);GO:0090554(phosphatidylcholine-translocating ATPase activity);GO:0008559(xenobiotic-transporting ATPase activity);GO:0005548(phospholipid transporter activity);GO:0008525(phosphatidylcholine transporter activity);GO:0032376(positive regulation of cholesterol transport);GO:0055088(lipid homeostasis);GO:0061092(positive regulation of phospholipid translocation);GO:1901557(response to fenofibrate);GO:1903413(cellular response to bile acid);GO:0001666(response to hypoxia);GO:0001890(placenta development);GO:0006855(drug transmembrane transport);GO:0007420(brain development);GO:0007595(lactation);GO:0007623(circadian rhythm);GO:0009914(hormone transport);GO:0010033(response to organic substance);GO:0010046(response to mycotoxin);GO:0014070(response to organic cyclic compound);GO:0014072(response to isoquinoline alkaloid);GO:0031667(response to nutrient levels);GO:0032355(response to estradiol);GO:0033189(response to vitamin A);GO:0033231(carbohydrate export);GO:0033280(response to vitamin D);GO:0035633(maintenance of permeability of blood-brain barrier);GO:0036146(cellular response to mycotoxin);GO:0043215(daunorubicin transport);GO:0043278(response to morphine);GO:0046618(drug export);GO:0046686(response to cadmium ion);GO:0050892(intestinal absorption);GO:0060548(negative regulation of cell death);GO:0060856(establishment of blood-brain barrier);GO:0071217(cellular response to external biotic stimulus);GO:0071236(cellular response to antibiotic);GO:0071312(cellular response to alkaloid);GO:0071392(cellular response to estradiol stimulus);GO:0071407(cellular response to organic cyclic compound);GO:0071475(cellular hyperosmotic salinity response);GO:0071548(response to dexamethasone);GO:0071549(cellular response to dexamethasone stimulus);GO:0097068(response to thyroxine);GO:0097327(response to antineoplastic agent);GO:1902065(response to L-glutamate);GO:1903416(response to glycoside);GO:1904478(regulation of intestinal absorption);GO:1905231(cellular response to borneol);GO:1905232(cellular response to L-glutamate);GO:1905233(response to codeine);GO:1905235(response to quercetin);GO:1905237(response to cyclosporin A);GO:1990962(drug transport across blood-brain barrier);GO:1990963(establishment of blood-retinal barrier);GO:2001025(positive regulation of response to drug);GO:0031526(brush border membrane);GO:0045177(apical part of cell);GO:0046581(intercellular canaliculus)02010(ABC transporters);04976(Bile secretion)K05659EC:3.6.3.44ATP binding cassette subfamily B member 4 [Source:HGNC Symbol;Acc:HGNC:45]0.000.02
ENSG00000005483KMT2EENST00000311117;ENST00000476671;ENST00000482560;ENST00000478079GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0030218(erythrocyte differentiation);GO:0018024(histone-lysine N-methyltransferase activity);GO:0034968(histone lysine methylation);GO:0005654(nucleoplasm);GO:0007050(cell cycle arrest);GO:0045652(regulation of megakaryocyte differentiation);GO:0042119(neutrophil activation);GO:0006306(DNA methylation);GO:0002446(neutrophil mediated immunity);GO:0002446(neutrophil mediated immunity)00310(Lysine degradation);00310(Lysine degradation)K09189EC:2.1.1.43lysine methyltransferase 2E [Source:HGNC Symbol;Acc:HGNC:18541]3.113.54
ENSG00000005486RHBDD2ENST00000006777;ENST00000318622;ENST00000476218;ENST00000467406GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0000139(Golgi membrane);GO:0048471(perinuclear region of cytoplasm);GO:0048471(perinuclear region of cytoplasm)NANANArhomboid domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23082]26.950872279803424.1745259303564
ENSG00000005513SOX8ENST00000566034GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0000981(RNA polymerase II transcription factor activity, sequence-specific DNA binding);GO:0007165(signal transduction);GO:0045893(positive regulation of transcription, DNA-templated);GO:0007283(spermatogenesis);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0045444(fat cell differentiation);GO:0060612(adipose tissue development);GO:0008584(male gonad development);GO:0043066(negative regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045662(negative regulation of myoblast differentiation);GO:0060041(retina development in camera-type eye);GO:0001701(in utero embryonic development);GO:0045165(cell fate commitment);GO:0001755(neural crest cell migration);GO:0001649(osteoblast differentiation);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0033690(positive regulation of osteoblast proliferation);GO:0090184(positive regulation of kidney development);GO:0048709(oligodendrocyte differentiation);GO:0048484(enteric nervous system development);GO:0060221(retinal rod cell differentiation);GO:0061138(morphogenesis of a branching epithelium);GO:0072034(renal vesicle induction);GO:0072289(metanephric nephron tubule formation);GO:0007422(peripheral nervous system development);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0008134(transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0046982(protein heterodimerization activity);GO:0010628(positive regulation of gene expression);GO:0010817(regulation of hormone levels);GO:0014015(positive regulation of gliogenesis);GO:0035914(skeletal muscle cell differentiation);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0048469(cell maturation);GO:0060009(Sertoli cell development);GO:0060018(astrocyte fate commitment);GO:0072197(ureter morphogenesis);GO:0044798(nuclear transcription factor complex)NANANASRY-box 8 [Source:HGNC Symbol;Acc:HGNC:11203]00.02
ENSG00000005700IBTKENST00000306270;ENST00000505222;ENST00000508381;ENST00000471036GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005654(nucleoplasm);GO:0019901(protein kinase binding);GO:0061099(negative regulation of protein tyrosine kinase activity);GO:0001933(negative regulation of protein phosphorylation);GO:0030292(protein tyrosine kinase inhibitor activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051209(release of sequestered calcium ion into cytosol)NANANAinhibitor of Bruton tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:17853]2.793.02
ENSG00000005801ZNF195ENST00000528796;ENST00000354599;ENST00000620374;ENST00000429541;ENST00000529789;ENST00000529228;ENST00000526540;ENST00000526598;ENST00000528636;ENST00000330692;ENST00000526501;ENST00000527386GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated);GO:0005622(intracellular);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0008270(zinc ion binding);GO:0008270(zinc ion binding)NANANAzinc finger protein 195 [Source:HGNC Symbol;Acc:HGNC:12986]2.362.41
ENSG00000005810MYCBP2ENST00000544440;ENST00000482517;ENST00000462987GO:0005634(nucleus);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016567(protein ubiquitination);GO:0005515(protein binding);GO:0004842(ubiquitin-protein transferase activity);GO:0004842(ubiquitin-protein transferase activity)NANANAMYC binding protein 2, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:23386]3.564.16

Definition of table:

termDescription
gene_idDefines the ID of gene
gene_nameDefines the name of gene or gene symbol
transcript_idDefines the ID of transcript
GOGene ontology term and description http://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
KO_EntryKO functional ortholog, KO groups identified by K numbers and, in metabolic maps
ECenzyme
DescriptionDescription of gene
FPKM.ANormalization of gene expression level by FPKM value

document location:summary6_transcript_expression/4_genes_fpkm_expression.xlsx



4.6.2 Transcript expression profiling


t_idclass_codechrstrandstartendt_namenum_exonslengthgene_idgene_nameGOKEGGKO_ENTRYECDescriptioncov.M14_OEFPKM.M14_OEcov.M14_NCFPKM.M14_NC
1NAchr1+1186914409ENST0000045632831657ENSG00000223972DDX11L1NANANANADEAD/H-box helicase 11 like 1 [Source:HGNC Symbol;Acc:HGNC:37102]0.100.010.320.04
2NAchr1+1201013670ENST000004503056632ENSG00000223972DDX11L1NANANANADEAD/H-box helicase 11 like 1 [Source:HGNC Symbol;Acc:HGNC:37102]0.050.0100
3NAchr1-1440429570ENST00000488147111351ENSG00000227232WASH7PNANANANAWAS protein family homolog 7 pseudogene [Source:HGNC Symbol;Acc:HGNC:38034]31.9959413.8625.7931863.32
5NAchr1+2955431097ENST000004733583712ENSG00000243485MIR1302-2HGNANANANAMIR1302-2 host gene [Source:HGNC Symbol;Acc:HGNC:52482]000.200.03
11NAchr1+5759864116ENST0000064211631414ENSG00000240361OR4G11PNANANANAolfactory receptor family 4 subfamily G member 11 pseudogene [Source:HGNC Symbol;Acc:HGNC:31276]000.160.02
14NAchr1+6905570108ENST0000033513711054ENSG00000186092OR4F5GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0004984(olfactory receptor activity);GO:0007608(sensory perception of smell);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell);GO:0004888(transmembrane signaling receptor activity);GO:0050907(detection of chemical stimulus involved in sensory perception)04740(Olfactory transduction)K04257NAolfactory receptor family 4 subfamily F member 5 [Source:HGNC Symbol;Acc:HGNC:14825]000.280.04
15NAchr1-89295120932ENST0000046643042748ENSG00000238009AL627309.1NANANANANA0.080.010.680.09
18NAchr1-110953129173ENST000004712483629ENSG00000238009AL627309.1NANANANANA0.230.0300
21NAchr1+131025134836ENST0000044298713812ENSG00000233750CICP27NANANANAcapicua transcriptional repressor pseudogene 27 [Source:HGNC Symbol;Acc:HGNC:48835]0.500.060.550.07
24NAchr1-139790140339ENST000004937972323ENSG00000239906AL627309.2NANANANANA0.180.020.120.02
25NAchr1-141474149707ENST0000048485924860ENSG00000241860AL627309.5NANANANANA0.140.020.030.00
27NAchr1-146386173862ENST0000046655781301ENSG00000241860AL627309.5NANANANANA1.370.171.080.14
29NAchr1+160446161525ENST000004964882457ENSG00000241599AL627309.4NANANANANA000.290.04
30NAchr1-165889168767ENST000004919623278ENSG00000241860AL627309.5NANANANANA0.100.0100
31NAchr1+182696184174ENST000006244315570ENSG00000279928FO538757.2NANANANANA1.210.153.000.39
32NAchr1-185217195411ENST00000623083101397ENSG00000279457FO538757.1NANANANANA24.9902863.0130.2326343.89
35NAchr1-257913268816ENST0000044895842250ENSG00000228463AP006222.1NANANANANA000.120.02
36NAchr1-258144359681ENST0000044186642256ENSG00000228463AP006222.1NANANANANA0.130.020.070.01
39NAchr1-263015297502ENST0000042458745603ENSG00000228463AP006222.1NANANANANA0.230.030.020.00
51NAchr1-484832495476ENST000006018143635ENSG00000237094AL732372.2NANANANANA000.050.01
54NAchr1+487101489906ENST0000043272322477ENSG00000233653CICP7NANANANAcapicua transcriptional repressor pseudogene 7 [Source:HGNC Symbol;Acc:HGNC:37756]0.280.030.390.05
55NAchr1-491225493241ENST0000051443621239ENSG00000250575AL732372.3NANANANANA1.600.192.080.27
56NAchr1-494382496605ENST000004191602547ENSG00000237094AL732372.2NANANANANA000.680.09
57NAchr1-494464502508ENST000004400385793ENSG00000237094AL732372.2NANANANANA4.000.483.180.41
62NAchr1-497205502598ENST000006418456571ENSG00000237094AL732372.2NANANANANA000.030.00
64NAchr1-497240499002ENST000006014864696ENSG00000237094AL732372.2NANANANANA4.500.542.670.34
70NAchr1-501604517225ENST000006410635473ENSG00000237094AL732372.2NANANANANA0.100.010.150.02
71NAchr1-504470514413ENST000006410492519ENSG00000237094AL732372.2NANANANANA1.440.171.130.15
72NAchr1-504865522928ENST000006421244456ENSG00000237094AL732372.2NANANANANA0.150.020.030.00
80NAchr1-594198631204ENST0000064129661127ENSG00000230021AL669831.3NANANANANA0.490.060.230.03
81NAchr1-594308598551ENST0000035787621702ENSG00000230021AL669831.3NANANANANA000.170.02
87NAchr1+629640630683ENST0000045754011044ENSG00000225630MTND2P28NANANANAmitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 28 [Source:HGNC Symbol;Acc:HGNC:42129]2019.034546243.438981723.17749221.695282
88NAchr1+631074632616ENST0000041427311543ENSG00000237973MTCO1P12NANANANAmitochondrially encoded cytochrome c oxidase I pseudogene 12 [Source:HGNC Symbol;Acc:HGNC:52014]811.73944197.873032831.252197106.944695
92NAchr1+633696634376ENST000005140571681ENSG00000248527MTATP6P1NANANANAmitochondrially encoded ATP synthase 6 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44575]003385.140381435.515015
93NAchr1+634376634922ENST000004167181547ENSG00000198744MTCO3P12NANANANAmitochondrially encoded cytochrome c oxidase III pseudogene 12 [Source:HGNC Symbol;Acc:HGNC:52042]116.7237414.07361100
97NAchr1-711867732212ENST000004146883421ENSG00000230021AL669831.3NANANANANA3.990.483.170.41
98NAchr1-720024720206ENST000006366761183ENSG00000230021AL669831.3NANANANANA0.470.0600
100NAchr1+722092724903ENST0000044078222455ENSG00000229376CICP3NANANANAcapicua transcriptional repressor pseudogene 3 [Source:HGNC Symbol;Acc:HGNC:37742]0.750.090.430.06
101NAchr1-725885778626ENST00000506640166432ENSG00000228327AL669831.1NANANANANA7.150.867.050.91
105NAchr1+778770784690ENST000004342643844ENSG00000237491AL669831.5NANANANANA0.430.050.700.09
107NAchr1+778930784655ENST000005898994809ENSG00000237491AL669831.5NANANANANA0.190.020.230.03
121NAchr1+784396807321ENST0000058628871040ENSG00000237491AL669831.5NANANANANA0.080.010.430.06
122NAchr1+785800787672ENST0000059170211873ENSG00000237491AL669831.5NANANANANA0.160.020.390.05
123NAchr1-800879817712ENST000004475005872ENSG00000230092AL669831.4NANANANANA2.150.261.740.22
125NAchr1+804932810060ENST000004121153581ENSG00000237491AL669831.5NANANANANA0.220.030.610.08
127NAchr1+817371819837ENST0000032673421947ENSG00000177757FAM87BNANANANAfamily with sequence similarity 87 member B [Source:HGNC Symbol;Acc:HGNC:32236]0.130.020.150.02
128NAchr1+825138849592ENST000006249273677ENSG00000228794LINC01128NANANANAlong intergenic non-protein coding RNA 1128 [Source:HGNC Symbol;Acc:HGNC:49377]0.960.120.890.11
129NAchr1-826206827522ENST0000047379811317ENSG00000225880LINC00115NANANANAlong intergenic non-protein coding RNA 115 [Source:HGNC Symbol;Acc:HGNC:26211]2.610.3100
131NAchr1+827608859446ENST0000044511856606ENSG00000228794LINC01128NANANANAlong intergenic non-protein coding RNA 1128 [Source:HGNC Symbol;Acc:HGNC:49377]3.730.453.450.44
140NAchr1+827721852090ENST000006090096767ENSG00000228794LINC01128NANANANAlong intergenic non-protein coding RNA 1128 [Source:HGNC Symbol;Acc:HGNC:49377]0.650.081.220.16
142NAchr1+831605842020ENST000004152952894ENSG00000228794LINC01128NANANANAlong intergenic non-protein coding RNA 1128 [Source:HGNC Symbol;Acc:HGNC:49377]3.480.424.980.64
144NAchr1-868071876903ENST0000044613631807ENSG00000230368FAM41CNANANANAfamily with sequence similarity 41 member C [Source:HGNC Symbol;Acc:HGNC:27635]0.060.0100
147NAchr1+873292874349ENST0000041548111058ENSG00000234711TUBB8P11NANANANAtubulin beta 8 class VIII pseudogene 11 [Source:HGNC Symbol;Acc:HGNC:32337]13.503781.6310.7400761.38
148NAchr1-874529877234ENST000006355575837ENSG00000283040AL669831.6NANANANANA000.360.05
149NAchr1+904834915976ENST000006077692351ENSG00000272438AL645608.7NANANANANA000.320.04
150NAchr1+911435914948ENST0000044817923043ENSG00000230699AL645608.3NANANANANA0.390.050.490.06
152NAchr1-916865921016ENST0000060920714152ENSG00000223764AL645608.1NANANANANA2.350.2800
155NAchr1+923928939291ENST0000042019071578ENSG00000187634SAMD11GO:0003677(DNA binding);GO:0005634(nucleus)NANANAsterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]9.951.205.790.74
156NAchr1+925150935793ENST000004379635387ENSG00000187634SAMD11GO:0003677(DNA binding);GO:0005634(nucleus)NANANAsterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]000.430.05
165NAchr1+925741944581ENST00000622503142557ENSG00000187634SAMD11GO:0003677(DNA binding);GO:0005634(nucleus)NANANAsterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]3.300.403.250.42
169NAchr1+941076942994ENST000004744614862ENSG00000187634SAMD11GO:0003677(DNA binding);GO:0005634(nucleus)NANANAsterile alpha motif domain containing 11 [Source:HGNC Symbol;Acc:HGNC:28706]0.790.108.071.04
173NAchr1-944204959290ENST00000327044192790ENSG00000188976NOC2LGO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0005654(nucleoplasm);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0003682(chromatin binding);GO:0042273(ribosomal large subunit biogenesis);GO:0042393(histone binding);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0070491(repressing transcription factor binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:0034644(cellular response to UV);GO:0031497(chromatin assembly);GO:0035067(negative regulation of histone acetylation);GO:0002903(negative regulation of B cell apoptotic process);GO:0031491(nucleosome binding);GO:0030690(Noc1p-Noc2p complex);GO:0030691(Noc2p-Noc3p complex)NANANANOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517]42.1494375.085.280.68
174NAchr1-944205958458ENST00000477976174201ENSG00000188976NOC2LGO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0005654(nucleoplasm);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0003682(chromatin binding);GO:0042273(ribosomal large subunit biogenesis);GO:0042393(histone binding);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0070491(repressing transcription factor binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:0034644(cellular response to UV);GO:0031497(chromatin assembly);GO:0035067(negative regulation of histone acetylation);GO:0002903(negative regulation of B cell apoptotic process);GO:0031491(nucleosome binding);GO:0030690(Noc1p-Noc2p complex);GO:0030691(Noc2p-Noc3p complex)NANANANOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517]0.260.0324.1655333.11
175NAchr1-945319945562ENST000004969382149ENSG00000188976NOC2LGO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0005654(nucleoplasm);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0003682(chromatin binding);GO:0042273(ribosomal large subunit biogenesis);GO:0042393(histone binding);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0070491(repressing transcription factor binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:0034644(cellular response to UV);GO:0031497(chromatin assembly);GO:0035067(negative regulation of histone acetylation);GO:0002903(negative regulation of B cell apoptotic process);GO:0031491(nucleosome binding);GO:0030690(Noc1p-Noc2p complex);GO:0030691(Noc2p-Noc3p complex)NANANANOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517]000.690.09
177NAchr1-958246959256ENST000004695632878ENSG00000188976NOC2LGO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0005654(nucleoplasm);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0003682(chromatin binding);GO:0042273(ribosomal large subunit biogenesis);GO:0042393(histone binding);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0070491(repressing transcription factor binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:0034644(cellular response to UV);GO:0031497(chromatin assembly);GO:0035067(negative regulation of histone acetylation);GO:0002903(negative regulation of B cell apoptotic process);GO:0031491(nucleosome binding);GO:0030690(Noc1p-Noc2p complex);GO:0030691(Noc2p-Noc3p complex)NANANANOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517]0.780.091.030.13
178NAchr1+960587965715ENST00000338591122560ENSG00000187961KLHL17GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0003779(actin binding);GO:0005886(plasma membrane);GO:0005615(extracellular space);GO:0030054(cell junction);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0004842(ubiquitin-protein transferase activity);GO:0051015(actin filament binding);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0014069(postsynaptic density);GO:0015629(actin cytoskeleton);GO:0030036(actin cytoskeleton organization);GO:0007420(brain development);GO:0032947(protein complex scaffold);GO:0032839(dendrite cytoplasm);GO:0031208(POZ domain binding);GO:0043025(neuronal cell body)NANANAkelch like family member 17 [Source:HGNC Symbol;Acc:HGNC:24023]15.5623671.8819.2519992.48
183NAchr1+966497975108ENST00000379410162404ENSG00000187583PLEKHN1GO:0016020(membrane);GO:0005886(plasma membrane);GO:0005515(protein binding)NANANApleckstrin homology domain containing N1 [Source:HGNC Symbol;Acc:HGNC:25284]7.740.9311.2678261.45
186NAchr1+970875971523ENST000004802673464ENSG00000187583PLEKHN1GO:0016020(membrane);GO:0005886(plasma membrane);GO:0005515(protein binding)NANANApleckstrin homology domain containing N1 [Source:HGNC Symbol;Acc:HGNC:25284]0.150.0200
188NAchr1-975204982093ENST0000034129053035ENSG00000187642PERM1GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0014850(response to muscle activity)NANANAPPARGC1 and ESRR induced regulator, muscle 1 [Source:HGNC Symbol;Acc:HGNC:28208]4.040.492.530.32
191NAchr1-995966998051ENST0000060603412086ENSG00000272512AL645608.8NANANANANA1.290.1600
192NAchr1-9989621000172ENST0000042877131040ENSG00000188290HES4GO:0005634(nucleus);GO:0046983(protein dimerization activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0008134(transcription factor binding)05165(Human papillomavirus infection)K09089NAhes family bHLH transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:24149]20.6616632.4916.7991432.16
196NAchr1+10011381014541ENST000006246973788ENSG00000187608ISG15GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0042742(defense response to bacterium);GO:0051607(defense response to virus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0045071(negative regulation of viral genome replication);GO:0016032(viral process);GO:0030501(positive regulation of bone mineralization);GO:0031397(negative regulation of protein ubiquitination);GO:0060337(type I interferon signaling pathway);GO:0019985(translesion synthesis);GO:0032480(negative regulation of type I interferon production);GO:0031386(protein tag);GO:0019941(modification-dependent protein catabolic process);GO:0032020(ISG15-protein conjugation);GO:0032649(regulation of interferon-gamma production);GO:0034340(response to type I interferon);GO:0045648(positive regulation of erythrocyte differentiation)04622(RIG-I-like receptor signaling pathway);05165(Human papillomavirus infection)NANAISG15 ubiquitin-like modifier [Source:HGNC Symbol;Acc:HGNC:4053]25.2386113.045.760.74
199NAchr1-10119971013193ENST000004585552471ENSG00000224969AL645608.2NANANANANA001.220.16
200NAchr1+10134231014540ENST000003793892711ENSG00000187608ISG15GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0042742(defense response to bacterium);GO:0051607(defense response to virus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0045071(negative regulation of viral genome replication);GO:0016032(viral process);GO:0030501(positive regulation of bone mineralization);GO:0031397(negative regulation of protein ubiquitination);GO:0060337(type I interferon signaling pathway);GO:0019985(translesion synthesis);GO:0032480(negative regulation of type I interferon production);GO:0031386(protein tag);GO:0019941(modification-dependent protein catabolic process);GO:0032020(ISG15-protein conjugation);GO:0032649(regulation of interferon-gamma production);GO:0034340(response to type I interferon);GO:0045648(positive regulation of erythrocyte differentiation)04622(RIG-I-like receptor signaling pathway);05165(Human papillomavirus infection)K12159NAISG15 ubiquitin-like modifier [Source:HGNC Symbol;Acc:HGNC:4053]16.1817511.9528.4734713.66
201NAchr1+10201231056116ENST00000379370367323ENSG00000188157AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)K06254NAagrin [Source:HGNC Symbol;Acc:HGNC:329]14.2869931.7231.3357334.03
202NAchr1+10201231056118ENST00000620552397394ENSG00000188157AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)K06254NAagrin [Source:HGNC Symbol;Acc:HGNC:329]313.87121637.84407251.31811532.333313
203NAchr1+10341061040725ENST000004775853707ENSG00000188157AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)NANAagrin [Source:HGNC Symbol;Acc:HGNC:329]2.620.320.820.11
205NAchr1+10453991046349ENST000004797074584ENSG00000188157AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)NANAagrin [Source:HGNC Symbol;Acc:HGNC:329]4.920.592.740.35
208NAchr1+10485291049394ENST000004929472690ENSG00000188157AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)NANAagrin [Source:HGNC Symbol;Acc:HGNC:329]3.300.401.770.23
210NAchr1+10519861056112ENST0000046111133385ENSG00000188157AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen)04512(ECM-receptor interaction)NANAagrin [Source:HGNC Symbol;Acc:HGNC:329]6.410.7700
212NAchr1+10597341066456ENST000004279984977ENSG00000217801AL390719.1NANANANANA25.3481563.0622.7693182.93
213NAchr1+10610201066005ENST000003945173397ENSG00000217801AL390719.1NANANANANA5.150.624.000.51
214NAchr1-10622081063288ENST000004422922829ENSG00000273443AL645608.9NANANANANA8.391.015.200.67
216NAchr1+10630791069355ENST00000412397101219ENSG00000217801AL390719.1NANANANANA1.370.162.140.28
219NAchr1-10709661074307ENST0000045346421902ENSG00000237330RNF223GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)NANANAring finger protein 223 [Source:HGNC Symbol;Acc:HGNC:40020]000.250.03
220NAchr1-10818181116081ENST00000379339122429ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]3.990.480.130.02
224NAchr1-10818251087636ENST0000048717733315ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]39.8748514.8139.1957555.04
226NAchr1-10818251116089ENST00000477196103214ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]001.490.19
228NAchr1-10822351092174ENST0000037932082324ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]2.750.334.290.55
229NAchr1-10827001106127ENST00000379319101097ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]0.260.030.740.09
233NAchr1-10871411092294ENST000004736005793ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]001.020.13
236NAchr1-10904061092813ENST000004277875575ENSG00000131591C1orf159GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAchromosome 1 open reading frame 159 [Source:HGNC Symbol;Acc:HGNC:26062]1.500.1800
244NAchr1-11730561179555ENST0000037931723532ENSG00000205231TTLL10-AS1NANANANATTLL10 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:41159]000.130.02
246NAchr1+11739031197935ENST00000379290162283ENSG00000162571TTLL10GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0006464(cellular protein modification process);GO:0005515(protein binding);GO:0005829(cytosol);GO:0070735(protein-glycine ligase activity);GO:0018094(protein polyglycylation)NANANAtubulin tyrosine ligase like 10 [Source:HGNC Symbol;Acc:HGNC:26693]0.470.060.120.02
248NAchr1+11796971185864ENST0000037928892114ENSG00000162571TTLL10GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0006464(cellular protein modification process);GO:0005515(protein binding);GO:0005829(cytosol);GO:0070735(protein-glycine ligase activity);GO:0018094(protein polyglycylation)NANANAtubulin tyrosine ligase like 10 [Source:HGNC Symbol;Acc:HGNC:26693]0.140.0200
261NAchr1-12169311232031ENST0000046572772095ENSG00000078808SDF4GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005794(Golgi apparatus);GO:0046872(metal ion binding);GO:0005509(calcium ion binding);GO:0045444(fat cell differentiation);GO:0005770(late endosome);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0006887(exocytosis);GO:0070062(extracellular exosome);GO:0042802(identical protein binding);GO:0032059(bleb);GO:0045471(response to ethanol);GO:0009650(UV protection);GO:0021549(cerebellum development);GO:0017156(calcium ion regulated exocytosis);GO:0070625(zymogen granule exocytosis)NANANAstromal cell derived factor 4 [Source:HGNC Symbol;Acc:HGNC:24188]348.80374142.055954309.04406739.76004
263NAchr1-12169341220293ENST0000047893822591ENSG00000078808SDF4GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005794(Golgi apparatus);GO:0046872(metal ion binding);GO:0005509(calcium ion binding);GO:0045444(fat cell differentiation);GO:0005770(late endosome);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0006887(exocytosis);GO:0070062(extracellular exosome);GO:0042802(identical protein binding);GO:0032059(bleb);GO:0045471(response to ethanol);GO:0009650(UV protection);GO:0021549(cerebellum development);GO:0017156(calcium ion regulated exocytosis);GO:0070625(zymogen granule exocytosis)NANANAstromal cell derived factor 4 [Source:HGNC Symbol;Acc:HGNC:24188]1.210.151.350.17
266NAchr1+12322651235041ENST0000037919812777ENSG00000176022B3GALT6GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0006486(protein glycosylation);GO:0005794(Golgi apparatus);GO:0008378(galactosyltransferase activity);GO:0032580(Golgi cisterna membrane);GO:0000139(Golgi membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0005797(Golgi medial cisterna);GO:0035250(UDP-galactosyltransferase activity);GO:0030206(chondroitin sulfate biosynthetic process);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0047220(galactosylxylosylprotein 3-beta-galactosyltransferase activity)00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)K00734EC:2.4.1.134beta-1,3-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:17978]0067.9043058.74
269NAchr1-12424531246722ENST0000033038881036ENSG00000184163C1QTNF12GO:0005576(extracellular region);GO:0005179(hormone activity);GO:0010906(regulation of glucose metabolic process);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0045721(negative regulation of gluconeogenesis);GO:0046324(regulation of glucose import);GO:0046326(positive regulation of glucose import);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0050728(negative regulation of inflammatory response);GO:0051897(positive regulation of protein kinase B signaling);GO:0005615(extracellular space)NANANAC1q and TNF related 12 [Source:HGNC Symbol;Acc:HGNC:32308]0.910.110.670.09

Definition of table:

termDescription
chrThe name of the chromosome (e.g. chr3, chrY, chr2 random) or scaffold (e.g. scaffold10671)
strandsense strand="+"; antisense strand="-"
startThe starting position of transcript in the chromosome or scaffold
endThe ending position of transcript in the chromosome or scaffold
t_nameThe name of transcript
num_exonsnumber of exons
lengthlength of transcript
gene_idThe ID of gene, some ids started with "MSTRG" are named by transcript assembly software StringTie
gene_nameThe name of gene,or gene symbol
GOGene ontology term and description http://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
KO_EntryKO functional ortholog, KO groups identified by K numbers and, in metabolic maps
ECenzyme
DescriptionDescription of gene
cov.Acount number or coverage of transcript
FPKM.ANormalization of gene expression level by FPKM value

Definition of class code:

Class codeDescription
=Complete match (mRNA, lncRNA etc)
cContained
jPotentially novel isoform (fragment): at least one splice junction is hared with a reference transcript
eSingle exon transfrag overlapping a reference exon and at least 10 bp of a reference intron, indicating a possible pre-mRNA fragment.
iA transfrag falling entirely within a reference intron
oGeneric exonic overlap with a reference transcript
pPossible polymerase run-on fragment (within 2Kbases of a reference transcript)
rRepeat. Currently determined by looking at the soft-masked reference sequence and applied to transcripts where at least 50% of the are lower casebases
uUnknown, intergenic transcript
xExonic overlap with reference on the opposite strand
sAn intron of the transfrag overlaps a reference intron on the opposite strand (likely due to read mapping errors)
.(.tracking file only, indicates multiple classifications)

document location: summary6_transcript_expression/5_isoforms_fpkm_expression.xlsx


4.6.3 Density and boxplot of gene expression


Density:





Boxplot:





document location

summary6_transcript_expression/*_gene_expression_density.png

summary6_transcript_expression/*_transcript_expression_density.png

summary6_transcript_expression/*_gene_expression_boxplot.png

summary6_transcript_expression/*_transcript_expression_boxplot.png


4.7 Differential expression analysis of mRNA


Exploratory analysis, visualization and statistical modeling are the next steps after assembling and quantifying genes and transcripts from StringTie. The assembly of input reads reconstructs the exon–intron structure of genes and their isoforms. R package edgeR takes both transcript and gene expression levels from StringTie and applies rigorous statistical methods to determine which transcripts and genes are differentially expressed between two or more experiments. edgeR also includes plotting tools as part of the R/Bioconductor package that help visualize the results.


4.7.1 Profiling of differentially expressed genes


gene_idgene_nametranscript_idGOKEGGKO_ENTRYECDescriptionFPKM.M14_OEFPKM.M14_NCfclog2(fc)pvalqvalregulationsignificant
ENSG00000132967HMGB1P5ENST00000451497NANANANAhigh mobility group box 1 pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:4997]0.83278.684080.00-8.399809908877482.08e-202.99e-16downyes
ENSG00000166897ELFN2ENST00000402918;ENST00000451509;ENST00000414347;ENST00000435824;ENST00000424973GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005615(extracellular space);GO:0004864(protein phosphatase inhibitor activity);GO:0019902(phosphatase binding);GO:0010923(negative regulation of phosphatase activity);GO:0010923(negative regulation of phosphatase activity)NANANAextracellular leucine rich repeat and fibronectin type III domain containing 2 [Source:HGNC Symbol;Acc:HGNC:29396]0.0711.61136887098610.01-7.401247919820423.03e-172.01e-13downyes
ENSG00000223361FTH1P10ENST00000401830NANANANAferritin heavy chain 1 pseudogene 10 [Source:HGNC Symbol;Acc:HGNC:3980]1.64251.2008510.01-7.258302540862274.20e-172.01e-13downyes
ENSG00000145388METTL14ENST00000388822GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0006139(nucleobase-containing compound metabolic process);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0000398(mRNA splicing, via spliceosome);GO:0016070(RNA metabolic process);GO:0019827(stem cell population maintenance);GO:0061157(mRNA destabilization);GO:0080009(mRNA methylation);GO:0036396(MIS complex);GO:0016422(mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity)NANANAmethyltransferase like 14 [Source:HGNC Symbol;Acc:HGNC:29330]113.0793132564850.97116.9252152556146.872.82e-161.01e-12upyes
ENSG00000268173AC007192.1ENST00000593731NANANANA0.1315.3354080.01-6.835209724510061.07e-153.08e-12downyes
ENSG00000180574AC068775.1ENST00000322446;ENST00000538173GO:0005525(GTP binding);GO:0003924(GTPase activity);GO:0003743(translation initiation factor activity);GO:0006412(translation);GO:0006413(translational initiation);GO:0000166(nucleotide binding);GO:0000166(nucleotide binding)NANANAPutative eukaryotic translation initiation factor 2 subunit 3-like protein [Source:UniProtKB/Swiss-Prot;Acc:Q2VIR3]0.5356.48134639290140.01-6.72974624493921.61e-153.85e-12downyes
ENSG00000161654LSM12ENST00000585388;ENST00000591247NANANANALSM12 homolog [Source:HGNC Symbol;Acc:HGNC:26407]0.2410.99607826467450.02-5.50213366478139.52e-121.95e-08downyes
ENSG00000240184PCDHGC3ENST00000622656;ENST00000622836;ENST00000611950GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005509(calcium ion binding);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0070062(extracellular exosome);GO:0007399(nervous system development);GO:0007267(cell-cell signaling);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules)NANANAprotocadherin gamma subfamily C, 3 [Source:HGNC Symbol;Acc:HGNC:8716]4.020.1039.51495243768335.302.49e-114.48e-08upyes
ENSG00000111328CDK2AP1ENST00000618072;ENST00000261692;ENST00000538446;ENST00000544658;ENST00000535979GO:0005634(nucleus);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0001934(positive regulation of protein phosphorylation);GO:0070182(DNA polymerase binding);GO:0006261(DNA-dependent DNA replication);GO:0006261(DNA-dependent DNA replication)NANANAcyclin dependent kinase 2 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:14002]27.69701646871990.7835.30629557718815.144.02e-116.43e-08upyes
ENSG00000231120BTF3P10ENST00000433415NANANANAbasic transcription factor 3 pseudogene 10 [Source:HGNC Symbol;Acc:HGNC:38570]175.6635745.3732.68396665060355.037.46e-111.07e-07upyes
ENSG00000167395ZNF646ENST00000564189;ENST00000394979GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005515(protein binding)NANANAzinc finger protein 646 [Source:HGNC Symbol;Acc:HGNC:29004]0.124.070.03-5.119387502885848.69e-111.13e-07downyes
ENSG00000139146FAM60AENST00000536836;ENST00000337682;ENST00000454658GO:0005634(nucleus);GO:0005515(protein binding);GO:0030336(negative regulation of cell migration);GO:0016580(Sin3 complex);GO:0016580(Sin3 complex)NANANAfamily with sequence similarity 60 member A [Source:HGNC Symbol;Acc:HGNC:30702]0.268.770.03-5.068084225389731.08e-101.29e-07downyes
ENSG00000165821SALL2ENST00000611430;ENST00000614342GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0001654(eye development);GO:0007165(signal transduction);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001228(transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0043565(sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0006366(transcription from RNA polymerase II promoter);GO:0021915(neural tube development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0016581(NuRD complex);GO:0016581(NuRD complex)NANANAspalt like transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:10526]3.520.1132.0471476845875.001.95e-102.16e-07upyes
ENSG00000131100ATP6V1E1ENST00000253413;ENST00000460085;ENST00000484653GO:0006810(transport);GO:0016787(hydrolase activity);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0006811(ion transport);GO:0015991(ATP hydrolysis coupled proton transport);GO:0015992(proton transport);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:0005515(protein binding);GO:0033178(proton-transporting two-sector ATPase complex, catalytic domain);GO:0005768(endosome);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0016324(apical plasma membrane);GO:0008286(insulin receptor signaling pathway);GO:0016241(regulation of macroautophagy);GO:0033572(transferrin transport);GO:0090383(phagosome acidification);GO:0051117(ATPase binding);GO:0016469(proton-transporting two-sector ATPase complex);GO:0008553(hydrogen-exporting ATPase activity, phosphorylative mechanism);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005902(microvillus);GO:0005902(microvillus)00190(Oxidative phosphorylation);04150(mTOR signaling pathway);04145(Phagosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection);05120(Epithelial cell signaling in Helicobacter pylori infection)K02150NAATPase H+ transporting V1 subunit E1 [Source:HGNC Symbol;Acc:HGNC:857]6.050.1931.25473872656284.972.29e-102.32e-07upyes
ENSG00000147955SIGMAR1ENST00000497006;ENST00000378892GO:0006810(transport);GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0006869(lipid transport);GO:0030054(cell junction);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0031410(cytoplasmic vesicle);GO:0038003(opioid receptor signaling pathway);GO:0030426(growth cone);GO:0005637(nuclear inner membrane);GO:0014069(postsynaptic density);GO:0005887(integral component of plasma membrane);GO:0005811(lipid particle);GO:0005635(nuclear envelope);GO:0070207(protein homotrimerization);GO:0005640(nuclear outer membrane);GO:0043523(regulation of neuron apoptotic process);GO:0008144(drug binding);GO:0004872(receptor activity);GO:0004985(opioid receptor activity);GO:0007399(nervous system development);GO:0007399(nervous system development)NANANAsigma non-opioid intracellular receptor 1 [Source:HGNC Symbol;Acc:HGNC:8157]2.1063.06463596357010.03-4.907615031997832.42e-102.32e-07downyes
ENSG00000143252SDHCENST00000367975;ENST00000515731;ENST00000470743GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0006099(tricarboxylic acid cycle);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:0009055(electron carrier activity);GO:0020037(heme binding);GO:0000104(succinate dehydrogenase activity);GO:0045281(succinate dehydrogenase complex);GO:0006121(mitochondrial electron transport, succinate to ubiquinone);GO:0005749(mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone));GO:0009060(aerobic respiration);GO:0045273(respiratory chain complex II);GO:0045273(respiratory chain complex II)00020(Citrate cycle (TCA cycle));00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD));04932(Non-alcoholic fatty liver disease (NAFLD))K00236NAsuccinate dehydrogenase complex subunit C [Source:HGNC Symbol;Acc:HGNC:10682]0.123.640.03-4.868353236268213.69e-103.31e-07downyes
ENSG00000271303SRXN1ENST00000381962GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005829(cytosol);GO:0098869(cellular oxidant detoxification);GO:0006979(response to oxidative stress);GO:0034599(cellular response to oxidative stress);GO:0016209(antioxidant activity);GO:0016667(oxidoreductase activity, acting on a sulfur group of donors);GO:0032542(sulfiredoxin activity)NANANAsulfiredoxin 1 [Source:HGNC Symbol;Acc:HGNC:16132]62.6526452.4525.58668005095074.686.59e-105.57e-07upyes
ENSG00000180764PIPSLENST00000480546NANANANAPIP5K1A and PSMD4-like, pseudogene [Source:HGNC Symbol;Acc:HGNC:23733]54.9894262.1825.24397299018194.667.50e-105.98e-07upyes
ENSG00000265241RBM8AENST00000632040;ENST00000583313GO:0005634(nucleus);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0006396(RNA processing);GO:0006397(mRNA processing);GO:0006810(transport);GO:0008380(RNA splicing);GO:0051028(mRNA transport);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0005515(protein binding);GO:0005681(spliceosomal complex);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006417(regulation of translation);GO:0000398(mRNA splicing, via spliceosome);GO:0006369(termination of RNA polymerase II transcription);GO:0006405(RNA export from nucleus);GO:0031124(mRNA 3'-end processing);GO:0035145(exon-exon junction complex);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0006406(mRNA export from nucleus);GO:0071013(catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)03040(Spliceosome);03013(RNA transport);03015(mRNA surveillance pathway);03015(mRNA surveillance pathway)K12876NARNA binding motif protein 8A [Source:HGNC Symbol;Acc:HGNC:9905]0.205.240.04-4.683045622312441.40e-091.06e-06downyes
ENSG00000163807KIAA1143ENST00000296121;ENST00000484437GO:0005515(protein binding);GO:0005515(protein binding)NANANAKIAA1143 [Source:HGNC Symbol;Acc:HGNC:29198]0.225.460.04-4.628787018779581.95e-091.40e-06downyes
ENSG00000134899ERCC5ENST00000355739;ENST00000375954;ENST00000375958GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0003677(DNA binding);GO:0003824(catalytic activity);GO:0042803(protein homodimerization activity);GO:0004519(endonuclease activity);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016788(hydrolase activity, acting on ester bonds);GO:0006289(nucleotide-excision repair);GO:0004518(nuclease activity);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0003690(double-stranded DNA binding);GO:0047485(protein N-terminus binding);GO:0043066(negative regulation of apoptotic process);GO:0009411(response to UV);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0005662(DNA replication factor A complex);GO:0016591(DNA-directed RNA polymerase II, holoenzyme);GO:0006293(nucleotide-excision repair, preincision complex stabilization);GO:0006295(nucleotide-excision repair, DNA incision, 3'-to lesion);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0033683(nucleotide-excision repair, DNA incision);GO:0006294(nucleotide-excision repair, preincision complex assembly);GO:0009650(UV protection);GO:0005675(holo TFIIH complex);GO:0010225(response to UV-C);GO:0004520(endodeoxyribonuclease activity);GO:0000405(bubble DNA binding);GO:0000405(bubble DNA binding)03420(Nucleotide excision repair);03420(Nucleotide excision repair)K10846NAERCC excision repair 5, endonuclease [Source:HGNC Symbol;Acc:HGNC:3437]0.235.410.04-4.541496798757123.23e-092.21e-06downyes
ENSG00000116044NFE2L2ENST00000397062;ENST00000458603;ENST00000477534;ENST00000423513;ENST00000397063GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0071356(cellular response to tumor necrosis factor);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0016567(protein ubiquitination);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0005886(plasma membrane);GO:0005813(centrosome);GO:0005515(protein binding);GO:0034599(cellular response to oxidative stress);GO:0019904(protein domain specific binding);GO:0006366(transcription from RNA polymerase II promoter);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0010499(proteasomal ubiquitin-independent protein catabolic process);GO:1903206(negative regulation of hydrogen peroxide-induced cell death);GO:0071498(cellular response to fluid shear stress);GO:0071499(cellular response to laminar fluid shear stress);GO:1903071(positive regulation of ER-associated ubiquitin-dependent protein catabolic process);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0010628(positive regulation of gene expression);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:0036499(PERK-mediated unfolded protein response);GO:0070301(cellular response to hydrogen peroxide);GO:0044212(transcription regulatory region DNA binding);GO:0036003(positive regulation of transcription from RNA polymerase II promoter in response to stress);GO:0032993(protein-DNA complex);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001205(transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding);GO:0001221(transcription cofactor binding);GO:0008134(transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0006954(inflammatory response);GO:0007568(aging);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010976(positive regulation of neuron projection development);GO:0030194(positive regulation of blood coagulation);GO:0034976(response to endoplasmic reticulum stress);GO:0035690(cellular response to drug);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0042149(cellular response to glucose starvation);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045454(cell redox homeostasis);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045995(regulation of embryonic development);GO:0046223(aflatoxin catabolic process);GO:0046326(positive regulation of glucose import);GO:0060548(negative regulation of cell death);GO:0071456(cellular response to hypoxia);GO:1902037(negative regulation of hematopoietic stem cell differentiation);GO:1903788(positive regulation of glutathione biosynthetic process);GO:1904753(negative regulation of vascular associated smooth muscle cell migration);GO:2000121(regulation of removal of superoxide radicals);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:0000785(chromatin);GO:0000785(chromatin)04141(Protein processing in endoplasmic reticulum);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis)K05638NAnuclear factor, erythroid 2 like 2 [Source:HGNC Symbol;Acc:HGNC:7782]12.44329370245860.5821.30661642876354.414.05e-092.64e-06upyes
ENSG00000258947TUBB3ENST00000554444;ENST00000553967;ENST00000554927;ENST00000555810;ENST00000315491;ENST00000555609;ENST00000556536;ENST00000554116GO:0005525(GTP binding);GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0015630(microtubule cytoskeleton);GO:0005200(structural constituent of cytoskeleton);GO:0007010(cytoskeleton organization);GO:0005874(microtubule);GO:0007017(microtubule-based process);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0007411(axon guidance);GO:0030425(dendrite);GO:0030425(dendrite)04145(Phagosome);04540(Gap junction);05130(Pathogenic Escherichia coli infection);05130(Pathogenic Escherichia coli infection)K07375NAtubulin beta 3 class III [Source:HGNC Symbol;Acc:HGNC:20772]16.30566871512420.7721.23310973491264.414.25e-092.65e-06upyes
ENSG00000155008APOOLENST00000622540GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005576(extracellular region);GO:0061617(MICOS complex);GO:0042407(cristae formation);GO:0005515(protein binding);GO:0002576(platelet degranulation);GO:0031093(platelet alpha granule lumen)NANANAapolipoprotein O like [Source:HGNC Symbol;Acc:HGNC:24009]0.092.150.04-4.5595597360614.89e-092.93e-06downyes
ENSG00000135482ZC3H10ENST00000257940;ENST00000551880GO:0003723(RNA binding);GO:0046872(metal ion binding);GO:0005515(protein binding);GO:0005515(protein binding)NANANAzinc finger CCCH-type containing 10 [Source:HGNC Symbol;Acc:HGNC:25893]1.960.0921.2001371534964.416.91e-093.97e-06upyes
ENSG00000213644SAPCD2P1ENST00000395413NANANANAsuppressor APC domain containing 2 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:51277]0.4810.8313540.04-4.486013489159317.75e-094.28e-06downyes
ENSG00000172340SUCLG2ENST00000492795;ENST00000493112;ENST00000307227GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0006099(tricarboxylic acid cycle);GO:0005739(mitochondrion);GO:0003824(catalytic activity);GO:0005525(GTP binding);GO:0008152(metabolic process);GO:0005886(plasma membrane);GO:0016874(ligase activity);GO:0004776(succinate-CoA ligase (GDP-forming) activity);GO:0006104(succinyl-CoA metabolic process);GO:0005759(mitochondrial matrix);GO:0019003(GDP binding);GO:0046982(protein heterodimerization activity);GO:0006105(succinate metabolic process);GO:0043234(protein complex);GO:0045244(succinate-CoA ligase complex (GDP-forming));GO:0000287(magnesium ion binding);GO:0004775(succinate-CoA ligase (ADP-forming) activity);GO:0004775(succinate-CoA ligase (ADP-forming) activity)00020(Citrate cycle (TCA cycle));00640(Propanoate metabolism);00640(Propanoate metabolism)K01900EC:6.2.1.4 6.2.1.5succinate-CoA ligase GDP-forming beta subunit [Source:HGNC Symbol;Acc:HGNC:11450]7.300.3819.32580141023184.271.32e-087.04e-06upyes
ENSG00000141985SH3GL1ENST00000269886;ENST00000598219;ENST00000593591GO:0005737(cytoplasm);GO:0016020(membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0045202(synapse);GO:0030054(cell junction);GO:0042802(identical protein binding);GO:0008289(lipid binding);GO:0005768(endosome);GO:0045296(cadherin binding);GO:0006897(endocytosis);GO:0002102(podosome);GO:0031901(early endosome membrane);GO:0007165(signal transduction);GO:0007417(central nervous system development);GO:0019902(phosphatase binding);GO:0051020(GTPase binding);GO:0016191(synaptic vesicle uncoating);GO:0016191(synaptic vesicle uncoating)04144(Endocytosis);04144(Endocytosis)K11247NASH3 domain containing GRB2 like 1, endophilin A2 [Source:HGNC Symbol;Acc:HGNC:10830]26.03867551804611.4318.20453941219244.191.57e-088.05e-06upyes
ENSG00000253421ZNHIT1P1ENST00000523947NANANANAzinc finger HIT-type containing 1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44474]51.7561112.9917.32507953532094.113.19e-081.58e-05upyes
ENSG00000249489GAPDHP70ENST00000515281NANANANAglyceraldehyde 3 phosphate dehydrogenase pseudogene 70 [Source:HGNC Symbol;Acc:HGNC:4148]29.9623721.7916.75921278208324.073.81e-081.77e-05upyes
ENSG00000213742ZNF337-AS1ENST00000414393;ENST00000428254NANANANAZNF337 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40759]0.142.500.06-4.181352119801673.83e-081.77e-05downyes
ENSG00000175582RAB6AENST00000310653;ENST00000400470;ENST00000336083GO:0006810(transport);GO:0016020(membrane);GO:0015031(protein transport);GO:0005794(Golgi apparatus);GO:0005525(GTP binding);GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0005886(plasma membrane);GO:0016192(vesicle-mediated transport);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0061024(membrane organization);GO:0019904(protein domain specific binding);GO:0016032(viral process);GO:0043312(neutrophil degranulation);GO:0032588(trans-Golgi network membrane);GO:0031489(myosin V binding);GO:0030667(secretory granule membrane);GO:0031410(cytoplasmic vesicle);GO:0019882(antigen processing and presentation);GO:0005802(trans-Golgi network);GO:0000042(protein targeting to Golgi);GO:0018125(peptidyl-cysteine methylation);GO:0034067(protein localization to Golgi apparatus);GO:0034498(early endosome to Golgi transport);GO:0072385(minus-end-directed organelle transport along microtubule);GO:0070381(endosome to plasma membrane transport vesicle);GO:0005622(intracellular);GO:0007264(small GTPase mediated signal transduction);GO:0007264(small GTPase mediated signal transduction)NANANARAB6A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9786]14.02472242606210.8516.50483545503964.043.94e-081.77e-05upyes
ENSG00000213782DDX47ENST00000542123;ENST00000542832;ENST00000544497;ENST00000544032GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005634(nucleus);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005730(nucleolus);GO:0016787(hydrolase activity);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0006364(rRNA processing);GO:0005737(cytoplasm);GO:0005654(nucleoplasm);GO:0004004(ATP-dependent RNA helicase activity);GO:0010501(RNA secondary structure unwinding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors)NANANADEAD-box helicase 47 [Source:HGNC Symbol;Acc:HGNC:18682]0.315.470.06-4.133523471203394.11e-081.78e-05downyes
ENSG00000213585VDAC1ENST00000395044;ENST00000466080;ENST00000492324;ENST00000265333;ENST00000489906;ENST00000425992GO:0006810(transport);GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0008308(voltage-gated anion channel activity);GO:0098656(anion transmembrane transport);GO:1903959(regulation of anion transmembrane transport);GO:0005741(mitochondrial outer membrane);GO:0005739(mitochondrion);GO:0006811(ion transport);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0045121(membrane raft);GO:0006820(anion transport);GO:0070062(extracellular exosome);GO:0044325(ion channel binding);GO:0016032(viral process);GO:1903146(regulation of mitophagy);GO:0030855(epithelial cell differentiation);GO:0042645(mitochondrial nucleoid);GO:0015288(porin activity);GO:0016236(macroautophagy);GO:0019901(protein kinase binding);GO:0046930(pore complex);GO:0005253(anion channel activity);GO:0032403(protein complex binding);GO:0001662(behavioral fear response);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0007268(chemical synaptic transmission);GO:0007270(neuron-neuron synaptic transmission);GO:0007612(learning);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:0005743(mitochondrial inner membrane);GO:0008021(synaptic vesicle);GO:0043209(myelin sheath);GO:0043234(protein complex);GO:0043234(protein complex)04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04217(Necroptosis);04218(Cellular senescence);04621(NOD-like receptor signaling pathway);04979(Cholesterol metabolism);05012(Parkinson's disease);05016(Huntington's disease);05166(HTLV-I infection);05164(Influenza A);05164(Influenza A)K05862NAvoltage dependent anion channel 1 [Source:HGNC Symbol;Acc:HGNC:12669]3.0750.51454285109070.06-4.039873689109585.68e-082.40e-05downyes
ENSG00000083312TNPO1ENST00000337273;ENST00000605210;ENST00000511754;ENST00000513944GO:0003723(RNA binding);GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0005515(protein binding);GO:0008536(Ran GTPase binding);GO:0035735(intraciliary transport involved in cilium assembly);GO:0005929(cilium);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0043488(regulation of mRNA stability);GO:0016032(viral process);GO:0008565(protein transporter activity);GO:0006607(NLS-bearing protein import into nucleus);GO:0031965(nuclear membrane);GO:0034399(nuclear periphery);GO:0008139(nuclear localization sequence binding);GO:0006610(ribosomal protein import into nucleus);GO:0000060(protein import into nucleus, translocation);GO:0000060(protein import into nucleus, translocation)NANANAtransportin 1 [Source:HGNC Symbol;Acc:HGNC:6401]0.284.420.06-3.994270171882778.41e-083.45e-05downyes
ENSG00000099860GADD45BENST00000592937;ENST00000586759GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0051726(regulation of cell cycle);GO:0006950(response to stress);GO:0043065(positive regulation of apoptotic process);GO:0046330(positive regulation of JNK cascade);GO:0000185(activation of MAPKKK activity);GO:0000186(activation of MAPKK activity);GO:0006469(negative regulation of protein kinase activity);GO:1900745(positive regulation of p38MAPK cascade);GO:1900745(positive regulation of p38MAPK cascade)04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04068(FoxO signaling pathway);04110(Cell cycle);04210(Apoptosis);04115(p53 signaling pathway);04218(Cellular senescence);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05223(Non-small cell lung cancer)NANAgrowth arrest and DNA damage inducible beta [Source:HGNC Symbol;Acc:HGNC:4096]0.568.510.07-3.938662686887291.45e-075.81e-05downyes
ENSG00000163866SMIM12ENST00000446026;ENST00000426886;ENST00000417239;ENST00000521580GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)NANANAsmall integral membrane protein 12 [Source:HGNC Symbol;Acc:HGNC:25154]0.466.700.07-3.86234209456151.84e-077.17e-05downyes
ENSG00000226789AC110926.1ENST00000412499NANANANA3.350.2314.60666178751293.872.00e-077.39e-05upyes
ENSG00000197119SLC25A29ENST00000553574;ENST00000556844;ENST00000554912;ENST00000359232;ENST00000557438GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:1990822(basic amino acid transmembrane transport);GO:1903826(arginine transmembrane transport);GO:0015171(amino acid transmembrane transporter activity);GO:0006839(mitochondrial transport);GO:1902616(acyl carnitine transmembrane transport);GO:0006865(amino acid transport);GO:0015174(basic amino acid transmembrane transporter activity);GO:0005289(high-affinity arginine transmembrane transporter activity);GO:0005292(high-affinity lysine transmembrane transporter activity);GO:0015227(acyl carnitine transmembrane transporter activity);GO:0006844(acyl carnitine transport);GO:0015822(ornithine transport);GO:0089709(L-histidine transmembrane transport);GO:1903400(L-arginine transmembrane transport);GO:1903401(L-lysine transmembrane transport);GO:1990575(mitochondrial L-ornithine transmembrane transport);GO:1990575(mitochondrial L-ornithine transmembrane transport)NANANAsolute carrier family 25 member 29 [Source:HGNC Symbol;Acc:HGNC:20116]0.578.220.07-3.844575653247252.00e-077.39e-05downyes
ENSG00000102401ARMCX3ENST00000477980;ENST00000341189GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034613(cellular protein localization);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0031307(integral component of mitochondrial outer membrane);GO:0031307(integral component of mitochondrial outer membrane)NANANAarmadillo repeat containing, X-linked 3 [Source:HGNC Symbol;Acc:HGNC:24065]7.260.5313.66883694989943.772.28e-078.19e-05upyes
ENSG00000128609NDUFA5ENST00000471770;ENST00000466896;ENST00000467117;ENST00000490618GO:0016020(membrane);GO:0055114(oxidation-reduction process);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:0005515(protein binding);GO:0070469(respiratory chain);GO:0016651(oxidoreductase activity, acting on NAD(P)H);GO:0022904(respiratory electron transport chain);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0005747(mitochondrial respiratory chain complex I);GO:0045271(respiratory chain complex I);GO:0045271(respiratory chain complex I)00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD));04932(Non-alcoholic fatty liver disease (NAFLD))K03949NANADH:ubiquinone oxidoreductase subunit A5 [Source:HGNC Symbol;Acc:HGNC:7688]1.030.0714.54039505645813.862.43e-078.53e-05upyes
ENSG00000160131VMA21ENST00000330374;ENST00000370361;ENST00000477649GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0031410(cytoplasmic vesicle);GO:0070072(vacuolar proton-transporting V-type ATPase complex assembly);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0012507(ER to Golgi transport vesicle membrane);GO:0043462(regulation of ATPase activity);GO:0005764(lysosome);GO:0005764(lysosome)NANANAVMA21, vacuolar ATPase assembly factor [Source:HGNC Symbol;Acc:HGNC:22082]0.506.960.07-3.795796861414962.88e-079.86e-05downyes
ENSG00000254413CHKB-CPT1BENST00000492556;ENST00000453634GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0046474(glycerophospholipid biosynthetic process);GO:0046474(glycerophospholipid biosynthetic process)NANANACHKB-CPT1B readthrough (NMD candidate) [Source:HGNC Symbol;Acc:HGNC:41998]2.340.1813.30149463722983.733.87e-070.00upyes
ENSG00000152944MED21ENST00000282892;ENST00000544998;ENST00000536711GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0005515(protein binding);GO:0061630(ubiquitin protein ligase activity);GO:0001824(blastocyst development);GO:0016567(protein ubiquitination);GO:0019827(stem cell population maintenance);GO:0000151(ubiquitin ligase complex);GO:0016592(mediator complex);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0003713(transcription coactivator activity);GO:0001104(RNA polymerase II transcription cofactor activity);GO:0001104(RNA polymerase II transcription cofactor activity)NANANAmediator complex subunit 21 [Source:HGNC Symbol;Acc:HGNC:11473]6.600.5212.58864703774553.655.04e-070.00upyes
ENSG00000185515BRCC3ENST00000340647;ENST00000369462GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0016787(hydrolase activity);GO:0016569(covalent chromatin modification);GO:0051301(cell division);GO:0050790(regulation of catalytic activity);GO:0006281(DNA repair);GO:0005856(cytoskeleton);GO:0008233(peptidase activity);GO:0006508(proteolysis);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0008237(metallopeptidase activity);GO:0070531(BRCA1-A complex);GO:0070552(BRISC complex);GO:0000922(spindle pole);GO:0070536(protein K63-linked deubiquitination);GO:0005515(protein binding);GO:0005829(cytosol);GO:0016579(protein deubiquitination);GO:0061578(Lys63-specific deubiquitinase activity);GO:0031572(G2 DNA damage checkpoint);GO:0045739(positive regulation of DNA repair);GO:0006302(double-strand break repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0010212(response to ionizing radiation);GO:0031593(polyubiquitin binding);GO:0030234(enzyme regulator activity);GO:0010165(response to X-ray);GO:0070537(histone H2A K63-linked deubiquitination);GO:0000151(ubiquitin ligase complex);GO:0000152(nuclear ubiquitin ligase complex);GO:0000152(nuclear ubiquitin ligase complex)03440(Homologous recombination);04621(NOD-like receptor signaling pathway);04621(NOD-like receptor signaling pathway)K11864EC:3.4.19.-BRCA1/BRCA2-containing complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:24185]0.425.370.08-3.687724602418756.32e-070.00downyes
ENSG00000183955KMT5AENST00000537270;ENST00000461103;ENST00000478781;ENST00000437502;ENST00000402868GO:0005634(nucleus);GO:0005829(cytosol);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0051301(cell division);GO:0005694(chromosome);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0018024(histone-lysine N-methyltransferase activity);GO:0018026(peptidyl-lysine monomethylation);GO:0016279(protein-lysine N-methyltransferase activity);GO:0034968(histone lysine methylation);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0045892(negative regulation of transcription, DNA-templated);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0002039(p53 binding);GO:0042799(histone methyltransferase activity (H4-K20 specific));GO:0016278(lysine N-methyltransferase activity);GO:0034770(histone H4-K20 methylation);GO:0043516(regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043516(regulation of DNA damage response, signal transduction by p53 class mediator)00310(Lysine degradation);00310(Lysine degradation)K11428EC:2.1.1.43lysine methyltransferase 5A [Source:HGNC Symbol;Acc:HGNC:29489]6.030.5211.70490494970193.558.48e-070.00upyes
ENSG00000198633ZNF534ENST00000301085GO:0003676(nucleic acid binding);GO:0006355(regulation of transcription, DNA-templated);GO:0005622(intracellular);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding)NANANAzinc finger protein 534 [Source:HGNC Symbol;Acc:HGNC:26337]0.344.200.08-3.626381984126869.65e-070.00downyes
ENSG00000170545SMAGPENST00000603798;ENST00000380103;ENST00000603838GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0005515(protein binding);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0005887(integral component of plasma membrane);GO:0004872(receptor activity);GO:0005102(receptor binding);GO:0042803(protein homodimerization activity);GO:0050839(cell adhesion molecule binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0005913(cell-cell adherens junction);GO:0008037(cell recognition);GO:0008037(cell recognition)NANANAsmall cell adhesion glycoprotein [Source:HGNC Symbol;Acc:HGNC:26918]5.760.5111.23042633378553.491.30e-060.00upyes
ENSG00000138107ACTR1AENST00000369905;ENST00000636707;ENST00000480947GO:0005869(dynactin complex);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0015630(microtubule cytoskeleton);GO:0005856(cytoskeleton);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005515(protein binding);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0005938(cell cortex);GO:0000086(G2/M transition of mitotic cell cycle);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0097711(ciliary basal body docking);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0016192(vesicle-mediated transport);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0005875(microtubule associated complex);GO:0099738(cell cortex region);GO:0007283(spermatogenesis);GO:0002177(manchette);GO:0005814(centriole);GO:0030137(COPI-coated vesicle);GO:0043209(myelin sheath);GO:0043209(myelin sheath)NANANAARP1 actin related protein 1 homolog A [Source:HGNC Symbol;Acc:HGNC:167]49.55916588160724.6210.71676591231063.421.52e-060.00upyes
ENSG00000179085DPM3ENST00000368399GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006486(protein glycosylation);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0006506(GPI anchor biosynthetic process);GO:0031647(regulation of protein stability);GO:0005975(carbohydrate metabolic process);GO:0004582(dolichyl-phosphate beta-D-mannosyltransferase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0035268(protein mannosylation);GO:0035269(protein O-linked mannosylation);GO:0033185(dolichol-phosphate-mannose synthase complex);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0018406(protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan);GO:0031501(mannosyltransferase complex)00510(N-Glycan biosynthesis)K09659NAdolichyl-phosphate mannosyltransferase subunit 3 [Source:HGNC Symbol;Acc:HGNC:3007]0.9511.60417804180060.08-3.611160134535591.57e-060.00downyes
ENSG00000178458H3F3AP6ENST00000230495NANANANAH3 histone, family 3A, pseudogene 6 [Source:HGNC Symbol;Acc:HGNC:42982]4.3249.4193570.09-3.514669842147631.65e-060.00downyes
ENSG00000167625ZNF526ENST00000597945;ENST00000301215GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0003677(DNA binding)NANANAzinc finger protein 526 [Source:HGNC Symbol;Acc:HGNC:29415]4.850.4510.88061025885783.441.66e-060.00upyes
ENSG00000179195ZNF664ENST00000539644;ENST00000542820;ENST00000539501;ENST00000540498;ENST00000537532;ENST00000538932;ENST00000542493GO:0005634(nucleus);GO:0003676(nucleic acid binding);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0008150(biological_process)NANANAzinc finger protein 664 [Source:HGNC Symbol;Acc:HGNC:25406]2.5327.62542417555210.09-3.448229500287581.97e-060.00downyes
ENSG00000050344NFE2L3ENST00000056233GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0003713(transcription coactivator activity);GO:0006366(transcription from RNA polymerase II promoter);GO:0045893(positive regulation of transcription, DNA-templated);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter)NANANAnuclear factor, erythroid 2 like 3 [Source:HGNC Symbol;Acc:HGNC:7783]1.5416.78287416144980.09-3.446492113499372.07e-060.00downyes
ENSG00000284057AP001273.2ENST00000638767GO:0005634(nucleus);GO:0001104(RNA polymerase II transcription cofactor activity);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0016592(mediator complex)NANANA2.700.2511.00461011698533.462.31e-060.00upyes
ENSG00000125814NAPBENST00000617876;ENST00000487502;ENST00000398425GO:0006810(transport);GO:0016020(membrane);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0005515(protein binding);GO:0016192(vesicle-mediated transport);GO:0019905(syntaxin binding);GO:0070062(extracellular exosome);GO:0031201(SNARE complex);GO:0061025(membrane fusion);GO:0005483(soluble NSF attachment protein activity);GO:0035494(SNARE complex disassembly);GO:0005774(vacuolar membrane);GO:0010807(regulation of synaptic vesicle priming);GO:0035249(synaptic transmission, glutamatergic);GO:0043209(myelin sheath);GO:0070044(synaptobrevin 2-SNAP-25-syntaxin-1a complex);GO:0070044(synaptobrevin 2-SNAP-25-syntaxin-1a complex)NANANANSF attachment protein beta [Source:HGNC Symbol;Acc:HGNC:15751]1.870.1710.7254666048953.422.38e-060.00upyes
ENSG00000176014TUBB6ENST00000586810;ENST00000591909;ENST00000590693;ENST00000417736;ENST00000590967;ENST00000317702;ENST00000587204GO:0005525(GTP binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0007010(cytoskeleton organization);GO:0005874(microtubule);GO:0007017(microtubule-based process);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0015630(microtubule cytoskeleton);GO:0005856(cytoskeleton);GO:0003674(molecular_function);GO:0070062(extracellular exosome);GO:0070062(extracellular exosome)04145(Phagosome);04540(Gap junction);05130(Pathogenic Escherichia coli infection);05130(Pathogenic Escherichia coli infection)K07375NAtubulin beta 6 class V [Source:HGNC Symbol;Acc:HGNC:20776]56.85569073937335.719.963.322.83e-060.00upyes
ENSG00000154102C16orf74ENST00000602719;ENST00000602583;ENST00000602758GO:0005515(protein binding);GO:0005515(protein binding)NANANAchromosome 16 open reading frame 74 [Source:HGNC Symbol;Acc:HGNC:23362]7.880.7610.33789315263093.372.84e-060.00upyes
ENSG00000235173HGH1ENST00000525101;ENST00000530409;ENST00000347708GO:0003674(molecular_function);GO:0008150(biological_process);GO:0005575(cellular_component);GO:0005575(cellular_component)NANANAHGH1 homolog [Source:HGNC Symbol;Acc:HGNC:24161]23.5869929349682.379.963.322.98e-060.00upyes
ENSG00000062485CSENST00000549143;ENST00000546585;ENST00000542324;ENST00000551473;ENST00000546621;ENST00000551137GO:0016740(transferase activity);GO:0006099(tricarboxylic acid cycle);GO:0005739(mitochondrion);GO:0046912(transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer);GO:0006101(citrate metabolic process);GO:0004108(citrate (Si)-synthase activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005759(mitochondrial matrix);GO:0005975(carbohydrate metabolic process);GO:0070062(extracellular exosome);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)00020(Citrate cycle (TCA cycle));00630(Glyoxylate and dicarboxylate metabolism);00630(Glyoxylate and dicarboxylate metabolism)NANAcitrate synthase [Source:HGNC Symbol;Acc:HGNC:2422]19.77757835707592.009.913.313.02e-060.00upyes
ENSG00000204628RACK1ENST00000514455;ENST00000514183;ENST00000508044;ENST00000507261;ENST00000510199;ENST00000507000;ENST00000512805;ENST00000511473GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0030529(intracellular ribonucleoprotein complex);GO:0005840(ribosome);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0048511(rhythmic process);GO:0006915(apoptotic process);GO:0007275(multicellular organism development);GO:0048471(perinuclear region of cytoplasm);GO:0065009(regulation of molecular function);GO:0043022(ribosome binding);GO:0030425(dendrite);GO:0030496(midbody);GO:0045296(cadherin binding);GO:2000114(regulation of establishment of cell polarity);GO:0043204(perikaryon);GO:0070062(extracellular exosome);GO:0001934(positive regulation of protein phosphorylation);GO:0001891(phagocytic cup);GO:0043547(positive regulation of GTPase activity);GO:0042169(SH2 domain binding);GO:0040008(regulation of growth);GO:0032947(protein complex scaffold);GO:0006417(regulation of translation);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030335(positive regulation of cell migration);GO:0043065(positive regulation of apoptotic process);GO:0016032(viral process);GO:0005102(receptor binding);GO:0017148(negative regulation of translation);GO:0008200(ion channel inhibitor activity);GO:0006412(translation);GO:0043473(pigmentation);GO:1903208(negative regulation of hydrogen peroxide-induced neuron death);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0044297(cell body);GO:0010629(negative regulation of gene expression);GO:0019903(protein phosphatase binding);GO:0030308(negative regulation of cell growth);GO:0042803(protein homodimerization activity);GO:0051726(regulation of cell cycle);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway);GO:0030971(receptor tyrosine kinase binding);GO:0051302(regulation of cell division);GO:0019899(enzyme binding);GO:0008656(cysteine-type endopeptidase activator activity involved in apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0051898(negative regulation of protein kinase B signaling);GO:0071333(cellular response to glucose stimulus);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0071363(cellular response to growth factor stimulus);GO:0032880(regulation of protein localization);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0050765(negative regulation of phagocytosis);GO:2000304(positive regulation of ceramide biosynthetic process);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:1990630(IRE1-RACK1-PP2A complex);GO:0030822(positive regulation of cAMP catabolic process);GO:0042998(positive regulation of Golgi to plasma membrane protein transport);GO:0030292(protein tyrosine kinase inhibitor activity);GO:0061099(negative regulation of protein tyrosine kinase activity);GO:0007369(gastrulation);GO:0005080(protein kinase C binding);GO:0032464(positive regulation of protein homooligomerization);GO:2000543(positive regulation of gastrulation);GO:0015935(small ribosomal subunit);GO:0035591(signaling adaptor activity);GO:0051343(positive regulation of cyclic-nucleotide phosphodiesterase activity);GO:0051901(positive regulation of mitochondrial depolarization);GO:0072344(rescue of stalled ribosome);GO:1900102(negative regulation of endoplasmic reticulum unfolded protein response);GO:1900102(negative regulation of endoplasmic reticulum unfolded protein response)05162(Measles);05162(Measles)K14753NAreceptor for activated C kinase 1 [Source:HGNC Symbol;Acc:HGNC:4399]4.3645.04072271118530.10-3.369161156315523.11e-060.00downyes
ENSG00000105193RPS16ENST00000602153;ENST00000339471;ENST00000601390;ENST00000595386GO:0030529(intracellular ribonucleoprotein complex);GO:0003735(structural constituent of ribosome);GO:0006412(translation);GO:0005840(ribosome);GO:0003723(RNA binding);GO:0016020(membrane);GO:0005515(protein binding);GO:0022627(cytosolic small ribosomal subunit);GO:0005925(focal adhesion);GO:0006364(rRNA processing);GO:0042274(ribosomal small subunit biogenesis);GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0031012(extracellular matrix);GO:0006413(translational initiation);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0019083(viral transcription);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0097421(liver regeneration);GO:1990830(cellular response to leukemia inhibitory factor);GO:0015935(small ribosomal subunit);GO:0015935(small ribosomal subunit)03010(Ribosome);03010(Ribosome)K02960NAribosomal protein S16 [Source:HGNC Symbol;Acc:HGNC:10396]7.050.7010.10363483306183.343.30e-060.00upyes
ENSG00000129128SPCS3ENST00000507001;ENST00000507678;ENST00000503362GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008233(peptidase activity);GO:0006508(proteolysis);GO:0006465(signal peptide processing);GO:0005787(signal peptidase complex);GO:0043231(intracellular membrane-bounded organelle);GO:0031090(organelle membrane);GO:0045047(protein targeting to ER);GO:0045047(protein targeting to ER)03060(Protein export);03060(Protein export)K12948EC:3.4.-.-signal peptidase complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:26212]0.414.290.10-3.381094589590553.36e-060.00downyes
ENSG00000142686C1orf216ENST00000503824;ENST00000270815GO:0005515(protein binding);GO:0005515(protein binding)NANANAchromosome 1 open reading frame 216 [Source:HGNC Symbol;Acc:HGNC:26800]0.485.030.10-3.378763005284183.70e-060.00downyes
ENSG00000166548TK2ENST00000299697;ENST00000562552;ENST00000563478;ENST00000562484GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0006139(nucleobase-containing compound metabolic process);GO:0005739(mitochondrion);GO:0019206(nucleoside kinase activity);GO:0009165(nucleotide biosynthetic process);GO:0005759(mitochondrial matrix);GO:0009157(deoxyribonucleoside monophosphate biosynthetic process);GO:0004797(thymidine kinase activity);GO:0071897(DNA biosynthetic process);GO:0043097(pyrimidine nucleoside salvage);GO:0004137(deoxycytidine kinase activity);GO:0046092(deoxycytidine metabolic process);GO:0046104(thymidine metabolic process);GO:0046104(thymidine metabolic process)00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes);00983(Drug metabolism - other enzymes)K00857EC:2.7.1.21thymidine kinase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:11831]4.400.459.763.293.88e-060.00upyes
ENSG00000168000BSCL2ENST00000463679;ENST00000403550;ENST00000449636;ENST00000531524;ENST00000413908;ENST00000530009;ENST00000405837GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019915(lipid storage);GO:0006629(lipid metabolic process);GO:0016042(lipid catabolic process);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0003674(molecular_function);GO:0045444(fat cell differentiation);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0034389(lipid particle organization);GO:0050995(negative regulation of lipid catabolic process);GO:0050995(negative regulation of lipid catabolic process)NANANABSCL2, seipin lipid droplet biogenesis associated [Source:HGNC Symbol;Acc:HGNC:15832]0.878.770.10-3.336669178353244.24e-060.00downyes
ENSG00000188242PP7080ENST00000342584;ENST00000510714NANANANAuncharacterized LOC25845 [Source:NCBI gene;Acc:25845]5.980.619.783.294.24e-060.00upyes
ENSG00000169567HINT1ENST00000511475;ENST00000304043;ENST00000513345;ENST00000506207GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003824(catalytic activity);GO:0005886(plasma membrane);GO:0006915(apoptotic process);GO:0070062(extracellular exosome);GO:0000118(histone deacetylase complex);GO:0007165(signal transduction);GO:0005856(cytoskeleton);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0005080(protein kinase C binding);GO:0009154(purine ribonucleotide catabolic process);GO:0050850(positive regulation of calcium-mediated signaling);GO:0050850(positive regulation of calcium-mediated signaling)NANANAhistidine triad nucleotide binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4912]1.4915.09241705785120.10-3.33892350896334.36e-060.00downyes
ENSG00000113558SKP1ENST00000522552;ENST00000520417;ENST00000523966;ENST00000353411GO:0016567(protein ubiquitination);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0000209(protein polyubiquitination);GO:0002223(stimulatory C-type lectin receptor signaling pathway);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0038061(NIK/NF-kappaB signaling);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043687(post-translational protein modification);GO:0050852(T cell receptor signaling pathway);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition);GO:0000086(G2/M transition of mitotic cell cycle);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0004842(ubiquitin-protein transferase activity);GO:0031519(PcG protein complex);GO:0019904(protein domain specific binding);GO:0016055(Wnt signaling pathway);GO:0051403(stress-activated MAPK cascade);GO:0008013(beta-catenin binding);GO:0061630(ubiquitin protein ligase activity);GO:0097602(cullin family protein binding);GO:0035518(histone H2A monoubiquitination);GO:0006879(cellular iron ion homeostasis);GO:0019005(SCF ubiquitin ligase complex);GO:0010265(SCF complex assembly);GO:0031467(Cul7-RING ubiquitin ligase complex);GO:0051457(maintenance of protein location in nucleus);GO:0051457(maintenance of protein location in nucleus)04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis);04310(Wnt signaling pathway);04350(TGF-beta signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);04710(Circadian rhythm);05200(Pathways in cancer);05168(Herpes simplex infection);05168(Herpes simplex infection)K03094NAS-phase kinase associated protein 1 [Source:HGNC Symbol;Acc:HGNC:10899]0.202.040.10-3.323546631650174.64e-060.00downyes
ENSG00000240303ACAD11ENST00000496418;ENST00000487024GO:0005634(nucleus);GO:0016491(oxidoreductase activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0008152(metabolic process);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0031966(mitochondrial membrane);GO:0005743(mitochondrial inner membrane);GO:0006635(fatty acid beta-oxidation);GO:0003995(acyl-CoA dehydrogenase activity);GO:0033539(fatty acid beta-oxidation using acyl-CoA dehydrogenase);GO:0004466(long-chain-acyl-CoA dehydrogenase activity);GO:0017099(very-long-chain-acyl-CoA dehydrogenase activity);GO:0070991(medium-chain-acyl-CoA dehydrogenase activity);GO:0070991(medium-chain-acyl-CoA dehydrogenase activity)NANANAacyl-CoA dehydrogenase family member 11 [Source:HGNC Symbol;Acc:HGNC:30211]0.131.320.09-3.396804766169644.83e-060.00downyes
ENSG00000126005MMP24-AS1ENST00000435366;ENST00000566203;ENST00000438751;ENST00000594413;ENST00000456350NANANANAMMP24 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:44421]0.414.140.10-3.325267193320054.87e-060.00downyes
ENSG00000173276ZBTB21ENST00000310826;ENST00000425521;ENST00000398497GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0008327(methyl-CpG binding);GO:0008327(methyl-CpG binding)NANANAzinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083]1.500.159.783.295.00e-060.00upyes
ENSG00000273344PAXIP1-AS1ENST00000608317NANANANAPAXIP1 antisense RNA 1 (head to head) [Source:HGNC Symbol;Acc:HGNC:27328]0.383.910.10-3.350036429381425.36e-060.00downyes
ENSG00000172840PDP2ENST00000566543;ENST00000561704;ENST00000568398;ENST00000568720;ENST00000311765GO:0003824(catalytic activity);GO:0006470(protein dephosphorylation);GO:0004722(protein serine/threonine phosphatase activity);GO:0043169(cation binding);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0005739(mitochondrion);GO:0004721(phosphoprotein phosphatase activity);GO:0005759(mitochondrial matrix);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0004741([pyruvate dehydrogenase (lipoamide)] phosphatase activity);GO:0004741([pyruvate dehydrogenase (lipoamide)] phosphatase activity)NANANApyruvate dehyrogenase phosphatase catalytic subunit 2 [Source:HGNC Symbol;Acc:HGNC:30263]0.101.030.10-3.350466269277245.59e-060.00downyes
ENSG00000131446MGAT1ENST00000333055;ENST00000307826;ENST00000510341;ENST00000514760;ENST00000506708;ENST00000506033;ENST00000502678;ENST00000514283GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0006486(protein glycosylation);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0008375(acetylglucosaminyltransferase activity);GO:0070062(extracellular exosome);GO:0005975(carbohydrate metabolic process);GO:1903561(extracellular vesicle);GO:0003827(alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity);GO:0001701(in utero embryonic development);GO:0006049(UDP-N-acetylglucosamine catabolic process);GO:0006049(UDP-N-acetylglucosamine catabolic process)00510(N-Glycan biosynthesis);00510(N-Glycan biosynthesis)K00726EC:2.4.1.101mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7044]0.595.740.10-3.275490197312595.70e-060.00downyes
ENSG00000265683SYPL1P2ENST00000582878NANANANAsynaptophysin like 1 pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:53547]1.4213.7119540.10-3.274541856004577.71e-060.00downyes
ENSG00000181924COA4ENST00000544575;ENST00000355693;ENST00000541455;ENST00000537581GO:0005739(mitochondrion);GO:0033617(mitochondrial respiratory chain complex IV assembly);GO:0005758(mitochondrial intermembrane space);GO:0005758(mitochondrial intermembrane space)NANANAcytochrome c oxidase assembly factor 4 homolog [Source:HGNC Symbol;Acc:HGNC:24604]20.8007283717722.368.803.148.62e-060.00upyes
ENSG00000277957SENP3-EIF4A1ENST00000614237GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0005634(nucleus);GO:0004175(endopeptidase activity);GO:0016929(SUMO-specific protease activity);GO:0016926(protein desumoylation)NANANASENP3-EIF4A1 readthrough (NMD candidate) [Source:HGNC Symbol;Acc:HGNC:49182]0.212.030.10-3.266422165686549.36e-060.00downyes
ENSG00000042429MED17ENST00000525613;ENST00000507258;ENST00000640411;ENST00000640077;ENST00000251871;ENST00000640027GO:0005634(nucleus);GO:0016020(membrane);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0001104(RNA polymerase II transcription cofactor activity);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0016592(mediator complex);GO:0005515(protein binding);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0005654(nucleoplasm);GO:0004872(receptor activity);GO:0003713(transcription coactivator activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005667(transcription factor complex);GO:0003712(transcription cofactor activity);GO:0030518(intracellular steroid hormone receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0042809(vitamin D receptor binding);GO:0046966(thyroid hormone receptor binding);GO:0046966(thyroid hormone receptor binding)04919(Thyroid hormone signaling pathway);04919(Thyroid hormone signaling pathway)K15133NAmediator complex subunit 17 [Source:HGNC Symbol;Acc:HGNC:2375]0.080.720.11-3.245922567599379.43e-060.00downyes
ENSG00000264364DYNLL2ENST00000579991GO:0005739(mitochondrion);GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005874(microtubule);GO:0003774(motor activity);GO:0005813(centrosome);GO:0030286(dynein complex);GO:0005886(plasma membrane);GO:0007017(microtubule-based process);GO:0035735(intraciliary transport involved in cilium assembly);GO:0005929(cilium);GO:0097542(ciliary tip);GO:0005829(cytosol);GO:0060271(cilium assembly);GO:0051959(dynein light intermediate chain binding);GO:0007062(sister chromatid cohesion);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:2000582(positive regulation of ATP-dependent microtubule motor activity, plus-end-directed);GO:0005868(cytoplasmic dynein complex);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0016236(macroautophagy);GO:0008092(cytoskeletal protein binding);GO:0045505(dynein intermediate chain binding);GO:0010970(transport along microtubule);GO:0005875(microtubule associated complex);GO:0008039(synaptic target recognition);GO:0016459(myosin complex);GO:0031475(myosin V complex)04962(Vasopressin-regulated water reabsorption)K10418NAdynein light chain LC8-type 2 [Source:HGNC Symbol;Acc:HGNC:24596]9.731.138.613.119.79e-060.00upyes
ENSG00000186814ZSCAN30ENST00000588832;ENST00000588448;ENST00000639929;ENST00000420878;ENST00000592598GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding)NANANAzinc finger and SCAN domain containing 30 [Source:HGNC Symbol;Acc:HGNC:33517]0.960.118.873.151.22e-050.00upyes
ENSG00000158122AAED1ENST00000375234GO:0098869(cellular oxidant detoxification);GO:0055114(oxidation-reduction process);GO:0016209(antioxidant activity)NANANAAhpC/TSA antioxidant enzyme domain containing 1 [Source:HGNC Symbol;Acc:HGNC:16881]3.070.358.673.121.26e-050.00upyes
ENSG00000171310CHST11ENST00000550711;ENST00000549016;ENST00000547956;ENST00000303694GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0008146(sulfotransferase activity);GO:0005975(carbohydrate metabolic process);GO:0016051(carbohydrate biosynthetic process);GO:0016020(membrane);GO:0030206(chondroitin sulfate biosynthetic process);GO:0001537(N-acetylgalactosamine 4-O-sulfotransferase activity);GO:0047756(chondroitin 4-sulfotransferase activity);GO:0050659(N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity);GO:0002063(chondrocyte development);GO:0007585(respiratory gaseous exchange);GO:0009791(post-embryonic development);GO:0030204(chondroitin sulfate metabolic process);GO:0030326(embryonic limb morphogenesis);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0033037(polysaccharide localization);GO:0036342(post-anal tail morphogenesis);GO:0042127(regulation of cell proliferation);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0048589(developmental growth);GO:0048703(embryonic viscerocranium morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0051216(cartilage development);GO:0051216(cartilage development)00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)K01017EC:2.8.2.5carbohydrate sulfotransferase 11 [Source:HGNC Symbol;Acc:HGNC:17422]0.776.670.11-3.121298841628691.35e-050.00downyes
ENSG00000168818STX18ENST00000505286;ENST00000515687;ENST00000503692GO:0005622(intracellular);GO:0006886(intracellular protein transport);GO:0016020(membrane);GO:0005484(SNAP receptor activity);GO:0061025(membrane fusion);GO:0006810(transport);GO:0016021(integral component of membrane);GO:0015031(protein transport);GO:0005794(Golgi apparatus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0016192(vesicle-mediated transport);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0031201(SNARE complex);GO:1903358(regulation of Golgi organization);GO:1902953(positive regulation of ER to Golgi vesicle-mediated transport);GO:1902117(positive regulation of organelle assembly);GO:0019904(protein domain specific binding);GO:0090158(endoplasmic reticulum membrane organization);GO:0090158(endoplasmic reticulum membrane organization)04130(SNARE interactions in vesicular transport);04145(Phagosome);04145(Phagosome)NANAsyntaxin 18 [Source:HGNC Symbol;Acc:HGNC:15942]2.070.258.443.081.47e-050.00upyes
ENSG00000143570SLC39A1ENST00000368623;ENST00000621013;ENST00000310483GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006811(ion transport);GO:0005886(plasma membrane);GO:0046873(metal ion transmembrane transporter activity);GO:0030001(metal ion transport);GO:0005385(zinc ion transmembrane transporter activity);GO:0006829(zinc II ion transport);GO:0071577(zinc II ion transmembrane transport);GO:0022890(inorganic cation transmembrane transporter activity);GO:0006812(cation transport);GO:0005102(receptor binding);GO:0001701(in utero embryonic development);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0060173(limb development);GO:0060173(limb development)NANANAsolute carrier family 39 member 1 [Source:HGNC Symbol;Acc:HGNC:12876]89.827231662337711.08054137190088.113.021.52e-050.00upyes
ENSG00000213516RBMXL1ENST00000399794GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005634(nucleus);GO:0030529(intracellular ribonucleoprotein complex);GO:0001047(core promoter binding);GO:0003682(chromatin binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)03040(Spliceosome)K12885NARNA binding motif protein, X-linked like 1 [Source:HGNC Symbol;Acc:HGNC:25073]18.90550611519562.338.113.021.55e-050.00upyes
ENSG00000166881NEMP1ENST00000379391;ENST00000300128;ENST00000553654GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0005637(nuclear inner membrane);GO:0005635(nuclear envelope);GO:0005635(nuclear envelope)NANANAnuclear envelope integral membrane protein 1 [Source:HGNC Symbol;Acc:HGNC:29001]10.93886753153471.358.123.021.60e-050.00upyes
ENSG00000101220C20orf27ENST00000379772;ENST00000217195GO:0003674(molecular_function);GO:0008150(biological_process);GO:0005575(cellular_component);GO:0005575(cellular_component)NANANAchromosome 20 open reading frame 27 [Source:HGNC Symbol;Acc:HGNC:15873]19.46312068571432.408.113.021.62e-050.00upyes
ENSG00000186470BTN3A2ENST00000508906;ENST00000604202GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0002376(immune system process);GO:0002250(adaptive immune response);GO:0002456(T cell mediated immunity);GO:0072643(interferon-gamma secretion);GO:0072643(interferon-gamma secretion)NANANAbutyrophilin subfamily 3 member A2 [Source:HGNC Symbol;Acc:HGNC:1139]0.141.190.11-3.137523240564381.73e-050.00downyes
ENSG00000259399TGIF2-C20orf24ENST00000558530GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005739(mitochondrion)NANANATGIF2-C20orf24 readthrough [Source:HGNC Symbol;Acc:HGNC:44664]38.1818664.817.942.991.97e-050.00upyes
ENSG00000105647PIK3R2ENST00000222254;ENST00000600533;ENST00000426902;ENST00000459743GO:0043409(negative regulation of MAPK cascade);GO:0006810(transport);GO:0005634(nucleus);GO:0015031(protein transport);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0005515(protein binding);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0050900(leukocyte migration);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005829(cytosol);GO:0005096(GTPase activator activity);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0050852(T cell receptor signaling pathway);GO:0035014(phosphatidylinositol 3-kinase regulator activity);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0046854(phosphatidylinositol phosphorylation);GO:0046935(1-phosphatidylinositol-3-kinase regulator activity);GO:0008286(insulin receptor signaling pathway);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:2001275(positive regulation of glucose import in response to insulin stimulus);GO:0019903(protein phosphatase binding);GO:0046982(protein heterodimerization activity);GO:0046934(phosphatidylinositol-4,5-bisphosphate 3-kinase activity);GO:0006661(phosphatidylinositol biosynthetic process);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0038111(interleukin-7-mediated signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0001784(phosphotyrosine residue binding);GO:0016303(1-phosphatidylinositol-3-kinase activity);GO:0030971(receptor tyrosine kinase binding);GO:0001678(cellular glucose homeostasis);GO:0010506(regulation of autophagy);GO:0032869(cellular response to insulin stimulus);GO:0034976(response to endoplasmic reticulum stress);GO:0042993(positive regulation of transcription factor import into nucleus);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048010(vascular endothelial growth factor receptor signaling pathway)04014(Ras signaling pathway);04015(Rap1 signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);04919(Thyroid hormone signaling pathway);04973(Carbohydrate digestion and absorption);04960(Aldosterone-regulated sodium reabsorption);04725(Cholinergic synapse);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04360(Axon guidance);04380(Osteoclast differentiation);04211(Longevity regulating pathway - mammal);04213(Longevity regulating pathway - multiple species);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05418(Fluid shear stress and atherosclerosis);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05167(Kaposi's sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));01521(EGFR tyrosine kinase inhibitor resistance);01524(Platinum drug resistance);01522(Endocrine resistance);01522(Endocrine resistance)K02649NAphosphoinositide-3-kinase regulatory subunit 2 [Source:HGNC Symbol;Acc:HGNC:8980]20.508879586872.647.782.962.16e-050.00upyes
ENSG00000261408TEN1-CDK3ENST00000567351NANANANATEN1-CDK3 readthrough (NMD candidate) [Source:HGNC Symbol;Acc:HGNC:44420]0.262.190.12-3.086473312562592.36e-050.00downyes
ENSG00000180329CCDC43ENST00000588210;ENST00000457422;ENST00000315286;ENST00000588687GO:0005515(protein binding);GO:0005515(protein binding)NANANAcoiled-coil domain containing 43 [Source:HGNC Symbol;Acc:HGNC:26472]0.977.900.12-3.033304376522782.49e-050.00downyes
ENSG00000175548ALG10BENST00000553138;ENST00000308742GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005789(endoplasmic reticulum membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006486(protein glycosylation);GO:0004583(dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity);GO:0060050(positive regulation of protein glycosylation);GO:1901980(positive regulation of inward rectifier potassium channel activity);GO:1901980(positive regulation of inward rectifier potassium channel activity)00510(N-Glycan biosynthesis);00510(N-Glycan biosynthesis)K03850EC:2.4.1.256ALG10B, alpha-1,2-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:31088]0.100.840.12-3.024663462316862.81e-050.00downyes
ENSG00000168283BMI1ENST00000376663;ENST00000496174;ENST00000602524;ENST00000456675;ENST00000602358;ENST00000442508GO:0048146(positive regulation of fibroblast proliferation);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0008270(zinc ion binding);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0005654(nucleoplasm);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex);GO:0030097(hemopoiesis);GO:0000151(ubiquitin ligase complex);GO:1990841(promoter-specific chromatin binding);GO:0045814(negative regulation of gene expression, epigenetic);GO:0010468(regulation of gene expression);GO:0071535(RING-like zinc finger domain binding);GO:0007379(segment specification);GO:0051443(positive regulation of ubiquitin-protein transferase activity);GO:0051443(positive regulation of ubiquitin-protein transferase activity)04550(Signaling pathways regulating pluripotency of stem cells);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05206(MicroRNAs in cancer)K11459NABMI1 proto-oncogene, polycomb ring finger [Source:HGNC Symbol;Acc:HGNC:1066]7.170.957.582.922.88e-050.00upyes
ENSG00000229807XISTENST00000434839;ENST00000602587;ENST00000429829;ENST00000635841;ENST00000602495NANANANAX inactive specific transcript (non-protein coding) [Source:HGNC Symbol;Acc:HGNC:12810]0.090.710.12-3.009672013327623.06e-050.00downyes
ENSG00000102100SLC35A2ENST00000376521;ENST00000635015GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0005634(nucleus);GO:0000139(Golgi membrane);GO:0008643(carbohydrate transport);GO:0005351(sugar:proton symporter activity);GO:0015992(proton transport);GO:0005783(endoplasmic reticulum);GO:0006012(galactose metabolic process);GO:0005459(UDP-galactose transmembrane transporter activity);GO:0015785(UDP-galactose transport);GO:0072334(UDP-galactose transmembrane transport);GO:0072334(UDP-galactose transmembrane transport)NANANAsolute carrier family 35 member A2 [Source:HGNC Symbol;Acc:HGNC:11022]0.836.530.13-2.985365536917953.07e-050.00downyes
ENSG00000178878APOLD1ENST00000540583;ENST00000326765;ENST00000534843GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0042157(lipoprotein metabolic process);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0001525(angiogenesis);GO:0001666(response to hypoxia);GO:0042118(endothelial cell activation);GO:0045601(regulation of endothelial cell differentiation);GO:0045601(regulation of endothelial cell differentiation)NANANAapolipoprotein L domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25268]5.240.707.492.913.08e-050.00upyes
ENSG00000162971TYW5ENST00000354611;ENST00000493181GO:0046872(metal ion binding);GO:0008033(tRNA processing);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0042803(protein homodimerization activity);GO:0051213(dioxygenase activity);GO:0000049(tRNA binding);GO:0005506(iron ion binding);GO:0016706(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors);GO:0006400(tRNA modification);GO:0031591(wybutosine biosynthetic process);GO:0005737(cytoplasm);GO:0005737(cytoplasm)NANANAtRNA-yW synthesizing protein 5 [Source:HGNC Symbol;Acc:HGNC:26754]0.550.077.872.983.52e-050.01upyes

Definition of table:

term意义
gene_idThe ID of gene, some ids started with "MSTRG" are named by transcript assembly software StringTie
gene_nameThe name of gene (gene symbol)
transcript_idThe name of transcript, separated by comma
GOGene ontology term and description http://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
KO_EntryKO functional ortholog, KO groups identified by K numbers and, in metabolic maps
ECenzyme
DescriptionDescription of gene
FPKM.ANormalization of gene expression level by FPKM value
fcfold change
log2(fc)log2 of fold change value
pvalp value
qvalq value or FDR value
regulationup-regulation or down-regulation
significantyes or no

document location: summary/7_differential_expression/*VS*/*_Gene_differential_expression.xlsx


4.7.2 Profiling of differentially expressed transcripts


t_idclass_codechrstrandstartendt_namenum_exonslengthgene_idgene_nameGOKEGGKO_ENTRYECDescriptionFPKM.M14_OEFPKM.M14_NCfclog2(fc)pvalqvalregulationsignificant
40732NAchr12-4912778249131395ENST0000033602341627ENSG00000123416TUBA1BGO:0005737(cytoplasm);GO:0005525(GTP binding);GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0015630(microtubule cytoskeleton);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005200(structural constituent of cytoskeleton);GO:0005874(microtubule);GO:0007017(microtubule-based process);GO:0070062(extracellular exosome);GO:0031625(ubiquitin protein ligase binding);GO:0003725(double-stranded RNA binding);GO:0005198(structural molecule activity);GO:0030705(cytoskeleton-dependent intracellular transport);GO:0051301(cell division);GO:0000226(microtubule cytoskeleton organization);GO:0071353(cellular response to interleukin-4);GO:0005881(cytoplasmic microtubule);GO:0043209(myelin sheath);GO:0045121(membrane raft);GO:0007010(cytoskeleton organization)04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction);05130(Pathogenic Escherichia coli infection)K07374NAtubulin alpha 1b [Source:HGNC Symbol;Acc:HGNC:18809]0.611269.2106930.00-11.02026617047842.61e-284.77e-24downyes
186296NAchr8-143915153143950876ENST000003228103215249ENSG00000178209PLECGO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0003779(actin binding);GO:0005925(focal adhesion);GO:0045111(intermediate filament cytoskeleton);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0008092(cytoskeletal protein binding);GO:0030054(cell junction);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0042383(sarcolemma);GO:0031012(extracellular matrix);GO:0005886(plasma membrane);GO:0008307(structural constituent of muscle);GO:0030506(ankyrin binding);GO:0031581(hemidesmosome assembly);GO:0030056(hemidesmosome);GO:0043034(costamere);GO:0016528(sarcoplasm);GO:0005903(brush border);GO:0043292(contractile fiber)NANANAplectin [Source:HGNC Symbol;Acc:HGNC:9069]0.1265.7692260.00-9.151353927711248.91e-238.14e-19downyes
132693NAchr3+2238194522382929ENST000004514971985ENSG00000132967HMGB1P5NANANANAhigh mobility group box 1 pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:4997]0.93314.3330080.00-8.399809908877482.08e-201.26e-16downyes
11017NAchr1-153606886153609337ENST0000036870431146ENSG00000188643S100A16GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0042803(protein homodimerization activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005730(nucleolus);GO:0070062(extracellular exosome);GO:0051592(response to calcium ion)NANANAS100 calcium binding protein A16 [Source:HGNC Symbol;Acc:HGNC:20441]355.6963811.23288.2352167539548.175.06e-202.31e-16upyes
186292NAchr8-143915147143939590ENST000003451363214803ENSG00000178209PLECGO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0003779(actin binding);GO:0005925(focal adhesion);GO:0045111(intermediate filament cytoskeleton);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0008092(cytoskeletal protein binding);GO:0030054(cell junction);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0042383(sarcolemma);GO:0031012(extracellular matrix);GO:0005886(plasma membrane);GO:0008307(structural constituent of muscle);GO:0030506(ankyrin binding);GO:0031581(hemidesmosome assembly);GO:0030056(hemidesmosome);GO:0043034(costamere);GO:0016528(sarcoplasm);GO:0005903(brush border);GO:0043292(contractile fiber)NANANAplectin [Source:HGNC Symbol;Acc:HGNC:9069]67.5273590.31220.5673601107947.795.57e-192.03e-15upyes
113163NAchr2-130151392130181757ENST00000431183173614ENSG00000136699SMPD4GO:0050290(sphingomyelin phosphodiesterase D activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071356(cellular response to tumor necrosis factor);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0005794(Golgi apparatus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0000139(Golgi membrane);GO:0006687(glycosphingolipid metabolic process);GO:0004767(sphingomyelin phosphodiesterase activity);GO:0046513(ceramide biosynthetic process);GO:0046475(glycerophospholipid catabolic process);GO:0006685(sphingomyelin catabolic process);GO:0005802(trans-Golgi network)00600(Sphingolipid metabolism)K12353EC:3.1.4.12sphingomyelin phosphodiesterase 4 [Source:HGNC Symbol;Acc:HGNC:32949]31.9245620.19164.7736337923497.361.99e-176.07e-14upyes
152173NAchr5-1735369517354624ENST000004018301930ENSG00000223361FTH1P10NANANANAferritin heavy chain 1 pseudogene 10 [Source:HGNC Symbol;Acc:HGNC:3980]1.64251.2008510.01-7.258302540862274.20e-171.09e-13downyes
135852NAchr3-5322565253235607ENST0000046034367286ENSG00000163931TKTGO:0016607(nuclear speck);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0016740(transferase activity);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0042803(protein homodimerization activity);GO:0005515(protein binding);GO:0048037(cofactor binding);GO:0016604(nuclear body);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0031982(vesicle);GO:0006098(pentose-phosphate shunt);GO:0004802(transketolase activity);GO:0005999(xylulose biosynthetic process);GO:0009052(pentose-phosphate shunt, non-oxidative branch);GO:0046166(glyceraldehyde-3-phosphate biosynthetic process);GO:0040008(regulation of growth);GO:0043209(myelin sheath)00030(Pentose phosphate pathway);01051(Biosynthesis of ansamycins)NANAtransketolase [Source:HGNC Symbol;Acc:HGNC:11834]0.2028.9081440.01-7.173263392306397.75e-171.76e-13downyes
41959NAchr12+5432512754351849ENST0000026206191897ENSG00000111481COPZ1GO:0006810(transport);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0031410(cytoplasmic vesicle);GO:0030663(COPI-coated vesicle membrane);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0030133(transport vesicle);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0030126(COPI vesicle coat);GO:1901998(toxin transport)NANANAcoatomer protein complex subunit zeta 1 [Source:HGNC Symbol;Acc:HGNC:2243]0.6481.7719040.01-7.000282314317182.50e-164.70e-13downyes
148905NAchr4+118685368118715433ENST00000388822116669ENSG00000145388METTL14GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0006139(nucleobase-containing compound metabolic process);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0000398(mRNA splicing, via spliceosome);GO:0016070(RNA metabolic process);GO:0019827(stem cell population maintenance);GO:0061157(mRNA destabilization);GO:0080009(mRNA methylation);GO:0036396(MIS complex);GO:0016422(mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity)NANANAmethyltransferase like 14 [Source:HGNC Symbol;Acc:HGNC:29330]116.3518141.00116.9252152556146.872.82e-164.70e-13upyes
96594NAchr19-1448174714483463ENST0000058781111717ENSG00000123159GIPC1GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005829(cytosol);GO:0005515(protein binding);GO:0007186(G-protein coupled receptor signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0003779(actin binding);GO:0017022(myosin binding);GO:0030165(PDZ domain binding);GO:0042803(protein homodimerization activity);GO:0006605(protein targeting);GO:0007268(chemical synaptic transmission);GO:0014047(glutamate secretion);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031647(regulation of protein stability);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0043542(endothelial cell migration);GO:0048167(regulation of synaptic plasticity);GO:0005903(brush border);GO:0008021(synaptic vesicle);GO:0012506(vesicle membrane);GO:0030139(endocytic vesicle);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0005938(cell cortex);GO:0005102(receptor binding);GO:0032467(positive regulation of cytokinesis)NANANAGIPC PDZ domain containing family member 1 [Source:HGNC Symbol;Acc:HGNC:1226]43.6767310.35126.1560286760716.982.83e-164.70e-13upyes
97483NAchr19+1815315818178117ENST00000593731255142ENSG00000268173AC007192.1NANANANANA0.1315.3354080.01-6.835209724510061.07e-151.51e-12downyes
42528NAchr12-5627169956300318ENST00000549143112811ENSG00000062485CSGO:0016740(transferase activity);GO:0006099(tricarboxylic acid cycle);GO:0005739(mitochondrion);GO:0046912(transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer);GO:0006101(citrate metabolic process);GO:0004108(citrate (Si)-synthase activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005759(mitochondrial matrix);GO:0005975(carbohydrate metabolic process);GO:0070062(extracellular exosome);GO:0016020(membrane);GO:0016021(integral component of membrane)00020(Citrate cycle (TCA cycle));00630(Glyoxylate and dicarboxylate metabolism)NANAcitrate synthase [Source:HGNC Symbol;Acc:HGNC:2422]44.7386320.42106.7386041007586.741.08e-151.51e-12upyes
92969NAchr19+572565583490ENST0000033351191974ENSG00000172270BSGGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0030246(carbohydrate binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0042470(melanosome);GO:0005925(focal adhesion);GO:0050900(leukocyte migration);GO:0005887(integral component of plasma membrane);GO:0005515(protein binding);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0007166(cell surface receptor signaling pathway);GO:0006090(pyruvate metabolic process);GO:0000139(Golgi membrane);GO:0030198(extracellular matrix organization);GO:0022617(extracellular matrix disassembly);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0005537(mannose binding);GO:0015718(monocarboxylic acid transport);GO:0072661(protein targeting to plasma membrane);GO:0007566(embryo implantation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043434(response to peptide hormone);GO:0046689(response to mercury ion);GO:0046697(decidualization);GO:0051591(response to cAMP);GO:0002080(acrosomal membrane);GO:0042383(sarcolemma);GO:0045121(membrane raft)NANANAbasigin (Ok blood group) [Source:HGNC Symbol;Acc:HGNC:1116]1.32134.2032470.01-6.669379290222451.97e-152.57e-12downyes
31382NAchr11+6661663166644632ENST0000042135532034ENSG00000248643RBM14-RBM4GO:0003676(nucleic acid binding);GO:0003723(RNA binding)NANANARBM14-RBM4 readthrough [Source:HGNC Symbol;Acc:HGNC:38840]28.0062080.27101.8800264829356.672.33e-152.84e-12upyes
175804NAchr7-106090503106112331ENST0000045538552151ENSG00000008282SYPL1GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006810(transport);GO:0005215(transporter activity);GO:0008021(synaptic vesicle);GO:0042470(melanosome);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0070062(extracellular exosome);GO:0005887(integral component of plasma membrane);GO:0007268(chemical synaptic transmission);GO:0030285(integral component of synaptic vesicle membrane);GO:0030141(secretory granule)NANANAsynaptophysin like 1 [Source:HGNC Symbol;Acc:HGNC:11507]0.3131.0977040.01-6.656011195763313.71e-154.24e-12downyes
121376NAchr20-2530019825390976ENST00000339157132117ENSG00000100997ABHD12GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0005886(plasma membrane);GO:0047372(acylglycerol lipase activity);GO:0052651(monoacylglycerol catabolic process);GO:0046464(acylglycerol catabolic process);GO:0004622(lysophospholipase activity);GO:0006660(phosphatidylserine catabolic process);GO:0007628(adult walking behavior);GO:0010996(response to auditory stimulus);GO:0046475(glycerophospholipid catabolic process);GO:0032281(AMPA glutamate receptor complex)NANANAabhydrolase domain containing 12 [Source:HGNC Symbol;Acc:HGNC:15868]0.9081.8128360.01-6.504262450645076.58e-157.06e-12downyes
172305NAchr7-5059006850792969ENST00000403097185432ENSG00000106070GRB10GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0005515(protein binding);GO:0005158(insulin receptor binding);GO:0005070(SH3/SH2 adaptor activity);GO:0005829(cytosol);GO:0030178(negative regulation of Wnt signaling pathway);GO:0043234(protein complex);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway);GO:0046325(negative regulation of glucose import);GO:0009967(positive regulation of signal transduction);GO:0042326(negative regulation of phosphorylation);GO:0048009(insulin-like growth factor receptor signaling pathway)04150(mTOR signaling pathway)K20064NAgrowth factor receptor bound protein 10 [Source:HGNC Symbol;Acc:HGNC:4564]17.4215150.2182.7507481119086.371.29e-141.31e-11upyes
79058NAchr17+1643932716441779ENST000004910093863ENSG00000175061LRRC75A-AS1NANANANALRRC75A antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:28619]313.4777534.2074.68194264972716.222.49e-142.39e-11upyes
8702NAchr1-109309568109393357ENST00000538502206993ENSG00000134243SORT1GO:0048471(perinuclear region of cytoplasm);GO:0051005(negative regulation of lipoprotein lipase activity);GO:0006810(transport);GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0005764(lysosome);GO:0032580(Golgi cisterna membrane);GO:0005768(endosome);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0001503(ossification);GO:0009986(cell surface);GO:0031965(nuclear membrane);GO:0016050(vesicle organization);GO:0031410(cytoplasmic vesicle);GO:0019899(enzyme binding);GO:0005769(early endosome);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005905(clathrin-coated pit);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0007218(neuropeptide signaling pathway);GO:0010468(regulation of gene expression);GO:0048406(nerve growth factor binding);GO:0046323(glucose import);GO:0032868(response to insulin);GO:0008333(endosome to lysosome transport);GO:0010465(nerve growth factor receptor activity);GO:0030379(neurotensin receptor activity, non-G-protein coupled);GO:0006895(Golgi to endosome transport);GO:0014902(myotube differentiation);GO:0032509(endosome transport via multivesicular body sorting pathway);GO:0038180(nerve growth factor signaling pathway);GO:0045599(negative regulation of fat cell differentiation);GO:0048011(neurotrophin TRK receptor signaling pathway);GO:0048227(plasma membrane to endosome transport);GO:1904037(positive regulation of epithelial cell apoptotic process);GO:0030136(clathrin-coated vesicle);GO:0030140(trans-Golgi network transport vesicle);GO:0030425(dendrite);GO:0030659(cytoplasmic vesicle membrane);GO:0043025(neuronal cell body);GO:0043231(intracellular membrane-bounded organelle)04142(Lysosome);04979(Cholesterol metabolism);04722(Neurotrophin signaling pathway)K12388NAsortilin 1 [Source:HGNC Symbol;Acc:HGNC:11186]7.040.0975.46454843760056.244.00e-143.65e-11upyes
78166NAchr17-76654167687491ENST00000635293121883ENSG00000141510TP53GO:0008285(negative regulation of cell proliferation);GO:0010628(positive regulation of gene expression);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0005829(cytosol);GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0005739(mitochondrion);GO:0006915(apoptotic process);GO:0005515(protein binding);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0048511(rhythmic process);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0005759(mitochondrial matrix);GO:0044212(transcription regulatory region DNA binding);GO:0051262(protein tetramerization);GO:0045893(positive regulation of transcription, DNA-templated);GO:0005730(nucleolus);GO:0042802(identical protein binding);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0019901(protein kinase binding);GO:0016579(protein deubiquitination);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0003682(chromatin binding);GO:0008283(cell proliferation);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0007050(cell cycle arrest);GO:0043065(positive regulation of apoptotic process);GO:0016032(viral process);GO:0031625(ubiquitin protein ligase binding);GO:0006284(base-excision repair);GO:0047485(protein N-terminus binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0008134(transcription factor binding);GO:0030308(negative regulation of cell growth);GO:0002020(protease binding);GO:0042981(regulation of apoptotic process);GO:0005507(copper ion binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0000790(nuclear chromatin);GO:0016363(nuclear matrix);GO:0046982(protein heterodimerization activity);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0043234(protein complex);GO:0001085(RNA polymerase II transcription factor binding);GO:0016605(PML body);GO:0038111(interleukin-7-mediated signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0000981(RNA polymerase II transcription factor activity, sequence-specific DNA binding);GO:0035690(cellular response to drug);GO:0012501(programmed cell death);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway);GO:0001046(core promoter sequence-specific DNA binding);GO:0051087(chaperone binding);GO:0090399(replicative senescence);GO:1902895(positive regulation of pri-miRNA transcription from RNA polymerase II promoter);GO:0006461(protein complex assembly);GO:0032461(positive regulation of protein oligomerization);GO:0007569(cell aging);GO:0071456(cellular response to hypoxia);GO:0002039(p53 binding);GO:0003684(damaged DNA binding);GO:0010165(response to X-ray);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0043153(entrainment of circadian clock by photoperiod);GO:0042149(cellular response to glucose starvation);GO:0071158(positive regulation of cell cycle arrest);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:0008104(protein localization);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0051721(protein phosphatase 2A binding);GO:0046677(response to antibiotic);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0097252(oligodendrocyte apoptotic process);GO:0048512(circadian behavior);GO:0003730(mRNA 3'-UTR binding);GO:0097718(disordered domain specific binding);GO:0035035(histone acetyltransferase binding);GO:0043066(negative regulation of apoptotic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:0048147(negative regulation of fibroblast proliferation);GO:0007265(Ras protein signal transduction);GO:0071480(cellular response to gamma radiation);GO:0005622(intracellular);GO:0005669(transcription factor TFIID complex);GO:0016604(nuclear body);GO:0000990(transcription factor activity, core RNA polymerase binding);GO:0001228(transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding);GO:0030971(receptor tyrosine kinase binding);GO:0042826(histone deacetylase binding);GO:0043621(protein self-association);GO:0000733(DNA strand renaturation);GO:0006289(nucleotide-excision repair);GO:0006914(autophagy);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0006983(ER overload response);GO:0008340(determination of adult lifespan);GO:0010332(response to gamma radiation);GO:0031065(positive regulation of histone deacetylation);GO:0031497(chromatin assembly);GO:0031571(mitotic G1 DNA damage checkpoint);GO:0034644(cellular response to UV);GO:0043525(positive regulation of neuron apoptotic process);GO:0046827(positive regulation of protein export from nucleus);GO:0046902(regulation of mitochondrial membrane permeability);GO:0051097(negative regulation of helicase activity);GO:0051289(protein homotetramerization);GO:0051974(negative regulation of telomerase activity);GO:0070245(positive regulation of thymocyte apoptotic process);GO:0071479(cellular response to ionizing radiation);GO:0072331(signal transduction by p53 class mediator);GO:0072717(cellular response to actinomycin D);GO:0090403(oxidative stress-induced premature senescence);GO:0097193(intrinsic apoptotic signaling pathway);GO:1900119(positive regulation of execution phase of apoptosis);GO:1902749(regulation of cell cycle G2/M phase transition);GO:0005657(replication fork);GO:0016020(membrane);GO:0016021(integral component of membrane)04010(MAPK signaling pathway);04310(Wnt signaling pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04137(Mitophagy - animal);04110(Cell cycle);04210(Apoptosis);04216(Ferroptosis);04115(p53 signaling pathway);04218(Cellular senescence);04919(Thyroid hormone signaling pathway);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington's disease);05418(Fluid shear stress and atherosclerosis);05166(HTLV-I infection);05162(Measles);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi's sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);01524(Platinum drug resistance);01522(Endocrine resistance)NANAtumor protein p53 [Source:HGNC Symbol;Acc:HGNC:11998]22.521170.3173.19577878602726.196.51e-145.48e-11upyes
47619NAchr12+123973123124015422ENST0000053964465108ENSG00000179195ZNF664GO:0005634(nucleus);GO:0003676(nucleic acid binding);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003674(molecular_function);GO:0008150(biological_process)NANANAzinc finger protein 664 [Source:HGNC Symbol;Acc:HGNC:25406]0.4733.7053950.01-6.156579407299796.60e-145.48e-11downyes
43793NAchr12+6958566669601565ENST00000543146162189ENSG00000166226CCT2GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006457(protein folding);GO:0005515(protein binding);GO:0005874(microtubule);GO:0051082(unfolded protein binding);GO:0005576(extracellular region);GO:0070062(extracellular exosome);GO:0031012(extracellular matrix);GO:0043312(neutrophil degranulation);GO:0035578(azurophil granule lumen);GO:0050821(protein stabilization);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0051973(positive regulation of telomerase activity);GO:0031625(ubiquitin protein ligase binding);GO:1904851(positive regulation of establishment of protein localization to telomere);GO:1904874(positive regulation of telomerase RNA localization to Cajal body);GO:0044183(protein binding involved in protein folding);GO:0090666(scaRNA localization to Cajal body);GO:1904871(positive regulation of protein localization to Cajal body);GO:0005832(chaperonin-containing T-complex);GO:0007339(binding of sperm to zona pellucida);GO:0051086(chaperone mediated protein folding independent of cofactor);GO:0051131(chaperone-mediated protein complex assembly);GO:1901998(toxin transport);GO:0002199(zona pellucida receptor complex);GO:0043209(myelin sheath);GO:0044297(cell body)NANANAchaperonin containing TCP1 subunit 2 [Source:HGNC Symbol;Acc:HGNC:1615]0.3122.7473160.01-6.213674858849397.50e-145.96e-11downyes
88861NAchr17-8224266782273731ENST0000031402893712ENSG00000141551CSNK1DGO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0048511(rhythmic process);GO:0016055(Wnt signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0000139(Golgi membrane);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0045296(cadherin binding);GO:0008360(regulation of cell shape);GO:0000086(G2/M transition of mitotic cell cycle);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0097711(ciliary basal body docking);GO:0005876(spindle microtubule);GO:0032922(circadian regulation of gene expression);GO:0006364(rRNA processing);GO:0048208(COPII vesicle coating);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0042752(regulation of circadian rhythm);GO:0051225(spindle assembly);GO:0006897(endocytosis);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0018105(peptidyl-serine phosphorylation);GO:0050321(tau-protein kinase activity);GO:0042277(peptide binding);GO:0007020(microtubule nucleation);GO:0007030(Golgi organization);GO:0030177(positive regulation of Wnt signaling pathway);GO:0034067(protein localization to Golgi apparatus);GO:0061512(protein localization to cilium);GO:0071539(protein localization to centrosome);GO:1905426(positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation);GO:1905515(non-motile cilium assembly);GO:1990090(cellular response to nerve growth factor stimulus);GO:2000052(positive regulation of non-canonical Wnt signaling pathway);GO:0043005(neuron projection)04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04540(Gap junction);04710(Circadian rhythm)K08959EC:2.7.11.1casein kinase 1 delta [Source:HGNC Symbol;Acc:HGNC:2452]0.4027.1618120.01-6.101630555463991.12e-138.54e-11downyes
105475NAchr19+5838640058394806ENST0000060152171203ENSG00000083845RPS5GO:0003723(RNA binding);GO:0016020(membrane);GO:0006412(translation);GO:0006413(translational initiation);GO:0030529(intracellular ribonucleoprotein complex);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0015935(small ribosomal subunit);GO:0022627(cytosolic small ribosomal subunit);GO:0005925(focal adhesion);GO:0019843(rRNA binding);GO:0003729(mRNA binding);GO:0000028(ribosomal small subunit assembly);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0031012(extracellular matrix);GO:0005515(protein binding);GO:0006364(rRNA processing);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0019083(viral transcription);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0006450(regulation of translational fidelity)03010(Ribosome)NANAribosomal protein S5 [Source:HGNC Symbol;Acc:HGNC:10426]42.7272420.6466.9728031800426.071.25e-139.13e-11upyes
31117NAchr11-6591680865919117ENST0000043857621619ENSG00000175573C11orf68GO:0003723(RNA binding);GO:0005515(protein binding)NANANAchromosome 11 open reading frame 68 [Source:HGNC Symbol;Acc:HGNC:28801]61.7032740.9664.00701446461036.001.30e-139.13e-11upyes
4956NAchr1-4336339843367738ENST0000062194381625ENSG00000066322ELOVL1GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0006629(lipid metabolic process);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0009922(fatty acid elongase activity);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0034625(fatty acid elongation, monounsaturated fatty acid);GO:0005515(protein binding);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0036109(alpha-linolenic acid metabolic process);GO:0030148(sphingolipid biosynthetic process);GO:0043651(linoleic acid metabolic process);GO:0034626(fatty acid elongation, polyunsaturated fatty acid)00062(Fatty acid elongation)K10247EC:2.3.1.199ELOVL fatty acid elongase 1 [Source:HGNC Symbol;Acc:HGNC:14418]1.2884.1095430.02-6.041755432239751.46e-139.84e-11downyes
77812NAchr17-72350287239506ENST0000032031652037ENSG00000040633PHF23GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006914(autophagy);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:1902902(negative regulation of autophagosome assembly);GO:0007076(mitotic chromosome condensation);GO:0031398(positive regulation of protein ubiquitination);GO:1901097(negative regulation of autophagosome maturation)NANANAPHD finger protein 23 [Source:HGNC Symbol;Acc:HGNC:28428]23.3449270.3566.09829692653996.051.50e-139.84e-11upyes
191838NAchr9+128203417128255246ENST00000627543224734ENSG00000106976DNM1GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0005525(GTP binding);GO:0000166(nucleotide binding);GO:0016787(hydrolase activity);GO:0003924(GTPase activity);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0045202(synapse);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0042802(identical protein binding);GO:0072583(clathrin-dependent endocytosis);GO:0006897(endocytosis);GO:0070062(extracellular exosome);GO:0008017(microtubule binding);GO:0048013(ephrin receptor signaling pathway);GO:0003374(dynamin family protein polymerization involved in mitochondrial fission);GO:0006898(receptor-mediated endocytosis);GO:0019901(protein kinase binding);GO:0061025(membrane fusion);GO:0031966(mitochondrial membrane);GO:0000266(mitochondrial fission);GO:0008022(protein C-terminus binding);GO:0031749(D2 dopamine receptor binding);GO:0032403(protein complex binding);GO:0046983(protein dimerization activity);GO:0050998(nitric-oxide synthase binding);GO:0002031(G-protein coupled receptor internalization);GO:0007032(endosome organization);GO:0007605(sensory perception of sound);GO:0008344(adult locomotory behavior);GO:0016185(synaptic vesicle budding from presynaptic endocytic zone membrane);GO:0031623(receptor internalization);GO:0051262(protein tetramerization);GO:0051932(synaptic transmission, GABAergic);GO:1901998(toxin transport);GO:1903423(positive regulation of synaptic vesicle recycling);GO:0001917(photoreceptor inner segment);GO:0005794(Golgi apparatus);GO:0008021(synaptic vesicle);GO:0030117(membrane coat);GO:0043196(varicosity);GO:0043209(myelin sheath);GO:0043234(protein complex)04072(Phospholipase D signaling pathway);04144(Endocytosis);04961(Endocrine and other factor-regulated calcium reabsorption);04721(Synaptic vesicle cycle);05100(Bacterial invasion of epithelial cells)K01528EC:3.6.5.5dynamin 1 [Source:HGNC Symbol;Acc:HGNC:2972]0.128.110.01-6.114745940500731.86e-131.17e-10downyes
93192NAchr19+11039261106787ENST000006160667927ENSG00000167468GPX4GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005654(nucleoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005739(mitochondrion);GO:0007275(multicellular organism development);GO:0098869(cellular oxidant detoxification);GO:0004601(peroxidase activity);GO:0004602(glutathione peroxidase activity);GO:0006979(response to oxidative stress);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0043234(protein complex);GO:0006644(phospholipid metabolic process);GO:0019372(lipoxygenase pathway);GO:0042802(identical protein binding);GO:0047066(phospholipid-hydroperoxide glutathione peroxidase activity);GO:0051258(protein polymerization)00480(Glutathione metabolism);04216(Ferroptosis)NANAglutathione peroxidase 4 [Source:HGNC Symbol;Acc:HGNC:4556]71.2487871.1760.91462146796055.932.47e-131.50e-10upyes
47492NAchr12-123260971123268254ENST0000061807241144ENSG00000111328CDK2AP1GO:0005634(nucleus);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0001934(positive regulation of protein phosphorylation);GO:0070182(DNA polymerase binding);GO:0006261(DNA-dependent DNA replication)NANANAcyclin dependent kinase 2 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:14002]74.1212921.3056.88226757682855.834.24e-132.50e-10upyes
198694NAchrX+151397204151409364ENST0000033037434717ENSG00000160131VMA21GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0031410(cytoplasmic vesicle);GO:0070072(vacuolar proton-transporting V-type ATPase complex assembly);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0012507(ER to Golgi transport vesicle membrane);GO:0043462(regulation of ATPase activity);GO:0005764(lysosome)NANANAVMA21, vacuolar ATPase assembly factor [Source:HGNC Symbol;Acc:HGNC:22082]0.127.530.02-5.940871014592595.27e-132.94e-10downyes
30214NAchr11+6383892863911019ENST00000402010194728ENSG00000072518MARK2GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005654(nucleoplasm);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0016055(Wnt signaling pathway);GO:0000287(magnesium ion binding);GO:0030154(cell differentiation);GO:0000226(microtubule cytoskeleton organization);GO:0030010(establishment of cell polarity);GO:0008289(lipid binding);GO:0045296(cadherin binding);GO:0016328(lateral plasma membrane);GO:0046777(protein autophosphorylation);GO:0005739(mitochondrion);GO:0035556(intracellular signal transduction);GO:0005884(actin filament);GO:0051493(regulation of cytoskeleton organization);GO:0050770(regulation of axonogenesis);GO:0010976(positive regulation of neuron projection development);GO:0001764(neuron migration);GO:0097427(microtubule bundle);GO:0000422(mitophagy);GO:0018107(peptidyl-threonine phosphorylation);GO:0050321(tau-protein kinase activity);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0032147(activation of protein kinase activity);GO:0051646(mitochondrion localization);GO:0030295(protein kinase activator activity)NANANAmicrotubule affinity regulating kinase 2 [Source:HGNC Symbol;Acc:HGNC:3332]10.5497870.1857.23346299280095.845.32e-132.94e-10upyes
14594NAchr1-201483532201492499ENST0000053340228475ENSG00000159176CSRP1GO:0003723(RNA binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005925(focal adhesion);GO:0070062(extracellular exosome);GO:0070527(platelet aggregation);GO:0008270(zinc ion binding)NANANAcysteine and glycine rich protein 1 [Source:HGNC Symbol;Acc:HGNC:2469]22.9563620.4551.06702051457735.679.71e-135.19e-10upyes
154605NAchr5-7848521778648825ENST0000038034555043ENSG00000145685LHFPL2GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0005575(cellular_component);GO:0002576(platelet degranulation);GO:0031092(platelet alpha granule membrane)NANANALHFPL tetraspan subfamily member 2 [Source:HGNC Symbol;Acc:HGNC:6588]7.010.1353.85500015375635.759.95e-135.19e-10upyes
164710NAchr6+4424616644253888ENST00000620073122644ENSG00000096384HSP90AB1GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006457(protein folding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0042470(melanosome);GO:0051082(unfolded protein binding);GO:0006950(response to stress);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0006986(response to unfolded protein);GO:0005654(nucleoplasm);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0008180(COP9 signalosome);GO:0071157(negative regulation of cell cycle arrest);GO:0043234(protein complex);GO:0006805(xenobiotic metabolic process);GO:0043312(neutrophil degranulation);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0034774(secretory granule lumen);GO:1904813(ficolin-1-rich granule lumen);GO:0045597(positive regulation of cell differentiation);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030911(TPR domain binding);GO:1990226(histone methyltransferase binding);GO:0051973(positive regulation of telomerase activity);GO:0007004(telomere maintenance via telomerase);GO:0042277(peptide binding);GO:0042826(histone deacetylase binding);GO:1900034(regulation of cellular response to heat);GO:0019900(kinase binding);GO:0003725(double-stranded RNA binding);GO:0042803(protein homodimerization activity);GO:0046983(protein dimerization activity);GO:0031072(heat shock protein binding);GO:0097718(disordered domain specific binding);GO:0030235(nitric-oxide synthase regulator activity);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0023026(MHC class II protein complex binding);GO:0070182(DNA polymerase binding);GO:0031396(regulation of protein ubiquitination);GO:0050821(protein stabilization);GO:1905323(telomerase holoenzyme complex assembly);GO:0043008(ATP-dependent protein binding);GO:0019062(virion attachment to host cell);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0051131(chaperone-mediated protein complex assembly);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0060338(regulation of type I interferon-mediated signaling pathway);GO:0097435(supramolecular fiber organization);GO:1901389(negative regulation of transforming growth factor beta activation);GO:2000010(positive regulation of protein localization to cell surface);GO:0034751(aryl hydrocarbon receptor complex);GO:0002134(UTP binding);GO:0002135(CTP binding);GO:0005525(GTP binding);GO:0008144(drug binding);GO:0017098(sulfonylurea receptor binding);GO:0019887(protein kinase regulator activity);GO:0019901(protein kinase binding);GO:0032564(dATP binding);GO:0044325(ion channel binding);GO:0001890(placenta development);GO:0009651(response to salt stress);GO:0010033(response to organic substance);GO:0032092(positive regulation of protein binding);GO:0033160(positive regulation of protein import into nucleus, translocation);GO:0035690(cellular response to drug);GO:0042220(response to cocaine);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045793(positive regulation of cell size);GO:0071353(cellular response to interleukin-4);GO:0071407(cellular response to organic cyclic compound);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:1903660(negative regulation of complement-dependent cytotoxicity);GO:0005622(intracellular);GO:0005765(lysosomal membrane);GO:0009986(cell surface);GO:0016234(inclusion body);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0031526(brush border membrane);GO:1990913(sperm head plasma membrane);GO:1990917(ooplasm)04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04217(Necroptosis);04621(NOD-like receptor signaling pathway);04612(Antigen processing and presentation);04659(Th17 cell differentiation);04657(IL-17 signaling pathway);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);05200(Pathways in cancer);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)K04079NAheat shock protein 90 alpha family class B member 1 [Source:HGNC Symbol;Acc:HGNC:5258]2.53132.6211240.02-5.714746268364811.12e-125.68e-10downyes
95387NAchr19-1031621210333546ENST00000617231133501ENSG00000161847RAVER1GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0000398(mRNA splicing, via spliceosome)NANANAribonucleoprotein, PTB binding 1 [Source:HGNC Symbol;Acc:HGNC:30296]10.0256380.1953.36646723161445.741.20e-125.95e-10upyes
116243NAchr2+191245389191425384ENST00000392318315082ENSG00000128641MYO1BGO:0005524(ATP binding);GO:0003774(motor activity);GO:0016459(myosin complex);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0003779(actin binding);GO:0005886(plasma membrane);GO:0048471(perinuclear region of cytoplasm);GO:0005516(calmodulin binding);GO:0045296(cadherin binding);GO:0051015(actin filament binding);GO:0030175(filopodium);GO:0070062(extracellular exosome);GO:0071944(cell periphery);GO:0005769(early endosome);GO:0010008(endosome membrane);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005903(brush border);GO:0051017(actin filament bundle assembly);GO:0005884(actin filament);GO:0007015(actin filament organization);GO:0032588(trans-Golgi network membrane);GO:0000146(microfilament motor activity);GO:0006892(post-Golgi vesicle-mediated transport);GO:0030048(actin filament-based movement);GO:0030898(actin-dependent ATPase activity);GO:0045177(apical part of cell)NANANAmyosin IB [Source:HGNC Symbol;Acc:HGNC:7596]11.2810310.2250.34736057554985.651.67e-128.06e-10upyes
173230NAchr7+7383086373832693ENST0000034095811831ENSG00000189143CLDN4GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005198(structural molecule activity);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0007165(signal transduction);GO:0005923(bicellular tight junction);GO:0005887(integral component of plasma membrane);GO:0042802(identical protein binding);GO:0016338(calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules);GO:0004888(transmembrane signaling receptor activity);GO:0007565(female pregnancy);GO:0007623(circadian rhythm);GO:0032570(response to progesterone);GO:0061436(establishment of skin barrier);GO:0009925(basal plasma membrane);GO:0016324(apical plasma membrane);GO:0016327(apicolateral plasma membrane);GO:0016328(lateral plasma membrane)04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)K06087NAclaudin 4 [Source:HGNC Symbol;Acc:HGNC:2046]2.13105.4561540.02-5.631594661859742.04e-129.55e-10downyes
132799NAchr3-2559790525664372ENST00000264331365358ENSG00000077097TOP2BGO:0005524(ATP binding);GO:0003677(DNA binding);GO:0006265(DNA topological change);GO:0003918(DNA topoisomerase type II (ATP-hydrolyzing) activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0016853(isomerase activity);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006259(DNA metabolic process);GO:0003916(DNA topoisomerase activity);GO:0000712(resolution of meiotic recombination intermediates);GO:0003682(chromatin binding);GO:0008022(protein C-terminus binding);GO:0019899(enzyme binding);GO:0046982(protein heterodimerization activity);GO:0042826(histone deacetylase binding);GO:0016925(protein sumoylation);GO:0000792(heterochromatin);GO:0005080(protein kinase C binding);GO:0000819(sister chromatid segregation);GO:0044774(mitotic DNA integrity checkpoint);GO:0001764(neuron migration);GO:0007409(axonogenesis);GO:0030900(forebrain development)01524(Platinum drug resistance)K03164EC:5.99.1.3topoisomerase (DNA) II beta [Source:HGNC Symbol;Acc:HGNC:11990]5.620.1150.09235717021985.652.35e-121.07e-09upyes
110591NAchr2+8553964285543608ENST0000040901781927ENSG00000168906MAT2AGO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016740(transferase activity);GO:0006730(one-carbon metabolic process);GO:0005515(protein binding);GO:0042802(identical protein binding);GO:0004478(methionine adenosyltransferase activity);GO:0006556(S-adenosylmethionine biosynthetic process);GO:1990830(cellular response to leukemia inhibitory factor);GO:0005829(cytosol);GO:0051291(protein heterooligomerization);GO:0034214(protein hexamerization);GO:0032259(methylation);GO:0048269(methionine adenosyltransferase complex)00270(Cysteine and methionine metabolism)NANAmethionine adenosyltransferase 2A [Source:HGNC Symbol;Acc:HGNC:6904]0.6833.3208890.02-5.604608807280833.08e-121.37e-09downyes
93198NAchr19+11044151105761ENST000005853624859ENSG00000167468GPX4GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005654(nucleoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005739(mitochondrion);GO:0007275(multicellular organism development);GO:0098869(cellular oxidant detoxification);GO:0004601(peroxidase activity);GO:0004602(glutathione peroxidase activity);GO:0006979(response to oxidative stress);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0043234(protein complex);GO:0006644(phospholipid metabolic process);GO:0019372(lipoxygenase pathway);GO:0042802(identical protein binding);GO:0047066(phospholipid-hydroperoxide glutathione peroxidase activity);GO:0051258(protein polymerization)00480(Glutathione metabolism);04216(Ferroptosis)NANAglutathione peroxidase 4 [Source:HGNC Symbol;Acc:HGNC:4556]65.2686921.4146.30124718636435.533.48e-121.51e-09upyes
122315NAchr20+3729689637317260ENST0000037360541915ENSG00000101363MANBALGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding)NANANAmannosidase beta like [Source:HGNC Symbol;Acc:HGNC:15799]0.7435.4091950.02-5.571165903439193.85e-121.63e-09downyes
22868NAchr10-102479229102502711ENST00000369905112829ENSG00000138107ACTR1AGO:0005869(dynactin complex);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0015630(microtubule cytoskeleton);GO:0005856(cytoskeleton);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005515(protein binding);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0005938(cell cortex);GO:0000086(G2/M transition of mitotic cell cycle);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0097711(ciliary basal body docking);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0016192(vesicle-mediated transport);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0005875(microtubule associated complex);GO:0099738(cell cortex region);GO:0007283(spermatogenesis);GO:0002177(manchette);GO:0005814(centriole);GO:0030137(COPI-coated vesicle);GO:0043209(myelin sheath)NANANAARP1 actin related protein 1 homolog A [Source:HGNC Symbol;Acc:HGNC:167]81.4707791.9142.63280512488835.415.41e-122.24e-09upyes
106313NAchr2+1167759511824887ENST00000449576223077ENSG00000134324LPIN1GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006629(lipid metabolic process);GO:0005829(cytosol);GO:0008195(phosphatidate phosphatase activity);GO:0016311(dephosphorylation);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006631(fatty acid metabolic process);GO:0019432(triglyceride biosynthetic process);GO:0009062(fatty acid catabolic process);GO:0003674(molecular_function);GO:0005654(nucleoplasm);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0031965(nuclear membrane);GO:0007077(mitotic nuclear envelope disassembly);GO:0003713(transcription coactivator activity);GO:0005635(nuclear envelope);GO:0006656(phosphatidylcholine biosynthetic process);GO:0006646(phosphatidylethanolamine biosynthetic process);GO:0005741(mitochondrial outer membrane);GO:0006642(triglyceride mobilization);GO:0031100(animal organ regeneration);GO:0032869(cellular response to insulin stimulus)00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04150(mTOR signaling pathway)K15728EC:3.1.3.4lipin 1 [Source:HGNC Symbol;Acc:HGNC:13345]8.750.2044.72628898139535.486.96e-122.72e-09upyes
125017NAchr21-2588055026170654ENST00000346798183467ENSG00000142192APPGO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0003677(DNA binding);GO:0007155(cell adhesion);GO:0005794(Golgi apparatus);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0010951(negative regulation of endopeptidase activity);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007399(nervous system development);GO:0006915(apoptotic process);GO:0048471(perinuclear region of cytoplasm);GO:0005615(extracellular space);GO:0007219(Notch signaling pathway);GO:0005790(smooth endoplasmic reticulum);GO:0005905(clathrin-coated pit);GO:0008201(heparin binding);GO:0005576(extracellular region);GO:0030414(peptidase inhibitor activity);GO:0010466(negative regulation of peptidase activity);GO:0042802(identical protein binding);GO:0046914(transition metal ion binding);GO:0016504(peptidase activator activity);GO:0070851(growth factor receptor binding);GO:0001967(suckling behavior);GO:0006378(mRNA polyadenylation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0006878(cellular copper ion homeostasis);GO:0006897(endocytosis);GO:0006979(response to oxidative stress);GO:0007176(regulation of epidermal growth factor-activated receptor activity);GO:0007409(axonogenesis);GO:0007617(mating behavior);GO:0007626(locomotory behavior);GO:0008088(axo-dendritic transport);GO:0008203(cholesterol metabolic process);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0010288(response to lead ion);GO:0010468(regulation of gene expression);GO:0010952(positive regulation of peptidase activity);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016199(axon midline choice point recognition);GO:0016322(neuron remodeling);GO:0016358(dendrite development);GO:0030198(extracellular matrix organization);GO:0030900(forebrain development);GO:0031175(neuron projection development);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0040014(regulation of multicellular organism growth);GO:0043393(regulation of protein binding);GO:0045665(negative regulation of neuron differentiation);GO:0045931(positive regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048669(collateral sprouting in absence of injury);GO:0050803(regulation of synapse structure or activity);GO:0050885(neuromuscular process controlling balance);GO:0051124(synaptic growth at neuromuscular junction);GO:0051247(positive regulation of protein metabolic process);GO:0051402(neuron apoptotic process);GO:0051563(smooth endoplasmic reticulum calcium ion homeostasis);GO:0071320(cellular response to cAMP);GO:0071874(cellular response to norepinephrine stimulus);GO:1990090(cellular response to nerve growth factor stimulus);GO:0005791(rough endoplasmic reticulum);GO:0005911(cell-cell junction);GO:0009986(cell surface);GO:0030134(ER to Golgi transport vesicle);GO:0030424(axon);GO:0030426(growth cone);GO:0031410(cytoplasmic vesicle);GO:0031594(neuromuscular junction);GO:0035253(ciliary rootlet);GO:0043005(neuron projection);GO:0043195(terminal bouton);GO:0044304(main axon);GO:0045177(apical part of cell);GO:0051233(spindle midzone);GO:0097449(astrocyte projection);GO:1990761(growth cone lamellipodium);GO:1990812(growth cone filopodium);GO:0005768(endosome);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0008285(negative regulation of cell proliferation);GO:0043687(post-translational protein modification);GO:0045087(innate immune response);GO:0005887(integral component of plasma membrane);GO:0031904(endosome lumen);GO:0032588(trans-Golgi network membrane);GO:0002576(platelet degranulation);GO:0010628(positive regulation of gene expression);GO:1904646(cellular response to amyloid-beta);GO:0005788(endoplasmic reticulum lumen);GO:0031093(platelet alpha granule lumen);GO:0005796(Golgi lumen);GO:0005102(receptor binding);GO:0043235(receptor complex);GO:0019899(enzyme binding);GO:0014005(microglia development);GO:0032640(tumor necrosis factor production);GO:0043197(dendritic spine);GO:0045202(synapse);GO:0007611(learning or memory);GO:0090647(modulation of age-related behavioral decline);GO:1900273(positive regulation of long-term synaptic potentiation);GO:0046330(positive regulation of JNK cascade);GO:0051425(PTB domain binding);GO:0001934(positive regulation of protein phosphorylation);GO:0002265(astrocyte activation involved in immune response);GO:0009987(cellular process);GO:0010629(negative regulation of gene expression);GO:0048143(astrocyte activation);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0050808(synapse organization);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0098815(modulation of excitatory postsynaptic potential);GO:1990000(amyloid fibril formation);GO:2000310(regulation of NMDA receptor activity);GO:0005641(nuclear envelope lumen);GO:0043198(dendritic shaft);GO:0045121(membrane raft)04726(Serotonergic synapse);05010(Alzheimer's disease)K04520NAamyloid beta precursor protein [Source:HGNC Symbol;Acc:HGNC:620]0.3816.8960060.02-5.483878367109716.98e-122.72e-09downyes
167305NAchr6-127288710127343609ENST0000045485962341ENSG00000093144ECHDC1GO:0005737(cytoplasm);GO:0003824(catalytic activity);GO:0016829(lyase activity);GO:0008152(metabolic process);GO:0005829(cytosol);GO:0016831(carboxy-lyase activity);GO:0005739(mitochondrion);GO:0070062(extracellular exosome);GO:0006635(fatty acid beta-oxidation);GO:0004300(enoyl-CoA hydratase activity);GO:0004492(methylmalonyl-CoA decarboxylase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)00640(Propanoate metabolism)K18426EC:4.1.1.94 4.1.1.41ethylmalonyl-CoA decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:21489]13.8041550.3144.4892049464845.487.02e-122.72e-09upyes
118082NAchr2+219178217219185479ENST0000043029794618ENSG00000144567RETREG2GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAreticulophagy regulator family member 2 [Source:HGNC Symbol;Acc:HGNC:28450]15.9066130.3842.11809080486255.407.37e-122.80e-09upyes
78177NAchr17-76684027687550ENST00000617185122724ENSG00000141510TP53GO:0008285(negative regulation of cell proliferation);GO:0010628(positive regulation of gene expression);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0005829(cytosol);GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0005739(mitochondrion);GO:0006915(apoptotic process);GO:0005515(protein binding);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0048511(rhythmic process);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0005759(mitochondrial matrix);GO:0044212(transcription regulatory region DNA binding);GO:0051262(protein tetramerization);GO:0045893(positive regulation of transcription, DNA-templated);GO:0005730(nucleolus);GO:0042802(identical protein binding);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0019901(protein kinase binding);GO:0016579(protein deubiquitination);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0003682(chromatin binding);GO:0008283(cell proliferation);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0007050(cell cycle arrest);GO:0043065(positive regulation of apoptotic process);GO:0016032(viral process);GO:0031625(ubiquitin protein ligase binding);GO:0006284(base-excision repair);GO:0047485(protein N-terminus binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0008134(transcription factor binding);GO:0030308(negative regulation of cell growth);GO:0002020(protease binding);GO:0042981(regulation of apoptotic process);GO:0005507(copper ion binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0000790(nuclear chromatin);GO:0016363(nuclear matrix);GO:0046982(protein heterodimerization activity);GO:1901796(regulation of signal transduction by p53 class mediator);GO:0043234(protein complex);GO:0001085(RNA polymerase II transcription factor binding);GO:0016605(PML body);GO:0038111(interleukin-7-mediated signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0000981(RNA polymerase II transcription factor activity, sequence-specific DNA binding);GO:0035690(cellular response to drug);GO:0012501(programmed cell death);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway);GO:0001046(core promoter sequence-specific DNA binding);GO:0051087(chaperone binding);GO:0090399(replicative senescence);GO:1902895(positive regulation of pri-miRNA transcription from RNA polymerase II promoter);GO:0006461(protein complex assembly);GO:0032461(positive regulation of protein oligomerization);GO:0007569(cell aging);GO:0071456(cellular response to hypoxia);GO:0002039(p53 binding);GO:0003684(damaged DNA binding);GO:0010165(response to X-ray);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0043153(entrainment of circadian clock by photoperiod);GO:0042149(cellular response to glucose starvation);GO:0071158(positive regulation of cell cycle arrest);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:0008104(protein localization);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0051721(protein phosphatase 2A binding);GO:0046677(response to antibiotic);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0097252(oligodendrocyte apoptotic process);GO:0048512(circadian behavior);GO:0003730(mRNA 3'-UTR binding);GO:0097718(disordered domain specific binding);GO:0035035(histone acetyltransferase binding);GO:0043066(negative regulation of apoptotic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:0048147(negative regulation of fibroblast proliferation);GO:0007265(Ras protein signal transduction);GO:0071480(cellular response to gamma radiation);GO:0005622(intracellular);GO:0005669(transcription factor TFIID complex);GO:0016604(nuclear body);GO:0000990(transcription factor activity, core RNA polymerase binding);GO:0001228(transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding);GO:0030971(receptor tyrosine kinase binding);GO:0042826(histone deacetylase binding);GO:0043621(protein self-association);GO:0000733(DNA strand renaturation);GO:0006289(nucleotide-excision repair);GO:0006914(autophagy);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0006983(ER overload response);GO:0008340(determination of adult lifespan);GO:0010332(response to gamma radiation);GO:0031065(positive regulation of histone deacetylation);GO:0031497(chromatin assembly);GO:0031571(mitotic G1 DNA damage checkpoint);GO:0034644(cellular response to UV);GO:0043525(positive regulation of neuron apoptotic process);GO:0046827(positive regulation of protein export from nucleus);GO:0046902(regulation of mitochondrial membrane permeability);GO:0051097(negative regulation of helicase activity);GO:0051289(protein homotetramerization);GO:0051974(negative regulation of telomerase activity);GO:0070245(positive regulation of thymocyte apoptotic process);GO:0071479(cellular response to ionizing radiation);GO:0072331(signal transduction by p53 class mediator);GO:0072717(cellular response to actinomycin D);GO:0090403(oxidative stress-induced premature senescence);GO:0097193(intrinsic apoptotic signaling pathway);GO:1900119(positive regulation of execution phase of apoptosis);GO:1902749(regulation of cell cycle G2/M phase transition);GO:0005657(replication fork);GO:0016020(membrane);GO:0016021(integral component of membrane)04010(MAPK signaling pathway);04310(Wnt signaling pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04137(Mitophagy - animal);04110(Cell cycle);04210(Apoptosis);04216(Ferroptosis);04115(p53 signaling pathway);04218(Cellular senescence);04919(Thyroid hormone signaling pathway);04722(Neurotrophin signaling pathway);04211(Longevity regulating pathway - mammal);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05214(Glioma);05216(Thyroid cancer);05220(Chronic myeloid leukemia);05217(Basal cell carcinoma);05218(Melanoma);05219(Bladder cancer);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington's disease);05418(Fluid shear stress and atherosclerosis);05166(HTLV-I infection);05162(Measles);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05167(Kaposi's sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05165(Human papillomavirus infection);01524(Platinum drug resistance);01522(Endocrine resistance)K04451NAtumor protein p53 [Source:HGNC Symbol;Acc:HGNC:11998]1.0846.8745880.02-5.438808064856927.66e-122.85e-09downyes
83274NAchr17-4431962544324870ENST00000225308121607ENSG00000013306SLC25A39GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:0055085(transmembrane transport);GO:0006783(heme biosynthetic process);GO:0006839(mitochondrial transport);GO:0022857(transmembrane transporter activity)NANANAsolute carrier family 25 member 39 [Source:HGNC Symbol;Acc:HGNC:24279]1.0244.6314930.02-5.453129210727628.13e-122.96e-09downyes
28445NAchr11+4726937647330031ENST00000342922336005ENSG00000110514MADDGO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043547(positive regulation of GTPase activity);GO:0005515(protein binding);GO:0006915(apoptotic process);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0061024(membrane organization);GO:0042981(regulation of apoptotic process);GO:0007166(cell surface receptor signaling pathway);GO:0051726(regulation of cell cycle);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0000187(activation of MAPK activity);GO:0097194(execution phase of apoptosis);GO:0032483(regulation of Rab protein signal transduction);GO:0030295(protein kinase activator activity);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:0005123(death receptor binding);GO:2001236(regulation of extrinsic apoptotic signaling pathway)NANANAMAP kinase activating death domain [Source:HGNC Symbol;Acc:HGNC:6766]0.219.230.02-5.451284867521939.07e-123.24e-09downyes
47678NAchr12-124776856124863917ENST00000339570123329ENSG00000073060SCARB1GO:0010595(positive regulation of endothelial cell migration);GO:0042632(cholesterol homeostasis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0005901(caveola);GO:0006898(receptor-mediated endocytosis);GO:0046718(viral entry into host cell);GO:0070062(extracellular exosome);GO:0016032(viral process);GO:0009986(cell surface);GO:0005215(transporter activity);GO:0001530(lipopolysaccharide binding);GO:0030666(endocytic vesicle membrane);GO:0015914(phospholipid transport);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0001618(virus receptor activity);GO:0033344(cholesterol efflux);GO:0034384(high-density lipoprotein particle clearance);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0034375(high-density lipoprotein particle remodeling);GO:0043691(reverse cholesterol transport);GO:0034185(apolipoprotein binding);GO:0034186(apolipoprotein A-I binding);GO:0030169(low-density lipoprotein particle binding);GO:0010867(positive regulation of triglyceride biosynthetic process);GO:0010899(regulation of phosphatidylcholine catabolic process);GO:0034383(low-density lipoprotein particle clearance);GO:0070508(cholesterol import);GO:0042060(wound healing);GO:0070328(triglyceride homeostasis);GO:0010886(positive regulation of cholesterol storage);GO:0044406(adhesion of symbiont to host);GO:0050764(regulation of phagocytosis);GO:0005044(scavenger receptor activity);GO:0015920(lipopolysaccharide transport);GO:0001786(phosphatidylserine binding);GO:0001875(lipopolysaccharide receptor activity);GO:0005545(1-phosphatidylinositol binding);GO:0070506(high-density lipoprotein particle receptor activity);GO:0032497(detection of lipopolysaccharide);GO:0035461(vitamin transmembrane transport);GO:0043654(recognition of apoptotic cell);GO:0001540(amyloid-beta binding);GO:0008035(high-density lipoprotein particle binding);GO:0042803(protein homodimerization activity);GO:0001935(endothelial cell proliferation);GO:0006702(androgen biosynthetic process);GO:0006707(cholesterol catabolic process);GO:0006869(lipid transport);GO:0006910(phagocytosis, recognition);GO:0030301(cholesterol transport);GO:0043534(blood vessel endothelial cell migration);GO:0050892(intestinal absorption);GO:0005737(cytoplasm);GO:0005887(integral component of plasma membrane);GO:0031528(microvillus membrane)04145(Phagosome);04913(Ovarian Steroidogenesis);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04976(Bile secretion);04975(Fat digestion and absorption);04979(Cholesterol metabolism);04977(Vitamin digestion and absorption);05160(Hepatitis C)K13885NAscavenger receptor class B member 1 [Source:HGNC Symbol;Acc:HGNC:1664]29.6805650.7440.16847295040485.331.03e-113.61e-09upyes
51060NAchr13+102844844102876001ENST00000355739155082ENSG00000134899ERCC5GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0003677(DNA binding);GO:0003824(catalytic activity);GO:0042803(protein homodimerization activity);GO:0004519(endonuclease activity);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016788(hydrolase activity, acting on ester bonds);GO:0006289(nucleotide-excision repair);GO:0004518(nuclease activity);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0003690(double-stranded DNA binding);GO:0047485(protein N-terminus binding);GO:0043066(negative regulation of apoptotic process);GO:0009411(response to UV);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0005662(DNA replication factor A complex);GO:0016591(DNA-directed RNA polymerase II, holoenzyme);GO:0006293(nucleotide-excision repair, preincision complex stabilization);GO:0006295(nucleotide-excision repair, DNA incision, 3'-to lesion);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0033683(nucleotide-excision repair, DNA incision);GO:0006294(nucleotide-excision repair, preincision complex assembly);GO:0009650(UV protection);GO:0005675(holo TFIIH complex);GO:0010225(response to UV-C);GO:0004520(endodeoxyribonuclease activity);GO:0000405(bubble DNA binding)03420(Nucleotide excision repair)K10846NAERCC excision repair 5, endonuclease [Source:HGNC Symbol;Acc:HGNC:3437]0.156.770.02-5.464073397958191.04e-113.61e-09downyes
126952NAchr22-1713752217143647ENST0000047715733614ENSG00000069998HDHD5GO:0005739(mitochondrion);GO:0046474(glycerophospholipid biosynthetic process)NANANAhaloacid dehalogenase like hydrolase domain containing 5 [Source:HGNC Symbol;Acc:HGNC:1843]7.030.1742.16147522799365.401.20e-114.06e-09upyes
127316NAchr22+1994177319968958ENST0000040371061548ENSG00000093010COMTGO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0000287(magnesium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0008171(O-methyltransferase activity);GO:0016206(catechol O-methyltransferase activity);GO:0006584(catecholamine metabolic process);GO:0007565(female pregnancy);GO:0007612(learning);GO:0007614(short-term memory);GO:0008210(estrogen metabolic process);GO:0009712(catechol-containing compound metabolic process);GO:0014070(response to organic cyclic compound);GO:0016036(cellular response to phosphate starvation);GO:0032496(response to lipopolysaccharide);GO:0032502(developmental process);GO:0035814(negative regulation of renal sodium excretion);GO:0042135(neurotransmitter catabolic process);GO:0042417(dopamine metabolic process);GO:0042420(dopamine catabolic process);GO:0042493(response to drug);GO:0045963(negative regulation of dopamine metabolic process);GO:0048265(response to pain);GO:0048609(multicellular organismal reproductive process);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0050668(positive regulation of homocysteine metabolic process);GO:0051930(regulation of sensory perception of pain);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0030424(axon);GO:0030425(dendrite);GO:0043197(dendritic spine);GO:0044297(cell body);GO:0045211(postsynaptic membrane);GO:0070062(extracellular exosome);GO:0102084(L-dopa O-methyltransferase activity);GO:0102938(-)00140(Steroid hormone biosynthesis);00350(Tyrosine metabolism);04728(Dopaminergic synapse)K00545EC:2.1.1.6catechol-O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:2228]19.4180930.4642.06565008860225.391.24e-114.07e-09upyes
129733NAchr22+3767560837679806ENST000002159094560ENSG00000100097LGALS1GO:0005615(extracellular space);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0030246(carbohydrate binding);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0005576(extracellular region);GO:0006915(apoptotic process);GO:0005578(proteinaceous extracellular matrix);GO:0007165(signal transduction);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0031012(extracellular matrix);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0042981(regulation of apoptotic process);GO:0046598(positive regulation of viral entry into host cell);GO:0005788(endoplasmic reticulum lumen);GO:0005622(intracellular);GO:0030395(lactose binding);GO:0042803(protein homodimerization activity);GO:0043236(laminin binding);GO:0002317(plasma cell differentiation);GO:0010812(negative regulation of cell-substrate adhesion);GO:0010977(negative regulation of neuron projection development);GO:0031295(T cell costimulation);GO:0034120(positive regulation of erythrocyte aggregation);GO:0035900(response to isolation stress);GO:0042493(response to drug);GO:0045445(myoblast differentiation);GO:0048678(response to axon injury);GO:0071333(cellular response to glucose stimulus);GO:0071407(cellular response to organic cyclic compound);GO:0005634(nucleus);GO:0005829(cytosol);GO:0009986(cell surface)NANANAgalectin 1 [Source:HGNC Symbol;Acc:HGNC:6561]4.01166.5626830.02-5.376418107367171.24e-114.07e-09downyes
68187NAchr16-36580383678304ENST00000575671132309ENSG00000126602TRAP1GO:0005524(ATP binding);GO:0006457(protein folding);GO:0051082(unfolded protein binding);GO:0006950(response to stress);GO:0003723(RNA binding);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005515(protein binding);GO:0019901(protein kinase binding);GO:1903751(negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:0005758(mitochondrial intermembrane space);GO:0070062(extracellular exosome);GO:0005164(tumor necrosis factor receptor binding);GO:1903427(negative regulation of reactive oxygen species biosynthetic process);GO:0009386(translational attenuation);GO:0061077(chaperone-mediated protein folding);GO:1901856(negative regulation of cellular respiration);GO:0005811(lipid particle)NANANATNF receptor associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16264]15.597780.3840.85883881513465.351.33e-114.28e-09upyes
43423NAchr12-6471344564752871ENST00000418919134877ENSG00000135677GNSGO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0005764(lysosome);GO:0008484(sulfuric ester hydrolase activity);GO:0008449(N-acetylglucosamine-6-sulfatase activity);GO:0030203(glycosaminoglycan metabolic process);GO:0046872(metal ion binding);GO:0016787(hydrolase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0070062(extracellular exosome);GO:0043312(neutrophil degranulation);GO:1904813(ficolin-1-rich granule lumen);GO:0043202(lysosomal lumen);GO:0035578(azurophil granule lumen);GO:0042340(keratan sulfate catabolic process);GO:0006027(glycosaminoglycan catabolic process)00531(Glycosaminoglycan degradation);04142(Lysosome)NANAglucosamine (N-acetyl)-6-sulfatase [Source:HGNC Symbol;Acc:HGNC:4422]49.840371.2938.5605881838675.271.39e-114.39e-09upyes
55435NAchr14-6733807167360249ENST0000021644291845ENSG00000100554ATP6V1DGO:0006810(transport);GO:0016020(membrane);GO:0005765(lysosomal membrane);GO:0055085(transmembrane transport);GO:0006811(ion transport);GO:0005515(protein binding);GO:0015992(proton transport);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0060271(cilium assembly);GO:0005929(cilium);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0030030(cell projection organization);GO:0043312(neutrophil degranulation);GO:0035579(specific granule membrane);GO:0008286(insulin receptor signaling pathway);GO:0016241(regulation of macroautophagy);GO:0033572(transferrin transport);GO:0090383(phagosome acidification);GO:0061512(protein localization to cilium);GO:0033176(proton-transporting V-type ATPase complex)00190(Oxidative phosphorylation);04150(mTOR signaling pathway);04145(Phagosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection)K02149NAATPase H+ transporting V1 subunit D [Source:HGNC Symbol;Acc:HGNC:13527]17.9016550.4440.46175248737665.341.51e-114.70e-09upyes
53439NAchr14-3110011231127868ENST00000554882183748ENSG00000092148HECTD1GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0046872(metal ion binding);GO:0005737(cytoplasm);GO:0061630(ubiquitin protein ligase activity);GO:0005515(protein binding)NANANAHECT domain E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:20157]0.177.030.02-5.382537245439352.09e-116.36e-09downyes
81579NAchr17-3649563836535415ENST00000610992275743ENSG00000278259MYO19GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0003774(motor activity);GO:0016459(myosin complex);GO:0003779(actin binding);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0005741(mitochondrial outer membrane);GO:0016887(ATPase activity);GO:0032465(regulation of cytokinesis);GO:0090140(regulation of mitochondrial fission);GO:0032027(myosin light chain binding);GO:0060002(plus-end directed microfilament motor activity)NANANAmyosin XIX [Source:HGNC Symbol;Acc:HGNC:26234]8.300.2237.24799171118325.222.65e-117.93e-09upyes
172331NAchr7-5101621351316818ENST00000395542145339ENSG00000106078COBLGO:0003779(actin binding);GO:0048471(perinuclear region of cytoplasm);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005886(plasma membrane);GO:0005856(cytoskeleton);GO:0042995(cell projection);GO:0048565(digestive tract development);GO:0001726(ruffle);GO:0000578(embryonic axis specification);GO:0001843(neural tube closure);GO:0030424(axon);GO:0030041(actin filament polymerization);GO:0005884(actin filament);GO:0003785(actin monomer binding);GO:0001757(somite specification);GO:0001889(liver development);GO:0030903(notochord development);GO:0033504(floor plate development);GO:0048669(collateral sprouting in absence of injury);GO:0051639(actin filament network formation);GO:1900006(positive regulation of dendrite development);GO:0005938(cell cortex);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0044294(dendritic growth cone);GO:0044295(axonal growth cone);GO:1900029(positive regulation of ruffle assembly)NANANAcordon-bleu WH2 repeat protein [Source:HGNC Symbol;Acc:HGNC:22199]6.690.1837.33522879464295.223.02e-118.89e-09upyes
120358NAchr20-26583952664188ENST00000488299111620ENSG00000101365IDH3BGO:0000287(magnesium ion binding);GO:0055114(oxidation-reduction process);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0051287(NAD binding);GO:0046872(metal ion binding);GO:0016491(oxidoreductase activity);GO:0006099(tricarboxylic acid cycle);GO:0005739(mitochondrion);GO:0004449(isocitrate dehydrogenase (NAD+) activity);GO:0006102(isocitrate metabolic process);GO:0006103(2-oxoglutarate metabolic process);GO:0006734(NADH metabolic process);GO:0005634(nucleus);GO:0005759(mitochondrial matrix);GO:0009055(electron carrier activity)00020(Citrate cycle (TCA cycle))K00030EC:1.1.1.41isocitrate dehydrogenase 3 (NAD(+)) beta [Source:HGNC Symbol;Acc:HGNC:5385]39.3571931.1035.70412540879885.163.64e-111.05e-08upyes
79388NAchr17-1824483618258726ENST00000578558172377ENSG00000177731FLIIGO:0051015(actin filament binding);GO:0030036(actin cytoskeleton organization);GO:0051014(actin filament severing);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0005815(microtubule organizing center);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003779(actin binding);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0030054(cell junction);GO:0005925(focal adhesion);GO:0005903(brush border)NANANAFLII, actin remodeling protein [Source:HGNC Symbol;Acc:HGNC:3750]0.8731.8829570.03-5.202244617372253.89e-111.11e-08downyes
133690NAchr3+4119944541239736ENST00000453024172841ENSG00000168036CTNNB1GO:0048471(perinuclear region of cytoplasm);GO:0016525(negative regulation of angiogenesis);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005737(cytoplasm);GO:0005634(nucleus);GO:0061154(endothelial tube morphogenesis);GO:0016020(membrane);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0004871(signal transducer activity);GO:0007155(cell adhesion);GO:0005886(plasma membrane);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0034333(adherens junction assembly);GO:0016055(Wnt signaling pathway);GO:0030054(cell junction);GO:0045202(synapse);GO:0007399(nervous system development);GO:0008134(transcription factor binding);GO:0003713(transcription coactivator activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0005925(focal adhesion);GO:0000922(spindle pole);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005654(nucleoplasm);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0005622(intracellular);GO:0008285(negative regulation of cell proliferation);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0016323(basolateral plasma membrane);GO:0005912(adherens junction);GO:0043065(positive regulation of apoptotic process);GO:0043234(protein complex);GO:0008022(protein C-terminus binding);GO:0005913(cell-cell adherens junction);GO:0005667(transcription factor complex);GO:0044325(ion channel binding);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:1904837(beta-catenin-TCF complex assembly);GO:0030521(androgen receptor signaling pathway);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0032355(response to estradiol);GO:1904886(beta-catenin destruction complex disassembly);GO:0001569(branching involved in blood vessel morphogenesis);GO:0032481(positive regulation of type I interferon production);GO:1904948(midbrain dopaminergic neuron differentiation);GO:0005911(cell-cell junction);GO:0016342(catenin complex);GO:0070411(I-SMAD binding);GO:0046332(SMAD binding);GO:0060070(canonical Wnt signaling pathway);GO:0016328(lateral plasma membrane);GO:0030877(beta-catenin destruction complex);GO:0071944(cell periphery);GO:0050681(androgen receptor binding);GO:0007223(Wnt signaling pathway, calcium modulating pathway);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0071363(cellular response to growth factor stimulus);GO:0045765(regulation of angiogenesis);GO:0019900(kinase binding);GO:0051149(positive regulation of muscle cell differentiation);GO:0032993(protein-DNA complex);GO:0035635(entry of bacterium into host cell);GO:0019827(stem cell population maintenance);GO:0005938(cell cortex);GO:1990909(Wnt signalosome);GO:0035315(hair cell differentiation);GO:0042493(response to drug);GO:0016337(single organismal cell-cell adhesion);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0090279(regulation of calcium ion import);GO:2000008(regulation of protein localization to cell surface);GO:0044336(canonical Wnt signaling pathway involved in negative regulation of apoptotic process);GO:1904954(canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation);GO:0005719(nuclear euchromatin);GO:0060548(negative regulation of cell death);GO:0071681(cellular response to indole-3-methanol);GO:0001837(epithelial to mesenchymal transition);GO:0045294(alpha-catenin binding);GO:0034394(protein localization to cell surface);GO:0001085(RNA polymerase II transcription factor binding);GO:0033234(negative regulation of protein sumoylation);GO:0072182(regulation of nephron tubule epithelial cell differentiation);GO:0030331(estrogen receptor binding);GO:0035257(nuclear hormone receptor binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0030997(regulation of centriole-centriole cohesion);GO:0035411(catenin import into nucleus);GO:0036023(embryonic skeletal limb joint morphogenesis);GO:0043525(positive regulation of neuron apoptotic process);GO:0044334(canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition);GO:0045976(negative regulation of mitotic cell cycle, embryonic);GO:0048145(regulation of fibroblast proliferation);GO:0048660(regulation of smooth muscle cell proliferation);GO:0050767(regulation of neurogenesis);GO:0051571(positive regulation of histone H3-K4 methylation);GO:0061324(canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation);GO:0061549(sympathetic ganglion development);GO:0070602(regulation of centromeric sister chromatid cohesion);GO:1904798(positive regulation of core promoter binding);GO:2000144(positive regulation of DNA-templated transcription, initiation);GO:0070369(beta-catenin-TCF7L2 complex);GO:1990907(beta-catenin-TCF complex);GO:0007165(signal transduction);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0019901(protein kinase binding);GO:0046982(protein heterodimerization activity);GO:0070491(repressing transcription factor binding);GO:0097718(disordered domain specific binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000578(embryonic axis specification);GO:0000904(cell morphogenesis involved in differentiation);GO:0001501(skeletal system development);GO:0001570(vasculogenesis);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001701(in utero embryonic development);GO:0001702(gastrulation with mouth forming second);GO:0001706(endoderm formation);GO:0001708(cell fate specification);GO:0001709(cell fate determination);GO:0001711(endodermal cell fate commitment);GO:0001764(neuron migration);GO:0001822(kidney development);GO:0001840(neural plate development);GO:0001944(vasculature development);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002089(lens morphogenesis in camera-type eye);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003338(metanephros morphogenesis);GO:0003340(negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007160(cell-matrix adhesion);GO:0007268(chemical synaptic transmission);GO:0007398(ectoderm development);GO:0007403(glial cell fate determination);GO:0007507(heart development);GO:0008283(cell proliferation);GO:0008284(positive regulation of cell proliferation);GO:0009948(anterior/posterior axis specification);GO:0009950(dorsal/ventral axis specification);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016331(morphogenesis of embryonic epithelium);GO:0021819(layer formation in cerebral cortex);GO:0022009(central nervous system vasculogenesis);GO:0022405(hair cycle process);GO:0030097(hemopoiesis);GO:0030154(cell differentiation);GO:0030182(neuron differentiation);GO:0030217(T cell differentiation);GO:0030316(osteoclast differentiation);GO:0030324(lung development);GO:0030539(male genitalia development);GO:0030856(regulation of epithelial cell differentiation);GO:0030858(positive regulation of epithelial cell differentiation);GO:0030900(forebrain development);GO:0030901(midbrain development);GO:0030902(hindbrain development);GO:0031016(pancreas development);GO:0031069(hair follicle morphogenesis);GO:0031641(regulation of myelination);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0032331(negative regulation of chondrocyte differentiation);GO:0033077(T cell differentiation in thymus);GO:0034332(adherens junction organization);GO:0034613(cellular protein localization);GO:0035050(embryonic heart tube development);GO:0035112(genitalia morphogenesis);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0042127(regulation of cell proliferation);GO:0042129(regulation of T cell proliferation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042981(regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043410(positive regulation of MAPK cascade);GO:0043588(skin development);GO:0045453(bone resorption);GO:0045595(regulation of cell differentiation);GO:0045596(negative regulation of cell differentiation);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045667(regulation of osteoblast differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045670(regulation of osteoclast differentiation);GO:0045671(negative regulation of osteoclast differentiation);GO:0045743(positive regulation of fibroblast growth factor receptor signaling pathway);GO:0048096(chromatin-mediated maintenance of transcription);GO:0048469(cell maturation);GO:0048489(synaptic vesicle transport);GO:0048513(animal organ development);GO:0048538(thymus development);GO:0048599(oocyte development);GO:0048617(embryonic foregut morphogenesis);GO:0048643(positive regulation of skeletal muscle tissue development);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0050808(synapse organization);GO:0051145(smooth muscle cell differentiation);GO:0051884(regulation of timing of anagen);GO:0051973(positive regulation of telomerase activity);GO:0060066(oviduct development);GO:0060173(limb development);GO:0060439(trachea morphogenesis);GO:0060440(trachea formation);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060479(lung cell differentiation);GO:0060484(lung-associated mesenchyme development);GO:0060492(lung induction);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0060789(hair follicle placode formation);GO:0060916(mesenchymal cell proliferation involved in lung development);GO:0061047(positive regulation of branching involved in lung morphogenesis);GO:0061198(fungiform papilla formation);GO:0061550(cranial ganglion development);GO:0072001(renal system development);GO:0072033(renal vesicle formation);GO:0072053(renal inner medulla development);GO:0072054(renal outer medulla development);GO:0072079(nephron tubule formation);GO:1901215(negative regulation of neuron death);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1904501(positive regulation of chromatin-mediated maintenance of transcription);GO:1904793(regulation of euchromatin binding);GO:1904796(regulation of core promoter binding);GO:1904888(cranial skeletal system development);GO:1990403(embryonic brain development);GO:1990791(dorsal root ganglion development);GO:2000017(positive regulation of determination of dorsal identity);GO:2001234(negative regulation of apoptotic signaling pathway);GO:0005916(fascia adherens);GO:0005923(bicellular tight junction);GO:0014704(intercalated disc);GO:0016600(flotillin complex);GO:0030018(Z disc);GO:0030027(lamellipodium);GO:0031253(cell projection membrane);GO:0031528(microvillus membrane);GO:0034750(Scrib-APC-beta-catenin complex);GO:0043296(apical junction complex);GO:0044798(nuclear transcription factor complex);GO:0045177(apical part of cell);GO:0071664(catenin-TCF7L2 complex)04015(Rap1 signaling pathway);04310(Wnt signaling pathway);04390(Hippo signaling pathway);04510(Focal adhesion);04520(Adherens junction);04550(Signaling pathways regulating pluripotency of stem cells);04670(Leukocyte transendothelial migration);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05216(Thyroid cancer);05217(Basal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05224(Breast cancer);05418(Fluid shear stress and atherosclerosis);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05130(Pathogenic Escherichia coli infection);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection);05167(Kaposi's sarcoma-associated herpesvirus infection);05165(Human papillomavirus infection)K02105NAcatenin beta 1 [Source:HGNC Symbol;Acc:HGNC:2514]0.3111.801210.03-5.246391407586124.00e-111.12e-08downyes
172016NAchr7+4479668044803117ENST0000046881252238ENSG00000196262PPIAGO:0016853(isomerase activity);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0000413(protein peptidyl-prolyl isomerization);GO:0006457(protein folding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0005829(cytosol);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005925(focal adhesion);GO:0050900(leukocyte migration);GO:0070062(extracellular exosome);GO:0019058(viral life cycle);GO:0016032(viral process);GO:0043312(neutrophil degranulation);GO:0035722(interleukin-12-mediated signaling pathway);GO:0034774(secretory granule lumen);GO:1904813(ficolin-1-rich granule lumen);GO:0031982(vesicle);GO:0050714(positive regulation of protein secretion);GO:0051082(unfolded protein binding);GO:0045070(positive regulation of viral genome replication);GO:0019076(viral release from host cell);GO:0075713(establishment of integrated proviral latency);GO:0019064(fusion of virus membrane with host plasma membrane);GO:0030260(entry into host cell);GO:0019068(virion assembly);GO:0046790(virion binding);GO:0016018(cyclosporin A binding);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0019061(uncoating of virus);GO:0034389(lipid particle organization);GO:0045069(regulation of viral genome replication)04217(Necroptosis)K03767EC:5.2.1.8peptidylprolyl isomerase A [Source:HGNC Symbol;Acc:HGNC:9253]70.5320052.0534.46865630795625.114.15e-111.14e-08upyes
192193NAchr9-129636892129642165ENST0000027745862330ENSG00000148331ASB6GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0005515(protein binding);GO:0005829(cytosol);GO:0043687(post-translational protein modification);GO:0005622(intracellular)NANANAankyrin repeat and SOCS box containing 6 [Source:HGNC Symbol;Acc:HGNC:17181]15.1676490.4235.82818936845695.164.34e-111.18e-08upyes
160437NAchr5-179798165179800597ENST000005208758964ENSG00000161013MGAT4BGO:0016020(membrane);GO:0005975(carbohydrate metabolic process);GO:0016758(transferase activity, transferring hexosyl groups);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0005794(Golgi apparatus);GO:0000139(Golgi membrane);GO:0006486(protein glycosylation);GO:0006491(N-glycan processing);GO:0008454(alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity);GO:0008375(acetylglucosaminyltransferase activity);GO:0006487(protein N-linked glycosylation)00510(N-Glycan biosynthesis)NANAmannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B [Source:HGNC Symbol;Acc:HGNC:7048]0.9937.1321980.03-5.223477007242674.43e-111.19e-08downyes
40896NAchr12+4975062049762948ENST0000055237010882ENSG00000139644TMBIM6GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043066(negative regulation of apoptotic process);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006915(apoptotic process);GO:0006914(autophagy);GO:0006986(response to unfolded protein);GO:0005887(integral component of plasma membrane);GO:0005737(cytoplasm);GO:0005634(nucleus);GO:0005515(protein binding);GO:0031625(ubiquitin protein ligase binding);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:0019899(enzyme binding);GO:0032091(negative regulation of protein binding);GO:2001234(negative regulation of apoptotic signaling pathway);GO:0031966(mitochondrial membrane);GO:0060698(endoribonuclease inhibitor activity);GO:0010523(negative regulation of calcium ion transport into cytosol);GO:0060702(negative regulation of endoribonuclease activity);GO:1902065(response to L-glutamate);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1904721(negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0034976(response to endoplasmic reticulum stress);GO:0051025(negative regulation of immunoglobulin secretion);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:1990441(negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)NANANAtransmembrane BAX inhibitor motif containing 6 [Source:HGNC Symbol;Acc:HGNC:11723]0.8331.0787430.03-5.231145334285714.73e-111.25e-08downyes
79642NAchr17-1897571019003780ENST0000039909634393ENSG00000188522FAM83GGO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005515(protein binding);GO:0030509(BMP signaling pathway)NANANAfamily with sequence similarity 83 member G [Source:HGNC Symbol;Acc:HGNC:32554]0.269.370.03-5.192846991761294.99e-111.30e-08downyes
177084NAchr7-132123332132576564ENST000003210633213061ENSG00000221866PLXNA4GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0007165(signal transduction);GO:0005886(plasma membrane);GO:0017154(semaphorin receptor activity);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0021602(cranial nerve morphogenesis);GO:0021610(facial nerve morphogenesis);GO:0021612(facial nerve structural organization);GO:0021615(glossopharyngeal nerve morphogenesis);GO:0021636(trigeminal nerve morphogenesis);GO:0021637(trigeminal nerve structural organization);GO:0021644(vagus nerve morphogenesis);GO:0021784(postganglionic parasympathetic fiber development);GO:0021785(branchiomotor neuron axon guidance);GO:0021793(chemorepulsion of branchiomotor axon);GO:0021960(anterior commissure morphogenesis);GO:0048485(sympathetic nervous system development);GO:0048812(neuron projection morphogenesis);GO:0048841(regulation of axon extension involved in axon guidance);GO:0050923(regulation of negative chemotaxis);GO:0071526(semaphorin-plexin signaling pathway);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:0002116(semaphorin receptor complex)04360(Axon guidance)K06820NAplexin A4 [Source:HGNC Symbol;Acc:HGNC:9102]3.340.1034.80031277693795.125.07e-111.30e-08upyes
110587NAchr2+8553916585545280ENST0000030643492819ENSG00000168906MAT2AGO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016740(transferase activity);GO:0006730(one-carbon metabolic process);GO:0005515(protein binding);GO:0042802(identical protein binding);GO:0004478(methionine adenosyltransferase activity);GO:0006556(S-adenosylmethionine biosynthetic process);GO:1990830(cellular response to leukemia inhibitory factor);GO:0005829(cytosol);GO:0051291(protein heterooligomerization);GO:0034214(protein hexamerization);GO:0032259(methylation);GO:0048269(methionine adenosyltransferase complex)00270(Cysteine and methionine metabolism)K00789EC:2.5.1.6methionine adenosyltransferase 2A [Source:HGNC Symbol;Acc:HGNC:6904]37.4954111.1233.53589495451085.075.67e-111.42e-08upyes
17866NAchr10-37759963785275ENST0000049757144656ENSG00000067082KLF6GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0001077(transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0030183(B cell differentiation)NANANAKruppel like factor 6 [Source:HGNC Symbol;Acc:HGNC:2235]0.2910.3669190.03-5.163720959847325.68e-111.42e-08downyes
192713NAchr9+135499984135504673ENST0000037178551640ENSG00000122140MRPS2GO:0005739(mitochondrion);GO:0030529(intracellular ribonucleoprotein complex);GO:0005622(intracellular);GO:0003735(structural constituent of ribosome);GO:0006412(translation);GO:0005840(ribosome);GO:0015935(small ribosomal subunit);GO:0032543(mitochondrial translation);GO:0005743(mitochondrial inner membrane);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination);GO:0005763(mitochondrial small ribosomal subunit)03010(Ribosome)K02967NAmitochondrial ribosomal protein S2 [Source:HGNC Symbol;Acc:HGNC:14495]2.4985.3865360.03-5.101574854685516.93e-111.71e-08downyes
117700NAchr2+216633429216664433ENST0000049036224414ENSG00000115457IGFBP2GO:0005576(extracellular region);GO:0005520(insulin-like growth factor binding);GO:0032868(response to insulin);GO:0005615(extracellular space);GO:0042104(positive regulation of activated T cell proliferation);GO:0005515(protein binding);GO:0001558(regulation of cell growth);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0040008(regulation of growth);GO:0019838(growth factor binding);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0031994(insulin-like growth factor I binding);GO:0005102(receptor binding);GO:0031995(insulin-like growth factor II binding);GO:0043567(regulation of insulin-like growth factor receptor signaling pathway);GO:0007165(signal transduction);GO:0007565(female pregnancy);GO:0007568(aging);GO:0007584(response to nutrient);GO:0009612(response to mechanical stimulus);GO:0010226(response to lithium ion);GO:0032355(response to estradiol);GO:0032526(response to retinoic acid);GO:0032870(cellular response to hormone stimulus);GO:0042493(response to drug);GO:0043627(response to estrogen);GO:0048545(response to steroid hormone);GO:0051384(response to glucocorticoid);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle)NANANAinsulin like growth factor binding protein 2 [Source:HGNC Symbol;Acc:HGNC:5471]0.217.630.03-5.151465625234457.25e-111.76e-08downyes
168433NAchr6+149977922149978416ENST000004334151495ENSG00000231120BTF3P10NANANANAbasic transcription factor 3 pseudogene 10 [Source:HGNC Symbol;Acc:HGNC:38570]175.6635745.3732.68396665060355.037.45e-111.79e-08upyes
76317NAchr16+8992185189936091ENST0000055444441978ENSG00000258947TUBB3GO:0005525(GTP binding);GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0015630(microtubule cytoskeleton);GO:0005200(structural constituent of cytoskeleton);GO:0007010(cytoskeleton organization);GO:0005874(microtubule);GO:0007017(microtubule-based process);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0007411(axon guidance);GO:0030425(dendrite)04145(Phagosome);04540(Gap junction);05130(Pathogenic Escherichia coli infection)K07375NAtubulin beta 3 class III [Source:HGNC Symbol;Acc:HGNC:20772]18.9703850.5733.51054226976765.077.63e-111.81e-08upyes
28927NAchr11-5732598657335851ENST00000293880116296ENSG00000149136SSRP1GO:0005634(nucleus);GO:0003723(RNA binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005694(chromosome);GO:0005515(protein binding);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0006260(DNA replication);GO:0003682(chromatin binding);GO:0005730(nucleolus);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:1901796(regulation of signal transduction by p53 class mediator)NANANAstructure specific recognition protein 1 [Source:HGNC Symbol;Acc:HGNC:11327]0.9029.6620370.03-5.040365635927089.82e-112.30e-08downyes
17356NAchr1-244840638244854748ENST00000366527212852ENSG00000153187HNRNPUGO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0003723(RNA binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0030529(intracellular ribonucleoprotein complex);GO:0005515(protein binding);GO:0005681(spliceosomal complex);GO:0048511(rhythmic process);GO:0001047(core promoter binding);GO:0031012(extracellular matrix);GO:0000398(mRNA splicing, via spliceosome);GO:0009986(cell surface);GO:0032922(circadian regulation of gene expression);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0070034(telomerase RNA binding);GO:0005697(telomerase holoenzyme complex);GO:0016070(RNA metabolic process);GO:0006396(RNA processing);GO:0071013(catalytic step 2 spliceosome);GO:0001649(osteoblast differentiation);GO:0070934(CRD-mediated mRNA stabilization);GO:0070937(CRD-mediated mRNA stability complex);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0034046(poly(G) binding);GO:0035326(enhancer binding);GO:0043021(ribonucleoprotein complex binding);GO:0010628(positive regulation of gene expression);GO:0055013(cardiac muscle cell development);GO:0071549(cellular response to dexamethasone stimulus);GO:2000373(positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity)03040(Spliceosome)NANAheterogeneous nuclear ribonucleoprotein U [Source:HGNC Symbol;Acc:HGNC:5048]0.216.800.03-5.039136568282331.09e-102.52e-08downyes
37113NAchr12+30773553286564ENST0000053797184284ENSG00000011105TSPAN9GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0005887(integral component of plasma membrane);GO:0003674(molecular_function);GO:0008150(biological_process);GO:0007166(cell surface receptor signaling pathway);GO:0097197(tetraspanin-enriched microdomain)NANANAtetraspanin 9 [Source:HGNC Symbol;Acc:HGNC:21640]14.3965670.4730.65316824937194.941.42e-103.25e-08upyes
35185NAchr11-117820070117828698ENST000005280147672ENSG00000137731FXYD2GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005216(ion channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0005886(plasma membrane);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0005887(integral component of plasma membrane);GO:0017080(sodium channel regulator activity);GO:2000649(regulation of sodium ion transmembrane transporter activity);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:1903779(regulation of cardiac conduction);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0005215(transporter activity);GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0036376(sodium ion export from cell);GO:1990573(potassium ion import across plasma membrane);GO:0090662(ATP hydrolysis coupled transmembrane transport);GO:0001558(regulation of cell growth);GO:0042127(regulation of cell proliferation);GO:0016323(basolateral plasma membrane);GO:0043231(intracellular membrane-bounded organelle)04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation)NANAFXYD domain containing ion transport regulator 2 [Source:HGNC Symbol;Acc:HGNC:4026]1.9964.2061310.03-5.013959436771571.54e-103.47e-08downyes
126991NAchr22-1759213617628818ENST0000025341391402ENSG00000131100ATP6V1E1GO:0006810(transport);GO:0016787(hydrolase activity);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0006811(ion transport);GO:0015991(ATP hydrolysis coupled proton transport);GO:0015992(proton transport);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:0005515(protein binding);GO:0033178(proton-transporting two-sector ATPase complex, catalytic domain);GO:0005768(endosome);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0016324(apical plasma membrane);GO:0008286(insulin receptor signaling pathway);GO:0016241(regulation of macroautophagy);GO:0033572(transferrin transport);GO:0090383(phagosome acidification);GO:0051117(ATPase binding);GO:0016469(proton-transporting two-sector ATPase complex);GO:0008553(hydrogen-exporting ATPase activity, phosphorylative mechanism);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005902(microvillus)00190(Oxidative phosphorylation);04150(mTOR signaling pathway);04145(Phagosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection)K02150NAATPase H+ transporting V1 subunit E1 [Source:HGNC Symbol;Acc:HGNC:857]13.8260560.4332.3398358922545.021.55e-103.47e-08upyes
108372NAchr2+4740296947483228ENST00000233146163307ENSG00000095002MSH2GO:0005634(nucleus);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0030983(mismatched DNA binding);GO:0006298(mismatch repair);GO:0032301(MutSalpha complex);GO:0005654(nucleoplasm);GO:0019901(protein kinase binding);GO:0006302(double-strand break repair);GO:0031573(intra-S DNA damage checkpoint);GO:0000784(nuclear chromosome, telomeric region);GO:0008022(protein C-terminus binding);GO:0032300(mismatch repair complex);GO:0019899(enzyme binding);GO:0010165(response to X-ray);GO:0008094(DNA-dependent ATPase activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0030183(B cell differentiation);GO:0042803(protein homodimerization activity);GO:0003697(single-stranded DNA binding);GO:0032405(MutLalpha complex binding);GO:0016887(ATPase activity);GO:0008584(male gonad development);GO:0032139(dinucleotide insertion or deletion binding);GO:0032142(single guanine insertion binding);GO:0032181(dinucleotide repeat insertion binding);GO:0000403(Y-form DNA binding);GO:0000404(heteroduplex DNA loop binding);GO:0000406(double-strand/single-strand DNA junction binding);GO:0043570(maintenance of DNA repeat elements);GO:0045910(negative regulation of DNA recombination);GO:0051096(positive regulation of helicase activity);GO:0032302(MutSbeta complex);GO:0000287(magnesium ion binding);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0000400(four-way junction DNA binding);GO:0003690(double-stranded DNA binding);GO:0032137(guanine/thymine mispair binding);GO:0032143(single thymine insertion binding);GO:0032357(oxidized purine DNA binding);GO:0043531(ADP binding);GO:0003684(damaged DNA binding);GO:0019237(centromeric DNA binding);GO:0001701(in utero embryonic development);GO:0002204(somatic recombination of immunoglobulin genes involved in immune response);GO:0006119(oxidative phosphorylation);GO:0006301(postreplication repair);GO:0006311(meiotic gene conversion);GO:0007050(cell cycle arrest);GO:0007281(germ cell development);GO:0008340(determination of adult lifespan);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010224(response to UV-B);GO:0016447(somatic recombination of immunoglobulin gene segments);GO:0019724(B cell mediated immunity);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0045128(negative regulation of reciprocal meiotic recombination);GO:0045190(isotype switching);GO:0048298(positive regulation of isotype switching to IgA isotypes);GO:0048304(positive regulation of isotype switching to IgG isotypes)03430(Mismatch repair);05200(Pathways in cancer);05210(Colorectal cancer);01524(Platinum drug resistance)K08735NAmutS homolog 2 [Source:HGNC Symbol;Acc:HGNC:7325]10.0056420.3230.80791932876614.951.69e-103.72e-08upyes
194805NAchrX+4722285347228990ENST00000428400113016ENSG00000102225CDK16GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005886(plasma membrane);GO:0015630(microtubule cytoskeleton);GO:0005515(protein binding);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0031410(cytoplasmic vesicle);GO:0007283(spermatogenesis);GO:0006887(exocytosis);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043005(neuron projection);GO:0031175(neuron projection development);GO:0008021(synaptic vesicle);GO:0030133(transport vesicle);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0030252(growth hormone secretion)NANANAcyclin dependent kinase 16 [Source:HGNC Symbol;Acc:HGNC:8749]12.6116870.4130.51792960762734.931.83e-103.99e-08upyes
170601NAchr7-2293421123014129ENST000004321761113177ENSG00000122591FAM126AGO:0005737(cytoplasm);GO:0016020(membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0005515(protein binding);GO:0090002(establishment of protein localization to plasma membrane);GO:0042552(myelination);GO:0046854(phosphatidylinositol phosphorylation);GO:0043005(neuron projection)NANANAfamily with sequence similarity 126 member A [Source:HGNC Symbol;Acc:HGNC:24587]2.130.0730.87082282700064.951.87e-104.02e-08upyes
79055NAchr17+1643906316441861ENST0000058191341091ENSG00000175061LRRC75A-AS1NANANANALRRC75A antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:28619]1.0833.8610190.03-4.975175681677841.99e-104.24e-08downyes
192124NAchr9+129119022129131639ENST000004175045567ENSG00000119383PTPAGO:0005634(nucleus);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016853(isomerase activity);GO:0005654(nucleoplasm);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005515(protein binding);GO:0000413(protein peptidyl-prolyl isomerization);GO:0070062(extracellular exosome);GO:0043065(positive regulation of apoptotic process);GO:0019211(phosphatase activator activity);GO:0005102(receptor binding);GO:0034704(calcium channel complex);GO:0042803(protein homodimerization activity);GO:0016887(ATPase activity);GO:0046982(protein heterodimerization activity);GO:0008160(protein tyrosine phosphatase activator activity);GO:0019888(protein phosphatase regulator activity);GO:0051721(protein phosphatase 2A binding);GO:0030472(mitotic spindle organization in nucleus);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0035307(positive regulation of protein dephosphorylation);GO:0035308(negative regulation of protein dephosphorylation);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0000159(protein phosphatase type 2A complex);GO:0043085(positive regulation of catalytic activity)04931(Insulin resistance)NANAprotein phosphatase 2 phosphatase activator [Source:HGNC Symbol;Acc:HGNC:9308]33.0365521.0631.17394024434094.962.15e-104.52e-08upyes
115532NAchr2-177230305177265131ENST0000039706252853ENSG00000116044NFE2L2GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0071356(cellular response to tumor necrosis factor);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006351(transcription, DNA-templated);GO:0016567(protein ubiquitination);GO:0003677(DNA binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0005886(plasma membrane);GO:0005813(centrosome);GO:0005515(protein binding);GO:0034599(cellular response to oxidative stress);GO:0019904(protein domain specific binding);GO:0006366(transcription from RNA polymerase II promoter);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0010499(proteasomal ubiquitin-independent protein catabolic process);GO:1903206(negative regulation of hydrogen peroxide-induced cell death);GO:0071498(cellular response to fluid shear stress);GO:0071499(cellular response to laminar fluid shear stress);GO:1903071(positive regulation of ER-associated ubiquitin-dependent protein catabolic process);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0010628(positive regulation of gene expression);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:0036499(PERK-mediated unfolded protein response);GO:0070301(cellular response to hydrogen peroxide);GO:0044212(transcription regulatory region DNA binding);GO:0036003(positive regulation of transcription from RNA polymerase II promoter in response to stress);GO:0032993(protein-DNA complex);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001205(transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding);GO:0001221(transcription cofactor binding);GO:0008134(transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0006954(inflammatory response);GO:0007568(aging);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010976(positive regulation of neuron projection development);GO:0030194(positive regulation of blood coagulation);GO:0034976(response to endoplasmic reticulum stress);GO:0035690(cellular response to drug);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0042149(cellular response to glucose starvation);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045454(cell redox homeostasis);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045995(regulation of embryonic development);GO:0046223(aflatoxin catabolic process);GO:0046326(positive regulation of glucose import);GO:0060548(negative regulation of cell death);GO:0071456(cellular response to hypoxia);GO:1902037(negative regulation of hematopoietic stem cell differentiation);GO:1903788(positive regulation of glutathione biosynthetic process);GO:1904753(negative regulation of vascular associated smooth muscle cell migration);GO:2000121(regulation of removal of superoxide radicals);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:0000785(chromatin)04141(Protein processing in endoplasmic reticulum);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)K05638NAnuclear factor, erythroid 2 like 2 [Source:HGNC Symbol;Acc:HGNC:7782]25.0177590.8629.21986825354194.872.18e-104.52e-08upyes
9947NAchr1-145854406145859779ENST0000036929961235ENSG00000131788PIAS3GO:0008270(zinc ion binding);GO:0019789(SUMO transferase activity);GO:0016925(protein sumoylation);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016874(ligase activity);GO:0005515(protein binding);GO:0065009(regulation of molecular function);GO:0005654(nucleoplasm);GO:0008022(protein C-terminus binding);GO:0019899(enzyme binding);GO:0033235(positive regulation of protein sumoylation);GO:0033234(negative regulation of protein sumoylation);GO:0015459(potassium channel regulator activity);GO:0047485(protein N-terminus binding);GO:0009725(response to hormone);GO:0010628(positive regulation of gene expression);GO:0045838(positive regulation of membrane potential);GO:0030425(dendrite);GO:0045202(synapse)04120(Ubiquitin mediated proteolysis);04630(Jak-STAT signaling pathway)NANAprotein inhibitor of activated STAT 3 [Source:HGNC Symbol;Acc:HGNC:16861]16.405920.5330.69200462458894.942.24e-104.61e-08upyes
95711NAchr19-1134277611346305ENST000004473374916ENSG00000105518TMEM205GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0070062(extracellular exosome)NANANAtransmembrane protein 205 [Source:HGNC Symbol;Acc:HGNC:29631]0.7824.7022670.03-4.979765578242332.57e-105.20e-08downyes
108389NAchr2+4778308247806945ENST0000054002183930ENSG00000116062MSH6GO:0005634(nucleus);GO:0005794(Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0005694(chromosome);GO:0005515(protein binding);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0030983(mismatched DNA binding);GO:0006298(mismatch repair);GO:0032301(MutSalpha complex);GO:0016032(viral process);GO:0035064(methylated histone binding);GO:0008094(DNA-dependent ATPase activity);GO:0008340(determination of adult lifespan);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0032405(MutLalpha complex binding);GO:0016887(ATPase activity);GO:0032142(single guanine insertion binding);GO:0045910(negative regulation of DNA recombination);GO:0051096(positive regulation of helicase activity);GO:0009411(response to UV);GO:0000287(magnesium ion binding);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0000400(four-way junction DNA binding);GO:0003690(double-stranded DNA binding);GO:0032137(guanine/thymine mispair binding);GO:0032143(single thymine insertion binding);GO:0032357(oxidized purine DNA binding);GO:0043531(ADP binding);GO:0016447(somatic recombination of immunoglobulin gene segments);GO:0045190(isotype switching);GO:0000710(meiotic mismatch repair);GO:0097193(intrinsic apoptotic signaling pathway);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0045830(positive regulation of isotype switching);GO:0000790(nuclear chromatin)03430(Mismatch repair);05200(Pathways in cancer);05210(Colorectal cancer);01524(Platinum drug resistance)K08737NAmutS homolog 6 [Source:HGNC Symbol;Acc:HGNC:7329]23.1621360.8128.52781944885794.832.59e-105.20e-08upyes
20758NAchr10-7029897370381914ENST0000035579053414ENSG00000172731LRRC20GO:0005515(protein binding)NANANAleucine rich repeat containing 20 [Source:HGNC Symbol;Acc:HGNC:23421]1.2837.8839650.03-4.884134823677652.80e-105.57e-08downyes
192868NAchr9-136440097136477689ENST00000313050308806ENSG00000148396SEC16AGO:0048208(COPII vesicle coating);GO:0000139(Golgi membrane);GO:0006810(transport);GO:0016020(membrane);GO:0015031(protein transport);GO:0005794(Golgi apparatus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0016192(vesicle-mediated transport);GO:0021762(substantia nigra development);GO:0007029(endoplasmic reticulum organization)NANANASEC16 homolog A, endoplasmic reticulum export factor [Source:HGNC Symbol;Acc:HGNC:29006]0.9527.6021270.03-4.862122655032822.97e-105.83e-08downyes
171991NAchr7+4460659144708328ENST00000449767233479ENSG00000105953OGDHGO:0055114(oxidation-reduction process);GO:0006099(tricarboxylic acid cycle);GO:0005739(mitochondrion);GO:0008152(metabolic process);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0004591(oxoglutarate dehydrogenase (succinyl-transferring) activity);GO:0030976(thiamine pyrophosphate binding);GO:0046872(metal ion binding);GO:0016491(oxidoreductase activity);GO:0006096(glycolytic process);GO:0005759(mitochondrial matrix);GO:0031966(mitochondrial membrane);GO:0006554(lysine catabolic process);GO:0034641(cellular nitrogen compound metabolic process);GO:0006091(generation of precursor metabolites and energy);GO:0045252(oxoglutarate dehydrogenase complex);GO:0031072(heat shock protein binding);GO:0034602(oxoglutarate dehydrogenase (NAD+) activity);GO:0051087(chaperone binding);GO:0006103(2-oxoglutarate metabolic process);GO:0006104(succinyl-CoA metabolic process);GO:0006734(NADH metabolic process);GO:0021695(cerebellar cortex development);GO:0021756(striatum development);GO:0021766(hippocampus development);GO:0021794(thalamus development);GO:0021860(pyramidal neuron development);GO:0022028(tangential migration from the subventricular zone to the olfactory bulb);GO:0061034(olfactory bulb mitral cell layer development)00020(Citrate cycle (TCA cycle));00310(Lysine degradation);00380(Tryptophan metabolism)K00164EC:1.2.4.2oxoglutarate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:8124]8.960.3128.49089291105854.833.46e-106.72e-08upyes
68330NAchr16-44635684469365ENST000005761763672ENSG00000153406NMRAL1GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0048471(perinuclear region of cytoplasm);GO:0005829(cytosol);GO:0000050(urea cycle)NANANANmrA like redox sensor 1 [Source:HGNC Symbol;Acc:HGNC:24987]1.3641.0620650.03-4.915568689379563.62e-106.96e-08downyes
94968NAchr19+84184058439017ENST0000060211751667ENSG00000099785MARCH2GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0031410(cytoplasmic vesicle);GO:0005764(lysosome);GO:0005768(endosome);GO:0006897(endocytosis);GO:0010008(endosome membrane);GO:0004842(ubiquitin-protein transferase activity)NANANAmembrane associated ring-CH-type finger 2 [Source:HGNC Symbol;Acc:HGNC:28038]0.3911.778810.03-4.934165152622893.78e-107.20e-08downyes
190398NAchr9-100302084100352939ENST00000374902153074ENSG00000136891TEX10GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0031965(nuclear membrane);GO:0071339(MLL1 complex);GO:0006364(rRNA processing);GO:0097344(Rix1 complex)NANANAtestis expressed 10 [Source:HGNC Symbol;Acc:HGNC:25988]0.5616.0430620.03-4.839099061347834.43e-108.35e-08downyes
120342NAchr20+26554132658392ENST0000061223312980ENSG00000101361NOP56GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0030529(intracellular ribonucleoprotein complex);GO:0001650(fibrillar center);GO:0005654(nucleoplasm);GO:0042254(ribosome biogenesis);GO:0005730(nucleolus);GO:0032040(small-subunit processome);GO:0005515(protein binding);GO:0045296(cadherin binding);GO:0031428(box C/D snoRNP complex);GO:0006364(rRNA processing);GO:0030515(snoRNA binding);GO:1990226(histone methyltransferase binding);GO:0000154(rRNA modification);GO:0005732(small nucleolar ribonucleoprotein complex);GO:0070761(pre-snoRNP complex)03008(Ribosome biogenesis in eukaryotes)NANANOP56 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:15911]0.195.730.03-4.909754966562064.81e-108.96e-08downyes
191802NAchr9-128166065128191568ENST00000372954172731ENSG00000148337CIZ1GO:0005634(nucleus);GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0030332(cyclin binding);GO:0032298(positive regulation of DNA-dependent DNA replication initiation);GO:0051457(maintenance of protein location in nucleus)NANANACDKN1A interacting zinc finger protein 1 [Source:HGNC Symbol;Acc:HGNC:16744]1.2334.2066840.04-4.802658115799054.91e-109.07e-08downyes

Definition of table:

term意义
chrThe name of the chromosome (e.g. chr3, chrY, chr2 random) or scaffold (e.g. scaffold10671)
strandsense strand="+"; antisense strand="-"
startThe starting position of transcript in the chromosome or scaffold
endThe ending position of transcript in the chromosome or scaffold
t_nameThe name of transcript
num_exonsnumber of exons
lengthlength of transcript
gene_idThe ID of gene, some ids started with "MSTRG" are named by transcript assembly software StringTie
gene_nameThe name of gene (gene symbol)
GOGene ontology term and description http://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
KO_EntryKO functional ortholog, KO groups identified by K numbers and, in metabolic maps
ECenzyme
DescriptionDescription of gene
cov.Acount number or coverage of transcript
FPKM.ANormalization of gene expression level by FPKM value
fcfold change
log2(fc)log2 of fold change value
pvalp value
qvalq value or FDR value
regulationup-regulation or down-regulation
significantyes or no

document location: summary/7_differential_expression/*VS*/*_Transcript_differential_expression.xlsx


4.7.3 Volcano of differentially expressed genes





document location:

summary/7_differential_expression/*VS*/*_Genes_volcano.png

summary/7_differential_expression/*VS*/*_Transcripts_volcano.png


4.7.4 Heatmap of differentially expressed genes


Heatmap is a graphical representation of data where the individual z values (repeated) or Log10 (non-repeated) contained in a matrix are represented as color scheme. Calculation formula of z value is shown below. Sample-i means expression level (fpkm value).






document location:

summary/7_differential_expression/*VS*/*_genes_heatmap.png

summary/7_differential_expression/*VS*/*_transcripts_heatmap.png


4.7.5 GO enrichment analysis of differentially expressed genes


Gene ontology (GO) (http://www.geneontology.org) is a major bioinformatics initiative to unify the representation of gene and gene product attributes across all species. More specifically, the project aims to: 1) maintain and develop its controlled vocabulary of gene and gene product attributes; 2) annotate genes and gene products, and assimilate and disseminate annotation data; and 3) provide tools for easy access to all aspects of the data provided by the project, and to enable functional interpretation of experimental data using the GO, for example via enrichment analysis.

GO is part of a larger classification effort, the Open Biomedical Ontologies (OBO).

Although gene nomenclature itself aims to maintain and develop controlled vocabulary of gene and gene products, the Gene Ontology extends the effort by using markup language to make the data (not only of the genes and their products but also of all their attributes) machine readable, and to do so in a way that is unified across all species (whereas gene nomenclature conventions vary by biologic taxon).

Significant GO terms were calculated by Hypergeometric equation as shown below. TB gene number=number of total genes; TS gene number=number of differentially expressed genes in total genes; B gene number=total number of gene in all GO terms; S gene number=number of differentially expressed genes in this GO term. Those GO terms with p value<0.05 were defined as significant GO terms.



Significant GO terms:

GO_IDGO_TermGO_functionGO_classGenesS gene numberTS gene numberB gene numberTB gene numberpvalue
GO:0036518chemorepulsion of dopaminergic neuron axonNANARYK;WNT5A23682158740.00
GO:0003697single-stranded DNA bindingmolecular_function8BIVM-ERCC5;CNBP;ERCC5;POLR2D;RPA2;SSBP4;TWNK;XRCC2836886158740.00
GO:0016591DNA-directed RNA polymerase II, holoenzymecellular_component10ERCC5;GCOM1;RPRD1A336810158740.00
GO:0031369translation initiation factor bindingmolecular_function5CELF1;LARP1;POLR2D;ZPR1436822158740.00
GO:0030292protein tyrosine kinase inhibitor activitymolecular_function7FGFR1OP;RACK123683158740.00
GO:0071931positive regulation of transcription involved in G1/S transition of mitotic cell cyclebiological_process14ID2;ZPR123683158740.00
GO:0034067protein localization to Golgi apparatusbiological_process8CSNK1D;PAQR3;RAB6A336811158740.00
GO:0005634nucleuscellular_component9ACAD11;AGO1;AHCY;AHRR;AKT3;ANAPC11;ANKRA2;AP001273.2;APC;API5;ARHGEF5;BAG4;BCL2L13;BIVM-ERCC5;BMI1;BOLA2B;BRCC3;C19orf68;C1orf109;CCNL1;CD3EAP;CDK11A;CDK15;CDK19;CDK2AP1;CELF1;CFL2;CITED2;CNBP;CREB3;CREB5;CSNK1D;CS;DCXR;DDX39A;DDX47;DNAJB12;DPH1;DYNLL2;ELOF1;EMG1;ERCC5;FAM58A;FAM60A;FGFR1OP;FOXD1;GADD45B;GDAP1;GLO1;GMEB2;H3F3A;HDGF;HIC2;HINT1;HJURP;HKR1;ID2;IDH3B;IER3;IMPDH1;INTS6;KLF6;KMT5A;LBH;LSM2;LSM5;MAPK7;MATR3;MCL1;MED17;MED21;MEF2B;MEMO1;METTL14;MRPL19;NEMP1;NFE2L2;NFE2L3;NFIC;NSRP1;NXN;PAWR;PCGF1;PCNP;PHLPP2;PIH1D1;PIK3R2;PNN;POLR2D;PPIA;PRKACA;PSMA1;PSMC5;RACK1;RBAK;RBBP4;RBM22;RBM3;RBM8A;RBMXL1;RERG;RNF126;RPA2;RPL10;RPL17;RYK;S100A16;SALL2;SAP30BP;SAP30;SCAND1;SDR39U1;SENP3-EIF4A1;SIGMAR1;SKP1;SLC35A2;SOX6;SP1;SRSF3;SSBP4;TAF11;TFDP1;TGIF2-C20orf24;TMEM250;TNIP2;TNPO1;TRIM11;TUBB3;TUBB6;TUB;UBE2V2;VDAC1;WDFY1;XRCC2;YAF2;YY1;ZBTB21;ZBTB8A;ZFP1;ZNF132;ZNF24;ZNF267;ZNF268;ZNF324;ZNF383;ZNF500;ZNF526;ZNF534;ZNF587;ZNF646;ZNF664;ZNF665;ZNF721;ZNF746;ZNF766;ZPR1;ZSCAN30;ZSCAN321583685658158740.00
GO:0005789endoplasmic reticulum membranecellular_component11ALG10B;BSCL2;CLN6;CLN8;COPZ1;CREB3;CYB5RL;DNAJB12;DPM3;EBPL;EXTL2;GJB1;GJC1;HACD2;ILDR2;KRTCAP2;KSR1;LCLAT1;MGST3;MPDU1;ORMDL3;PCYT1A;PGAP1;RAB6A;SEC61G;SIGMAR1;SLC39A1;SPCS3;STX18;TMEM208;TRIQK;UBE2J2;VMA2133368846158740.00
GO:0031519PcG protein complexcellular_component11BMI1;PCGF1;SKP1;YY1436826158740.00
GO:0061631ubiquitin conjugating enzyme activitymolecular_function7UBE2D2;UBE2D4;UBE2J2;UBE2V2436828158740.00
GO:0003676nucleic acid bindingmolecular_function5AGO1;CELF1;CNBP;CREB5;DDX39A;DDX47;GPATCH4;HIC2;HKR1;IMPDH1;KLF6;MATR3;RBAK;RBM22;RBM3;RBM8A;RBMXL1;RBSN;SALL2;SP1;SRSF3;THAP6;YY1;ZBTB21;ZBTB8A;ZFP1;ZNF132;ZNF24;ZNF267;ZNF268;ZNF324;ZNF383;ZNF428;ZNF500;ZNF526;ZNF534;ZNF587;ZNF646;ZNF664;ZNF665;ZNF721;ZNF746;ZNF766;ZSCAN30;ZSCAN32453681311158740.01
GO:1990726Lsm1-7-Pat1 complexNANALSM2;LSM523685158740.01
GO:1904938planar cell polarity pathway involved in axon guidanceNANARYK;WNT5A23685158740.01
GO:0006099tricarboxylic acid cyclebiological_process10CS;IDH3B;SDHC;SUCLG2436831158740.01
GO:0006895Golgi to endosome transportbiological_process7CORO7;RBSN;SYS1336817158740.01
GO:2000052positive regulation of non-canonical Wnt signaling pathwaybiological_process11CSNK1D;WNT5A23686158740.01
GO:0038202TORC1 signalingbiological_process9LARP1;MLST823686158740.01
GO:0071806protein transmembrane transportbiological_process6MCL1;SEC61G23686158740.01
GO:0036003positive regulation of transcription from RNA polymerase II promoter in response to stressbiological_process14MAPK7;NFE2L223686158740.01
GO:0048524positive regulation of viral processbiological_process6STOM;TMEM25023687158740.01
GO:0097428protein maturation by iron-sulfur cluster transferbiological_process7BOLA2B;ISCA223687158740.01
GO:0031931TORC1 complexcellular_component8LARP1;MLST823687158740.01
GO:0034115negative regulation of heterotypic cell-cell adhesionbiological_process7MAPK7;MYADM23687158740.01
GO:1901409positive regulation of phosphorylation of RNA polymerase II C-terminal domainbiological_process15CCNL1;FAM58A23687158740.01
GO:0017183peptidyl-diphthamide biosynthetic process from peptidyl-histidinebiological_process6DPH1;DPH223687158740.01
GO:0071499cellular response to laminar fluid shear stressbiological_process7MAPK7;NFE2L223687158740.01
GO:1904948midbrain dopaminergic neuron differentiationNANARYK;WNT5A23687158740.01
GO:0016264gap junction assemblybiological_process8GJB1;GJC123687158740.01
GO:1903358regulation of Golgi organizationbiological_process6RBSN;STX1823687158740.01
GO:0007017microtubule-based processbiological_process5DYNLL2;TUBA4A;TUBB3;TUBB6436838158740.01
GO:0050804modulation of synaptic transmissionbiological_process8HRH1;PRKACA;PSMC5336821158740.01
GO:0043066negative regulation of apoptotic processbiological_process9API5;BAG4;CHST11;CITED2;DDAH2;ERCC5;GLO1;IER3;LAMTOR5;MAPK7;MCL1;PLK2;RPL10;SEMA4D;SOCS2;TXNDC5;WNT5A;ZNF26818368432158740.01
GO:0000978RNA polymerase II core promoter proximal region sequence-specific DNA bindingmolecular_function11AGO1;CREB3;FOXD1;GMEB2;KLF6;MEF2B;NFE2L3;NFIC;RBBP4;SOX6;SP1;SSBP4;YY1;ZNF74614368306158740.01
GO:0005688U6 snRNPcellular_component9LSM2;LSM523688158740.01
GO:0006295nucleotide-excision repair, DNA incision, 3'-to lesionbiological_process12BIVM-ERCC5;ERCC5;RPA2336822158740.01
GO:0004520endodeoxyribonuclease activitymolecular_function8BIVM-ERCC5;ERCC5;XRCC2336822158740.01
GO:0003735structural constituent of ribosomemolecular_function4MRPL19;MRPL35;MRPL49;MRPS33;NDUFA7;RPL10;RPL17;RPS16;RPS59368163158740.01
GO:0006289nucleotide-excision repairbiological_process10BIVM-ERCC5;ERCC5;ORAOV1;RPA2436841158740.01
GO:0030163protein catabolic processbiological_process7AC068580.4;CLN6;CLN8;PSMC5436841158740.01
GO:0006355regulation of transcription, DNA-templatedbiological_process11AGO1;AHRR;BMI1;CCNL1;CDK11A;CITED2;CNBP;CREB3;CREB5;ELOF1;FOXD1;GMEB2;HDGF;HIC2;HINT1;HKR1;ID2;IGF2;KLF6;KMT5A;LBH;MED17;MED21;MEF2B;NFE2L2;NFE2L3;NFIC;PAWR;PCGF1;PIH1D1;PNN;RBAK;RBBP4;RNF141;SALL2;SAP30BP;SAP30;SCAND1;SOX6;SP1;TAF11;TFDP1;TGIF2-C20orf24;TNIP2;YAF2;YY1;ZBTB21;ZBTB8A;ZFP1;ZNF132;ZNF24;ZNF267;ZNF268;ZNF324;ZNF383;ZNF500;ZNF526;ZNF534;ZNF587;ZNF646;ZNF664;ZNF665;ZNF721;ZNF746;ZNF766;ZSCAN30;ZSCAN32673682232158740.01
GO:0030529intracellular ribonucleoprotein complexcellular_component7AGO1;CELF1;LSM2;LSM5;MRPL19;MRPL35;MRPL49;MRPS33;NSRP1;RACK1;RBMXL1;RPL10;RPL17;RPS16;RPS515368345158740.02
GO:0098869cellular oxidant detoxificationNANAAAED1;GPX2;MGST3;NXN;SRXN1536864158740.02
GO:0032886regulation of microtubule-based processbiological_process6APC;MEMO123689158740.02
GO:0034498early endosome to Golgi transportbiological_process8RAB6A;RBSN23689158740.02
GO:0048843negative regulation of axon extension involved in axon guidancebiological_process6RYK;WNT5A23689158740.02
GO:0032486Rap protein signal transductionbiological_process10PLK2;SGSM323689158740.02
GO:2000352negative regulation of endothelial cell apoptotic processbiological_process11MAPK7;NFE2L2;TNIP2336824158740.02
GO:0005921gap junctioncellular_component5GJB1;GJC1;SGSM3336824158740.02
GO:0006351transcription, DNA-templatedbiological_process10AGO1;AHRR;BMI1;CCNL1;CITED2;CNBP;CREB3;CREB5;ELOF1;FOXD1;GMEB2;HDGF;HIC2;HINT1;HKR1;ID2;KLF6;KMT5A;LBH;MED17;MED21;MEF2B;NFE2L2;NFE2L3;NFIC;PAWR;PCGF1;PIH1D1;PNN;POLR2D;RBAK;RBBP4;SALL2;SAP30BP;SAP30;SOX6;SP1;TAF11;TFDP1;TNIP2;YAF2;YY1;ZBTB21;ZBTB8A;ZFP1;ZNF132;ZNF24;ZNF267;ZNF268;ZNF324;ZNF383;ZNF500;ZNF526;ZNF534;ZNF587;ZNF646;ZNF664;ZNF665;ZNF721;ZNF746;ZNF766;ZSCAN30;ZSCAN32633682105158740.02
GO:0017070U6 snRNA bindingmolecular_function8LSM2;RBM22236810158740.02
GO:0010225response to UV-Cbiological_process8ERCC5;YY1236810158740.02
GO:2001020regulation of response to DNA damage stimulusbiological_process7IER3;MCL1236810158740.02
GO:0045047protein targeting to ERbiological_process7SEC61G;SPCS3236810158740.02
GO:0050684regulation of mRNA processingbiological_process11CDK11A;PTCD2236810158740.02
GO:0015935small ribosomal subunitcellular_component11RACK1;RPS16;RPS5336826158740.02
GO:0042795snRNA transcription from RNA polymerase II promoterbiological_process12INTS6;POLR2D;RPRD1A;SP1;TAF11536870158740.02
GO:1900102negative regulation of endoplasmic reticulum unfolded protein responsebiological_process10RACK113681158740.02
GO:0036517chemoattraction of serotonergic neuron axonNANAWNT5A13681158740.02
GO:0070377negative regulation of ERK5 cascadebiological_process12MAPK713681158740.02
GO:0010009cytoplasmic side of endosome membranecellular_component12RBSN13681158740.02
GO:2001145negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activitybiological_process11BAG413681158740.02
GO:0042745circadian sleep/wake cyclebiological_process6AHCY13681158740.02
GO:0006049UDP-N-acetylglucosamine catabolic processbiological_process11MGAT113681158740.02
GO:2000103positive regulation of mammary stem cell proliferationbiological_process6LBH13681158740.02
GO:0004462lactoylglutathione lyase activitymolecular_function6GLO113681158740.02
GO:0050038L-xylulose reductase (NADP+) activitymolecular_function7DCXR13681158740.02
GO:0052835inositol-3,4,6-trisphosphate 1-kinase activitymolecular_function8ITPK113681158740.02
GO:0044328canonical Wnt signaling pathway involved in positive regulation of endothelial cell migrationbiological_process13PLPP313681158740.02
GO:0032655regulation of interleukin-12 productionbiological_process7HLA-B13681158740.02
GO:0042023DNA endoreduplicationbiological_process11ZPR113681158740.02
GO:0035838growing cell tipcellular_component6PI4K2A13681158740.02
GO:0036335intestinal stem cell homeostasisbiological_process7LGR413681158740.02
GO:0051343positive regulation of cyclic-nucleotide phosphodiesterase activitybiological_process7RACK113681158740.02
GO:0042404thyroid hormone catabolic processbiological_process6DIO213681158740.02
GO:0071629ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasomebiological_process11RNF12613681158740.02
GO:0090158endoplasmic reticulum membrane organizationbiological_process6STX1813681158740.02
GO:1904677positive regulation of somatic stem cell divisionNANALBH13681158740.02
GO:0072202cell differentiation involved in metanephros developmentbiological_process8LGR413681158740.02
GO:0043004cytoplasmic sequestering of CFTR proteinbiological_process8GOPC13681158740.02
GO:0002399MHC class II protein complex assemblybiological_process10HLA-DMB13681158740.02
GO:0070486leukocyte aggregationbiological_process8SEMA4D13681158740.02
GO:0015785UDP-galactose transportbiological_process8SLC35A213681158740.02
GO:1900131negative regulation of lipid bindingbiological_process7PEX1913681158740.02
GO:1990261pre-mRNA catabolic processbiological_process9ZPR113681158740.02
GO:1904955planar cell polarity pathway involved in midbrain dopaminergic neuron differentiationNANAWNT5A13681158740.02
GO:0072213metanephric capsule developmentbiological_process11FOXD113681158740.02
GO:1902379chemoattractant activity involved in axon guidancemolecular_function4WNT5A13681158740.02
GO:00905602-(3-amino-3-carboxypropyl)histidine synthase activitymolecular_function6DPH213681158740.02
GO:0052725inositol-1,3,4-trisphosphate 6-kinase activitymolecular_function8ITPK113681158740.02
GO:0047325inositol tetrakisphosphate 1-kinase activitymolecular_function8ITPK113681158740.02
GO:0046223aflatoxin catabolic processbiological_process8NFE2L213681158740.02
GO:0004638phosphoribosylaminoimidazole carboxylase activitymolecular_function7PAICS13681158740.02
GO:0052825inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activitymolecular_function10ITPK113681158740.02
GO:0015822ornithine transportbiological_process7SLC25A2913681158740.02
GO:0002828regulation of type 2 immune responsebiological_process6ECM113681158740.02
GO:2000404regulation of T cell migrationbiological_process7ECM113681158740.02
GO:0036105peroxisome membrane class-1 targeting sequence bindingmolecular_function9PEX1913681158740.02
GO:0009154purine ribonucleotide catabolic processbiological_process11HINT113681158740.02

document location: summary/7_differential_expression/*VS*/GO_Enrichment/*VS*_GO_enrichment_Gene.xlsx


Barplot of enriched GO terms:




document location: summary/7_differential_expression/*VS*/1_GO_Enrichment/*VS*_GO_enrichment.png


Scatterplot of enriched GO terms:

Number of differentially expressed genes enriched in GO terms, p value and rich factor are shown in scatterplot. Rich factor=(number of differentially expressed genes in GO term)/(total number of genes in GO term). The larger rich factor is, the higher enrichment is.





document location: summary/7_differential_expression/*VS*/1_GO_Enrichment/*VS*_GO_enrichment_scatterplot.png


4.7.6 KEGG enrichment analysis of differentially expressed genes


KEGG (Kyoto Encyclopedia of Genes and Genomes) (http://www.kegg.jp/) is a collection of databases dealing with genomes, biological pathways, diseases, drugs, and chemical substances. KEGG is utilized for bioinformatics research and education, including data analysis in genomics, metagenomics, metabolomics and other omics studies, modeling and simulation in systems biology, and translational research in drug development.

Significant KEGG pathways were calculated by Hypergeometric equation as shown below. TB gene number=number of total genes; TS gene number=number of differentially expressed genes in total genes; B gene number=total number of genes in KEGG pathways; S gene number=number of differentially expressed genes in this KEGG pathway. Those KEGG pathways with p value<0.05 were defined as significant KEGG pathways.



Significant KEGG pathways:

pathway_idpathway_nameGenesS gene numberTS gene numberB gene numberTB gene numberpvalue
ko04550Signaling pathways regulating pluripotency of stem cellsAKT3;APC;BMI1;COMMD3-BMI1;ID2;PCGF1;PIK3R2;WNT5A;WNT5B913112260240.00
ko05016Huntington's diseaseAP2S1;CREB3;CREB5;DNAL1;NDUFA5;NDUFA7;POLR2D;SDHC;SP1;UQCRB;VDAC11113117760240.00
ko04727GABAergic synapseABAT;GABARAPL1;GABARAP;GABRE;GNG7;PRKACA61317160240.00
ko00020Citrate cycle (TCA cycle)CS;IDH3B;SDHC;SUCLG241313160240.00
ko05225Hepatocellular carcinomaAKT3;APC;GADD45B;IGF2;MGST3;NFE2L2;PIK3R2;WNT5A;WNT5B913115660240.01
ko04145PhagosomeATP6V1E1;HLA-B;HLA-DMB;SEC61G;STX18;TUBA4A;TUBB3;TUBB6813113360240.01
ko04540Gap junctionCSNK1D;MAPK7;PRKACA;TUBA4A;TUBB3;TUBB661318560240.01
ko04150mTOR signaling pathwayAKT3;ATP6V1E1;CAB39L;LAMTOR5;MLST8;PIK3R2;WNT5A;WNT5B813113960240.01
ko04137Mitophagy - animalBCL2L13;CITED2;GABARAPL1;GABARAP;SP151316460240.01
ko04962Vasopressin-regulated water reabsorptionCREB3;CREB5;DYNLL2;PRKACA41314260240.01
ko05012Parkinson's diseaseNDUFA5;NDUFA7;PRKACA;SDHC;UBE2J2;UQCRB;VDAC1713112260240.02
ko04915Estrogen signaling pathwayAKT3;CREB3;CREB5;PIK3R2;PRKACA;SP161319660240.02
ko04725Cholinergic synapseAKT3;CREB3;CREB5;GNG7;PIK3R2;PRKACA61319960240.02
ko04141Protein processing in endoplasmic reticulumDNAJB12;NFE2L2;SEC61G;SKP1;TXNDC5;UBE2D2;UBE2D4;UBE2J2813115960240.02
ko05224Breast cancerAKT3;APC;GADD45B;PIK3R2;SP1;WNT5A;WNT5B713113360240.03
ko04136Autophagy - other eukaryotesGABARAPL1;GABARAP;MLST831313160240.03
ko04927Cortisol synthesis and secretionCREB3;CREB5;PRKACA;SP141315460240.03
ko05166HTLV-I infectionAKT3;ANAPC11;APC;HLA-B;HLA-DMB;PIK3R2;PRKACA;VDAC1;WNT5A;WNT5B1013123460240.03
ko04211Longevity regulating pathway - mammalAKT3;CREB3;CREB5;PIK3R2;PRKACA51318260240.03
ko05217Basal cell carcinomaAPC;GADD45B;WNT5A;WNT5B41315760240.03
ko05213Endometrial cancerAKT3;APC;GADD45B;PIK3R241315860240.04
ko04926Relaxin signaling pathwayAKT3;CREB3;CREB5;GNG7;PIK3R2;PRKACA613112160240.05
ko04068FoxO signaling pathwayAKT3;GABARAPL1;GABARAP;GADD45B;PIK3R2;PLK2613112360240.05
ko04140Autophagy - animalAKT3;GABARAPL1;GABARAP;MLST8;PIK3R2;PRKACA613112460240.05
ko05231Choline metabolism in cancerAKT3;PCYT1A;PIK3R2;PLPP3;SP151319560240.06
ko04918Thyroid hormone synthesisCREB3;CREB5;GPX2;PRKACA41316760240.06
ko04371Apelin signaling pathwayAKT3;GABARAPL1;GABARAP;GNG7;MEF2B;PRKACA613112760240.06
ko03440Homologous recombinationBRCC3;RPA2;XRCC231314160240.06
ko03040SpliceosomeLSM2;LSM5;RBM22;RBM8A;RBMXL1;SRSF3613113060240.06
ko04210ApoptosisAKT3;GADD45B;MCL1;PIK3R2;TNFRSF10B;TUBA4A613113260240.07
ko04668TNF signaling pathwayAKT3;BAG4;CREB3;CREB5;PIK3R2513110160240.07
ko03010RibosomeMRPL19;MRPL35;RPL10;RPL17;RPS16;RPS5613113360240.07
ko05210Colorectal cancerAKT3;APC;GADD45B;PIK3R241317260240.07
ko05226Gastric cancerAKT3;APC;GADD45B;PIK3R2;WNT5A;WNT5B613113460240.07
ko04932Non-alcoholic fatty liver disease (NAFLD)AKT3;NDUFA5;NDUFA7;PIK3R2;SDHC;UQCRB613113560240.07
ko03420Nucleotide excision repairBIVM-ERCC5;ERCC5;RPA231314560240.07
ko00510N-Glycan biosynthesisALG10B;DPM3;MGAT131314660240.08
ko04923Regulation of lipolysis in adipocyteAKT3;PIK3R2;PRKACA31314760240.08
ko05030Cocaine addictionCREB3;CREB5;PRKACA31314760240.08
ko03060Protein exportSEC61G;SPCS321312360240.09
ko05330Allograft rejectionHLA-B;HLA-DMB21312360240.09
ko05110Vibrio cholerae infectionATP6V1E1;PRKACA;SEC61G31314960240.09
ko05206MicroRNAs in cancerAPC;BMI1;COMMD3-BMI1;MAPK7;MCL1;PIK3R2613114360240.09
ko04152AMPK signaling pathwayAKT3;CAB39L;CREB3;CREB5;PIK3R2513111160240.09
ko04919Thyroid hormone signaling pathwayAKT3;DIO2;MED17;PIK3R2;PRKACA513111160240.09
ko04350TGF-beta signaling pathwayID2;SKP1;SP1;TFDP141318160240.10
ko05320Autoimmune thyroid diseaseHLA-B;HLA-DMB21312560240.10
ko05332Graft-versus-host diseaseHLA-B;HLA-DMB21312560240.10
ko00190Oxidative phosphorylationATP6V1E1;NDUFA5;NDUFA7;SDHC;UQCRB513111460240.10
ko04218Cellular senescenceAKT3;GADD45B;HLA-B;PIK3R2;RBBP4;VDAC1613115160240.11
ko05130Pathogenic Escherichia coli infectionTUBA4A;TUBB3;TUBB631315560240.12
ko04723Retrograde endocannabinoid signalingGABRE;GNG7;NDUFA5;NDUFA7;PRKACA513112160240.12
ko05202Transcriptional misregulation in cancersBMI1;COMMD3-BMI1;GADD45B;H3F3A;ID2;SP1613115660240.12
ko00440Phosphonate and phosphinate metabolismPCYT1A1131660240.12
ko04666Fc gamma R-mediated phagocytosisAKT3;CFL2;PIK3R2;PLPP341318860240.12
ko04728Dopaminergic synapseAKT3;CREB3;CREB5;GNG7;PRKACA513112260240.13
ko04213Longevity regulating pathway - multiple speciesAKT3;PIK3R2;PRKACA31315860240.13
ko04914Progesterone-mediated oocyte maturationAKT3;ANAPC11;PIK3R2;PRKACA41319060240.13
ko05167Kaposi's sarcoma-associated herpesvirus infectionAKT3;GABARAPL1;GABARAP;GNG7;HLA-B;PIK3R2613116060240.13
ko04916MelanogenesisCREB3;PRKACA;WNT5A;WNT5B41319160240.14
ko04710Circadian rhythmCSNK1D;SKP121313060240.14
ko04940Type I diabetes mellitusHLA-B;HLA-DMB21313060240.14
ko01522Endocrine resistanceAKT3;PIK3R2;PRKACA;SP141319260240.14
ko05161Hepatitis BAKT3;CREB3;CREB5;LAMTOR5;PIK3R2513112760240.14
ko05215Prostate cancerAKT3;CREB3;CREB5;PIK3R241319460240.15
ko05418Fluid shear stress and atherosclerosisAKT3;MAPK7;MGST3;NFE2L2;PIK3R2513112960240.15
ko04261Adrenergic signaling in cardiomyocytesAKT3;CREB3;CREB5;PRKACA;TPM4513113060240.15
ko00640Propanoate metabolismABAT;SUCLG221313260240.15
ko04922Glucagon signaling pathwayAKT3;CREB3;CREB5;PRKACA41319660240.16
ko04917Prolactin signaling pathwayAKT3;PIK3R2;SOCS231316360240.16
ko05031Amphetamine addictionCREB3;CREB5;PRKACA31316360240.16
ko04122Sulfur relay systemURM11131860240.16
ko00740Riboflavin metabolismACP11131860240.16
ko04360Axon guidanceCFL2;PIK3R2;RYK;SEMA4D;WNT5A;WNT5B613116960240.16
ko05223Non-small cell lung cancerAKT3;GADD45B;PIK3R231316460240.16
ko04120Ubiquitin mediated proteolysisANAPC11;SKP1;UBE2D2;UBE2D4;UBE2J2513113460240.17
ko05218MelanomaAKT3;GADD45B;PIK3R231316560240.17
ko00983Drug metabolism - other enzymesIMPDH1;MGST3;TK231316560240.17
ko04310Wnt signaling pathwayAPC;PRKACA;SKP1;WNT5A;WNT5B513113560240.17
ko05165Human papillomavirus infectionAKT3;APC;CREB3;CREB5;HLA-B;PIK3R2;PRKACA;WNT5A;WNT5B913128760240.17
ko04931Insulin resistanceAKT3;CREB3;CREB5;PIK3R2413110160240.18
ko01524Platinum drug resistanceAKT3;MGST3;PIK3R231316760240.18
ko05214GliomaAKT3;GADD45B;PIK3R231316860240.18
ko04151PI3K-Akt signaling pathwayAKT3;CREB3;CREB5;GNG7;IGF2;MCL1;MLST8;PHLPP2;PIK3R2913129460240.19
ko05164Influenza AAKT3;HLA-DMB;PIK3R2;TNFRSF10B;VDAC1513114360240.20
ko04390Hippo signaling pathwayAPC;CSNK1D;ID2;WNT5A;WNT5B513114460240.20
ko05034AlcoholismCREB3;CREB5;GNG7;H3F3A;PRKACA513114660240.21
ko05169Epstein-Barr virus infectionAKT3;HLA-B;PIK3R2;POLR2D;PRKACA;PSMC5613118560240.21
ko04973Carbohydrate digestion and absorptionAKT3;PIK3R221314060240.22
ko05162MeaslesAKT3;PIK3R2;RACK1;TNFRSF10B413111060240.22
ko05212Pancreatic cancerAKT3;GADD45B;PIK3R231317460240.22
ko04911Insulin secretionCREB3;CREB5;PRKACA31317560240.22
ko05205Proteoglycans in cancerAKT3;IGF2;PIK3R2;PRKACA;WNT5A;WNT5B613118860240.22
ko05200Pathways in cancerAKT3;APC;GADD45B;GNG7;IGF2;MGST3;NFE2L2;PIK3R2;PRKACA;SKP1;SP1;WNT5A;WNT5B1313147360240.23
ko05032Morphine addictionGABRE;GNG7;PRKACA31317660240.23
ko04022cGMP - PKG signaling pathwayAKT3;CREB3;CREB5;MEF2B;VDAC1513115160240.23
ko03050ProteasomePSMA1;PSMC521314260240.23
ko00730Thiamine metabolismACP111311260240.23
ko05220Chronic myeloid leukemiaAKT3;GADD45B;PIK3R231317760240.23

document location: summary/7_differential_expression/*VS*/2_KEGG_Enrichment/*VS*_KEGG_enrichment_Gene.xlsx


Scatterplot of enriched KEGG pathways:




document location: summary/7_differential_expression/*VS*/2_KEGG_Enrichment/*VS*_KEGG_enrichment_scatterplot.png


KEGG pathway maps:

Graphical map objects

The KEGG pathway map is a moleculalr interaction/reaction network diagram represented in terms of the KEGG Orthology (KO) groups, so that experimental evidence in specific organisms can be generalized to other organisms through genomic information. Each map is manually drawn with in-house software called KegSketch, which generates the KGML+ file. This file is an SVG file containing graphics objects that are associated with KEGG objects (see KEGG object identifiers). Basic graphics objects in the reference KEGG pathway maps are:

boxes - ortholog (KO) groups identified by K numbers and, in metabolic maps, reactions identified by R numbers as well

circles - other molecules, usually chemical compounds identified by C numbers, but including glycans identified by G numbers

lines - reactions identified by R numbers in metabolic maps; ortholog (KO) groups identified by K numbers in global metabolism maps

and in organism specific pathway maps that are computationally generated:

boxes - genes or gene products identified by the combination of the KEGG organism code and gene identifiers

These map objects can be searched in the search box at the top of the KEGG PATHWAY page, in the search box in each pathway map, and by the KEGG Mapper tools.


Convention of map number prefix

Each pathway map is identified by the combination of 2-4 letter code and 5 digit number (see KEGG Identifiers). The prefix has the following meaning:

map - Reference pathway

ko - Reference pathway (KO)

ec - Reference pathway (EC)

rn - Reference pathway (Reaction)

org - Organism-specific pathway map

Only the first reference pathway map is manually drawn; all other maps are computationally generated. For metabolic pathways, each box (or line) in the reference map is linked to the K number (KO identifeir), the EC number, and the R number (reaction identifier). The KO, EC, and reaction maps are linked to only one of them. For all metabolic and non-metabolic maps, K numbers are converted to gene identifiers in each organism to generate organism-specific pathways.



As shown above, "map" pathways are not colored, "ko/ec/rn" pathways are colored blue, and organism-specific pathways are colored green, where coloring indicates that map objects exist and are linked to corresponding entries. For global metabolism maps, "map" pathways are fully colored, so that "ko/ec/rn" pathways and organism-specific pathways are generated by reducing the coloring indicating the absence of corresponding entries.

document location: summary/7_differential_expression/*VS*/3_KEGG_Pictures



4.8 Association analysis


4.8.1 Correlation between RNA-seq and m6A-seq


PEAK INFOm6A regulation INFOgene regulation INFO
seqnamesstartendwidthgeneIdtranscriptIddistanceToTSSgeneNameGOKEGGKO_ENTRYECDescriptionfold_enrchmentdiff.lg.fdrdiff.lg.pdiff.log2.fcm6A_regulationfclog2(fc)pvalqvalgene_regulationsignificant
chr110463421046449108ENSG00000188157ENST00000466223-752AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen);GO:0005796(Golgi lumen)04512(ECM-receptor interaction);04512(ECM-receptor interaction)K06254NAagrin [Source:HGNC Symbol;Acc:HGNC:329]1.58-1.73-2.96-1.47down1.100.140.791upno
chr110480791048288210ENSG00000188157ENST00000492947-241AGRNGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0005576(extracellular region);GO:0043236(laminin binding);GO:0007275(multicellular organism development);GO:0005578(proteinaceous extracellular matrix);GO:0030054(cell junction);GO:0045202(synapse);GO:0030154(cell differentiation);GO:0005200(structural constituent of cytoskeleton);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular exosome);GO:0043547(positive regulation of GTPase activity);GO:0031012(extracellular matrix);GO:0043202(lysosomal lumen);GO:0002162(dystroglycan binding);GO:0033691(sialic acid binding);GO:0035374(chondroitin sulfate binding);GO:0043395(heparan sulfate proteoglycan binding);GO:0001523(retinoid metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0045162(clustering of voltage-gated sodium channels);GO:0045887(positive regulation of synaptic growth at neuromuscular junction);GO:0050808(synapse organization);GO:0051491(positive regulation of filopodium assembly);GO:0005605(basal lamina);GO:0005796(Golgi lumen);GO:0005796(Golgi lumen)04512(ECM-receptor interaction);04512(ECM-receptor interaction)K06254NAagrin [Source:HGNC Symbol;Acc:HGNC:329]1.77-1.56-2.74-0.44down1.100.140.791upno
chr110554291056118690ENSG00000242590ENST00000418300396AL645608.6NANANANANA8.10-1.37-2.47-0.24down1011nono
chr1132770913288971189ENSG00000169962ENST00000339381-2417TAS1R3GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0046982(protein heterodimerization activity);GO:0008527(taste receptor activity);GO:0033041(sweet taste receptor activity);GO:0001582(detection of chemical stimulus involved in sensory perception of sweet taste);GO:0050916(sensory perception of sweet taste);GO:0050917(sensory perception of umami taste);GO:1903767(sweet taste receptor complex)04973(Carbohydrate digestion and absorption);04742(Taste transduction)K04626NAtaste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661]13.50-5.29-7.32-0.47down1.150.200.771upno
chr1143970614409041199ENSG00000179403ENST000004713983971VWA1GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005604(basement membrane);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0005788(endoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0030198(extracellular matrix organization);GO:0048266(behavioral response to pain);GO:0005614(interstitial matrix);GO:0005614(interstitial matrix)NANANAvon Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]14.20-5.65-7.74-0.35down1.010.010.951upno
chr115343301534657328ENSG00000205090ENST000006244265693TMEM240GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0030054(cell junction);GO:0045202(synapse);GO:0097060(synaptic membrane);GO:0097060(synaptic membrane)NANANAtransmembrane protein 240 [Source:HGNC Symbol;Acc:HGNC:25186]4.18-2.70-4.22-1.67down1.090.1311upno
chr125631132563352240ENSG00000157873ENST000004803051312TNFRSF14GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0002741(positive regulation of cytokine secretion involved in immune response);GO:0046642(negative regulation of alpha-beta T cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:2000406(positive regulation of T cell migration);GO:0009897(external side of plasma membrane);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006954(inflammatory response);GO:0046718(viral entry into host cell);GO:0097190(apoptotic signaling pathway);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0016032(viral process);GO:0031625(ubiquitin protein ligase binding);GO:0006955(immune response);GO:0007275(multicellular organism development);GO:0032496(response to lipopolysaccharide);GO:0042127(regulation of cell proliferation);GO:0007166(cell surface receptor signaling pathway);GO:0042981(regulation of apoptotic process);GO:0001618(virus receptor activity);GO:0031295(T cell costimulation);GO:0005031(tumor necrosis factor-activated receptor activity);GO:0005031(tumor necrosis factor-activated receptor activity)04060(Cytokine-cytokine receptor interaction);05168(Herpes simplex infection);05168(Herpes simplex infection)K05152NATNF receptor superfamily member 14 [Source:HGNC Symbol;Acc:HGNC:11912]2.92-2.04-3.36-1.36down0.76-0.400.591downno
chr125910512591469419ENSG00000142606ENST000004718401209MMEL1NANANANANA47.50-2.13-3.48-0.61down1011nono
chr166138356614104270ENSG00000116273ENST0000049538573PHF13GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0016569(covalent chromatin modification);GO:0051301(cell division);GO:0007049(cell cycle);GO:0005654(nucleoplasm);GO:0007059(chromosome segregation);GO:0003682(chromatin binding);GO:0030261(chromosome condensation);GO:0000278(mitotic cell cycle);GO:0035064(methylated histone binding);GO:0007076(mitotic chromosome condensation)NANANAPHD finger protein 13 [Source:HGNC Symbol;Acc:HGNC:22983]4-1.53-2.69-1.34down1.070.100.841upno
chr11102331011023998689ENSG00000120948ENST000006177570TARDBPGO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0003730(mRNA 3'-UTR binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0001205(transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding);GO:0032024(positive regulation of insulin secretion);GO:0034976(response to endoplasmic reticulum stress);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005726(perichromatin fibrils);GO:0005737(cytoplasm);GO:0016607(nuclear speck);GO:0035061(interchromatin granule);GO:0042802(identical protein binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0003690(double-stranded DNA binding);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0010629(negative regulation of gene expression);GO:0051726(regulation of cell cycle);GO:0001933(negative regulation of protein phosphorylation);GO:0042981(regulation of apoptotic process);GO:0043922(negative regulation by host of viral transcription);GO:0071765(nuclear inner membrane organization);GO:0071765(nuclear inner membrane organization)NANANATAR DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11571]4.35-2.38-3.810.33up0.99-0.010.971downno
chr111750615117544463832ENSG00000177674ENST000004717653103AGTRAPGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0038166(angiotensin-activated signaling pathway);GO:0004945(angiotensin type II receptor activity);GO:0001666(response to hypoxia);GO:0008217(regulation of blood pressure);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0005938(cell cortex)NANANAangiotensin II receptor associated protein [Source:HGNC Symbol;Acc:HGNC:13539]3.80-1.62-2.81-1.61down1.120.170.761upno
chr112009708120119572250ENSG00000270914ENST000006032875351AL096840.1NANANANANA5.02-1.55-2.720.30up1011nono
chr11540989515410163269ENSG00000142634ENST000003759800EFHD2GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005509(calcium ion binding);GO:0045121(membrane raft);GO:0045296(cadherin binding);GO:0045296(cadherin binding)NANANAEF-hand domain family member D2 [Source:HGNC Symbol;Acc:HGNC:28670]1.61-3.57-5.31-0.67down1.080.120.821upno
chr115719789157280938305ENSG00000116786ENST00000477849-1752PLEKHM2GO:0005737(cytoplasm);GO:0005515(protein binding);GO:0019894(kinesin binding);GO:0007030(Golgi organization);GO:0032418(lysosome localization);GO:0032880(regulation of protein localization);GO:0010008(endosome membrane);GO:1903527(positive regulation of membrane tubulation)05132(Salmonella infection)K15348NApleckstrin homology and RUN domain containing M2 [Source:HGNC Symbol;Acc:HGNC:29131]13.60-5.08-7.08-0.51down1.030.040.911upno
chr11578459515784893299ENSG00000162458ENST000005091387522FBLIM1GO:0001650(fibrillar center);GO:0005925(focal adhesion);GO:0030054(cell junction);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0007155(cell adhesion);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005829(cytosol);GO:0001725(stress fiber);GO:0005938(cell cortex);GO:0008360(regulation of cell shape);GO:0016337(single organismal cell-cell adhesion);GO:0031005(filamin binding);GO:0033623(regulation of integrin activation);GO:0034329(cell junction assembly);GO:0034329(cell junction assembly)NANANAfilamin binding LIM protein 1 [Source:HGNC Symbol;Acc:HGNC:24686]3-1.77-3.01-0.55down1.020.030.921upno
chr11965686919657463595ENSG00000158748ENST00000289753-7824HTR6GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0004993(G-protein coupled serotonin receptor activity);GO:0098664(G-protein coupled serotonin receptor signaling pathway);GO:0005887(integral component of plasma membrane);GO:0007268(chemical synaptic transmission);GO:0032008(positive regulation of TOR signaling);GO:0030594(neurotransmitter receptor activity);GO:0007187(G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0004969(histamine receptor activity);GO:0021795(cerebral cortex cell migration);GO:0005929(cilium)04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)K04162NA5-hydroxytryptamine receptor 6 [Source:HGNC Symbol;Acc:HGNC:5301]30-2.29-3.70-0.30down-inf-inf11downno
chr11965687319657441569ENSG00000158748ENST00000289753-7846HTR6GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0004871(signal transducer activity);GO:0007165(signal transduction);GO:0004993(G-protein coupled serotonin receptor activity);GO:0098664(G-protein coupled serotonin receptor signaling pathway);GO:0005887(integral component of plasma membrane);GO:0007268(chemical synaptic transmission);GO:0032008(positive regulation of TOR signaling);GO:0030594(neurotransmitter receptor activity);GO:0007187(G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0004969(histamine receptor activity);GO:0021795(cerebral cortex cell migration);GO:0005929(cilium)04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)K04162NA5-hydroxytryptamine receptor 6 [Source:HGNC Symbol;Acc:HGNC:5301]27.10-2.56-4.03-0.33down-inf-inf11downno
chr12182219821822707510ENSG00000187942ENST00000484271701LDLRAD2GO:0016020(membrane);GO:0016021(integral component of membrane)NANANAlow density lipoprotein receptor class A domain containing 2 [Source:HGNC Symbol;Acc:HGNC:32071]24.50-1.45-2.59-0.64down1.090.120.811upno
chr12286499422865174181ENSG00000133216ENST000004904360EPHB2GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005634(nucleus);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0004713(protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0005887(integral component of plasma membrane);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0030425(dendrite);GO:0005576(extracellular region);GO:0030424(axon);GO:0005829(cytosol);GO:0010628(positive regulation of gene expression);GO:0048013(ephrin receptor signaling pathway);GO:0060997(dendritic spine morphogenesis);GO:0060021(palate development);GO:0001525(angiogenesis);GO:0007411(axon guidance);GO:0071679(commissural neuron axon guidance);GO:0051965(positive regulation of synapse assembly);GO:0042472(inner ear morphogenesis);GO:0007612(learning);GO:0007611(learning or memory);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0098794(postsynapse);GO:1900273(positive regulation of long-term synaptic potentiation);GO:0001540(amyloid-beta binding);GO:0005005(transmembrane-ephrin receptor activity);GO:0044877(macromolecular complex binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0007413(axonal fasciculation);GO:0022038(corpus callosum development);GO:0031915(positive regulation of synaptic plasticity);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048168(regulation of neuronal synaptic plasticity);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0060996(dendritic spine development);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity);GO:0004872(receptor activity);GO:0005102(receptor binding);GO:0008046(axon guidance receptor activity);GO:0042802(identical protein binding);GO:0000902(cell morphogenesis);GO:0009887(animal organ morphogenesis);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0031290(retinal ganglion cell axon guidance);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(-);GO:0043025(neuronal cell body);GO:0043025(neuronal cell body)04360(Axon guidance);04360(Axon guidance)NANAEPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393]1.32-1.52-2.68-0.66down0.99-0.010.971downno
chr12446905324469263211ENSG00000001461ENST0000043201212887NIPAL3GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:1903830(magnesium ion transmembrane transport);GO:1903830(magnesium ion transmembrane transport)NANANANIPA like domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25233]2.20-2.10-3.44-1.81down0.95-0.070.961downno
chr12549826525498714450ENSG00000157978ENST00000374338-44866LDLRAP1GO:0042632(cholesterol homeostasis);GO:0006810(transport);GO:0005737(cytoplasm);GO:0009967(positive regulation of signal transduction);GO:0006629(lipid metabolic process);GO:0005829(cytosol);GO:0008202(steroid metabolic process);GO:0005515(protein binding);GO:0008203(cholesterol metabolic process);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0061024(membrane organization);GO:0005769(early endosome);GO:0009925(basal plasma membrane);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0009898(cytoplasmic side of plasma membrane);GO:0030424(axon);GO:0030665(clathrin-coated vesicle membrane);GO:0030159(receptor signaling complex scaffold activity);GO:0030276(clathrin binding);GO:0030121(AP-1 adaptor complex);GO:0035615(clathrin adaptor activity);GO:0030122(AP-2 adaptor complex);GO:0001540(amyloid-beta binding);GO:0034383(low-density lipoprotein particle clearance);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:0055037(recycling endosome);GO:0050750(low-density lipoprotein particle receptor binding);GO:0006898(receptor-mediated endocytosis);GO:1905602(positive regulation of receptor-mediated endocytosis involved in cholesterol transport);GO:0001784(phosphotyrosine residue binding);GO:0090003(regulation of establishment of protein localization to plasma membrane);GO:0005883(neurofilament);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0031623(receptor internalization);GO:0043393(regulation of protein binding);GO:0035591(signaling adaptor activity);GO:0035612(AP-2 adaptor complex binding);GO:0042982(amyloid precursor protein metabolic process);GO:0090205(positive regulation of cholesterol metabolic process);GO:0090205(positive regulation of cholesterol metabolic process)04144(Endocytosis);04979(Cholesterol metabolism);04979(Cholesterol metabolism)K12474NAlow density lipoprotein receptor adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:18640]4.33-1.76-3-1.04down1.090.130.801upno
chr12616993026170489560ENSG00000142684ENST000002708120ZNF593GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0030687(preribosome, large subunit precursor);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0043023(ribosomal large subunit binding);GO:0000055(ribosomal large subunit export from nucleus);GO:1903026(negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding)NANANAzinc finger protein 593 [Source:HGNC Symbol;Acc:HGNC:30943]4.95-3.29-4.97-0.83down1.370.450.481upno
chr126573328265750301703ENSG00000117676ENST000004389771058RPS6KA1GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0000287(magnesium ion binding);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0035556(intracellular signal transduction);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0005654(nucleoplasm);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0043066(negative regulation of apoptotic process);GO:0007165(signal transduction);GO:0045597(positive regulation of cell differentiation);GO:0030307(positive regulation of cell growth);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043620(regulation of DNA-templated transcription in response to stress);GO:0006915(apoptotic process);GO:0072574(hepatocyte proliferation);GO:0043555(regulation of translation in response to stress);GO:2000491(positive regulation of hepatic stellate cell activation);GO:2000491(positive regulation of hepatic stellate cell activation)04010(MAPK signaling pathway);04150(mTOR signaling pathway);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04931(Insulin resistance);04931(Insulin resistance)K04373EC:2.7.11.1ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430]16.10-2.21-3.60-0.61down1.00-0.000.961downno
chr126696040266974191380ENSG00000117713ENST000004575990ARID1AGO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0006338(chromatin remodeling);GO:0090544(BAF-type complex);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0005515(protein binding);GO:0007399(nervous system development);GO:0045893(positive regulation of transcription, DNA-templated);GO:0003713(transcription coactivator activity);GO:0000790(nuclear chromatin);GO:0030521(androgen receptor signaling pathway);GO:0016922(ligand-dependent nuclear receptor binding);GO:0031491(nucleosome binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006344(maintenance of chromatin silencing);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030900(forebrain development);GO:0042766(nucleosome mobilization);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0048096(chromatin-mediated maintenance of transcription);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:1901998(toxin transport);GO:0016514(SWI/SNF complex);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:0071565(nBAF complex)05225(Hepatocellular carcinoma);05225(Hepatocellular carcinoma)K11653NAAT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]18.80-2.02-3.34-0.72down1.090.130.801upno
chr12677476026775000241ENSG00000117713ENST000005327810ARID1AGO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0003677(DNA binding);GO:0006338(chromatin remodeling);GO:0090544(BAF-type complex);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0016569(covalent chromatin modification);GO:0005515(protein binding);GO:0007399(nervous system development);GO:0045893(positive regulation of transcription, DNA-templated);GO:0003713(transcription coactivator activity);GO:0000790(nuclear chromatin);GO:0030521(androgen receptor signaling pathway);GO:0016922(ligand-dependent nuclear receptor binding);GO:0031491(nucleosome binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001704(formation of primary germ layer);GO:0001843(neural tube closure);GO:0003205(cardiac chamber development);GO:0003408(optic cup formation involved in camera-type eye development);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006344(maintenance of chromatin silencing);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007369(gastrulation);GO:0007566(embryo implantation);GO:0019827(stem cell population maintenance);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030900(forebrain development);GO:0042766(nucleosome mobilization);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043044(ATP-dependent chromatin remodeling);GO:0048096(chromatin-mediated maintenance of transcription);GO:0055007(cardiac muscle cell differentiation);GO:0060674(placenta blood vessel development);GO:1901998(toxin transport);GO:0016514(SWI/SNF complex);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:0071565(nBAF complex)05225(Hepatocellular carcinoma);05225(Hepatocellular carcinoma)K11653NAAT-rich interaction domain 1A [Source:HGNC Symbol;Acc:HGNC:11110]1.92-2.03-3.35-0.88down1.090.130.801upno
chr126863228268644571230ENSG00000175793ENST0000033927690SFNGO:0005739(mitochondrion);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0019904(protein domain specific binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0042802(identical protein binding);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0045296(cadherin binding);GO:0070062(extracellular exosome);GO:0061024(membrane organization);GO:0007165(signal transduction);GO:0005615(extracellular space);GO:0061436(establishment of skin barrier);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:0030659(cytoplasmic vesicle membrane);GO:0001836(release of cytochrome c from mitochondria);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045606(positive regulation of epidermal cell differentiation);GO:0008426(protein kinase C inhibitor activity);GO:0019901(protein kinase binding);GO:0051219(phosphoprotein binding);GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0003334(keratinocyte development);GO:0006469(negative regulation of protein kinase activity);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010482(regulation of epidermal cell division);GO:0010839(negative regulation of keratinocyte proliferation);GO:0030216(keratinocyte differentiation);GO:0030307(positive regulation of cell growth);GO:0031424(keratinization);GO:0043588(skin development);GO:0046827(positive regulation of protein export from nucleus);GO:0051726(regulation of cell cycle)04110(Cell cycle);04115(p53 signaling pathway);04960(Aldosterone-regulated sodium reabsorption)K06644NAstratifin [Source:HGNC Symbol;Acc:HGNC:10773]26.10-3.37-5.06-0.19downinfinf11upno
chr12699370726994096390ENSG00000253368ENST000005221110TRNP1GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0042127(regulation of cell proliferation);GO:0051726(regulation of cell cycle);GO:0005719(nuclear euchromatin);GO:0021696(cerebellar cortex morphogenesis);GO:0061351(neural precursor cell proliferation)NANANATMF1-regulated nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:34348]3.86-2.99-4.58-0.50down1.190.250.671upno
chr126994545270001205576ENSG00000253368ENST00000531285226TRNP1GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0042127(regulation of cell proliferation);GO:0051726(regulation of cell cycle);GO:0005719(nuclear euchromatin);GO:0021696(cerebellar cortex morphogenesis);GO:0061351(neural precursor cell proliferation)NANANATMF1-regulated nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:34348]3.37-12.10-14.90-0.43down1.190.250.671upno
chr12874297928743188210ENSG00000198492ENST000004688633888YTHDF2GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0000932(P-body);GO:0005515(protein binding);GO:0006959(humoral immune response);GO:1990247(N6-methyladenosine-containing RNA binding);GO:0048598(embryonic morphogenesis);GO:0043488(regulation of mRNA stability);GO:0061157(mRNA destabilization);GO:1903679(positive regulation of cap-independent translational initiation);GO:1903679(positive regulation of cap-independent translational initiation)NANANAYTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675]1.68-1.32-2.41-0.63down0.48-1.060.121downno
chr1313489513136439215442ENSG00000229044ENST00000430143-2152AL451070.1NANANANANA3.74-1.72-2.940.57up1011nono
chr13143423331434441209ENSG00000168528ENST0000053638420420SERINC2GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006665(sphingolipid metabolic process);GO:0006658(phosphatidylserine metabolic process);GO:0070062(extracellular exosome);GO:0015194(L-serine transmembrane transporter activity);GO:0015825(L-serine transport);GO:1904219(positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity);GO:1904222(positive regulation of serine C-palmitoyltransferase activity);GO:1904222(positive regulation of serine C-palmitoyltransferase activity)NANANAserine incorporator 2 [Source:HGNC Symbol;Acc:HGNC:23231]2.11-2.64-4.15-0.88down0.88-0.180.831downno
chr13158703031587626597ENSG00000142910ENST000004805861879TINAGL1GO:0005615(extracellular space);GO:0005515(protein binding);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0005576(extracellular region);GO:0006955(immune response);GO:0005044(scavenger receptor activity);GO:0006898(receptor-mediated endocytosis);GO:0030247(polysaccharide binding);GO:0070062(extracellular exosome);GO:0007155(cell adhesion);GO:0016197(endosomal transport);GO:0031012(extracellular matrix);GO:0005201(extracellular matrix structural constituent);GO:0043236(laminin binding);GO:0005737(cytoplasm);GO:0005737(cytoplasm)NANANAtubulointerstitial nephritis antigen like 1 [Source:HGNC Symbol;Acc:HGNC:19168]3.02-2.18-3.56-0.37down0.80-0.320.661downno
chr132193259321954212163ENSG00000160050ENST00000373602-4965CCDC28BGO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0060271(cilium assembly);GO:0030030(cell projection organization);GO:0030030(cell projection organization)NANANAcoiled-coil domain containing 28B [Source:HGNC Symbol;Acc:HGNC:28163]9.21-1.38-2.49-0.29down1.160.210.721upno
chr13277098132771550570ENSG00000162522ENST000003734805314KIAA1522GO:0030154(cell differentiation);GO:0030154(cell differentiation)NANANAKIAA1522 [Source:HGNC Symbol;Acc:HGNC:29301]3.67-3.38-5.07-0.31down1.170.230.691upno
chr13328159333281831239ENSG00000160094ENST000004779341243ZNF362GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0003677(DNA binding)NANANAzinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079]4.54-1.61-2.801.09up1.060.090.851upno
chr1361561993617154615348ENSG00000116871ENST000003731510MAP7D1GO:0000226(microtubule cytoskeleton organization);GO:0015630(microtubule cytoskeleton);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005819(spindle);GO:0005198(structural molecule activity);GO:0005198(structural molecule activity)NANANAMAP7 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25514]8.10-2.99-4.58-0.27down0.97-0.050.981downno
chr13618031036180849540ENSG00000116871ENST000004871141289MAP7D1GO:0000226(microtubule cytoskeleton organization);GO:0015630(microtubule cytoskeleton);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005819(spindle);GO:0005198(structural molecule activity);GO:0005198(structural molecule activity)NANANAMAP7 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25514]22.90-1.31-2.39-0.27down0.97-0.050.981downno
chr136296667363043087642ENSG00000214193ENST00000453908-2079SH3D21GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0070062(extracellular exosome);GO:0070062(extracellular exosome)NANANASH3 domain containing 21 [Source:HGNC Symbol;Acc:HGNC:26236]23.60-3.44-5.150.48up0.73-0.460.541downno
chr13632237936322529151ENSG00000142694ENST000004904661086EVA1BGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005515(protein binding);GO:0005515(protein binding)NANANAeva-1 homolog B [Source:HGNC Symbol;Acc:HGNC:25558]2.15-2.08-3.42-0.80down1.260.330.581upno
chr13779958437800211628ENSG00000233728ENST00000433474668AL929472.3NANANANANA3.73-1.68-2.88-0.29down1011nono
chr13780810937808495387ENSG00000196449ENST000003730440YRDCGO:0016020(membrane);GO:0005739(mitochondrion);GO:0003725(double-stranded RNA binding);GO:0005737(cytoplasm);GO:0000049(tRNA binding);GO:0051051(negative regulation of transport);GO:0016779(nucleotidyltransferase activity);GO:0002949(tRNA threonylcarbamoyladenosine modification);GO:0006450(regulation of translational fidelity)NANANAyrdC N6-threonylcarbamoyltransferase domain containing [Source:HGNC Symbol;Acc:HGNC:28905]11.60-5.53-7.61-1.11down1.030.040.911upno
chr139026376390346368261ENSG00000168653ENST0000037296958NDUFS5GO:0016020(membrane);GO:0055114(oxidation-reduction process);GO:0005743(mitochondrial inner membrane);GO:0005739(mitochondrion);GO:0070469(respiratory chain);GO:0005758(mitochondrial intermembrane space);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0005747(mitochondrial respiratory chain complex I)00190(Oxidative phosphorylation);04723(Retrograde endocannabinoid signaling);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))K03938NANADH:ubiquinone oxidoreductase subunit S5 [Source:HGNC Symbol;Acc:HGNC:7712]113-1.40-2.51-0.80down1.630.710.261upno
chr1393883873940953121145ENSG00000127603ENST000005302750MACF1GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0005874(microtubule);GO:0045296(cadherin binding);GO:0051015(actin filament binding);GO:0045773(positive regulation of axon extension);GO:0032587(ruffle membrane);GO:0042060(wound healing);GO:0051893(regulation of focal adhesion assembly);GO:0032886(regulation of microtubule-based process);GO:0030177(positive regulation of Wnt signaling pathway);GO:0010632(regulation of epithelial cell migration);GO:0043001(Golgi to plasma membrane protein transport);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0015629(actin cytoskeleton);GO:0015629(actin cytoskeleton)NANANAmicrotubule-actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]2.87-2.41-3.850.53up0.74-0.430.551downno
chr13941259039412830241ENSG00000127603ENST000006411041567MACF1GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005856(cytoskeleton);GO:0008017(microtubule binding);GO:0016055(Wnt signaling pathway);GO:0016887(ATPase activity);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0042995(cell projection);GO:0005515(protein binding);GO:0005874(microtubule);GO:0045296(cadherin binding);GO:0051015(actin filament binding);GO:0045773(positive regulation of axon extension);GO:0032587(ruffle membrane);GO:0042060(wound healing);GO:0051893(regulation of focal adhesion assembly);GO:0032886(regulation of microtubule-based process);GO:0030177(positive regulation of Wnt signaling pathway);GO:0010632(regulation of epithelial cell migration);GO:0043001(Golgi to plasma membrane protein transport);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0015629(actin cytoskeleton);GO:0015629(actin cytoskeleton)NANANAmicrotubule-actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664]1.41-1.77-3.010.42up0.74-0.430.551downno
chr13948570839485888181ENSG00000183682ENST00000331593-5758BMP8AGO:0008083(growth factor activity);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0005125(cytokine activity);GO:0005615(extracellular space);GO:0030154(cell differentiation);GO:0060395(SMAD protein signal transduction);GO:0001503(ossification);GO:0051216(cartilage development);GO:0005160(transforming growth factor beta receptor binding);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0030509(BMP signaling pathway);GO:0042981(regulation of apoptotic process);GO:0043408(regulation of MAPK cascade);GO:0048468(cell development);GO:2000505(regulation of energy homeostasis);GO:0046676(negative regulation of insulin secretion);GO:0070700(BMP receptor binding);GO:0002024(diet induced thermogenesis)04350(TGF-beta signaling pathway);04390(Hippo signaling pathway)K16622NAbone morphogenetic protein 8a [Source:HGNC Symbol;Acc:HGNC:21650]1.84-3.02-4.620.44up2.201.1311upno
chr14335908143359533453ENSG00000117399ENST0000037246268CDC20GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0051301(cell division);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0000922(spindle pole);GO:0005815(microtubule organizing center);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016579(protein deubiquitination);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition);GO:0008022(protein C-terminus binding);GO:0010997(anaphase-promoting complex binding);GO:0097027(ubiquitin-protein transferase activator activity);GO:1904668(positive regulation of ubiquitin protein ligase activity);GO:0007062(sister chromatid cohesion);GO:0019899(enzyme binding);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0005680(anaphase-promoting complex);GO:0005819(spindle);GO:0090129(positive regulation of synapse maturation);GO:0031915(positive regulation of synaptic plasticity);GO:0042826(histone deacetylase binding);GO:0007064(mitotic sister chromatid cohesion);GO:0008284(positive regulation of cell proliferation);GO:0040020(regulation of meiotic nuclear division);GO:0050773(regulation of dendrite development);GO:0090307(mitotic spindle assembly);GO:0005813(centrosome);GO:0043234(protein complex);GO:0048471(perinuclear region of cytoplasm);GO:0048471(perinuclear region of cytoplasm)04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);05203(Viral carcinogenesis);05166(HTLV-I infection);05166(HTLV-I infection)NANAcell division cycle 20 [Source:HGNC Symbol;Acc:HGNC:1723]8.93-2.16-3.52-0.57down0.90-0.150.861downno
chr14360362743604166540ENSG00000142949ENST00000463041-1416PTPRFGO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0007155(cell adhesion);GO:0004725(protein tyrosine phosphatase activity);GO:0016791(phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0005886(plasma membrane);GO:0008201(heparin binding);GO:0070062(extracellular exosome);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0005887(integral component of plasma membrane);GO:0016477(cell migration);GO:0007185(transmembrane receptor protein tyrosine phosphatase signaling pathway);GO:0005001(transmembrane receptor protein tyrosine phosphatase activity);GO:0032403(protein complex binding);GO:0035373(chondroitin sulfate proteoglycan binding);GO:0010975(regulation of neuron projection development);GO:0031102(neuron projection regeneration);GO:0048679(regulation of axon regeneration);GO:1900121(negative regulation of receptor binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043025(neuronal cell body)04514(Cell adhesion molecules (CAMs));04520(Adherens junction);04910(Insulin signaling pathway);04931(Insulin resistance);04931(Insulin resistance)K05695EC:3.1.3.48protein tyrosine phosphatase, receptor type F [Source:HGNC Symbol;Acc:HGNC:9670]5.59-5.19-7.20-0.30down1.030.040.911upno
chr14396760343968022420ENSG00000117408ENST00000486876443IPO13GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0005515(protein binding);GO:0008536(Ran GTPase binding);GO:0008139(nuclear localization sequence binding);GO:0008565(protein transporter activity);GO:0031965(nuclear membrane);GO:0006606(protein import into nucleus);GO:0006606(protein import into nucleus)NANANAimportin 13 [Source:HGNC Symbol;Acc:HGNC:16853]8.32-1.36-2.45-1.48down0.97-0.050.991downno
chr14397230343972592290ENSG00000132768ENST00000527319834DPH2GO:0016740(transferase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine);GO:0090560(2-(3-amino-3-carboxypropyl)histidine synthase activity);GO:0090560(2-(3-amino-3-carboxypropyl)histidine synthase activity)NANANADPH2 homolog [Source:HGNC Symbol;Acc:HGNC:3004]2.55-1.35-2.45-0.54down0.34-1.570.020.91downyes
chr14399036243990781420ENSG00000159214ENST00000486064-578CCDC24GO:0005515(protein binding);GO:0005515(protein binding)NANANAcoiled-coil domain containing 24 [Source:HGNC Symbol;Acc:HGNC:28688]2.31-1.47-2.62-0.23down0.84-0.250.741downno
chr14463203444632296263ENSG00000187147ENST000004974690RNF220GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0016740(transferase activity);GO:0016567(protein ubiquitination);GO:0005515(protein binding);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0004842(ubiquitin-protein transferase activity);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0061630(ubiquitin protein ligase activity)NANANAring finger protein 220 [Source:HGNC Symbol;Acc:HGNC:25552]16.10-3.07-4.68-1.08down0.60-0.730.291downno
chr14550895545509194240ENSG00000132763ENST00000477188-239MMACHCGO:0005737(cytoplasm);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0042803(protein homodimerization activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0031419(cobalamin binding);GO:0071949(FAD binding);GO:0009235(cobalamin metabolic process);GO:0043295(glutathione binding);GO:0006749(glutathione metabolic process);GO:0032451(demethylase activity);GO:0009236(cobalamin biosynthetic process);GO:0033787(cyanocobalamin reductase (cyanide-eliminating) activity);GO:0070988(demethylation);GO:0005739(mitochondrion)04977(Vitamin digestion and absorption)K14618NAmethylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria [Source:HGNC Symbol;Acc:HGNC:24525]2.56-1.46-2.60-0.70down1.030.040.911upno
chr145606656456078361181ENSG00000281825ENST00000626823-926AL355480.4NANANANANA6.35-3.85-5.640.52up1011nono
chr150970312509743043993ENSG00000123080ENST00000371761368CDKN2CGO:0008285(negative regulation of cell proliferation);GO:0005737(cytoplasm);GO:0005634(nucleus);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0005829(cytosol);GO:0019901(protein kinase binding);GO:0030308(negative regulation of cell growth);GO:0007050(cell cycle arrest);GO:0000082(G1/S transition of mitotic cell cycle);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0042326(negative regulation of phosphorylation);GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0048709(oligodendrocyte differentiation)04110(Cell cycle);05202(Transcriptional misregulation in cancers);05166(HTLV-I infection);01522(Endocrine resistance)NANAcyclin dependent kinase inhibitor 2C [Source:HGNC Symbol;Acc:HGNC:1789]4.45-1.56-2.74-0.48down1.340.420.491upno
chr15506434555064673329ENSG00000162402ENST000004809628319USP24GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0005654(nucleoplasm);GO:0005654(nucleoplasm)NANANAubiquitin specific peptidase 24 [Source:HGNC Symbol;Acc:HGNC:12623]1.83-2.31-3.72-0.84down1.010.010.951upno
chr18558285585583304450ENSG00000142871ENST000004804131655CYR61GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0001934(positive regulation of protein phosphorylation);GO:0030335(positive regulation of cell migration);GO:0030513(positive regulation of BMP signaling pathway);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0000166(nucleotide binding);GO:0007155(cell adhesion);GO:0005576(extracellular region);GO:0005520(insulin-like growth factor binding);GO:0001558(regulation of cell growth);GO:0006935(chemotaxis);GO:0008201(heparin binding);GO:0044267(cellular protein metabolic process);GO:0031012(extracellular matrix);GO:0043687(post-translational protein modification);GO:0007267(cell-cell signaling);GO:0005578(proteinaceous extracellular matrix);GO:0045669(positive regulation of osteoblast differentiation);GO:0005788(endoplasmic reticulum lumen);GO:0009653(anatomical structure morphogenesis);GO:0008283(cell proliferation);GO:0045860(positive regulation of protein kinase activity);GO:0005178(integrin binding);GO:0019838(growth factor binding);GO:0050840(extracellular matrix binding);GO:0001649(osteoblast differentiation);GO:0002041(intussusceptive angiogenesis);GO:0003181(atrioventricular valve morphogenesis);GO:0003278(apoptotic process involved in heart morphogenesis);GO:0003281(ventricular septum development);GO:0010518(positive regulation of phospholipase activity);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016337(single organismal cell-cell adhesion);GO:0030198(extracellular matrix organization);GO:0033690(positive regulation of osteoblast proliferation);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0044319(wound healing, spreading of cells);GO:0045597(positive regulation of cell differentiation);GO:0060413(atrial septum morphogenesis);GO:0060548(negative regulation of cell death);GO:0060591(chondroblast differentiation);GO:0060710(chorio-allantoic fusion);GO:0060716(labyrinthine layer blood vessel development);GO:0061036(positive regulation of cartilage development);GO:0072593(reactive oxygen species metabolic process);GO:2000304(positive regulation of ceramide biosynthetic process);GO:0005615(extracellular space)NANANAcysteine rich angiogenic inducer 61 [Source:HGNC Symbol;Acc:HGNC:2654]5.26-1.35-2.450.17up0.96-0.060.971downno
chr1109929406109930004599ENSG00000184371ENST0000052600113749CSF1GO:0016021(integral component of membrane);GO:0008083(growth factor activity);GO:0005125(cytokine activity);GO:0005615(extracellular space);GO:0010628(positive regulation of gene expression);GO:0048471(perinuclear region of cytoplasm);GO:0030335(positive regulation of cell migration);GO:0016020(membrane);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0030154(cell differentiation);GO:0002376(immune system process);GO:0045087(innate immune response);GO:0006954(inflammatory response);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0008283(cell proliferation);GO:0008284(positive regulation of cell proliferation);GO:0042803(protein homodimerization activity);GO:0005788(endoplasmic reticulum lumen);GO:0030097(hemopoiesis);GO:0001954(positive regulation of cell-matrix adhesion);GO:0045860(positive regulation of protein kinase activity);GO:0042117(monocyte activation);GO:0030316(osteoclast differentiation);GO:0045672(positive regulation of osteoclast differentiation);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0032270(positive regulation of cellular protein metabolic process);GO:0045651(positive regulation of macrophage differentiation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0030225(macrophage differentiation);GO:1990682(CSF1-CSF1R complex);GO:0010759(positive regulation of macrophage chemotaxis);GO:0005157(macrophage colony-stimulating factor receptor binding);GO:0002158(osteoclast proliferation);GO:0003006(developmental process involved in reproduction);GO:0010743(regulation of macrophage derived foam cell differentiation);GO:0030278(regulation of ossification);GO:0032946(positive regulation of mononuclear cell proliferation);GO:0038145(macrophage colony-stimulating factor signaling pathway);GO:0040018(positive regulation of multicellular organism growth);GO:0042488(positive regulation of odontogenesis of dentin-containing tooth);GO:0045657(positive regulation of monocyte differentiation);GO:0046579(positive regulation of Ras protein signal transduction);GO:0048873(homeostasis of number of cells within a tissue);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060611(mammary gland fat development);GO:0060763(mammary duct terminal end bud growth);GO:1902228(positive regulation of macrophage colony-stimulating factor signaling pathway);GO:1904141(positive regulation of microglial cell migration);GO:1904141(positive regulation of microglial cell migration)04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04668(TNF signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);04380(Osteoclast differentiation);05323(Rheumatoid arthritis);05323(Rheumatoid arthritis)K05453NAcolony stimulating factor 1 [Source:HGNC Symbol;Acc:HGNC:2432]3.50-3.81-5.59-0.55down1.120.170.761upno
chr1111766908111767088181ENSG00000064703ENST000005342004491DDX20GO:0003676(nucleic acid binding);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0004386(helicase activity);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0016604(nuclear body);GO:0005730(nucleolus);GO:0000387(spliceosomal snRNP assembly);GO:0005654(nucleoplasm);GO:0010501(RNA secondary structure unwinding);GO:0043065(positive regulation of apoptotic process);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0005856(cytoskeleton);GO:0004004(ATP-dependent RNA helicase activity);GO:0051170(nuclear import);GO:0032797(SMN complex);GO:0034719(SMN-Sm protein complex);GO:0097504(Gemini of coiled bodies);GO:0006396(RNA processing);GO:0070491(repressing transcription factor binding);GO:0000244(spliceosomal tri-snRNP complex assembly);GO:0019904(protein domain specific binding);GO:0030674(protein binding, bridging);GO:0042826(histone deacetylase binding);GO:0008285(negative regulation of cell proliferation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048477(oogenesis);GO:0050810(regulation of steroid biosynthetic process);GO:0017053(transcriptional repressor complex);GO:0090571(RNA polymerase II transcription repressor complex);GO:0090571(RNA polymerase II transcription repressor complex)03013(RNA transport);03013(RNA transport)K13131EC:3.6.4.13DEAD-box helicase 20 [Source:HGNC Symbol;Acc:HGNC:2743]2.71-1.38-2.491.99up1.020.020.931upno
chr1112456911112457360450ENSG00000143079ENST0000060703993CTTNBP2NLGO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0015629(actin cytoskeleton);GO:0051721(protein phosphatase 2A binding);GO:0032410(negative regulation of transporter activity);GO:0034763(negative regulation of transmembrane transport);GO:0034763(negative regulation of transmembrane transport)NANANACTTNBP2 N-terminal like [Source:HGNC Symbol;Acc:HGNC:25330]3.12-1.43-2.560.46up0.43-1.220.071downno
chr11476158611476195243664ENSG00000116128ENST000004732924248BCL9GO:0005634(nucleus);GO:0003713(transcription coactivator activity);GO:0008013(beta-catenin binding);GO:0014908(myotube differentiation involved in skeletal muscle regeneration);GO:0035019(somatic stem cell population maintenance);GO:0035914(skeletal muscle cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060070(canonical Wnt signaling pathway);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0005515(protein binding);GO:0016055(Wnt signaling pathway);GO:0005654(nucleoplasm);GO:1904837(beta-catenin-TCF complex assembly);GO:1904837(beta-catenin-TCF complex assembly)NANANAB-cell CLL/lymphoma 9 [Source:HGNC Symbol;Acc:HGNC:1008]4.68-1.36-2.46-0.38down1.00-0.000.961downno
chr1149900232149900798567ENSG00000178096ENST00000369150606BOLA1GO:0005739(mitochondrion);GO:0005515(protein binding)NANANAbolA family member 1 [Source:HGNC Symbol;Acc:HGNC:24263]15-1.31-2.39-0.40down0.75-0.4211downno
chr1150471599150472347749ENSG00000143374ENST00000438568-15017TARS2GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0006412(translation);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0042803(protein homodimerization activity);GO:0016874(ligase activity);GO:0005759(mitochondrial matrix);GO:0004812(aminoacyl-tRNA ligase activity);GO:0006418(tRNA aminoacylation for protein translation);GO:0006450(regulation of translational fidelity);GO:0016876(ligase activity, forming aminoacyl-tRNA and related compounds);GO:0043039(tRNA aminoacylation);GO:0004829(threonine-tRNA ligase activity);GO:0006435(threonyl-tRNA aminoacylation);GO:0002161(aminoacyl-tRNA editing activity);GO:0070159(mitochondrial threonyl-tRNA aminoacylation);GO:0070159(mitochondrial threonyl-tRNA aminoacylation)00970(Aminoacyl-tRNA biosynthesis);00970(Aminoacyl-tRNA biosynthesis)K01868EC:6.1.1.3threonyl-tRNA synthetase 2, mitochondrial (putative) [Source:HGNC Symbol;Acc:HGNC:30740]4.21-1.44-2.570.33up1.050.070.881upno
chr1151286971151287420450ENSG00000143373ENST00000426871-64ZNF687GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005515(protein binding)NANANAzinc finger protein 687 [Source:HGNC Symbol;Acc:HGNC:29277]3.65-1.37-2.47-0.40down1.100.140.791upno
chr1151291491151291731241ENSG00000143373ENST000004366141040ZNF687GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005515(protein binding)NANANAzinc finger protein 687 [Source:HGNC Symbol;Acc:HGNC:29277]8.65-1.85-3.12-1.87down1.100.140.791upno
chr1151759642151759911270ENSG00000143436ENST000004958671009MRPL9GO:0003723(RNA binding);GO:0006412(translation);GO:0005739(mitochondrion);GO:0030529(intracellular ribonucleoprotein complex);GO:0005622(intracellular);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0005515(protein binding);GO:0005743(mitochondrial inner membrane);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination);GO:0005761(mitochondrial ribosome);GO:0005762(mitochondrial large ribosomal subunit);GO:0005762(mitochondrial large ribosomal subunit)03010(Ribosome);03010(Ribosome)K02939NAmitochondrial ribosomal protein L9 [Source:HGNC Symbol;Acc:HGNC:14277]2.67-1.76-2.990.54up0.89-0.170.841downno
chr1153661237153661385149ENSG00000143553ENST000004785582510SNAPINGO:0005737(cytoplasm);GO:0016020(membrane);GO:0006886(intracellular protein transport);GO:0005794(Golgi apparatus);GO:0005765(lysosomal membrane);GO:1904115(axon cytoplasm);GO:0005829(cytosol);GO:0005515(protein binding);GO:0000139(Golgi membrane);GO:0048471(perinuclear region of cytoplasm);GO:0030054(cell junction);GO:0045202(synapse);GO:0031410(cytoplasmic vesicle);GO:0005764(lysosome);GO:0031083(BLOC-1 complex);GO:0006887(exocytosis);GO:0016032(viral process);GO:0008333(endosome to lysosome transport);GO:0008089(anterograde axonal transport);GO:0032438(melanosome organization);GO:0048490(anterograde synaptic vesicle transport);GO:0030672(synaptic vesicle membrane);GO:0031175(neuron projection development);GO:0048489(synaptic vesicle transport);GO:0008021(synaptic vesicle);GO:0030141(secretory granule);GO:0007269(neurotransmitter secretion);GO:0000149(SNARE binding);GO:0007040(lysosome organization);GO:0007042(lysosomal lumen acidification);GO:0007268(chemical synaptic transmission);GO:0008090(retrograde axonal transport);GO:0010977(negative regulation of neuron projection development);GO:0016079(synaptic vesicle exocytosis);GO:0016188(synaptic vesicle maturation);GO:0031629(synaptic vesicle fusion to presynaptic active zone membrane);GO:0032418(lysosome localization);GO:0034629(cellular protein complex localization);GO:0043393(regulation of protein binding);GO:0051604(protein maturation);GO:0072553(terminal button organization);GO:0097352(autophagosome maturation);GO:1902774(late endosome to lysosome transport);GO:1902824(positive regulation of late endosome to lysosome transport);GO:0099078(BORC complex)NANANASNAP associated protein [Source:HGNC Symbol;Acc:HGNC:17145]1.28-1.34-2.43-0.51down0.87-0.200.801downno
chr1155017775155018522748ENSG00000160685ENST000002921763327ZBTB7BGO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0006366(transcription from RNA polymerase II promoter);GO:0007398(ectoderm development);GO:0010628(positive regulation of gene expression);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0042803(protein homodimerization activity);GO:0043370(regulation of CD4-positive, alpha-beta T cell differentiation);GO:0043376(regulation of CD8-positive, alpha-beta T cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)NANANAzinc finger and BTB domain containing 7B [Source:HGNC Symbol;Acc:HGNC:18668]8.79-2.94-4.52-0.63down1.070.090.851upno
chr11557370181557385301513ENSG00000132676ENST000004917776DAP3GO:0003723(RNA binding);GO:0000166(nucleotide binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0030529(intracellular ribonucleoprotein complex);GO:0005840(ribosome);GO:0005525(GTP binding);GO:0015935(small ribosomal subunit);GO:0006915(apoptotic process);GO:0005515(protein binding);GO:0005761(mitochondrial ribosome);GO:0003735(structural constituent of ribosome);GO:0005763(mitochondrial small ribosomal subunit);GO:0005743(mitochondrial inner membrane);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination);GO:0097190(apoptotic signaling pathway);GO:0097190(apoptotic signaling pathway)NANANAdeath associated protein 3 [Source:HGNC Symbol;Acc:HGNC:2673]9.95-2.17-3.540.76up0.77-0.380.601downno
chr1156114674156115004331ENSG00000160789ENST000003683000LMNAGO:0030334(regulation of cell migration);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005882(intermediate filament);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0031012(extracellular matrix);GO:0031965(nuclear membrane);GO:0005635(nuclear envelope);GO:0036498(IRE1-mediated unfolded protein response);GO:0034504(protein localization to nucleus);GO:0071456(cellular response to hypoxia);GO:0007077(mitotic nuclear envelope disassembly);GO:0005652(nuclear lamina);GO:0007084(mitotic nuclear envelope reassembly);GO:0008285(negative regulation of cell proliferation);GO:0030951(establishment or maintenance of microtubule cytoskeleton polarity);GO:0090343(positive regulation of cell aging);GO:0006997(nucleus organization);GO:0006998(nuclear envelope organization);GO:0010628(positive regulation of gene expression);GO:0035105(sterol regulatory element binding protein import into nucleus);GO:0055015(ventricular cardiac muscle cell development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:1900180(regulation of protein localization to nucleus);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0005638(lamin filament);GO:0005638(lamin filament)04210(Apoptosis);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05414(Dilated cardiomyopathy (DCM))K12641NAlamin A/C [Source:HGNC Symbol;Acc:HGNC:6636]8.29-3.57-5.31-0.20down0.77-0.370.611downno
chr11561152741561232007927ENSG00000160789ENST000005023570LMNAGO:0030334(regulation of cell migration);GO:0005634(nucleus);GO:0016607(nuclear speck);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005882(intermediate filament);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0031012(extracellular matrix);GO:0031965(nuclear membrane);GO:0005635(nuclear envelope);GO:0036498(IRE1-mediated unfolded protein response);GO:0034504(protein localization to nucleus);GO:0071456(cellular response to hypoxia);GO:0007077(mitotic nuclear envelope disassembly);GO:0005652(nuclear lamina);GO:0007084(mitotic nuclear envelope reassembly);GO:0008285(negative regulation of cell proliferation);GO:0030951(establishment or maintenance of microtubule cytoskeleton polarity);GO:0090343(positive regulation of cell aging);GO:0006997(nucleus organization);GO:0006998(nuclear envelope organization);GO:0010628(positive regulation of gene expression);GO:0035105(sterol regulatory element binding protein import into nucleus);GO:0055015(ventricular cardiac muscle cell development);GO:0072201(negative regulation of mesenchymal cell proliferation);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:1900180(regulation of protein localization to nucleus);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:0005638(lamin filament);GO:0005638(lamin filament)04210(Apoptosis);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05414(Dilated cardiomyopathy (DCM))K12641NAlamin A/C [Source:HGNC Symbol;Acc:HGNC:6636]1.45-1.48-2.63-0.44down0.77-0.370.611downno
chr11566419631566460924130ENSG00000132692ENST000004577770BCANGO:0016020(membrane);GO:0030246(carbohydrate binding);GO:0007155(cell adhesion);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0031225(anchored component of membrane);GO:0005540(hyaluronic acid binding);GO:0043202(lysosomal lumen);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0005796(Golgi lumen);GO:0005201(extracellular matrix structural constituent);GO:0001501(skeletal system development);GO:0007417(central nervous system development);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030207(chondroitin sulfate catabolic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0022617(extracellular matrix disassembly);GO:0021766(hippocampus development);GO:0021766(hippocampus development)NANANAbrevican [Source:HGNC Symbol;Acc:HGNC:23059]7.08-3.27-4.94-0.78down1.160.220.711upno
chr1158094725158095174450ENSG00000183853ENST000003681728045KIRREL1GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0007411(axon guidance);GO:0005911(cell-cell junction);GO:0031295(T cell costimulation);GO:0017022(myosin binding);GO:0001933(negative regulation of protein phosphorylation);GO:0007588(excretion);GO:0016337(single organismal cell-cell adhesion);GO:0030838(positive regulation of actin filament polymerization);GO:0031253(cell projection membrane);GO:0043198(dendritic shaft);GO:0045121(membrane raft);GO:0045121(membrane raft)NANANAkirre like nephrin family adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:15734]4-2.94-4.51-0.36down1.060.080.861upno
chr1159782219159782543325ENSG00000158716ENST000003681071216DUSP23GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005654(nucleoplasm);GO:0016787(hydrolase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016791(phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0005829(cytosol);GO:0004721(phosphoprotein phosphatase activity);GO:0005515(protein binding);GO:0070062(extracellular exosome);GO:0004722(protein serine/threonine phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity)NANANAdual specificity phosphatase 23 [Source:HGNC Symbol;Acc:HGNC:21480]34.20-1.64-2.83-0.35down1.030.050.901upno
chr1162383343162383792450ENSG00000239887ENST000004586261613C1orf226NANANANAchromosome 1 open reading frame 226 [Source:HGNC Symbol;Acc:HGNC:34351]3.09-1.39-2.510.57up1.850.890.161upno
chr11659059291659082702342ENSG00000283936ENST000006362910MIR3658NANANANANA3.77-1.73-2.960.43up1011nono
chr1169106354169106683330ENSG00000143153ENST0000036781531ATP1B1GO:0006810(transport);GO:0016020(membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0005622(intracellular);GO:0016021(integral component of membrane);GO:0007155(cell adhesion);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0050900(leukocyte migration);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0090662(ATP hydrolysis coupled transmembrane transport);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0042383(sarcolemma);GO:1903278(positive regulation of sodium ion export from cell);GO:1903779(regulation of cardiac conduction);GO:1903561(extracellular vesicle);GO:0051117(ATPase binding);GO:0050821(protein stabilization);GO:0060048(cardiac muscle contraction);GO:0005524(ATP binding);GO:0010107(potassium ion import);GO:0014704(intercalated disc);GO:0016887(ATPase activity);GO:0023026(MHC class II protein complex binding);GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0006883(cellular sodium ion homeostasis);GO:0030007(cellular potassium ion homeostasis);GO:0036376(sodium ion export from cell);GO:0055119(relaxation of cardiac muscle);GO:0086009(membrane repolarization);GO:0086013(membrane repolarization during cardiac muscle cell action potential);GO:0086064(cell communication by electrical coupling involved in cardiac conduction);GO:1990573(potassium ion import across plasma membrane);GO:0008144(drug binding);GO:0001671(ATPase activator activity);GO:0006874(cellular calcium ion homeostasis);GO:0010468(regulation of gene expression);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0032781(positive regulation of ATPase activity);GO:0044861(protein transport into plasma membrane raft);GO:0046034(ATP metabolic process);GO:0072659(protein localization to plasma membrane);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903281(positive regulation of calcium:sodium antiporter activity);GO:1903288(positive regulation of potassium ion import);GO:0008022(protein C-terminus binding);GO:0019901(protein kinase binding);GO:0001666(response to hypoxia);GO:0030001(metal ion transport);GO:1903169(regulation of calcium ion transmembrane transport);GO:0005901(caveola);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0043209(myelin sheath);GO:0043209(myelin sheath)04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04925(Aldosterone synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation);04964(Proximal tubule bicarbonate reclamation)K01540NAATPase Na+/K+ transporting subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:804]2.75-2.11-3.46-0.87down1.010.020.941upno
chr1169131346169131466121ENSG00000143153ENST0000049479723439ATP1B1GO:0006810(transport);GO:0016020(membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0005622(intracellular);GO:0016021(integral component of membrane);GO:0007155(cell adhesion);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0050900(leukocyte migration);GO:0010248(establishment or maintenance of transmembrane electrochemical gradient);GO:0090662(ATP hydrolysis coupled transmembrane transport);GO:0070062(extracellular exosome);GO:0034220(ion transmembrane transport);GO:0042383(sarcolemma);GO:1903278(positive regulation of sodium ion export from cell);GO:1903779(regulation of cardiac conduction);GO:1903561(extracellular vesicle);GO:0051117(ATPase binding);GO:0050821(protein stabilization);GO:0060048(cardiac muscle contraction);GO:0005524(ATP binding);GO:0010107(potassium ion import);GO:0014704(intercalated disc);GO:0016887(ATPase activity);GO:0023026(MHC class II protein complex binding);GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0006883(cellular sodium ion homeostasis);GO:0030007(cellular potassium ion homeostasis);GO:0036376(sodium ion export from cell);GO:0055119(relaxation of cardiac muscle);GO:0086009(membrane repolarization);GO:0086013(membrane repolarization during cardiac muscle cell action potential);GO:0086064(cell communication by electrical coupling involved in cardiac conduction);GO:1990573(potassium ion import across plasma membrane);GO:0008144(drug binding);GO:0001671(ATPase activator activity);GO:0006874(cellular calcium ion homeostasis);GO:0010468(regulation of gene expression);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0032781(positive regulation of ATPase activity);GO:0044861(protein transport into plasma membrane raft);GO:0046034(ATP metabolic process);GO:0072659(protein localization to plasma membrane);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903281(positive regulation of calcium:sodium antiporter activity);GO:1903288(positive regulation of potassium ion import);GO:0008022(protein C-terminus binding);GO:0019901(protein kinase binding);GO:0001666(response to hypoxia);GO:0030001(metal ion transport);GO:1903169(regulation of calcium ion transmembrane transport);GO:0005901(caveola);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0043209(myelin sheath);GO:0043209(myelin sheath)04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04925(Aldosterone synthesis and secretion);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation);04964(Proximal tubule bicarbonate reclamation)K01540NAATPase Na+/K+ transporting subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:804]1.48-1.47-2.620.62up1.010.020.941upno
chr11715324231715354583036ENSG00000117523ENST00000495585-6372PRRC2CGO:0003723(RNA binding);GO:0016020(membrane);GO:0008022(protein C-terminus binding);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002244(hematopoietic progenitor cell differentiation)NANANAproline rich coiled-coil 2C [Source:HGNC Symbol;Acc:HGNC:24903]5.25-10.10-12.700.77up0.96-0.060.971downno
chr1171557638171558027390ENSG00000117523ENST0000049558515808PRRC2CGO:0003723(RNA binding);GO:0016020(membrane);GO:0008022(protein C-terminus binding);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002244(hematopoietic progenitor cell differentiation)NANANAproline rich coiled-coil 2C [Source:HGNC Symbol;Acc:HGNC:24903]4.08-3.39-5.090.47up0.96-0.060.971downno
chr1178916503178916713211ENSG00000116191ENST0000047887122665RALGPS2GO:0005737(cytoplasm);GO:0016020(membrane);GO:0007264(small GTPase mediated signal transduction);GO:0005886(plasma membrane);GO:0043547(positive regulation of GTPase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0032485(regulation of Ral protein signal transduction);GO:0005622(intracellular);GO:0005622(intracellular)NANANARal GEF with PH domain and SH3 binding motif 2 [Source:HGNC Symbol;Acc:HGNC:30279]2.79-1.64-2.831.43up0.80-0.310.671downno
chr1179917842179918291450ENSG00000143337ENST0000044796413876TOR1AIP1GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0005515(protein binding);GO:0005637(nuclear inner membrane);GO:0008092(cytoskeletal protein binding);GO:0034504(protein localization to nucleus);GO:0032781(positive regulation of ATPase activity);GO:0001671(ATPase activator activity);GO:0051117(ATPase binding);GO:0005521(lamin binding);GO:0071763(nuclear membrane organization);GO:0005635(nuclear envelope);GO:0005635(nuclear envelope)NANANAtorsin 1A interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:29456]3.34-2.62-4.120.57up1.140.190.731upno
chr1180196307180196845539ENSG00000116260ENST000004430590QSOX1GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005794(Golgi apparatus);GO:0043231(intracellular membrane-bounded organelle);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0045454(cell redox homeostasis);GO:0045171(intercellular bridge);GO:0005576(extracellular region);GO:0000139(Golgi membrane);GO:0005615(extracellular space);GO:0003756(protein disulfide isomerase activity);GO:0016972(thiol oxidase activity);GO:0070062(extracellular exosome);GO:0044267(cellular protein metabolic process);GO:0043687(post-translational protein modification);GO:0043312(neutrophil degranulation);GO:0030173(integral component of Golgi membrane);GO:0002576(platelet degranulation);GO:0005788(endoplasmic reticulum lumen);GO:0031093(platelet alpha granule lumen);GO:0016971(flavin-linked sulfhydryl oxidase activity);GO:0016242(negative regulation of macroautophagy);GO:0035580(specific granule lumen);GO:1904724(tertiary granule lumen);GO:0005623(cell)NANANAquiescin sulfhydryl oxidase 1 [Source:HGNC Symbol;Acc:HGNC:9756]6.74-2.49-3.95-0.22down1.050.070.871upno
chr1200848977200849246270ENSG00000118200ENST00000475326-6848CAMSAP2GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0031175(neuron projection development);GO:0008017(microtubule binding);GO:0005874(microtubule);GO:0005516(calmodulin binding);GO:0005813(centrosome);GO:1990752(microtubule end);GO:0000226(microtubule cytoskeleton organization);GO:0030507(spectrin binding);GO:0051011(microtubule minus-end binding);GO:0033043(regulation of organelle organization)NANANAcalmodulin regulated spectrin associated protein family member 2 [Source:HGNC Symbol;Acc:HGNC:29188]2.22-1.42-2.540.92up0.82-0.290.691downno
chr1201782690201783465776ENSG00000134369ENST0000046913060NAV1GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0007275(multicellular organism development);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0005874(microtubule);GO:0001578(microtubule bundle formation);GO:0001764(neuron migration);GO:0015630(microtubule cytoskeleton);GO:0043194(axon initial segment);GO:0043194(axon initial segment)NANANAneuron navigator 1 [Source:HGNC Symbol;Acc:HGNC:15989]2.46-2.44-3.89-0.78down1.030.040.911upno
chr1201876152201876421270ENSG00000198700ENST000004567071837IPO9GO:0006810(transport);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0008536(Ran GTPase binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005635(nuclear envelope);GO:0042393(histone binding);GO:0008565(protein transporter activity);GO:0006606(protein import into nucleus);GO:0006606(protein import into nucleus)NANANAimportin 9 [Source:HGNC Symbol;Acc:HGNC:19425]3.66-2.19-3.570.35up0.98-0.041.001downno
chr1203165520203165968449ENSG00000133055ENST000006213809815MYBPHGO:0007155(cell adhesion);GO:0005515(protein binding);GO:0051015(actin filament binding);GO:0051371(muscle alpha-actinin binding);GO:0097493(structural molecule activity conferring elasticity);GO:0007015(actin filament organization);GO:0045214(sarcomere organization);GO:0071688(striated muscle myosin thick filament assembly);GO:0005859(muscle myosin complex);GO:0030018(Z disc);GO:0031430(M band);GO:0032982(myosin filament);GO:0008307(structural constituent of muscle);GO:0006942(regulation of striated muscle contraction)NANANAmyosin binding protein H [Source:HGNC Symbol;Acc:HGNC:7552]4.93-3.16-4.800.39up3.511.8111upno
chr120668497420672900844035ENSG00000162889ENST000003671030MAPKAPK2GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0005654(nucleoplasm);GO:0016740(transferase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0005813(centrosome);GO:0005515(protein binding);GO:0006974(cellular response to DNA damage stimulus);GO:0006954(inflammatory response);GO:0005829(cytosol);GO:0070062(extracellular exosome);GO:0043488(regulation of mRNA stability);GO:0032496(response to lipopolysaccharide);GO:0005516(calmodulin binding);GO:0004871(signal transducer activity);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0031572(G2 DNA damage checkpoint);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0006950(response to stress);GO:0018105(peptidyl-serine phosphorylation);GO:1900034(regulation of cellular response to heat);GO:0000187(activation of MAPK activity);GO:0034097(response to cytokine);GO:0002224(toll-like receptor signaling pathway);GO:0007265(Ras protein signal transduction);GO:0032680(regulation of tumor necrosis factor production);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0006691(leukotriene metabolic process);GO:0000165(MAPK cascade);GO:0004683(calmodulin-dependent protein kinase activity);GO:0009931(calcium-dependent protein serine/threonine kinase activity);GO:0051019(mitogen-activated protein kinase binding);GO:0032675(regulation of interleukin-6 production);GO:0044351(macropinocytosis);GO:0046777(protein autophosphorylation);GO:0038066(p38MAPK cascade);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0048255(mRNA stabilization);GO:0048839(inner ear development);GO:0048839(inner ear development)04010(MAPK signaling pathway);04370(VEGF signaling pathway);04218(Cellular senescence);04722(Neurotrophin signaling pathway);05203(Viral carcinogenesis);05167(Kaposi's sarcoma-associated herpesvirus infection);05167(Kaposi's sarcoma-associated herpesvirus infection)K04443EC:2.7.11.1mitogen-activated protein kinase-activated protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:6887]8.76-1.38-2.49-0.32down1.040.050.891upno
chr12124443442124463792036ENSG00000117691ENST0000047238911353NENFGO:0046872(metal ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0012505(endomembrane system);GO:0016020(membrane);GO:0032099(negative regulation of appetite);GO:0008083(growth factor activity);GO:0043410(positive regulation of MAPK cascade);GO:0043410(positive regulation of MAPK cascade)NANANAneudesin neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:30384]14.20-1.35-2.45-0.39down1.130.180.751upno
chr1214663689214663869181ENSG00000117724ENST000004698628541CENPFGO:0005634(nucleus);GO:0005737(cytoplasm);GO:0015031(protein transport);GO:0005654(nucleoplasm);GO:0051301(cell division);GO:0005694(chromosome);GO:0042803(protein homodimerization activity);GO:0008134(transcription factor binding);GO:0005856(cytoskeleton);GO:0005515(protein binding);GO:0007049(cell cycle);GO:0007275(multicellular organism development);GO:0048471(perinuclear region of cytoplasm);GO:0030154(cell differentiation);GO:0000922(spindle pole);GO:0005819(spindle);GO:0030496(midbody);GO:0007059(chromosome segregation);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0005829(cytosol);GO:0003682(chromatin binding);GO:0008283(cell proliferation);GO:0070840(dynein complex binding);GO:0007517(muscle organ development);GO:0008022(protein C-terminus binding);GO:0071897(DNA biosynthetic process);GO:0007062(sister chromatid cohesion);GO:0045892(negative regulation of transcription, DNA-templated);GO:0000785(chromatin);GO:0016363(nuclear matrix);GO:0005635(nuclear envelope);GO:0000278(mitotic cell cycle);GO:0051310(metaphase plate congression);GO:0007094(mitotic spindle assembly checkpoint);GO:0000940(condensed chromosome outer kinetochore);GO:0042493(response to drug);GO:0051726(regulation of cell cycle);GO:0016202(regulation of striated muscle tissue development);GO:0001822(kidney development);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0021591(ventricular system development);GO:0051382(kinetochore assembly);GO:0005813(centrosome);GO:0005930(axoneme);GO:0036064(ciliary basal body);GO:0045120(pronucleus);GO:0097539(ciliary transition fiber);GO:0097539(ciliary transition fiber)NANANAcentromere protein F [Source:HGNC Symbol;Acc:HGNC:1857]1.97-3.14-4.781.82up0.88-0.180.821downno
chr1215620254215620493240ENSG00000136636ENST000004656501549KCTD3GO:0051260(protein homooligomerization);GO:0051260(protein homooligomerization)NANANApotassium channel tetramerization domain containing 3 [Source:HGNC Symbol;Acc:HGNC:21305]2.17-2.45-3.900.78up0.89-0.160.851downno
chr12237529232237573754453ENSG00000162909ENST00000474026-249CAPN2GO:0016787(hydrolase activity);GO:0005622(intracellular);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0006508(proteolysis);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0005829(cytosol);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0030425(dendrite);GO:0051493(regulation of cytoskeleton organization);GO:0071230(cellular response to amino acid stimulus);GO:0070062(extracellular exosome);GO:0005783(endoplasmic reticulum);GO:0022617(extracellular matrix disassembly);GO:0045121(membrane raft);GO:0005794(Golgi apparatus);GO:0008092(cytoskeletal protein binding);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0046982(protein heterodimerization activity);GO:0001666(response to hypoxia);GO:0001824(blastocyst development);GO:0007520(myoblast fusion);GO:0016540(protein autoprocessing);GO:0000785(chromatin);GO:0005634(nucleus);GO:0005764(lysosome);GO:0030864(cortical actin cytoskeleton);GO:0031143(pseudopodium);GO:0097038(perinuclear endoplasmic reticulum);GO:0097038(perinuclear endoplasmic reticulum)04141(Protein processing in endoplasmic reticulum);04210(Apoptosis);04217(Necroptosis);04218(Cellular senescence);04510(Focal adhesion);05010(Alzheimer's disease);05010(Alzheimer's disease)K03853EC:3.4.22.53calpain 2 [Source:HGNC Symbol;Acc:HGNC:1479]1.59-1.85-3.120.26up0.99-0.020.981downno
chr1231000180231000536357ENSG00000173409ENST000004598914420ARV1GO:0006810(transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0006629(lipid metabolic process);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008202(steroid metabolic process);GO:0006869(lipid transport);GO:0008206(bile acid metabolic process);GO:0030301(cholesterol transport);GO:0090181(regulation of cholesterol metabolic process);GO:0008203(cholesterol metabolic process);GO:0005794(Golgi apparatus);GO:0006695(cholesterol biosynthetic process);GO:0015248(sterol transporter activity);GO:0032383(regulation of intracellular cholesterol transport);GO:0006665(sphingolipid metabolic process);GO:0097036(regulation of plasma membrane sterol distribution);GO:0032541(cortical endoplasmic reticulum);GO:0032541(cortical endoplasmic reticulum)NANANAARV1 homolog, fatty acid homeostasis modulator [Source:HGNC Symbol;Acc:HGNC:29561]9.31-1.35-2.45-0.59down1.080.110.831upno
chr12346070082346094832476ENSG00000168264ENST000004914300IRF2BP2GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated)NANANAinterferon regulatory factor 2 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:21729]3.07-1.36-2.460.16up1.070.100.831upno
chr1244053839244054435597ENSG00000179456ENST000003587042556ZBTB18GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0045171(intercellular bridge);GO:0015630(microtubule cytoskeleton);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0007519(skeletal muscle tissue development);GO:0000228(nuclear chromosome);GO:0000228(nuclear chromosome)NANANAzinc finger and BTB domain containing 18 [Source:HGNC Symbol;Acc:HGNC:13030]2.38-4.73-6.670.47up0.93-0.100.921downno
chr1244054555244055389835ENSG00000179456ENST000003587043272ZBTB18GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0045171(intercellular bridge);GO:0015630(microtubule cytoskeleton);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0003700(transcription factor activity, sequence-specific DNA binding);GO:0007519(skeletal muscle tissue development);GO:0000228(nuclear chromosome);GO:0000228(nuclear chromosome)NANANAzinc finger and BTB domain containing 18 [Source:HGNC Symbol;Acc:HGNC:13030]5.83-2.44-3.890.27up0.93-0.100.921downno
chr1248847393248847961569ENSG00000171163ENST000004620376562ZNF692GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0003677(DNA binding);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000122(negative regulation of transcription from RNA polymerase II promoter)NANANAzinc finger protein 692 [Source:HGNC Symbol;Acc:HGNC:26049]1.76-3.20-4.86-0.52down0.77-0.370.611downno
chr1975204975412209ENSG00000187642ENST000004793611229PERM1GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0014850(response to muscle activity)NANANAPPARGC1 and ESRR induced regulator, muscle 1 [Source:HGNC Symbol;Acc:HGNC:28208]7.95-1.49-2.64-2.53down1.500.580.371upno
chr113353651336229865ENSG00000107404ENST000006324453193DVL1GO:0005737(cytoplasm);GO:0016020(membrane);GO:0035556(intracellular signal transduction);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0016055(Wnt signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0098793(presynapse);GO:0042802(identical protein binding);GO:0006366(transcription from RNA polymerase II promoter);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0019899(enzyme binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050821(protein stabilization);GO:0060070(canonical Wnt signaling pathway);GO:0099054(presynapse assembly);GO:1905386(positive regulation of protein localization to presynapse);GO:0016328(lateral plasma membrane);GO:0005109(frizzled binding);GO:0019901(protein kinase binding);GO:0001505(regulation of neurotransmitter levels);GO:0006469(negative regulation of protein kinase activity);GO:0007269(neurotransmitter secretion);GO:0007528(neuromuscular junction development);GO:0021915(neural tube development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0032091(negative regulation of protein binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0034504(protein localization to nucleus);GO:0043113(receptor clustering);GO:0048813(dendrite morphogenesis);GO:0050808(synapse organization);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:1903827(regulation of cellular protein localization);GO:1904886(beta-catenin destruction complex disassembly);GO:0030426(growth cone);GO:0043005(neuron projection);GO:0045202(synapse);GO:0008013(beta-catenin binding);GO:0048365(Rac GTPase binding);GO:0001932(regulation of protein phosphorylation);GO:0001933(negative regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0010976(positive regulation of neuron projection development);GO:0022007(convergent extension involved in neural plate elongation);GO:0031122(cytoplasmic microtubule organization);GO:0035176(social behavior);GO:0035372(protein localization to microtubule);GO:0048668(collateral sprouting);GO:0048675(axon extension);GO:0060029(convergent extension involved in organogenesis);GO:0060134(prepulse inhibition);GO:0060997(dendritic spine morphogenesis);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090103(cochlea morphogenesis);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:0005874(microtubule);GO:0014069(postsynaptic density);GO:0015630(microtubule cytoskeleton);GO:0030136(clathrin-coated vesicle);GO:0030424(axon);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:1990909(Wnt signalosome);GO:0005622(intracellular);GO:0005622(intracellular)04310(Wnt signaling pathway);04330(Notch signaling pathway);04390(Hippo signaling pathway);04150(mTOR signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05217(Basal cell carcinoma);05224(Breast cancer);05166(HTLV-I infection);05165(Human papillomavirus infection);05165(Human papillomavirus infection)K02353NAdishevelled segment polarity protein 1 [Source:HGNC Symbol;Acc:HGNC:3084]8.25-1.85-3.13-0.33down1.150.210.711upno

Definition of table:

TermDescription
seqnamesThe name of the chromosome (e.g. chr3, chrY, chr2 random) or scaffold (e.g. scaffold10671)
startThe starting position of the methylation site in the chromosome or scaffold.
endThe ending position of the RNA methylation site in the chromosome or scaffold.
widthPeak region of methylation
geneIdDefines the ID of gene on which the RNA methylation site locates
transcriptIdDefines the ID of transcript on which the RNA methylation site locates
distanceToTSSDistrance from Peak site to transcription start site
geneNameDefines the name of gene (gene symbol) on which the RNA methylation site locates
GOGene ontology term and description http://www.geneontology.org/
KEGGKEGG pathway annotation and description http://www.kegg.jp/kegg/kegg3a.html
KO_EntryKO functional ortholog, KO groups identified by K numbers and, in metabolic maps
ECenzyme
DescriptionDescription of gene
fold_enrchmentfold enrichment within the peak in the IP sample compared with the input sample.
diff.lg.fdrresults from differential methylation analysis, log10(fdr) of the peak as a differential methylation site between the two experimental conditions tested.
diff.lg.presults from differential methylation analysis, log10(pvalue) of the peak as a differential methylation site between the two experimental conditions tested.
diff.log2.fcresults from differential methylation analysis, log2(odds ratio) of the peak as a differential methylation site between the two experimental conditions tested.
m6A_regulationup-regulation or down-regulation of methylated genes/transcripts
fcfold change
log2(fc)log2 of fold change value
qvalq value or FDR value
regulationup-regulation or down-regulation of genes/transcripts
significantyes or no

document location: summary/8_diffPeak_differential_expression/*VS*/*_diffPeak_Gene_differential_expression.xlsx



4.8.2 GO enrichment analysis of diff genes/peaks


This section is similar with 4.7.5 GO enrichment analysis of differentially expressed genes


document location: summary/8_diffPeak_differential_expression/*VS*/1_GO_Enrichment


4.8.3 KEGG enrichment analysis of diff genes/peaks


This section is similar with 4.7.6 KEGG enrichment analysis of differentially expressed genes


document location: summary/8_diffPeak_differential_expression/*VS*/2_KEGG_Enrichment




5. Contact us


2575 West Bellfort Street

Suite 270

Houston, TX

77054 USA


Local (713) 664-7087

Toll Free: 1-888-528-8818

Fax: (713) 664-8181

http://www.lcsciences.com/